# ::snt RanBP2 Modulates Cox11 and Hexokinase I Activities and Haploinsufficiency of RanBP2 Causes Deficits in Glucose Metabolism .
# ::tok RanBP2 Modulates Cox11 and Hexokinase I Activities and Haploinsufficiency of RanBP2 Causes Deficits in Glucose Metabolism .
# ::alignments 14-16|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 8-13|0.1.0.4+0.1.0.3+0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0.1.0.0 3-4|0 1-3|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:40.571
(a3 / and 
      :op1 (t2 / thing 
            :name (n3 / name 
                  :op1 (m2 / Modulates) 
                  :op2 (c / Cox11)) 
            :op1-of (a / and 
                  :op2 (a2 / activiti 
                        :mod (i / i)) 
                  :op3 (t / thing 
                        :name (n / name 
                              :op1 (g / Glucose) 
                              :op2 (m / Metabolism))))) 
      :op2 (o / organization 
            :name (n2 / name 
                  :op1 "Haploinsufficiency" 
                  :op2 "of" 
                  :op3 "RanBP2" 
                  :op4 "Causes" 
                  :op5 "Deficits")))

# ::snt The Ran-binding protein 2 ( RanBP2 ) is a large multimodular and pleiotropic protein .
# ::tok The Ran-binding protein 2 ( RanBP2 ) is a large multimodular and pleiotropic protein .
# ::alignments 13-14|0 11-12|0.1 9-10|0.0 5-6|0.1.1 3-4|0.0.0 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:40.692
(p / protein 
      :mod (l / large 
            :op1-of 2) 
      :op1-of (a / and 
            :domain-of (p2 / protein 
                  :mod (r2 / ran-bind)) 
            :op1-of (r / RanBP2)))

# ::snt Several molecular partners with distinct functions interacting specifically with selective modules of RanBP2 have been identified .
# ::tok Several molecular partners with distinct functions interacting specifically with selective modules of RanBP2 have been identified .
# ::alignments 15-16|0.0.0.1 12-13|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0 9-10|0 7-8|0.0.0.2 6-7|0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:41.028
(s / selective 
      :mod-of (m / module 
            :ARG1-of (i2 / interact-01 
                  :ARG1-of (p / partner-01 
                        :ARG0 (f / function-01 
                              :ARG1 (d / distinct)) 
                        :mod (m2 / molecule 
                              :quant (s3 / several))) 
                  :ARG1-of (i / identify-01) 
                  :manner (s2 / specific-02)) 
            :poss (t / thing 
                  :name (n / name 
                        :op1 "RanBP2"))))

# ::snt Yet , the significance of these interactions with RanBP2 and the genetic and physiological role ( s ) of RanBP2 in a whole-animal model remain elusive .
# ::tok Yet , the significance of these interactions with RanBP2 and the genetic and physiological role ( s ) of RanBP2 in a whole-animal model remain elusive .
# ::alignments 25-26|0.3.0.1 24-25|0.3.0 23-24|0.3.0.0 14-15|0.2 13-14|0.1 12-13|0 11-12|0.0 9-10|0.3 8-9|0.3.2.0.0+0.3.2.0+0.3.2 6-7|0.3.1.0 5-6|0.3.1.0.0 3-4|0.3.1 0-1|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:41.300
(a / and 
      :op1 (g / gene) 
      :op2 (p / physiological) 
      :op3 (r2 / role) 
      :op3-of (a2 / and 
            :ARG1-of (r / remain-01 
                  :ARG0 (m / model 
                        :mod (y / yet)) 
                  :ARG3 (e / elusive)) 
            :op1 (s / significant-02 
                  :ARG1 (i / interaction 
                        :mod (t2 / this))) 
            :op2 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2"))))

# ::snt Here , we report the identification of two novel partners of RanBP2 and a novel physiological role of RanBP2 in a mouse model .
# ::tok Here , we report the identification of two novel partners of RanBP2 and a novel physiological role of RanBP2 in a mouse model .
# ::alignments 22-23|0.1.0.0 21-22|0.1.0 16-17|0.3.1 15-16|0.3.1.0 14-15|0.3.1.1 12-13|0.3 11-12|0.3.0.0.0+0.3.0.0+0.3.0 9-10|0.1.1 8-9|0.1.1.0 7-8|0.1.1.1 5-6|0.1 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:42.165
(r2 / report-01 
      :ARG0 (w / we) 
      :ARG1 (i / identify-02 
            :ARG1 (m2 / mouse 
                  :mod-of (m / model)) 
            :ARG2 (p2 / partner-01 
                  :mod (n3 / novel) 
                  :quant 2)) 
      :location (h / here) 
      :op1-of (a / and 
            :op2 (t / thing 
                  :name (n2 / name 
                        :op1 "RanBP2")) 
            :op3 (r / role 
                  :mod (p / physiological) 
                  :mod (n / novel))))

# ::snt RanBP2 associates in vitro and in vivo and colocalizes with the mitochondrial metallochaperone , Cox11 , and the pacemaker of glycolysis , hexokinase type I ( HKI ) via its leucine-rich domain .
# ::tok RanBP2 associates in vitro and in vivo and colocalizes with the mitochondrial metallochaperone , Cox11 , and the pacemaker of glycolysis , hexokinase type I ( HKI ) via its leucine-rich domain .
# ::alignments 31-32|0.1.0.0.0 26-27|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 24-25|0.2.3 23-24|0.2.3.0 20-21|0.2.2.0 18-19|0.2.2 16-17|0.2 14-15|0.2.1 12-13|0.2.0 8-9|0.1 7-8|0 6-7|0.0 4-5|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:42.517
(a2 / and 
      :op1 (v / vivo) 
      :op2 (c2 / colocaliz 
            :op1-of (a3 / and 
                  :ARG1-of (a4 / associate-01 
                        :ARG0 (d / domain) 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "HKI"))))) 
      :op3 (a / and 
            :op1 (m / metallochaperone) 
            :op2 (c / Cox11) 
            :op3 (p / pacemak 
                  :mod (g / glycolysi)) 
            :op4 (i / i 
                  :mod (t / type))))

# ::snt The leucine-rich domain of RanBP2 also exhibits strong chaperone activity toward intermediate and mature folding species of Cox11 supporting a chaperone role of RanBP2 in the cytosol during Cox11 biogenesis .
# ::tok The leucine-rich domain of RanBP2 also exhibits strong chaperone activity toward intermediate and mature folding species of Cox11 supporting a chaperone role of RanBP2 in the cytosol during Cox11 biogenesis .
# ::alignments 29-30|0.0.3.2.0 26-27|0.0.3.0.1.1 21-22|0.0.3.0.1 20-21|0.0.3.0.1.0 18-19|0.0.3.0 17-18|0.0.3.0.0 15-16|0.0.3.3 14-15|0.0.3.3.0 13-14|0.0.3.2 12-13|0.0.3 11-12|0.0.3.1 9-10|0.0 8-9|0.0.1 7-8|0.0.2 6-7|0 5-6|0.1 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:43.286
(e / exhibit-01 
      :ARG1 (a2 / activity-06 
            :ARG0 (d / domain 
                  :poss (t / thing 
                        :name (n / name 
                              :op1 "RanBP2"))) 
            :ARG1 (c4 / chaperone-01) 
            :ARG1-of (s3 / strong-02) 
            :op1-of (a / and 
                  :ARG2-of (s / support-01 
                        :ARG0 (c3 / Cox11) 
                        :ARG1 (r / role 
                              :ARG1-of (c2 / chaperone-01) 
                              :op1 (c / cytosol))) 
                  :op2 (i / intermediate) 
                  :op3 (m / mature-02 
                        :ARG1 (b / biogenesi)) 
                  :op4 (s2 / species 
                        :ARG1-of (f / fold-01)))) 
      :mod (a3 / also))

# ::snt Cox11 partially colocalizes with HKI , thus supporting additional and distinct roles in cell function .
# ::tok Cox11 partially colocalizes with HKI , thus supporting additional and distinct roles in cell function .
# ::alignments 14-15|0.2.0 13-14|0.2.0.1 11-12|0.2 10-11|0.1 9-10|0 8-9|0.2.1 7-8|0.0 6-7|0.0.2 4-5|0.0.1.0.0+0.0.1.0+0.0.1 1-2|0.2.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:43.510
(a / and 
      :ARG1-of (s / support-01 
            :ARG0 (c2 / Cox11) 
            :ARG4 (o / organization 
                  :name (n / name 
                        :op1 "HKI")) 
            :time (t / thus-far)) 
      :op1 (d / distinct) 
      :op2 (r / role 
            :ARG2-of (f / function-01 
                  :ARG0 (p / partial) 
                  :ARG1 (c / cell)) 
            :mod (a2 / additional)))

# ::snt Cox11 is a strong inhibitor of HKI , and RanBP2 suppresses the inhibitory activity of Cox11 over HKI .
# ::tok Cox11 is a strong inhibitor of HKI , and RanBP2 suppresses the inhibitory activity of Cox11 over HKI .
# ::alignments 13-14|0.2.1 12-13|0.2.1.0 10-11|0.2 9-10|0.2.0.0.0+0.2.0.0+0.2.0 8-9|0 6-7|0.1.0.0+0.1.0+0.1 4-5|0.0 3-4|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:43.626
(a2 / and 
      :op1 (i2 / inhibitor 
            :ARG1-of (s2 / strong-02) 
            :domain (c / Cox11)) 
      :op2 (o / organization 
            :name (n2 / name 
                  :op1 "HKI")) 
      :op3 (s / suppress-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2")) 
            :ARG1 (a / activity-06 
                  :mod (i / inhibitory))))

# ::snt To probe the physiological role of RanBP2 and its role in HKI function , a mouse model harboring a genetically disrupted RanBP2 locus was generated .
# ::tok To probe the physiological role of RanBP2 and its role in HKI function , a mouse model harboring a genetically disrupted RanBP2 locus was generated .
# ::alignments 24-25|0 22-23|0.0 20-21|0.0.1 19-20|0.0.1.0 17-18|0.0.0 16-17|0.0.0.0 15-16|0.0.0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 9-10|0.0.0.1.1 7-8|0.0.0.1.1.0 6-7|0.0.0.1.1.0.0.2.0.0+0.0.0.1.1.0.0.2.0+0.0.0.1.1.0.0.2 4-5|0.0.0.1.1.0.0 3-4|0.0.0.1.1.0.0.1 1-2|0.0.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:44.819
(g / generate-01 
      :ARG1 (l / locu 
            :ARG1-of (h / harbor-01 
                  :ARG0 (m / model 
                        :mod (m2 / mouse)) 
                  :ARG1-of (f / function-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "HKI")) 
                        :ARG2 (r / role 
                              :op2-of (a / and 
                                    :op1 (r2 / role 
                                          :ARG1-of (p2 / probe-01) 
                                          :mod (p / physiological) 
                                          :poss (t / thing 
                                                :name (n2 / name 
                                                      :op1 "RanBP2"))))))) 
            :ARG1-of (d / disrupt-01 
                  :manner (g2 / genetics))))

# ::snt RanBP2  /  are embryonically lethal , and haploinsufficiency of RanBP2 in an inbred strain causes a pronounced decrease of HKI and ATP levels selectively in the central nervous system .
# ::tok RanBP2  /  are embryonically lethal , and haploinsufficiency of RanBP2 in an inbred strain causes a pronounced decrease of HKI and ATP levels selectively in the central nervous system .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:44.822
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Inbred RanBP2 + /  mice also exhibit deficits in growth rates and glucose catabolism without impairment of glucose uptake and gluconeogenesis .
# ::tok Inbred RanBP2 + /  mice also exhibit deficits in growth rates and glucose catabolism without impairment of glucose uptake and gluconeogenesis .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:44.830
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt These phenotypes are accompanied by a decrease in the electrophysiological responses of photosensory and postreceptoral neurons .
# ::tok These phenotypes are accompanied by a decrease in the electrophysiological responses of photosensory and postreceptoral neurons .
# ::alignments 15-16|0.1 13-14|0 10-11|0.0.1+0.0 6-7|0.0.0 3-4|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:44.898
(a / and 
      :op1 (t / thing 
            :ARG1-of (d / decrease-01 
                  :ARG0-of (a2 / accompany-01 
                        :ARG1 (p / phenotyp 
                              :mod (t2 / this)))) 
            :ARG2-of (r / respond-01)) 
      :op2 (n / neuron))

# ::snt Hence , RanBP2 and its partners emerge as critical modulators of neuronal HKI , glucose catabolism , energy homeostasis , and targets for metabolic , aging disorders and allied neuropathies .
# ::tok Hence , RanBP2 and its partners emerge as critical modulators of neuronal HKI , glucose catabolism , energy homeostasis , and targets for metabolic , aging disorders and allied neuropathies .
# ::alignments 29-30|0.1.0.2 28-29|0.1.0.2.0 27-28|0.1.0 26-27|0.1 25-26|0 23-24|0.1.0.1 21-22|0.1.0.0 20-21|0.1.0.0.0 18-19|0.1.0.0.0.3 17-18|0.1.0.0.0.3.0 15-16|0.1.0.0.0.2 14-15|0.1.0.0.0.2.0 12-13|0.1.0.0.0.1.1.0+0.1.0.0.0.1.1+0.1.0.0.0.1 11-12|0.1.0.0.0.1.0 9-10|0.1.0.0.0.0.1 8-9|0.1.0.0.0.0.1.0 6-7|0.1.0.0.0.0 5-6|0.1.0.0.0.0.0.0.0 3-4|0.1.0.0.0.0.0 2-3|0.1.0.0.0.0.0.0.1.0+0.1.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:45.582
(a3 / age-01 
      :ARG0 (h2 / hence) 
      :ARG1 (d / disorder 
            :op3-of (a2 / and 
                  :op1 (t / target 
                        :op4-of (a4 / and 
                              :ARG1-of (e2 / emerge-01 
                                    :ARG0 (a5 / and 
                                          :op1 (t2 / thing 
                                                :ARG1-of (p / partner-01) 
                                                :name (n4 / name 
                                                      :op1 "RanBP2"))) 
                                    :ARG2 (m2 / modulator 
                                          :ARG1-of (c2 / critical-02))) 
                              :op1 (o / organization 
                                    :mod (n3 / neuronal) 
                                    :name (n2 / name 
                                          :op1 "HKI")) 
                              :op2 (c / catabolism 
                                    :mod (g / glucose)) 
                              :op3 (h / homeostasi 
                                    :mod (e / energy)))) 
                  :op2 (m / metabolic) 
                  :op4 (n / neuropathi 
                        :ARG1-of (a / ally-01)))))

# ::snt The Ran-binding protein 2 ( RanBP2 ) is a large protein with several domains .
# ::tok The Ran-binding protein 2 ( RanBP2 ) is a large protein with several domains .
# ::alignments 13-14|0.2 12-13|0.2.0 10-11|0 9-10|0.1 5-6|0.2.0.1.0.0+0.2.0.1.0+0.2.0.1 3-4|0.2.0.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:45.638
(p / protein 
      :domain (p3 / protein 
            :mod (r / ran-bind)) 
      :mod (l / large) 
      :prep-with (d / domain 
            :quant (s / several 
                  :mod 2 
                  :quant-of (p2 / person 
                        :name (n / name 
                              :op1 "RanBP2")))))

# ::snt Although several protein partners were found to interact with selective domains of RanBP2 , none to this date were found toward its large leucine-rich domain ( LD ) .
# ::tok Although several protein partners were found to interact with selective domains of RanBP2 , none to this date were found toward its large leucine-rich domain ( LD ) .
# ::alignments 26-27|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 24-25|0.1 22-23|0.1.0 19-20|0 17-18|0.1.1 16-17|0.1.1.0 14-15|0.0 12-13|0.2.1.0.1.0.0+0.2.1.0.1.0+0.2.1.0.1 10-11|0.2.1.0 9-10|0.2.1.0.0 7-8|0.2.1 5-6|0.2 3-4|0.2.0 2-3|0.2.0.1 1-2|0.2.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:46.680
(f / find-01 
      :ARG0 (n2 / none) 
      :ARG1 (d / domain 
            :mod (l / large) 
            :poss (d2 / date 
                  :mod (t / this))) 
      :condition (f2 / find-01 
            :ARG1 (p / partner-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "LD")) 
                  :mod (p2 / protein) 
                  :quant (s2 / several)) 
            :ARG2 (i / interact-01 
                  :ARG1 (d3 / domain 
                        :mod (s / selective) 
                        :poss (t2 / thing 
                              :name (n3 / name 
                                    :op1 "RanBP2"))))))

# ::snt Cell-based experiments support several roles of RanBP2 in cell function , such as the production of functional proteins , control of protein trafficking between the nuclear and cytosol compartments , and control of multiple facets underlying cell division .
# ::tok Cell-based experiments support several roles of RanBP2 in cell function , such as the production of functional proteins , control of protein trafficking between the nuclear and cytosol compartments , and control of multiple facets underlying cell division .
# ::alignments 37-38|0.0.0.0.3.0 36-37|0.0.0.0.3.0.1 35-36|0.0.0.0.3.0.0 34-35|0.0.0.0.3.0.0.0 33-34|0.0.0.0.3.0.0.0.0 31-32|0.0.0.0.3 30-31|0.0.0.0 28-29|0.0.0.0.3.1.1 27-28|0.0.0.0.3.1.0 26-27|0.0.0.0.3.1 25-26|0.0.0.0.0.0.0.0 22-23|0.0 21-22|0 19-20|0.0.0 17-18|0.0.0.0.2.0 16-17|0.0.0.0.2.0.0 14-15|0.0.0.0.2 11-12|0.0.0.0.2.1 9-10|0.0.0.0.0.0.0.2 8-9|0.0.0.0.0.0.0.2.0 6-7|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.0.1.0+0.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:47.872
(p / protein 
      :ARG0-of (t / traffic-01 
            :ARG1-of (c5 / control-01 
                  :op4-of (a / and 
                        :op1 (r / role 
                              :ARG1-of (s3 / support-01 
                                    :ARG0 (e / experiment-01 
                                          :ARG0 (n / nucleus) 
                                          :ARG1 (t3 / thing 
                                                :name (n3 / name 
                                                      :op1 "Cell-based")) 
                                          :ARG2-of (f3 / function-01 
                                                :ARG1 (c6 / cell)))) 
                              :quant (s2 / several)) 
                        :op2 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "RanBP2")) 
                        :op3 (p3 / produce-01 
                              :ARG0 (p2 / protein 
                                    :mod (f2 / functional)) 
                              :ARG1 (s / such)) 
                        :op5 (c2 / control-01 
                              :ARG1 (d / division 
                                    :ARG1-of (u / underlie-01 
                                          :ARG0 (f / facet 
                                                :quant (m / multiple))) 
                                    :mod (c / cell)) 
                              :op3-of (a2 / and 
                                    :op1 (c4 / cytosol) 
                                    :op2 (c3 / compartment)))))))

# ::snt Still , the genetic and physiological implications of the interactions between RanBP2 and its partners and of the function of RanBP2 in a whole-animal model remain elusive .
# ::tok Still , the genetic and physiological implications of the interactions between RanBP2 and its partners and of the function of RanBP2 in a whole-animal model remain elusive .
# ::alignments 26-27|0.0.0 25-26|0.0 24-25|0.0.1.0.2.0.0 18-19|0.0.1.0.2.0 15-16|0.0.1.0.2 14-15|0.0.1.0.0 12-13|0.0.1 11-12|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 9-10|0.3.0 6-7|0.3+0.3.1 5-6|0.2 4-5|0 3-4|0.1 0-1|0.0.1.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:48.206
(a3 / and 
      :ARG0-of (r / remain-01 
            :ARG3 (e / elusive) 
            :op2-of (a2 / and 
                  :op1 (t / thing 
                        :ARG1-of (p / partner-01) 
                        :name (n / name 
                              :op1 "RanBP2") 
                        :op1-of (a / and 
                              :op2 (f / function-01 
                                    :ARG0 (m / model) 
                                    :ARG1 (s / still)))))) 
      :op1 (g / gene) 
      :op2 (p2 / physiological) 
      :op3 (i2 / imply-01 
            :ARG0 (i / interaction) 
            :ARG1 (t2 / thing)))

# ::snt The authors report the identification of two novel mitochondrial partners of the LD of RanBP2 , Cox11 and hexokinase type I ( HKI ) ; and with multidisciplinary approaches probe the role of RanBP2 and its LD on Cox11 , HKI , and functions allied to these .
# ::tok The authors report the identification of two novel mitochondrial partners of the LD of RanBP2 , Cox11 and hexokinase type I ( HKI ) ; and with multidisciplinary approaches probe the role of RanBP2 and its LD on Cox11 , HKI , and functions allied to these .
# ::alignments 46-47|0.1.1.2.0 44-45|0.1.1.2 43-44|0.1.1.2.1.0 42-43|0.1.1.2.1 34-35|0.1.1.1.1 31-32|0.1.1.1 29-30|0.1.1.1.0 28-29|0.1.1.1.0.0 25-26|0.1.1 24-25|0.1.1.0 22-23|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 20-21|0.1.0.0.1.1.1 19-20|0.2 17-18|0.1.0.0.1.1 16-17|0.1.0.0.1.1.0 14-15|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 12-13|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 9-10|0.1.0 8-9|0.1.0.2 7-8|0.1.1.1.0.0.0 6-7|0.1.0.3 4-5|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:50.735
(r2 / report-01 
      :ARG0 (a8 / author-01) 
      :ARG1 (i2 / identify-02 
            :ARG2 (p2 / partner-01 
                  :ARG0 (o2 / organization 
                        :name (n3 / name 
                              :op1 "LD") 
                        :part-of (t3 / thing 
                              :name (n2 / name 
                                    :op1 "RanBP2") 
                              :op1-of (a7 / and 
                                    :op2 (c / Cox11) 
                                    :op3 (i / i)))) 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "HKI")) 
                  :mod (m / mitochondrial) 
                  :quant 2) 
            :op1-of (a5 / and 
                  :op1-of (a6 / and) 
                  :op2 (r / role 
                        :ARG1-of (p / probe-01 
                              :ARG0 (a4 / approach-02 
                                    :ARG1 (n4 / novel))) 
                        :op1-of (a3 / and)) 
                  :op3 (a / ally-01 
                        :ARG0 (t / this) 
                        :ARG1 (a2 / and 
                              :op1 (f / function-01))))) 
      :beneficiary (t2 / type))

# ::snt The authors found that RanBP2 exhibits chaperone activity toward HKI and Cox11 .
# ::tok The authors found that RanBP2 exhibits chaperone activity toward HKI and Cox11 .
# ::alignments 10-11|0.1.0 9-10|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.1 6-7|0.1.1 5-6|0 4-5|0.0.0.0+0.0.0+0.0 2-3|0.2 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:50.874
(e / exhibit-01 
      :ARG0 (t / thing 
            :name (n2 / name 
                  :op1 "RanBP2")) 
      :ARG1 (a2 / activity-06 
            :ARG0 (a / and 
                  :op1 (o / organization 
                        :name (n / name 
                              :op1 "HKI"))) 
            :ARG1-of (c / chaperone-01)) 
      :ARG1-of (f / find-01 
            :ARG0 (a3 / author-01)))

# ::snt RanBP2 and Cox11 profoundly modulate HKI activity .
# ::tok RanBP2 and Cox11 profoundly modulate HKI activity .
# ::alignments 6-7|0.1 5-6|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0 3-4|0.2 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:50.916
(m / modulate-01 
      :ARG0 (a2 / and 
            :op1 (t / thing 
                  :name (n2 / name 
                        :op1 "RanBP2"))) 
      :ARG1 (a / activity-06 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "HKI"))) 
      :manner (p / profound))

# ::snt Moreover , partial loss-of-function of RanBP2 in a mouse model induces deficits in growth rates and breakdown of glucose , promotes the down-regulation of HKI and ATP levels selectively in the central nervous system , and impairs visual function .
# ::tok Moreover , partial loss-of-function of RanBP2 in a mouse model induces deficits in growth rates and breakdown of glucose , promotes the down-regulation of HKI and ATP levels selectively in the central nervous system , and impairs visual function .
# ::alignments 38-39|0.1.0 37-38|0.1.0.0 36-37|0.1 35-36|0 33-34|0.0.2 32-33|0.0.2.0 31-32|0.0.2.1 28-29|0.0.3.0.0 27-28|0.0.1 26-27|0.0.3.1.0.0+0.0.3.1.0+0.0.3.1 25-26|0.0.3 24-25|0.0.3.0.1.0+0.0.3.0.1+0.0.3.0 20-21|0.0 18-19|0.0.4.1.1 16-17|0.0.4.1 15-16|0.0.4 14-15|0.0.4.1.0.0.0.1 13-14|0.0.4.1.0.0.0 11-12|0.0.4.0.0 10-11|0.0.4.0 9-10|0.0.4.1.0 8-9|0.0.4.1.0.0 5-6|0.0.4.1.0.0.0.0.0.0+0.0.4.1.0.0.0.0.0+0.0.4.1.0.0.0.0 2-3|0.0.0 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:51.579
(a / and 
      :op1 (p / promote-02 
            :ARG0 (p2 / partial) 
            :ARG1 (l / level) 
            :location (s / system 
                  :ARG1-of (n / nervous-01 
                        :ARG0 (m3 / moreover)) 
                  :mod (c / central)) 
            :op1-of (a2 / and 
                  :op2 (o2 / organization 
                        :mod-of (s2 / selectively) 
                        :name (n3 / name 
                              :op1 "HKI")) 
                  :op3 (o / organization 
                        :name (n2 / name 
                              :op1 "ATP"))) 
            :op2-of (a3 / and 
                  :ARG1-of (i2 / induce-01 
                        :ARG2 (d / deficit)) 
                  :op1 (b / break-down-12 
                        :ARG0 (m / model 
                              :mod (m2 / mouse 
                                    :ARG0-of (g2 / grow-01 
                                          :ARG1 (t / thing 
                                                :name (n4 / name 
                                                      :op1 "RanBP2")) 
                                          :mod-of (r / rate)))) 
                        :ARG1 (g / glucose)))) 
      :op2 (i / impair-01 
            :ARG1 (f / function-01 
                  :ARG1 (v / visual))))

# ::snt These findings support a critical role of RanBP2 and its partners in metabolic processes and allied disease states .
# ::tok These findings support a critical role of RanBP2 and its partners in metabolic processes and allied disease states .
# ::alignments 17-18|0.1 16-17|0.1.1 15-16|0.1.0 14-15|0 13-14|0.0 12-13|0.0.0 10-11|0.2 8-9|0.2.0.1.2 7-8|0.2.0.0.0+0.2.0.0+0.2.0 5-6|0.2.0.1 4-5|0.2.0.1.1 2-3|0.2.0.1.0 1-2|0.2.0.1.0.0.0+0.2.0.1.0.0 0-1|0.2.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:52.080
(a2 / and 
      :op1 (p / process-02 
            :mod (m / metabolic)) 
      :op2 (s / state 
            :ARG1-of (a / ally-01) 
            :mod (d / disease)) 
      :topic-of (p2 / partner-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2") 
                  :poss-of (r / role 
                        :ARG1-of (s2 / support-01 
                              :ARG0 (t2 / thing 
                                    :ARG1-of (f / find-01) 
                                    :mod (t3 / this))) 
                        :ARG1-of (c / critical-02) 
                        :op1-of (a3 / and)))))

# ::snt The RanBP2/Nup358 is a unique vertebrate and large scaffold protein comprised of multiple structural and functional domains [ 1 -- 4 ] .
# ::tok The RanBP2/Nup358 is a unique vertebrate and large scaffold protein comprised of multiple structural and functional domains [ 1 -- 4 ] .
# ::alignments 20-21|0.0 18-19|0.1.0.1 16-17|0.2.2 15-16|0.2.1 14-15|0.2 13-14|0.2.0 12-13|0.2.2.0 10-11|0 9-10|0.1 8-9|0.1.1.3 7-8|0.1.1.2 6-7|0.1.1 5-6|0.1.1.1 4-5|0.1.1.0 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:52.548
(c / comprise-01 
      :ARG0 4 
      :ARG1 (p / protein 
            :domain (t / thing 
                  :name (n / name 
                        :op1 "RanBP2/Nup358") 
                  :quant 1) 
            :op4-of (a2 / and 
                  :mod (u / unique) 
                  :op1 (v / vertebrate) 
                  :op2 (l / large) 
                  :op3 (s2 / scaffold))) 
      :op1-of (a / and 
            :op2 (s / structure) 
            :op3 (f / functional) 
            :op4 (d / domain 
                  :quant (m / multiple))))

# ::snt Several roles of RanBP2 have emerged that implicate RanBP2 in nucleocytoplasmic trafficking [ 3,5 ] , protein biogenesis [ 6,7 ] , the formation of the mitotic spindle , assembly of the nuclear envelope [ 8 ] , and the integration of the nuclear envelope breakdown with kinetochore formation and maturation during early mitotic progression [ 9 ] .
# ::tok Several roles of RanBP2 have emerged that implicate RanBP2 in nucleocytoplasmic trafficking [ 3,5 ] , protein biogenesis [ 6,7 ] , the formation of the mitotic spindle , assembly of the nuclear envelope [ 8 ] , and the integration of the nuclear envelope breakdown with kinetochore formation and maturation during early mitotic progression [ 9 ] .
# ::alignments 56-57|0.0.1.0.0.1.0.2.0.0 54-55|0.0.1.0.0.1.0.1.1 53-54|0.0.0 52-53|0.0.1.0.0.1.0.1.1.0 50-51|0.0.1.0.0.1.0.2.1 49-50|0.0.1.0.0.1.0.2 48-49|0.0.1.0.0.1.0.2.0 47-48|0.0.1.0.0.1.0.2.0.1 45-46|0.0.1.0.0.1.0 44-45|0.0.1.0.0.1.0.0 43-44|0.0.1.0.0.1.0.0.0 40-41|0.0.1.0.0.1.0.1 38-39|0.0.1.0.0.1 35-36|0.0.1.0.0.1.1.0 33-34|0.0.1.0.1 32-33|0.0.1.0.1.0 29-30|0.0.1.0.0.0 27-28|0.0.1 26-27|0.0.1.1 23-24|0.0 17-18|0.0.1.0.0.1.0.1.0 16-17|0.0.1.0.0.1.0.1.0.0 11-12|0.0.1.0.0.1.1 7-8|0 5-6|0.0.1.0.0 3-4|0.0.1.0.2.0.0+0.0.1.0.2.0+0.0.1.0.2 1-2|0.0.1.0 0-1|0.0.1.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:53.846
(i2 / implicate-01 
      :ARG1 (f2 / form-01 
            :ARG0 (m / mitotic) 
            :ARG1 (s / spindle-01 
                  :mod (r / role 
                        :ARG0-of (e4 / emerge-02 
                              :ARG1 (a3 / assembly) 
                              :op1-of (a2 / and 
                                    :ARG0-of (b / break-down-12 
                                          :ARG1 (e2 / envelope 
                                                :mod (n / nucleus)) 
                                          :ARG1-of (i / integrate-01 
                                                :ARG0 (b2 / biogenesi 
                                                      :mod (p2 / protein)) 
                                                :ARG1-of (p / progress-01 
                                                      :mod (e / early))) 
                                          :purpose (a / and 
                                                :op1 (f / form-01 
                                                      :ARG0 9 
                                                      :ARG1 (k / kinetochore)) 
                                                :op2 (m2 / maturation))) 
                                    :ARG1-of (t / traffic-01 
                                          :ARG0 8))) 
                        :mod-of (e3 / envelope 
                              :mod (n2 / nucleus)) 
                        :poss (t2 / thing 
                              :name (n3 / name 
                                    :op1 "RanBP2")) 
                        :quant (s2 / several)) 
                  :mod (m3 / mitotic))))

# ::snt The specific interaction of RanBP2 with a diverse set of partners likely reflects a pleiotropic role of RanBP2 in cell function , possibly through the integration of multiple pathways .
# ::tok The specific interaction of RanBP2 with a diverse set of partners likely reflects a pleiotropic role of RanBP2 in cell function , possibly through the integration of multiple pathways .
# ::alignments 28-29|0.1.0 27-28|0.1.0.1 25-26|0.1.0.0 22-23|0.1 20-21|0.0.0.0.0 19-20|0.0.0.0.0.0 15-16|0.3 12-13|0 11-12|0.2 10-11|0.0.0.0 8-9|0.0.0 7-8|0.0.0.1 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:54.032
(r2 / reflect-01 
      :ARG1 (i2 / interact-01 
            :ARG0 (s / set 
                  :consist-of (p3 / partner-01 
                        :ARG1 (f / function-01 
                              :ARG1 (c / cell))) 
                  :mod (d / diverse)) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2")) 
            :ARG1-of (s2 / specific-02)) 
      :ARG1-of (p2 / possible-01 
            :ARG0 (p / pathway 
                  :ARG1-of (i / integrate-01) 
                  :quant (m / multiple))) 
      :ARG1-of (l / likely-01) 
      :ARG2 (r / role))

# ::snt On the other hand , the cell ( tissue ) - selective interaction of RanBP2 with some of its partners may also impart cell-restricted roles to RanBP2 .
# ::tok On the other hand , the cell ( tissue ) - selective interaction of RanBP2 with some of its partners may also impart cell-restricted roles to RanBP2 .
# ::alignments 24-25|0.0.1 23-24|0.0.1.0 22-23|0.0 21-22|0.0.3 20-21|0 19-20|0.0.2 16-17|0.0.2.2 14-15|0.0.2.1.1.0+0.0.2.1.1+0.0.2.1 12-13|0.0.2.1.0 11-12|0.0.2.1.0.0 8-9|0.0.0 6-7|0.0.2.0 3-4|0.0.1.1 2-3|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:54.373
(p / possible-01 
      :ARG1 (i / impart-01 
            :ARG0 (t2 / tissue) 
            :ARG1 (r / role 
                  :mod (c / cell-restrict) 
                  :part (h / hand 
                        :mod (o / other))) 
            :condition (p2 / partner-01 
                  :ARG1 (c2 / cell) 
                  :op1-of (t / thing 
                        :ARG1-of (i2 / interact-01 
                              :mod (s2 / selective)) 
                        :name (n / name 
                              :op1 "RanBP2")) 
                  :quant (s / some)) 
            :mod (a / also)))

# ::snt For example , the Ran-binding domains RBDn = 1-4 of RanBP2 associate with the nuclear import co-receptor , importin- [ 10,11 ] , and antibodies against RanBP2 inhibit the nuclear import pathway in HeLa cells [ 3 ] ; but such a role seems dispensable in Xenopus oocytes [ 12 ] .
# ::tok For example , the Ran-binding domains RBDn = 1-4 of RanBP2 associate with the nuclear import co-receptor , importin- [ 10,11 ] , and antibodies against RanBP2 inhibit the nuclear import pathway in HeLa cells [ 3 ] ; but such a role seems dispensable in Xenopus oocytes [ 12 ] .
# ::alignments 49-50|0.1 46-47|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 44-45|0.2.0 43-44|0.2 42-43|0.2.1.1 40-41|0.2.1.1.0 39-40|0 38-39|0.3 36-37|0.0.1.2.0 34-35|0.0.0 33-34|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 31-32|0.0 30-31|0.0.1 29-30|0.0.1.1 27-28|0.2.1.0 24-25|0.2.1.0.1 23-24|0.2.1 15-16|0.0.0.0.0 14-15|0.0.0.0.0.0 11-12|0.0.1.2 10-11|0.0.1.2.1.0.0+0.0.1.2.1.0+0.0.1.2.1 4-5|0.2.1.0.0 1-2|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:15:55.833
(c2 / contrast-01 
      :ARG0 (p / pathway 
            :location (c3 / cell 
                  :location (c4 / country 
                        :ARG2-of (i3 / import-01 
                              :ARG1 (n4 / nucleus)) 
                        :name (n2 / name 
                              :op1 "HeLa"))) 
            :mod (i / import-01 
                  :ARG0 (e / example) 
                  :ARG1 (n3 / nucleus) 
                  :ARG2 (a4 / associate-01 
                        :ARG0 3 
                        :ARG1 (t / thing 
                              :name (n5 / name 
                                    :op1 "RanBP2"))))) 
      :ARG1 12 
      :ARG2 (s / seem-01 
            :ARG1 (d / dispensable 
                  :location (c / country 
                        :name (n / name 
                              :op1 "Xenopus"))) 
            :op3-of (a3 / and 
                  :op1 (i2 / inhibit-01 
                        :ARG0 (r2 / ran-bind) 
                        :ARG1 (a2 / antibodi)) 
                  :op2 (r / role 
                        :mod (s2 / such)))) 
      :op1-of (a / and))

# ::snt In addition , the combination of the C-terminal domains , RBD4 and CY ( of RanBP2 ) , associates with a subset of G protein-coupled receptors , the red/green opsin , expressed in photosensory neurons and enhances opsin functional production [ 6,7 ] , while the interaction of the KBD of RanBP2 with a subset of the conventional microtubule-based motor proteins , the kinesins , KIF5B and KIF5C , occurs selectively in the central nervous system ( CNS ) [ 13 ] .
# ::tok In addition , the combination of the C-terminal domains , RBD4 and CY ( of RanBP2 ) , associates with a subset of G protein-coupled receptors , the red/green opsin , expressed in photosensory neurons and enhances opsin functional production [ 6,7 ] , while the interaction of the KBD of RanBP2 with a subset of the conventional microtubule-based motor proteins , the kinesins , KIF5B and KIF5C , occurs selectively in the central nervous system ( CNS ) [ 13 ] .
# ::alignments 80-81|0.4.0.1.0.2.0.0.0.0 77-78|0.2.1.0.0+0.2.1.0+0.2.1 75-76|0.4.0.1.0.2.0.0 74-75|0.4.0.1.0.2.0.0.0 73-74|0.4.0.1.0.2.0.0.1 70-71|0.4.0.1.0.2.0.1 69-70|0.4.0.1.0.2.0 67-68|0.4.0.1.0.2.3.0.0+0.4.0.1.0.2.3.0+0.4.0.1.0.2.3 66-67|0.4.0.1.0.2 65-66|0.4.0.1.0.2.2.0.0+0.4.0.1.0.2.2.0+0.4.0.1.0.2.2 63-64|0.4.0.1.0.2.1 60-61|0.4.0.1.2 59-60|0.4.0.1.2.0 58-59|0.4.0.1.2.1.0 57-58|0.4.0.1.2.1 54-55|0.4.0.1.2.2 49-52|0.4.0.1.0.0.0.2+0.4.0.1.0.0.0.1+0.4.0.1.0.0.0.0+0.4.0.1.0.0.0+0.4.0.1.0.0 46-47|0.4.0.1.0 39-40|0.4.0.1 38-39|0.4.0.1.1 37-38|0.4.1 36-37|0.4.0 35-36|0.4 34-35|0.3 31-32|0 29-30|0.0 25-26|0.2.0.0 24-25|0.2.0.0.1 23-24|0.2.0.0.0.1+0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 21-22|0.2.0 18-19|0.2 15-16|0.4.0.0.0.0.0+0.4.0.0.0.0+0.4.0.0.0 11-12|0.1 8-9|0.1.0 4-5|0.4.0.0 1-2|0.4.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:02.443
(e2 / express-01 
      :ARG0 (o5 / opsin) 
      :ARG1 (a4 / and 
            :op1 (d / domain)) 
      :ARG2 (a3 / associate-01 
            :ARG1 (s4 / subset 
                  :source (r / receptor 
                        :mod (o6 / organization 
                              :name (n7 / name 
                                    :op1 "G-8") 
                              :wiki "G8") 
                        :mod (p4 / protein-coupl))) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "CNS"))) 
      :manner (n6 / neuron) 
      :op1-of (a2 / and 
            :op2 (e / enhance-01 
                  :ARG0 (c3 / combine-01 
                        :ARG1 (t2 / thing 
                              :name (n8 / name 
                                    :op1 "RanBP2"))) 
                  :ARG1 (p3 / produce-01 
                        :ARG1-of (i / interact-01 
                              :ARG0 (o3 / organization 
                                    :name (n5 / name 
                                          :op1 "KBD" 
                                          :op2 "of" 
                                          :op3 "RanBP2")) 
                              :op1-of (a5 / addition) 
                              :op1-of (a / and 
                                    :ARG1-of (o2 / occur-01 
                                          :location (s / system 
                                                :ARG1-of (n2 / nervous-01 
                                                      :ARG0 13) 
                                                :mod (c / central)) 
                                          :manner (s2 / selectively)) 
                                    :op2 (k / kinesin) 
                                    :op3 (p / person 
                                          :name (n4 / name 
                                                :op1 "KIF5B")) 
                                    :op4 (t / thing 
                                          :name (n3 / name 
                                                :op1 "KIF5C")))) 
                        :mod (f / functional) 
                        :op1-of (p2 / protein 
                              :mod (m / motorcycle) 
                              :mod (c2 / conventional 
                                    :mod-of (m2 / microtubule-bas)) 
                              :poss-of (s3 / subset)))) 
            :op3 (o4 / opsin)))

# ::snt A diverse set of additional molecular partners , each associating specifically with a selective domain of RanBP2 , are likely to impart and integrate additional roles to RanBP2 .
# ::tok A diverse set of additional molecular partners , each associating specifically with a selective domain of RanBP2 , are likely to impart and integrate additional roles to RanBP2 .
# ::alignments 25-26|0.0.0.0.0.0.0.0.0 24-25|0.0.0.0.0.0.0.0.0.0 23-24|0.0.0.0.0.0.0.0 22-23|0.0.0.0.0.0.0 21-22|0.0.0.0.0 19-20|0.0.0.0.0.0 16-17|0.0.1.0.0+0.0.1.0+0.0.1 14-15|0.0 13-14|0 10-11|0.0.0.1 9-10|0.0.0 8-9|0.0.0.1.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.1 4-5|0.0.0.0.1.0 2-3|0.0.0.0 1-2|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:03.205
(s / selective 
      :mod-of (d / domain 
            :ARG2-of (a3 / associate-01 
                  :ARG1 (s3 / set 
                        :ARG1-of (i2 / impart-01 
                              :ARG1-of (l / likely-01 
                                    :ARG0 (a2 / and 
                                          :op1 (i / integrate-01 
                                                :ARG1 (r / role 
                                                      :mod (a / additional)))))) 
                        :consist-of (p / partner-01 
                              :mod (a4 / additional) 
                              :mod (m / molecule)) 
                        :mod (d2 / diverse)) 
                  :manner (s2 / specific-02 
                        :ARG1 (e / each))) 
            :poss (t / thing 
                  :name (n / name 
                        :op1 "RanBP2"))))

# ::snt For example , the cyclophilin-like domain ( CLD ) , the internal repeat ( W1W2/IR ) , and zinc-finger rich ( ZnF ) domains of RanBP2 associate specifically with components of the 19S cap of the proteasome [ 14 ] , the E2 SUMO-1-conjugating enzyme ( Ubc9 ) [ 15 ] , and the nuclear export receptor , CRM1/exportin -1 [ 16 ] , respectively .
# ::tok For example , the cyclophilin-like domain ( CLD ) , the internal repeat ( W1W2/IR ) , and zinc-finger rich ( ZnF ) domains of RanBP2 associate specifically with components of the 19S cap of the proteasome [ 14 ] , the E2 SUMO-1-conjugating enzyme ( Ubc9 ) [ 15 ] , and the nuclear export receptor , CRM1/exportin -1 [ 16 ] , respectively .
# ::alignments 64-65|0.0 61-62|0.1.0.2.1 58-59|0.1.6.0.0+0.1.6.0+0.1.6 56-57|0.1.5.0.0.2 55-56|0.1.5.0.0 54-55|0.1.5.0.0.1 52-53|0 49-50|0.1.3.2 44-45|0.1.0.2.0.0 43-44|0.1.0.2.0 42-43|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 38-39|0.1.5.0.0.0 33-34|0.1.3.1.0.0 32-33|0.1.3.1.0 29-30|0.1.0.1 27-28|0.1.0.2 26-27|0.1.0 25-26|0.1.5.0.1.0+0.1.5.0.1+0.1.5.0 23-24|0.1.5 19-20|0.1.5.0.0.3 18-19|0.1.5.0.0.4 17-18|0.1 14-15|0.1.4.0.0+0.1.4.0+0.1.4 12-13|0.1.3 11-12|0.1.3.1 7-8|0.1.3.0.0.0+0.1.3.0.0+0.1.3.0 5-6|0.1.2 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:04.702
(a / and 
      :mod (r / respective) 
      :op5-of (a3 / and 
            :ARG0-of (a2 / associate-01 
                  :ARG1 (t / thing 
                        :name (n3 / name 
                              :op1 "E2")) 
                  :ARG2 (c2 / component) 
                  :manner (s2 / specific-02 
                        :ARG0 (s / sumo-1-conjugat 
                              :mod-of (e2 / enzyme)) 
                        :op1-of 16)) 
            :beneficiary (e3 / example) 
            :op1 (d2 / domain) 
            :op2 (r4 / repeat-01 
                  :ARG0 (o / organization 
                        :name (n6 / name 
                              :op1 "CLD")) 
                  :ARG1-of (i / internal-02 
                        :ARG0 (14 / 19 
                              :quant-of (c / cap))) 
                  :op1-of 15) 
            :op3 (t3 / thing 
                  :name (n5 / name 
                        :op1 "W1W2/IR")) 
            :op4 (d / domain 
                  :poss (t2 / thing 
                        :ARG2-of (e / export-01 
                              :ARG0 14 
                              :ARG1 (n2 / nucleus) 
                              :mod-of (r2 / receptor) 
                              :op1-of (r3 / rich) 
                              :op1-of (z / zinc-fing)) 
                        :name (n4 / name 
                              :op1 "RanBP2"))) 
            :op6 (p / person 
                  :name (n / name 
                        :op1 "CRM1/exportin"))))

# ::snt RanBP2 itself was also found to exhibit SUMO1 E3 ligase activity [ 17 ] , supporting a direct link between RanBP2-mediated SUMO-1 substrate modification and relocation of SUMO-1 modified cytosolic substrates ( e.g. , RanGAP ) to the cytosolic face of the nuclear pore complex ( NPC ) [ 18 ] .
# ::tok RanBP2 itself was also found to exhibit SUMO1 E3 ligase activity [ 17 ] , supporting a direct link between RanBP2-mediated SUMO-1 substrate modification and relocation of SUMO-1 modified cytosolic substrates ( e.g. , RanGAP ) to the cytosolic face of the nuclear pore complex ( NPC ) [ 18 ] .
# ::alignments 49-50|0.1.0.1.2.0 46-47|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 44-45|0.0.1.0 43-44|0.0.1.0.0 42-43|0.0.1 39-40|0.0.1.0.1 32-33|0.0.0 30-31|0.1.0.1.2.2.0 29-30|0.1.0.1.2.2.0.0 28-29|0.1.0.1.2.2 25-26|0.1.0.1.2 24-25|0.1.0.1.0.1 23-24|0.1.0.1.0 22-23|0.1.0.1.0.0 20-21|0.0.1.0.0.0 18-19|0.1.0.1 17-18|0.1.0.1.1 15-16|0.1.0 12-13|0.1.0.1.2.1 10-11|0.0 6-7|0 4-5|0.1 3-4|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:05.770
(e2 / exhibit-01 
      :ARG1 (a2 / activity-06 
            :ARG1 (e / e.g.) 
            :mod (n2 / nucleus 
                  :mod-of (c / complex 
                        :mod (p / pore-01 
                              :ARG0 (r2 / ranbp2-mediat)) 
                        :part (f / face)))) 
      :ARG2-of (f2 / find-01 
            :ARG1 (s3 / support-01 
                  :ARG0 (g / government-organization 
                        :name (n / name 
                              :op1 "NPC") 
                        :wiki "National_People's_Congress") 
                  :ARG1 (l / link-01 
                        :ARG1 (m2 / modify-01 
                              :ARG1 (s2 / substrate) 
                              :op1-of (a / and)) 
                        :ARG1-of (d / direct-02) 
                        :ARG2 (r / relocate-01 
                              :ARG0 18 
                              :ARG1 17 
                              :ARG2-of (m / modify-01 
                                    :ARG1 (s / substrat 
                                          :mod (c2 / cytosolic)))))) 
            :mod (a3 / also)))

# ::snt Finally , RanBP2 was also found to localize prominently to the mitochondria-rich ellipsoid subcellular compartment of photosensory neurons [ 19 ] and to RanGTPase-restricted foci along cytoplasmic tracks [ 19 ] , in addition to its localization at cytoplasmic fibrils emanating from nuclear pores [ 2,3,10,12,19 ] .
# ::tok Finally , RanBP2 was also found to localize prominently to the mitochondria-rich ellipsoid subcellular compartment of photosensory neurons [ 19 ] and to RanGTPase-restricted foci along cytoplasmic tracks [ 19 ] , in addition to its localization at cytoplasmic fibrils emanating from nuclear pores [ 2,3,10,12,19 ] .
# ::alignments 43-44|0.0.1 42-43|0.0.1.1 40-41|0.0.1.0.0 39-40|0.0.1.0 38-39|0.0.1.0.1 36-37|0.0.1.0.0.0 33-34|0.1.0.0.2 29-30|0.1.1 27-28|0.0.2.0 26-27|0.0.2.0.0 25-26|0.0.2 24-25|0.0 23-24|0.0.0.0.0+0.0.0.0+0.0.0 21-22|0 19-20|0.0.1.0.0.1 17-18|0.1.0.0.0.1 14-15|0.1.0.0.0 13-14|0.1.0.0.0.0 12-13|0.1.0.0.0.2 8-9|0.1.0.0.1 7-8|0.1.0.0 5-6|0.1 4-5|0.1.2 2-3|0.1.0.1.0+0.1.0.1+0.1.0 0-1|0.1.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:06.860
(a3 / and 
      :ARG0-of (f2 / focus-01 
            :ARG1 (t2 / thing 
                  :name (n2 / name 
                        :op1 "RanGTPase-restricted")) 
            :ARG2 (p / pore-01 
                  :ARG0 (f / fibril 
                        :ARG1-of (e / emanate-01 
                              :ARG0 (l / localization) 
                              :ARG2 19) 
                        :mod (c / cytoplasmic)) 
                  :mod (n / nucleus)) 
            :location (a2 / along 
                  :op1 (t / track 
                        :mod (c2 / cytoplasmic)))) 
      :op1 (f3 / find-01 
            :ARG1 (t3 / thing 
                  :ARG1-of (l2 / localize-01 
                        :ARG2 (c3 / compartment 
                              :mod (s / subcellular) 
                              :mod (n3 / neuron) 
                              :mod (e2 / ellipsoid)) 
                        :manner (p2 / prominently) 
                        :op1-of (a / addition) 
                        :time (f4 / final)) 
                  :name (n4 / name 
                        :op1 "RanBP2")) 
            :ARG2 19 
            :mod (a4 / also)))

# ::snt Emerging evidence supports that the CNS-selective effects of RanBP2 may also underlie the pathogenesis of certain neuropathies .
# ::tok Emerging evidence supports that the CNS-selective effects of RanBP2 may also underlie the pathogenesis of certain neuropathies .
# ::alignments 16-17|0.0.0.0.1.0 15-16|0.0.0.0.1.0.0 13-14|0.0.0.0.1 11-12|0.0.0.0 10-11|0.0.0.0.2 9-10|0.0.0 8-9|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 6-7|0.0.0.0.0 2-3|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:07.017
(e2 / evidence-01 
      :ARG0-of (s / support-01 
            :ARG1 (p2 / possible-01 
                  :ARG1 (u / underlie-01 
                        :ARG0 (e / effect 
                              :poss (t / thing 
                                    :name (n2 / name 
                                          :op1 "RanBP2"))) 
                        :ARG1 (p / pathogenesi 
                              :mod (n / neuropathi 
                                    :mod (c / certain))) 
                        :mod (a / also)))) 
      :ARG1-of (e3 / emerge-01))

# ::snt Parkin is ubiquitously expressed and interacts with the Ubc9-interacting domain of RanBP2 [ 20 ] .
# ::tok Parkin is ubiquitously expressed and interacts with the Ubc9-interacting domain of RanBP2 [ 20 ] .
# ::alignments 13-14|0.0 11-12|0.1.1.0.0+0.1.1.0+0.1.1 9-10|0.1.0.1 8-9|0.1.0.1.0 5-6|0.1.0 4-5|0.1 3-4|0 0-1|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:07.141
(e / express-01 
      :ARG1 20 
      :op1-of (a / and 
            :op2 (i / interact-01 
                  :ARG1 (p / person 
                        :name (n2 / name 
                              :op1 "Parkin")) 
                  :ARG2 (d / domain 
                        :mod (u / ubc9-interact))) 
            :op3 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2"))))

# ::snt This promotes the ubiquitination and degradation of RanBP2 [ 20 ] , possibly via the interaction of the CLD domain of RanBP2 with the 19S cap subunits of the proteasome [ 14 ] .
# ::tok This promotes the ubiquitination and degradation of RanBP2 [ 20 ] , possibly via the interaction of the CLD domain of RanBP2 with the 19S cap subunits of the proteasome [ 14 ] .
# ::alignments 31-32|0.2.0 26-27|0.3.0 25-26|0.3.0.0 24-25|0.3.0.1 19-20|0.3.1 18-19|0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 15-16|0.3 12-13|0.2 9-10|0.2.0.0 7-8|0.3.2.0.0+0.3.2.0+0.3.2 5-6|0.4.0 4-5|0.4 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:07.690
(p2 / promote-02 
      :ARG0 (t2 / this) 
      :ARG1 (u / ubiquitination) 
      :ARG1-of (p / possible-01 
            :ARG2 (1 / 14 
                  :mod 20)) 
      :ARG2 (i / interact-01 
            :ARG1 (s / subunit 
                  :part-of (c / cap) 
                  :quant 19) 
            :poss-of (d / domain 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "CLD"))) 
            :topic (t / thing 
                  :name (n2 / name 
                        :op1 "RanBP2"))) 
      :op1-of (a / and 
            :op2 (d2 / degradation)))

# ::snt Interestingly , the small yeast Ran-binding protein 1 ( RanBP1 ) , Yrb1p , with strong homology to the Ran-binding domains of RanBP2 , is also required for cell-cycle regulated protein degradation [ 21 ] .
# ::tok Interestingly , the small yeast Ran-binding protein 1 ( RanBP1 ) , Yrb1p , with strong homology to the Ran-binding domains of RanBP2 , is also required for cell-cycle regulated protein degradation [ 21 ] .
# ::alignments 33-34|0.4 31-32|0.2 30-31|0.2.1 29-30|0.2.0 26-27|0 25-26|0.3 22-23|0.0.0.0.0+0.0.0.0+0.0.0 20-21|0.0 16-17|0.2.0.2.1 15-16|0.2.0.2 12-13|0.2.0.0 7-8|0.2.0.1 6-7|0.1 5-6|0.1.0 4-5|0.1.1.0 3-4|0.1.1 0-1|0.2.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:08.100
(r2 / require-01 
      :ARG0 (d2 / domain 
            :poss (t / thing 
                  :name (n / name 
                        :op1 "RanBP2"))) 
      :ARG1 (p2 / protein 
            :mod (r3 / ran-bind) 
            :mod (s2 / small 
                  :mod-of (y2 / yeast))) 
      :ARG2 (d / degradation 
            :ARG1-of (r / regulate-01 
                  :ARG0 (y / Yrb1p) 
                  :ARG2 1 
                  :purpose (s / strong-02 
                        :ARG0 (i / interesting) 
                        :ARG1 (h / homology))) 
            :mod (p / protein)) 
      :mod (a / also) 
      :time 21)

# ::snt Parkin , like RanBP2 [ 17 ] , has E3-ligase activity [ 22 -- 24 ] ; and loss-of-function of parkin leads to early onset autosomal recessive juvenile Parkinsonism [ 25 ] .
# ::tok Parkin , like RanBP2 [ 17 ] , has E3-ligase activity [ 22 -- 24 ] ; and loss-of-function of parkin leads to early onset autosomal recessive juvenile Parkinsonism [ 25 ] .
# ::alignments 30-31|0.3.2 28-29|0.4.0.2.0.0.0.0+0.4.0.2.0.0.0+0.4.0.2.0.0 27-28|0.3.1 26-27|0.3.0 25-26|0.4.0.2.0.1 24-25|0.2 23-24|0.2.0 21-22|0 20-21|0.1 17-18|0.4.0.2 16-17|0.4.0.2.1 14-15|0.0 12-13|0.4.0.0.0 10-11|0.4.0.0 5-6|0.3 3-4|0.4.0.2.0.2.0+0.4.0.2.0.2+0.4.0.2.0 2-3|0.4 0-1|0.4.0.1.0+0.4.0.1+0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:08.731
(l / lead-03 
      :ARG0 24 
      :ARG1 (p / parkin) 
      :location (o2 / onset 
            :mod (e / early)) 
      :op1-of (1 / 17 
            :mod (r / recessive) 
            :mod (j / juvenile) 
            :mod-of 25) 
      :purpose-of (r2 / resemble-01 
            :ARG2 (p2 / person 
                  :ARG0-of (a4 / activity-06 
                        :ARG1 22) 
                  :name (n3 / name 
                        :op1 "Parkin") 
                  :op1-of (a2 / and 
                        :op2 (t / thing 
                              :domain (o / organization 
                                    :name (n / name 
                                          :op1 "Parkinsonism")) 
                              :mod-of (a / autosomal) 
                              :name (n2 / name 
                                    :op1 "RanBP2")) 
                        :op3 (a3 / and)))))

# ::snt While the dopaminergic neuronal-restricted effects of mutations in parkin are not understood [ 25 ] , parkin  /  mice exhibit mitochondrial dysfunction and energy and growth deficits , and a fraction of parkin localizes to the cytoplasmic face of the mitochondria , where together with other partners is thought to promote the degradation of selective mitochondrial substrates and to exert a neuroprotective function [ 26 -- 29 ] .
# ::tok While the dopaminergic neuronal-restricted effects of mutations in parkin are not understood [ 25 ] , parkin  /  mice exhibit mitochondrial dysfunction and energy and growth deficits , and a fraction of parkin localizes to the cytoplasmic face of the mitochondria , where together with other partners is thought to promote the degradation of selective mitochondrial substrates and to exert a neuroprotective function [ 26 -- 29 ] .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:08.735
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt These data suggest that deficits in RanBP2 and parkin may share ( patho ) physiological pathways and support a multifaceted role of RanBP2 .
# ::tok These data suggest that deficits in RanBP2 and parkin may share ( patho ) physiological pathways and support a multifaceted role of RanBP2 .
# ::alignments 20-21|0.1.0.0.1 19-20|0.1.0.0.1.0 17-18|0.1.0.0 16-17|0.1.0 15-16|0.1.1 14-15|0.1.1.0 12-13|0.1.0.0.0 10-11|0.1 9-10|0.1.2 7-8|0.1.4 6-7|0.1.4.0.0.0+0.1.4.0.0+0.1.4.0 4-5|0.1.3 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:09.163
(s3 / suggest-01 
      :ARG0 (d2 / data 
            :mod (t2 / this)) 
      :ARG1 (s2 / share-01 
            :ARG0 (a / and 
                  :op1 (s / support-01 
                        :ARG0 (p3 / patho) 
                        :ARG1 (r / role 
                              :mod (m / multifacet)))) 
            :ARG1 (p / pathway 
                  :mod (p2 / physiological)) 
            :ARG1-of (p4 / possible-01) 
            :ARG2 (d / deficit) 
            :op2-of (a2 / and 
                  :op1 (t / thing 
                        :name (n / name 
                              :op1 "RanBP2")))))

# ::snt Yet clear functions of RanBP2 in animal and cell physiology remain elusive .
# ::tok Yet clear functions of RanBP2 in animal and cell physiology remain elusive .
# ::alignments 11-12|0.2.0.1 10-11|0.2.0 9-10|0.2 8-9|0.1 7-8|0 6-7|0.0 4-5|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 2-3|0.2.0.0 1-2|0.2.0.0.1 0-1|0.2.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:09.250
(a / and 
      :op1 (a2 / animal) 
      :op2 (c / cell) 
      :op3 (p / physiology 
            :ARG0-of (r / remain-01 
                  :ARG1 (f / function-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "RanBP2")) 
                        :ARG1-of (c2 / clear-06) 
                        :domain-of (y / yet)) 
                  :ARG3 (e / elusive))))

# ::snt Here , we report on the identification and function of two novel partners of RanBP2 , Cox11 and hexokinase type I ( HKI ) , which interact with a large and orphan domain of RanBP2 , the leucine-rich domain ( LD ) ; and on the outcome of partial loss-of-function of RanBP2 on HKI , animal physiology , and glucose/energy metabolism .
# ::tok Here , we report on the identification and function of two novel partners of RanBP2 , Cox11 and hexokinase type I ( HKI ) , which interact with a large and orphan domain of RanBP2 , the leucine-rich domain ( LD ) ; and on the outcome of partial loss-of-function of RanBP2 on HKI , animal physiology , and glucose/energy metabolism .
# ::alignments 60-61|0.0.0.2.1.1.2 58-59|0.0.0.2.1.1 56-57|0.0.0.2.1.1.1 55-56|0.0.0.2.1.1.1.0 48-49|0.0.0.2.0 46-47|0.0.0.2.1.1.0 43-44|0.0 42-43|0 40-41|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 38-39|0.0.0.2.1.0.0.0 32-33|0.0.0.2.1.0 31-32|0.0.0.2.1.0.0 30-31|0.0.0.2.1 29-30|0.0.0.3.0 26-27|0.0.0.2 22-23|0.0.1.0.0+0.0.1.0+0.0.1 20-21|0.0.0.1.2 19-20|0.0.0.3.1.1.0 17-18|0.0.0.1 16-17|0.0.0.1.1 14-15|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 12-13|0.0.0 11-12|0.0.0.4 10-11|0.0.0.1.2.0 8-9|0.0.0.3 7-8|0.0.0.3.1 6-7|0.0.0.3.1.1 3-4|0.0.0.3.1.0 2-3|0.0.0.3.1.0.0 0-1|0.0.0.3.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:10.493
(a4 / and 
      :op1 (a3 / and 
            :example-of (p3 / partner-01 
                  :ARG0 (o2 / organization 
                        :name (n / name 
                              :op1 "LD")) 
                  :ARG1 (a6 / and 
                        :op1 (t2 / thing 
                              :name (n3 / name 
                                    :op1 "RanBP2")) 
                        :op2 (c / Cox11) 
                        :op3 (i2 / i 
                              :quant 2)) 
                  :ARG1-of (i / interact-01 
                        :ARG0 (p2 / partial) 
                        :op1-of (a5 / and 
                              :op2 (d2 / domain 
                                    :ARG1-of (o3 / orphan-01 
                                          :op1-of (d / domain))) 
                              :op3 (a / and 
                                    :op1 (o / outcome) 
                                    :op2 (p / physiology 
                                          :mod (a2 / animal)) 
                                    :op3 (m / metabolism)))) 
                  :ARG2-of (f / function-01 
                        :ARG1 (l / large) 
                        :op2-of (a7 / and 
                              :ARG1-of (r / report-01 
                                    :ARG0 (w / we) 
                                    :location (h / here)) 
                              :op1 (i3 / identify-02 
                                    :ARG1 (t / type)))) 
                  :mod (n4 / novel)) 
            :op1 (o4 / organization 
                  :name (n2 / name 
                        :op1 "HKI"))))

# ::snt The LD of RanBP2 Interacts with Cox11 and HKI .
# ::tok The LD of RanBP2 Interacts with Cox11 and HKI .
# ::alignments 8-9|0.2.1.0.0+0.2.1.0+0.2.1 7-8|0.2 6-7|0.2.0 4-5|0 3-4|0.1 1-2|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:10.589
(i / interact-01 
      :ARG0 (o2 / organization 
            :name (n2 / name 
                  :op1 "LD")) 
      :ARG1 (r / RanBP2) 
      :ARG2 (a / and 
            :op1 (c / Cox11) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "HKI"))))

# ::snt The LD of RanBP2 ( Figure 1A ) is a large and orphan domain of ~ 700 residues ( ~ 80 kDa ) , for which no molecular partners have been identified until this date .
# ::tok The LD of RanBP2 ( Figure 1A ) is a large and orphan domain of ~ 700 residues ( ~ 80 kDa ) , for which no molecular partners have been identified until this date .
# ::alignments 34-35|0.2.0.2.0 33-34|0.2.0.2.0.0 32-33|0.2.0.2 31-32|0.2.0 28-29|0.2.0.0 27-28|0.2.0.0.2 26-27|0.2.0.1 21-22|0.2.0.0.1 20-21|0.0.0 17-18|0.2.1 16-17|0.0.1 13-14|0 12-13|0.0 11-12|0.2 10-11|0.2.0.0.0 5-6|0.2.0.2.0.0.0 3-4|0.1.1.0.0+0.1.1.0+0.1.1 1-2|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:10.994
(d2 / domain 
      :ARG1-of (o / orphan-01 
            :ARG0 80 
            :time 700) 
      :domain (o2 / organization 
            :name (n2 / name 
                  :op1 "LD") 
            :part-of (t2 / thing 
                  :name (n / name 
                        :op1 "RanBP2"))) 
      :op1-of (a / and 
            :op2 (i / identify-01 
                  :ARG1 (p / partner-01 
                        :ARG0 (l / large) 
                        :ARG1 (k / kDa) 
                        :mod (m / molecule)) 
                  :polarity - 
                  :time (u / until 
                        :op1 (d / date 
                              :mod (t / this 
                                    :mod-of (f / figure))))) 
            :poss (r / residu)))

# ::snt Brain and retina yeast two-hybrid libraries were screened with LD .
# ::tok Brain and retina yeast two-hybrid libraries were screened with LD .
# ::alignments 9-10|0.0.0.0+0.0.0+0.0 7-8|0 5-6|0.1.0.0.0 3-4|0.1.0.0 2-3|0.1.0.0.0.0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:11.151
(s / screen-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "LD")) 
      :ARG1 (a / and 
            :op1 (b / brain-01 
                  :ARG2 (y / yeast 
                        :mod-of (l / library 
                              :mod (r / retina))))))

# ::snt Cox11 was identified as a partner to this domain ( Figure 1B and 1C ) .
# ::tok Cox11 was identified as a partner to this domain ( Figure 1B and 1C ) .
# ::alignments 12-13|0 10-11|0.0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 5-6|0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:11.231
(a / and 
      :ARG1-of (i / identify-01 
            :ARG2 (p / partner-01 
                  :ARG1 (f / figure) 
                  :ARG2 (d / domain 
                        :mod (t / this)))))

# ::snt Cox11 is a metallochaperone implicated in cytochrome c oxidase assembly [ 30,31 ] .
# ::tok Cox11 is a metallochaperone implicated in cytochrome c oxidase assembly [ 30,31 ] .
# ::alignments 9-10|0.0.0.1.0 8-9|0.0.0.1 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0 3-4|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:11.268
(m / metallochaperone 
      :ARG1-of (i / implicate-01 
            :ARG0 (c / c 
                  :mod (c2 / cytochrome) 
                  :mod-of (o / oxidase 
                        :mod-of (a / assembly)))) 
      :domain (c3 / Cox11))

# ::snt Structure-function analysis of the interaction between mCox11 , LD of RanBP2 , and subdomains thereof , with quantitative yeast two-hybrid assays [ 32 ] , showed optimal interaction between the intact LD and Cox11 proteins ( Figure 1C ) .
# ::tok Structure-function analysis of the interaction between mCox11 , LD of RanBP2 , and subdomains thereof , with quantitative yeast two-hybrid assays [ 32 ] , showed optimal interaction between the intact LD and Cox11 proteins ( Figure 1C ) .
# ::alignments 36-37|0.0.1.4 34-35|0.0.2 32-33|0.0 30-31|0.0.0 27-28|0.1 26-27|0.1.2 25-26|0 22-23|0.0.1.0.1.0 20-21|0.1.0 18-19|0.0.1.0.2 17-18|0.1.0.0 14-15|0.1.1 13-14|0.0.1.3 12-13|0.0.1 10-11|0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 8-9|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 6-7|0.0.1.0.0 4-5|0.0.1.0 1-2|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:11.872
(s / show-01 
      :ARG0 (a / and 
            :mod (i / intact) 
            :op1 (a3 / and 
                  :ARG0-of (i3 / interact-01 
                        :ARG1 (m / mCox11) 
                        :ARG1-of (a4 / analyze-01 
                              :op1-of 32) 
                        :op1-of (y / yeast)) 
                  :op1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "LD")) 
                  :op2 (t2 / thing 
                        :name (n / name 
                              :op1 "RanBP2")) 
                  :op3 (s2 / subdomain) 
                  :op4 (f / figure)) 
            :op2 (p / protein)) 
      :ARG1 (i2 / interact-01 
            :ARG0 (a2 / assay 
                  :mod (q / quantitative)) 
            :ARG1 (t / thereof) 
            :mod (o / optimal)))

# ::snt Pull-down assays of retinal extracts with glutathione S-transferase ( GST ) - LD precipitates a sodium dodecyl sulfate-resistant dimer isoform of Cox11 ( Figure 1D , top panel ) , which does not bind to GST-LDZIP alone .
# ::tok Pull-down assays of retinal extracts with glutathione S-transferase ( GST ) - LD precipitates a sodium dodecyl sulfate-resistant dimer isoform of Cox11 ( Figure 1D , top panel ) , which does not bind to GST-LDZIP alone .
# ::alignments 36-37|0.1.1.2.0.3 35-36|0.1.1.2.0.1.0.0+0.1.1.2.0.1.0+0.1.1.2.0.1 33-34|0.1.1.2.0 32-33|0.1.1.2.0.2 27-28|0 26-27|0.0 23-24|0.1.1.2.0.0 21-22|0.1.1.2 19-20|0.1.1 18-19|0.1.1.1 15-16|0.1.1.0 13-14|0.1 12-13|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0.1.2+0.1.2.0 3-4|0.1.2.0.0 1-2|0.1.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:12.233
(p / panel 
      :mod (t2 / top) 
      :op1 (p2 / precipitate-01 
            :ARG0 (o / organization 
                  :name (n2 / name 
                        :op1 "LD")) 
            :ARG1 (i / isoform 
                  :mod (s / sodium) 
                  :mod (d / dimer) 
                  :mod (c / Cox11 
                        :ARG0-of (b / bind-01 
                              :ARG1 (f / figure) 
                              :ARG2 (t / thing 
                                    :name (n / name 
                                          :op1 "GST-LDZIP")) 
                              :polarity - 
                              :time (a / alone)))) 
            :ARG2-of (e / extract-01 
                  :ARG1 (t3 / thing 
                        :mod (r / retinal) 
                        :poss-of (a2 / assay)))))

# ::snt In addition to Cox11 , we also found that other mitochondrial components such as the outer membrane-associated protein , HKI [ 33 ] ( Figure 1D , bottom panel ) and mHsp70 ( unpublished data ) , associated with LD of RanBP2 .
# ::tok In addition to Cox11 , we also found that other mitochondrial components such as the outer membrane-associated protein , HKI [ 33 ] ( Figure 1D , bottom panel ) and mHsp70 ( unpublished data ) , associated with LD of RanBP2 .
# ::alignments 41-42|0.1.1.0.0+0.1.1.0+0.1.1 39-40|0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 37-38|0.1.1.1.0 34-35|0.0 33-34|0 31-32|0.1.1.1.0.1 30-31|0.1.1.1.0.1.0 28-29|0.1.5.0 27-28|0.1.5 24-25|0.1.2.0 21-22|0.1.3.0 19-20|0.1.1.1.2.0.0+0.1.1.1.2.0+0.1.1.1.2 17-18|0.1.1.1.0.2.0 16-17|0.1.1.1.0.2 15-16|0.1.1.1.0.2.0.0 12-13|0.1.1.1.0.3 11-12|0.1.1.1.0.0 9-10|0.1.1.1.0.0.0 7-8|0.1 6-7|0.1.4 5-6|0.1.0 3-4|0.1.2 1-2|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:12.908
(u / unpublish 
      :mod-of (d / data) 
      :op1 (f2 / find-01 
            :ARG0 (w / we) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2") 
                  :part (o / organization 
                        :ARG2-of (a / associate-01 
                              :ARG0 (c / component 
                                    :mod (o4 / other)) 
                              :ARG1 (m / mHsp70 
                                    :op1-of (a2 / and)) 
                              :op1-of (m2 / membrane-associat 
                                    :mod-of (p2 / protein 
                                          :mod (o3 / outer))) 
                              :op1-of (s / such)) 
                        :name (n2 / name 
                              :op1 "LD") 
                        :part (o2 / organization 
                              :name (n3 / name 
                                    :op1 "HKI")))) 
            :ARG2 (c2 / Cox11 
                  :mod-of (f / figure)) 
            :location (a4 / addition 
                  :poss-of 33) 
            :mod (a3 / also) 
            :op1-of (b / bottom 
                  :mod-of (p / panel))))

# ::snt This association was highly specific toward the HKI isoform , because HKII , HKIII , and glucokinase did not interact with the LD of RanBP2 ( unpublished data ) .
# ::tok This association was highly specific toward the HKI isoform , because HKII , HKIII , and glucokinase did not interact with the LD of RanBP2 ( unpublished data ) .
# ::alignments 27-28|0.0.0.0.0 26-27|0.0.0.0 24-25|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 22-23|0.1.0.0.0+0.1.0.0+0.1.0 19-20|0.1 18-19|0.1.1 15-16|0 11-12|0.2.0.0+0.2.0+0.2 10-11|0.0 8-9|0.0.0.1.0.0 7-8|0.0.0.1.0.1.0+0.0.0.1.0.1+0.0.0.1.0 4-5|0.0.0 3-4|0.0.0.2 1-2|0.0.0.1 0-1|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:13.561
(a / and 
      :ARG0-of (c / cause-01 
            :ARG1 (s / specific-02 
                  :ARG0 (u / unpublish 
                        :mod-of (d / data)) 
                  :ARG1 (a2 / associate-01 
                        :ARG1 (o2 / organization 
                              :mod-of (i2 / isoform) 
                              :name (n4 / name 
                                    :op1 "HKI")) 
                        :mod (t3 / this)) 
                  :degree (h / high))) 
      :ARG0-of (i / interact-01 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "LD") 
                  :part-of (t / thing 
                        :name (n / name 
                              :op1 "RanBP2"))) 
            :polarity -) 
      :op1 (t2 / thing 
            :name (n3 / name 
                  :op1 "HKII")))

# ::snt The interaction of Cox11 , HKI , and mHsp70 with RanBP2 occurred in vivo in retinal extracts , since antibodies against these and RanBP2 coimmunoprecipitated RanBP2 ( Figure 1E ) and HKI ( Figure 1F ) , respectively , and these interactions were observed across different tissues ( Figure S1 ) .
# ::tok The interaction of Cox11 , HKI , and mHsp70 with RanBP2 occurred in vivo in retinal extracts , since antibodies against these and RanBP2 coimmunoprecipitated RanBP2 ( Figure 1E ) and HKI ( Figure 1F ) , respectively , and these interactions were observed across different tissues ( Figure S1 ) .
# ::alignments 48-50|0.2.0.1+0.2.0.0+0.2.0+0.2 46-47|0.1.0.0 45-46|0.1.0.0.0 44-45|0.1.0 43-44|0.1.1 41-42|0.1.1.1 40-41|0.1.1.1.0 39-40|0.1 37-38|0.1.2.1.0.1 33-34|0.1.2.1.0.0.0 30-31|0.1.1.0 27-28|0.1.1.0.0 22-23|0 21-22|0.0 19-20|0.1.2.0 18-19|0.1.2 16-17|0.1.2.1.2.0+0.1.2.1.2 15-16|0.1.2.1.2.1 13-14|0.1.2.1.1 11-12|0.1.2.1 10-11|0.1.2.1.0.0.1.0.0+0.1.2.1.0.0.1.0+0.1.2.1.0.0.1 7-8|0.1.2.1.0 5-6|0.1.2.1.0.3.0.0+0.1.2.1.0.3.0+0.1.2.1.0.3 3-4|0.1.2.1.0.2 1-2|0.1.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:15.666
(a4 / and 
      :op1 (t4 / this) 
      :op2 (a2 / and 
            :location (a / across 
                  :op1 (t2 / tissue 
                        :ARG1-of (d / differ-02))) 
            :op1 (o / observe-01 
                  :ARG0 (a3 / and 
                        :op1 (f3 / figure)) 
                  :ARG1 (i / interaction 
                        :mod (t3 / this))) 
            :time (s2 / since 
                  :op1 (a5 / antibodi) 
                  :time-of (o2 / occur-01 
                        :ARG0 (a6 / and 
                              :ARG0-of (i2 / interact-01 
                                    :ARG1 (f2 / figure) 
                                    :ARG2 (t6 / thing 
                                          :name (n2 / name 
                                                :op1 "RanBP2"))) 
                              :mod (r / respective) 
                              :op1 (c / Cox11) 
                              :op2 (o3 / organization 
                                    :name (n3 / name 
                                          :op1 "HKI"))) 
                        :ARG1 (v / vivo) 
                        :ARG2 (t5 / thing 
                              :ARG1-of (e / extract-01) 
                              :mod (r2 / retinal))))) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 (f / Figure) 
                  :op2 (s / S1))))

# ::snt Since RanBP2 exhibits chaperone activity , we assessed whether the interaction between the LD of RanBP2 and Cox11 was direct and the chaperone activity of LD toward folding species of Cox11 .
# ::tok Since RanBP2 exhibits chaperone activity , we assessed whether the interaction between the LD of RanBP2 and Cox11 was direct and the chaperone activity of LD toward folding species of Cox11 .
# ::alignments 28-29|0.0.2.1.1.1.0.1.0.0 27-28|0.0.2.1.1.1.0.1.0 23-24|0.0.2.1 22-23|0.0.2.1.0 20-21|0.0.2 19-20|0.0.2.0 17-18|0.1 16-17|0 13-14|0.0.1.0+0.0.1+0.0 10-11|0.0.0 7-8|0.0.2.1.1 6-7|0.0.2.1.1.0 4-5|0.0.2.1.1.1.0.1 3-4|0.0.2.1.1.1.0.1.1 2-3|0.0.2.1.1.1.0 1-2|0.0.2.1.1.1.0.0.0.0+0.0.2.1.1.1.0.0.0+0.0.2.1.1.1.0.0 0-1|0.0.2.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:16.620
(a3 / and 
      :op1 (o / organization 
            :ARG0-of (i / interact-01) 
            :name (n / name 
                  :op1 "LD") 
            :poss (a2 / and 
                  :op1 (d / direct-02) 
                  :op2 (a / activity-06 
                        :ARG1-of (c / chaperone-01) 
                        :ARG1-of (a4 / assess-01 
                              :ARG0 (w / we) 
                              :time (s2 / since 
                                    :op1 (e / exhibit-01 
                                          :ARG0 (t / thing 
                                                :name (n2 / name 
                                                      :op1 "RanBP2")) 
                                          :ARG1 (a5 / activity-06 
                                                :ARG1 (f / fold-01 
                                                      :ARG1 (s / species)) 
                                                :ARG1-of (c3 / chaperone-01)))))))) 
      :op2 (c2 / Cox11))

# ::snt Reconstitution binding assays were carried out between purified LD and Cox11 , fully and partially denatured with GnHCl and urea , respectively , and native Cox11 ( Figure 1G and 1H ) .
# ::tok Reconstitution binding assays were carried out between purified LD and Cox11 , fully and partially denatured with GnHCl and urea , respectively , and native Cox11 ( Figure 1G and 1H ) .
# ::alignments 29-30|0 27-28|0.0.0.2.3 24-25|0.0.0.0.0.1 23-24|0.0.0.2.1.1 21-22|0.0.0.2.0 19-20|0.0.0.2.2 18-19|0.0.0.2 17-18|0.0.0.2.1.0.0+0.0.0.2.1.0+0.0.0.2.1 14-15|0.0.0.0.0.0 13-14|0.0.0.3 12-13|0.0.0.1 10-11|0.0.2 9-10|0.0 7-9|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 4-5|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:17.229
(a / and 
      :op1 (a5 / and 
            :ARG0-of (c2 / carry-out-03 
                  :ARG1 (a6 / assay 
                        :ARG0-of (b / binding-07 
                              :ARG1 (p2 / partial) 
                              :ARG2 (n / native))) 
                  :degree (f2 / full) 
                  :op1-of (a3 / and 
                        :mod (r / respective) 
                        :op2 (p / person 
                              :name (n2 / name 
                                    :op1 "GnHCl") 
                              :op1-of (a2 / and)) 
                        :op3 (u / urea) 
                        :op4 (f / figure)) 
                  :op1-of (a4 / and)) 
            :op1 (t / thing 
                  :name (n3 / name 
                        :op1 (p3 / purified) 
                        :op2 (l / LD))) 
            :op2 (c / Cox11)))

# ::snt Partial denatured Cox11 exhibits significantly higher and concentration-dependent binding affinity toward LD compared with the native and fully denatured Cox11 ( Figure 1G ) .
# ::tok Partial denatured Cox11 exhibits significantly higher and concentration-dependent binding affinity toward LD compared with the native and fully denatured Cox11 ( Figure 1G ) .
# ::alignments 21-22|0.1.1.2.0.1 17-18|0.1.1.0 16-17|0.1.1.2.0 15-16|0.1.1.2.0.0 12-13|0.1.2 11-12|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 9-10|0.1 8-9|0.1.0 6-7|0.1.1.2 5-6|0.1.1 4-5|0.1.1.1 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:17.542
(e / exhibit-01 
      :ARG0 (c2 / Cox11 
            :mod (d / denature) 
            :mod (p / partial)) 
      :ARG1 (a2 / affinity 
            :ARG0-of (b / binding-07) 
            :ARG1-of (h / high-02 
                  :ARG0 (f2 / full) 
                  :ARG1-of (s / significant-02) 
                  :op1-of (a3 / and 
                        :op2 (a / and 
                              :op1 (n / native) 
                              :op2 (f / figure)))) 
            :ARG1-of (c / compare-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "LD")))))

# ::snt In addition , native Cox11 purified upon expression in the presence of CuSO4 ( a prosthetic group tightly bound to Cox11 ) [ 31 ] , shows significantly higher binding activity toward the LD of RanBP2 , than in the absence of CuSO4 ( Figure 1H ) .
# ::tok In addition , native Cox11 purified upon expression in the presence of CuSO4 ( a prosthetic group tightly bound to Cox11 ) [ 31 ] , shows significantly higher binding activity toward the LD of RanBP2 , than in the absence of CuSO4 ( Figure 1H ) .
# ::alignments 44-45|0.1.0.0 40-41|0.1.0.3.0.0.0.0.0 35-36|0.1.0.3.1.1.0.0+0.1.0.3.1.1.0+0.1.0.3.1.1 33-34|0.1.0.3.1.0.0+0.1.0.3.1.0+0.1.0.3.1 30-31|0.1.0 29-30|0.1.0.2 28-29|0.1 27-28|0 26-27|0.1.0.3 23-24|0.1.0.3.0.0.0.1 18-19|0.1.0.1.0 17-18|0.1.0.1 16-17|0.1.0.1.0.0 15-16|0.1.0.1.0.0.0 12-13|0.1.0.3.0.0.0.0.1.0+0.1.0.3.0.0.0.0.1+0.1.0.3.0.0.0.0 10-11|0.1.0.3.0.0.0.0.2 7-8|0.1.0.3.0.0.0 5-6|0.1.0.3.0.0 4-5|0.1.0.3.0 3-4|0.1.0.3.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:18.675
(s / significant-02 
      :ARG0 (a3 / addition) 
      :ARG1 (h / high-02 
            :ARG1 (a2 / activity-06 
                  :ARG0 (f / figure) 
                  :ARG1 (t2 / tight-05 
                        :ARG1 (b2 / bind-01 
                              :ARG1 (g / group 
                                    :mod (p / prosthetic)))) 
                  :ARG1-of (b / binding-07) 
                  :ARG1-of (s2 / show-01 
                        :ARG0 (c / Cox11 
                              :ARG1-of (p4 / purify-01 
                                    :ARG2 (e / express-01 
                                          :ARG0 (p2 / person 
                                                :ARG1-of (a / absent-01) 
                                                :name (n3 / name 
                                                      :op1 "CuSO4") 
                                                :poss-of (p3 / presence)) 
                                          :ARG1 31)) 
                              :mod (n4 / native)) 
                        :ARG2 (o / organization 
                              :name (n2 / name 
                                    :op1 "LD") 
                              :part-of (t / thing 
                                    :name (n / name 
                                          :op1 "RanBP2")))))))

# ::snt The LD of RanBP2 Interacts with Cox11 and HKI .
# ::tok The LD of RanBP2 Interacts with Cox11 and HKI .
# ::alignments 8-9|0.2.1.0.0+0.2.1.0+0.2.1 7-8|0.2 6-7|0.2.0 4-5|0 3-4|0.1 1-2|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:18.765
(i / interact-01 
      :ARG0 (o2 / organization 
            :name (n2 / name 
                  :op1 "LD")) 
      :ARG1 (r / RanBP2) 
      :ARG2 (a / and 
            :op1 (c / Cox11) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "HKI"))))

# ::snt ( A ) Primary structure of RanBP2 and its structural/functional domains .
# ::tok ( A ) Primary structure of RanBP2 and its structural/functional domains .
# ::alignments 10-11|0.1.1 7-8|0.1 6-7|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:18.791
(s / structure 
      :mod (p / primary) 
      :op1-of (a / and 
            :op2 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2")) 
            :op3 (d / domain)))

# ::snt The N-terminal LD of RanBP2 is underlined .
# ::tok The N-terminal LD of RanBP2 is underlined .
# ::alignments 6-7|0 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:18.830
(u / underline-01 
      :ARG1 (o / organization 
            :name (n2 / name 
                  :op1 "LD") 
            :part-of (t / thing 
                  :name (n / name 
                        :op1 "RanBP2"))))

# ::snt ( B ) Sequence alignment of murine and yeast Cox11 .
# ::tok ( B ) Sequence alignment of murine and yeast Cox11 .
# ::alignments 9-10|0.0.2 8-9|0.0.2.0 7-8|0.0 6-7|0.0.1 4-5|0.0.0 3-4|0 1-2|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:18.944
(s / sequence 
      :source (a / and 
            :ARG1-of (a2 / align-01 
                  :ARG0 (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -)) 
            :op1 (m / murine) 
            :op2 (c / Cox11 
                  :mod (y / yeast))))

# ::snt The yeast Cox11 C - and N-terminal domains are poorly conserved .
# ::tok The yeast Cox11 C - and N-terminal domains are poorly conserved .
# ::alignments 10-11|0.1 9-10|0.1.2 7-8|0.1.1 5-6|0 3-4|0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:19.025
(a / and 
      :op1 (c2 / C) 
      :op2 (c / conserve-01 
            :ARG0 (y / yeast) 
            :ARG1 (d / domain) 
            :degree (p / poor)))

# ::snt Arrow and solid line denote the predicted mitochondrial cleavage site and membrane-spanning domain .
# ::tok Arrow and solid line denote the predicted mitochondrial cleavage site and membrane-spanning domain .
# ::alignments 12-13|0.0.1 11-12|0.0.1.0 10-11|0.1.1 9-10|0.1 8-9|0.1.0 6-7|0 4-5|0.1.1.0 3-4|0.1.1.0.1 2-3|0.1.1.0.0 1-2|0.0 0-1|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:19.445
(p / predict-01 
      :ARG0 (a2 / and 
            :op1 (p2 / product 
                  :name (n / name 
                        :op1 "Arrow") 
                  :wiki "Arrow_(Israeli_missile)") 
            :op2 (d / domain 
                  :mod (m / membrane-spann))) 
      :ARG1 (s / site 
            :mod (c / cleavage) 
            :op1-of (a / and 
                  :ARG1-of (d2 / denote-01 
                        :ARG1-of (s2 / solid-02) 
                        :mod (l / line)))))

# ::snt The dotted and dashed lines above the aligned sequences represent , respectively , Cox11-N and Cox11-C constructs shown in Figure 1C .
# ::tok The dotted and dashed lines above the aligned sequences represent , respectively , Cox11-N and Cox11-C constructs shown in Figure 1C .
# ::alignments 19-20|0.0.2.0.1 17-18|0.0.2.0 16-17|0.0.2.0.0 15-16|0.0.2.3.0.0+0.0.2.3.0+0.0.2.3 14-15|0.0.2 13-14|0.0.2.2.0.0+0.0.2.2.0+0.0.2.2 11-12|0.0.2.1 9-10|0.0 8-9|0.0.1.0 7-8|0.0.1.0.0 5-6|0.0.1 4-5|0.0.0 3-4|0.0.0.0 2-3|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:20.793
(a4 / and 
      :ARG1-of (r2 / represent-01 
            :ARG0 (l / line 
                  :ARG1-of (d / dash-01)) 
            :ARG2 (a3 / above 
                  :op1 (s2 / sequence 
                        :ARG1-of (a2 / align-01))) 
            :manner (a / and 
                  :ARG1-of (s / show-01 
                        :ARG0 (c / construct) 
                        :time (f / figure)) 
                  :location (r / respective) 
                  :op1 (p / person 
                        :name (n2 / name 
                              :op1 "Cox11-N")) 
                  :op2 (o / organization 
                        :name (n / name 
                              :op1 "Cox11-C")))) 
      :op1 (d2 / dot-01))

# ::snt ( C ) Structure-function analysis of the interaction between the LD of RanBP2 and Cox11 .
# ::tok ( C ) Structure-function analysis of the interaction between the LD of RanBP2 and Cox11 .
# ::alignments 14-15|0 13-14|0.0 12-13|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0.0.1.0+0.0.0.1+0.0.0 7-8|0.0.0.0 4-5|0.0.0.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:20.873
(c / Cox11 
      :op3-of (a / and 
            :op1 (o / organization 
                  :ARG0-of (i / interact-01 
                        :ARG1-of (a2 / analyze-01)) 
                  :name (n2 / name 
                        :op1 "LD")) 
            :op2 (c2 / country 
                  :name (n / name 
                        :op1 "RanBP2"))) 
      :poss-of (c3 / C))

# ::snt Optimal interaction between the LD and Cox11 occurred in the presence of constructs comprising both the complete LD and Cox11 .
# ::tok Optimal interaction between the LD and Cox11 occurred in the presence of constructs comprising both the complete LD and Cox11 .
# ::alignments 18-19|0 16-17|0.1 14-15|0.2 13-14|0.0 12-13|0.3.0.0.0.0 10-11|0.3.0.0.0 7-8|0.3.0.0 5-6|0.3.0.0.1 4-5|0.3.1.0+0.3.1+0.3 1-2|0.3.0 0-1|0.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:21.048
(a / and 
      :ARG1-of (c2 / comprise-01) 
      :ARG1-of (c / complete-02) 
      :mod (b / both) 
      :op1 (o2 / organization 
            :ARG0-of (i / interact-01 
                  :ARG0-of (o / occur-01 
                        :ARG1 (p / presence 
                              :mod (c3 / construct)) 
                        :op1-of (a2 / and)) 
                  :mod (o3 / optimal)) 
            :name (n / name 
                  :op1 "LD")))

# ::snt Although removal of the cytosolic N-terminal ( Cox11-C ) significantly decreased the interaction with LD , the mitochondrial intermembrane domain of Cox11 ( Cox11-C ) together with the C-terminal half of LD ( LD-C ) retained most of the interaction activity .
# ::tok Although removal of the cytosolic N-terminal ( Cox11-C ) significantly decreased the interaction with LD , the mitochondrial intermembrane domain of Cox11 ( Cox11-C ) together with the C-terminal half of LD ( LD-C ) retained most of the interaction activity .
# ::alignments 40-41|0.1 39-40|0 36-37|0.1.1.2 35-36|0.1.1 33-34|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 29-30|0.0 25-26|0.1.1.1.1.0.0 21-22|0.1.1.1.0.1 19-20|0.1.1.1.0 18-19|0.1.1.1.0.0 14-15|0.1.1.1.1.1.0.0+0.1.1.1.1.1.0+0.1.1.1.1.1 12-13|0.1.1.1.1 10-11|0.1.1.1 9-10|0.1.1.1.2 7-8|0.1.0.0.0+0.1.0.0+0.1.0 1-2|0.1.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:21.579
(i / interact-01 
      :ARG1 (h / half) 
      :ARG1-of (a / activity-06 
            :ARG0 (o3 / organization 
                  :name (n3 / name 
                        :op1 "Cox11-C")) 
            :ARG1-of (r / retain-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "LD-C")) 
                  :condition (d2 / decrease-01 
                        :ARG0 (d / domain 
                              :mod (i2 / intermembrane) 
                              :poss (c / Cox11)) 
                        :ARG1 (i3 / interact-01 
                              :ARG1 (r2 / remove-01 
                                    :ARG1 (t / together)) 
                              :prep-with (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "LD"))) 
                        :ARG1-of (s / significant-02)) 
                  :degree (m / most))))

# ::snt LD-N and LD-C ended and began with the leucine zipper domain of RanBP2 .
# ::tok LD-N and LD-C ended and began with the leucine zipper domain of RanBP2 .
# ::alignments 12-13|0.2.0.2.0.0+0.2.0.2.0+0.2.0.2 10-11|0.2.0 9-10|0.2.0.0 8-9|0.2.0.1 5-6|0.2 4-5|0 3-4|0.1 2-3|0.0.0.0+0.0.0+0.0 1-2|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:21.658
(a / and 
      :op1 (o / organization 
            :name (n2 / name 
                  :op1 "LD-C")) 
      :op2 (e / end-01) 
      :op3 (b / begin-01 
            :ARG2 (d / domain 
                  :mod (z / zipp) 
                  :mod (l / leucine) 
                  :poss (t / thing 
                        :name (n / name 
                              :op1 "RanBP2"))) 
            :op1-of (a2 / and)))

# ::snt White and black bars denote -galactosidase activity and growth rates in selective growth medium , respectively .
# ::tok White and black bars denote -galactosidase activity and growth rates in selective growth medium , respectively .
# ::alignments 15-16|0.0.1.0 13-14|0.0.1.1.0.0.0 12-13|0.0.1.1.0.0 11-12|0.0.1.1.0.0.0.0 9-10|0.0.1.1 8-9|0.0.1.1.0 7-8|0.0.1 6-7|0.0.0 4-5|0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:22.293
(a3 / and 
      :ARG0-of (d / denote-01 
            :ARG1 (a2 / activity-06 
                  :ARG0 (b / bar 
                        :ARG1-of (b2 / black-04))) 
            :ARG2 (a / and 
                  :mod (r / respective) 
                  :op1 (r2 / rate 
                        :mod (g2 / grow-01 
                              :ARG3 (g / grow-01 
                                    :mod-of (m / medium 
                                          :mod (s / selective))))))) 
      :op1 (w / white))

# ::snt Results shown represent the mean  SD , n = 3 .
# ::tok Results shown represent the mean  SD , n = 3 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:22.296
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( D ) GST pull-down assays with the LD of RanBP2 and its leucine zipper domain and retinal extracts .
# ::tok ( D ) GST pull-down assays with the LD of RanBP2 and its leucine zipper domain and retinal extracts .
# ::alignments 18-19|0.0.0+0.0 17-18|0 16-17|0.0.1 15-16|0.0.1.0.1.2 14-15|0.0.1.0.1.1 13-14|0.0.1.0.1.2.0 11-12|0.0.1.0.1 10-11|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 8-9|0.0.1.0.1.0.0.0+0.0.1.0.1.0.0+0.0.1.0.1.0 5-6|0.0.1.0.1.3 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:22.427
(r / retinal 
      :mod-of (t / thing 
            :ARG1-of (e / extract-01 
                  :ARG0 (d2 / D)) 
            :op2-of (a / and 
                  :op1 (t2 / thing 
                        :name (n / name 
                              :op1 "RanBP2") 
                        :op2-of (a2 / and 
                              :op1 (o / organization 
                                    :name (n2 / name 
                                          :op1 "LD")) 
                              :op3 (z / zipp) 
                              :op4 (d / domain 
                                    :mod (l / leucine)) 
                              :topic-of (a3 / assay))))))

# ::snt The LD , but not the leucine zipper domain of RanBP2 , associate with Cox11 ( top panel , lane 1 ) and HKI ( bottom panel , lane 1 ) .
# ::tok The LD , but not the leucine zipper domain of RanBP2 , associate with Cox11 ( top panel , lane 1 ) and HKI ( bottom panel , lane 1 ) .
# ::alignments 29-30|0.3.0.0.0.1 28-29|0.3 26-27|0.3.0.0.0.0 25-26|0.3.0.0.0.0.0 23-24|0.2.1.0.0+0.2.1.0+0.2.1 22-23|0.2 20-21|0.0 19-20|0.3.0.0.0 17-18|0.3.0 16-17|0.3.0.0 14-15|0.2.0 12-13|0.2.0.0 10-11|0.1.0.0+0.1.0+0.1 8-9|0.1.1 7-8|0.1.1.0 6-7|0.1.1.0.0 4-5|0.3.1 3-4|0 1-2|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:23.034
(c2 / contrast-01 
      :ARG0 1 
      :ARG1 (t2 / thing 
            :name (n2 / name 
                  :op1 "RanBP2") 
            :poss-of (d / domain 
                  :mod (z / zipp 
                        :mod (l3 / leucine)))) 
      :ARG2 (a / and 
            :op1 (c / Cox11 
                  :ARG2-of (a2 / associate-01 
                        :ARG0 (o2 / organization 
                              :name (n3 / name 
                                    :op1 "LD")))) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "HKI"))) 
      :ARG2-of (l / lane-01 
            :ARG0 (p2 / panel 
                  :mod (t / top 
                        :mod-of (l2 / lane-01 
                              :ARG0 (p / panel 
                                    :mod (b / bottom)) 
                              :ARG1 1))) 
            :op1-of -))

# ::snt ( E ) Coimmunoprecipitation of RanBP2 with antibodies against its molecular partners shows that RanBP2 forms a complex in vivo with HKI ( lanes 1 and 2 ) , mHsp70 ( lane 3 ) , and Cox11 ( lane 4 ) .
# ::tok ( E ) Coimmunoprecipitation of RanBP2 with antibodies against its molecular partners shows that RanBP2 forms a complex in vivo with HKI ( lanes 1 and 2 ) , mHsp70 ( lane 3 ) , and Cox11 ( lane 4 ) .
# ::alignments 39-40|0.1.2 38-39|0.1.0.0.0 36-37|0.1.0.3 35-36|0.1.0 32-33|0.1.0.0.0.0 31-32|0.2 26-27|0.1.0.1.0 25-26|0.1.0.2 24-25|0.0.1 23-24|0.1.0.1 21-22|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 19-20|0.0.0 17-18|0.1.1 15-16|0.1 12-13|0 11-12|0.0 10-11|0.0.2 7-8|0.0.3 5-6|0.1.0.2.0.0.0+0.1.0.2.0.0+0.1.0.2.0 1-2|0.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:24.020
(s / show-01 
      :ARG0 (p / partner-01 
            :ARG0 (v / vivo) 
            :ARG1 1 
            :mod (m / molecule) 
            :prep-against-of (a3 / antibodi)) 
      :ARG1 (f / form-02 
            :ARG0 (a / and 
                  :op1 (o / organization 
                        :ARG0-of (l / lane-01 
                              :ARG1 3) 
                        :name (n / name 
                              :op1 "HKI")) 
                  :op2 (l3 / lane-01 
                        :ARG0 2 
                        :ARG1 (e / E)) 
                  :op3 (a2 / and 
                        :op1 (t / thing 
                              :name (n2 / name 
                                    :op1 "RanBP2"))) 
                  :op4 (c / Cox11)) 
            :ARG1 (c2 / complex) 
            :ARG2 4) 
      :ARG2 (l2 / lane-01))

# ::snt Lanes 5 , 6 , and 7 are control immunoprecipitation reactions with different antibodies against the RanBP2 domains , KBD , ZnF , and XAFXFG of nucleoporins .
# ::tok Lanes 5 , 6 , and 7 are control immunoprecipitation reactions with different antibodies against the RanBP2 domains , KBD , ZnF , and XAFXFG of nucleoporins .
# ::alignments 26-27|0.2.2.1.2.0 24-26|0.2.2.1.2.1.1+0.2.2.1.2.1.0+0.2.2.1.2.1+0.2.2.1.2 23-24|0.2.2.1 21-22|0.2.2.0.0+0.2.2.0+0.2.2 19-20|0.2.2.1.1.0.0+0.2.2.1.1.0+0.2.2.1.1 17-18|0.2.2.1.0 16-17|0.2.2.1.0.0.0.0+0.2.2.1.0.0.0+0.2.2.1.0.0 13-14|0.1 12-13|0.1.0 10-11|0 9-10|0.0 8-9|0.2.0 6-7|0.1.0.1 5-6|0.2 3-4|0.1.0.2 1-2|0.1.0.0 0-1|0.2.1.0.0+0.2.1.0+0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:24.549
(r / react-01 
      :ARG1 (i / immunoprecipitation) 
      :ARG2 (a2 / antibodi 
            :ARG1-of (d2 / differ-02 
                  :ARG0 5 
                  :ARG2 7 
                  :op1-of 6)) 
      :domain (a3 / and 
            :ARG1-of (c / control-01) 
            :op1 (o3 / organization 
                  :name (n6 / name 
                        :op1 "Lanes")) 
            :op2 (p / person 
                  :name (n3 / name 
                        :op1 "ZnF") 
                  :op3-of (a / and 
                        :op1 (d / domain 
                              :mod (t / thing 
                                    :name (n5 / name 
                                          :op1 "RanBP2"))) 
                        :op2 (o2 / organization 
                              :name (n4 / name 
                                    :op1 "KBD")) 
                        :op4 (o / organization 
                              :mod-of (n / nucleoporin) 
                              :name (n2 / name 
                                    :op1 "XAFXFG" 
                                    :op2 "of"))))))

# ::snt ( F ) Reciprocal coimmunoprecipitation of HKI with antibodies against RanBP2 ( used and shown in ( E ) ) .
# ::tok ( F ) Reciprocal coimmunoprecipitation of HKI with antibodies against RanBP2 ( used and shown in ( E ) ) .
# ::alignments 17-18|0.0.1.0.1 14-15|0.0 13-14|0.0.1 12-13|0.0.1.0 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.0.0.1 6-7|0.2.0.0+0.2.0+0.2 4-5|0 3-4|0.1 1-2|0.0.1.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:24.698
(c / coimmunoprecipitation 
      :ARG1-of (s / show-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "RanBP2") 
                  :prep-against-of (a2 / antibodi)) 
            :op2-of (a / and 
                  :op1 (u / use-01 
                        :ARG0 (a3 / aircraft-type 
                              :name (n3 / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :ARG1 (e / E)))) 
      :mod (r / reciprocal) 
      :poss (o / organization 
            :name (n2 / name 
                  :op1 "HKI")))

# ::snt ( G ) Reconstitution pull-down assays with purified LD and increasing concentrations of native ( top panel ) , denatured ( middle panel ) , and partially denatured ( bottom panel ) Cox11 , respectively , in the absence and presence of denaturating agent , GnHCl and chaotropic agent , urea .
# ::tok ( G ) Reconstitution pull-down assays with purified LD and increasing concentrations of native ( top panel ) , denatured ( middle panel ) , and partially denatured ( bottom panel ) Cox11 , respectively , in the absence and presence of denaturating agent , GnHCl and chaotropic agent , urea .
# ::alignments 50-51|0.0.0.0 48-49|0.2 46-47|0 45-46|0.1.0.0+0.1.0+0.1 43-44|0.0 40-41|0.0.0.3.1 39-40|0.0.0.3 38-39|0.0.0 34-35|0.1.1.0 32-33|0.0.0.4.0 30-31|0.1.1.3.3 29-30|0.1.1.3.3.0 26-27|0.1.1.3.2 25-26|0.0.0.4 22-23|0.1.1.3.0 21-22|0.0.0.1 16-17|0.0.0.2 15-16|0.0.0.2.0 13-14|0.1.1.3.1.0 11-12|0.1.1.3.1 10-11|0.1.1.3 9-10|0.1.1 7-9|0.1.1.2.0.1+0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 5-6|0.1.1.1 1-2|0.0.0.3.0.1+0.0.0.3.0.0.0+0.0.0.3.0.0+0.0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:25.406
(a2 / and 
      :op1 (a3 / agent 
            :ARG1-of (a5 / absent-01 
                  :ARG0 (u / urea) 
                  :op1-of (m / middle) 
                  :op1-of (p6 / panel 
                        :mod (t / top)) 
                  :op2-of (a4 / and 
                        :op1 (o / organization 
                              :name (n4 / name 
                                    :op1 "G-8") 
                              :wiki "G8") 
                        :op3 (p2 / presence)) 
                  :time-of (a6 / and 
                        :op1 (c / Cox11)))) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "GnHCl") 
            :op4-of (a7 / and 
                  :mod (r / respective) 
                  :op1 (a8 / assay) 
                  :op2 (t2 / thing 
                        :name (n3 / name 
                              :op1 (p7 / purified) 
                              :op2 (l / LD))) 
                  :op3 (i / increase-01 
                        :ARG0 (p5 / panel) 
                        :ARG1 (c2 / concentration 
                              :mod (n2 / native)) 
                        :ARG2 (p4 / partial) 
                        :op1-of (p3 / panel 
                              :mod (b / bottom))))) 
      :op3 (a / agent))

# ::snt Folding intermediates ( lower panel ) of Cox11 exhibit the highest binding activity toward the LD of RanBP2 .
# ::tok Folding intermediates ( lower panel ) of Cox11 exhibit the highest binding activity toward the LD of RanBP2 .
# ::alignments 17-18|0.1.4.1.0.0+0.1.4.1.0+0.1.4.1 15-16|0.1.4.0.0+0.1.4.0+0.1.4 12-13|0.1 11-12|0.1.2 10-11|0.1.3.0+0.1.3 8-9|0 7-8|0.0 4-5|0.1.1 3-4|0.1.1.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:26.054
(e / exhibit-01 
      :ARG0 (c / Cox11) 
      :ARG1 (a / activity-06 
            :ARG0 (i / intermediate 
                  :ARG1-of (f / fold-01)) 
            :ARG1 (p2 / panel 
                  :ARG1-of (l / low-04)) 
            :ARG1-of (b / binding-07) 
            :ARG1-of (h / high-02 
                  :degree (m / most)) 
            :ARG2 (o / organization 
                  :name (n2 / name 
                        :op1 "LD") 
                  :part-of (p / person 
                        :name (n / name 
                              :op1 "RanBP2")))))

# ::snt ( H ) Similar experiments as in ( G ) but in the presence of native Cox11 expressed in the absence ( top panel ) or presence ( bottom panel ) of CuSO4 .
# ::tok ( H ) Similar experiments as in ( G ) but in the presence of native Cox11 expressed in the absence ( top panel ) or presence ( bottom panel ) of CuSO4 .
# ::alignments 32-33|0.0.2.0.0.0.0.0+0.0.2.0.0.0.0+0.0.2.0.0.0 29-30|0.0.0 28-29|0.0.0.0 26-27|0.0.2.0.0 25-26|0.0.2.0 23-24|0.1.0.1.0 22-23|0.1.0.1 20-21|0.0.2 17-18|0.0 16-17|0.0.1 15-16|0.0.1.0 13-14|0.0.1.1 10-11|0 8-9|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 4-5|0.1.0 3-4|0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:26.864
(c2 / contrast-01 
      :ARG1 (e / express-01 
            :ARG0 (p2 / panel 
                  :mod (b / bottom)) 
            :ARG1 (c / Cox11 
                  :mod (n2 / native) 
                  :mod-of (p5 / presence)) 
            :manner (a / absent-01 
                  :op1-of (o / or 
                        :op2 (p3 / presence 
                              :poss (p / person 
                                    :name (n / name 
                                          :op1 "CuSO4")))))) 
      :ARG2 (r / resemble-01 
            :ARG1 (e2 / experiment-01 
                  :ARG0 (h / h) 
                  :ARG1 (t / top 
                        :mod-of (p4 / panel))) 
            :ARG2 (o2 / organization 
                  :name (n3 / name 
                        :op1 "G-8") 
                  :wiki "G8")))

# ::snt The mature isoform of the metallochaperone has an increased affinity toward the LD of RanBP2 .
# ::tok The mature isoform of the metallochaperone has an increased affinity toward the LD of RanBP2 .
# ::alignments 14-15|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 12-13|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 9-10|0.0.0 8-9|0.0 5-6|0.2 2-3|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:27.041
(i2 / isoform 
      :ARG0-of (i / increase-01 
            :ARG1 (a / affinity 
                  :location (o / organization 
                        :name (n2 / name 
                              :op1 "LD") 
                        :part-of (t / thing 
                              :name (n / name 
                                    :op1 "RanBP2"))))) 
      :ARG1-of (m2 / mature-02) 
      :poss (m / metallochaperone))

# ::snt LD , leucine-rich domain ; LZ , leucine zipper domain ; RBD1 -- 4 , Ran-binding domains 1 -- 4 ; ZnF , zinc finger cluster domain ; KBD , kinesin ( KIF5B/KIF5C ) - binding domain ; CLD , cyclophilin-like domain ; IR , internal repeat domain ; CY , cyclophilin domain .
# ::tok LD , leucine-rich domain ; LZ , leucine zipper domain ; RBD1 -- 4 , Ran-binding domains 1 -- 4 ; ZnF , zinc finger cluster domain ; KBD , kinesin ( KIF5B/KIF5C ) - binding domain ; CLD , cyclophilin-like domain ; IR , internal repeat domain ; CY , cyclophilin domain .
# ::alignments 52-53|0.0.0.1.3.0.0 51-52|0.0.0.1.3.0 47-48|0.0.0.1.4 46-47|0.0.0.1 45-46|0.0.0.1.4.0 41-42|0.0.0.1.4.0.0 38-39|0.0.0.0.0+0.0.0.0+0.0.0 36-37|0.0.0.1.4.0.1.1.1 35-36|0.0.0.1.4.0.1.1 30-31|0.0.0.1.0 28-29|0.0.0.1.3.1.0+0.0.0.1.3.1+0.0.0.1.3 26-27|0.0.1.0 25-26|0.0.1 24-25|0.0 23-24|0 21-22|0.0.0.1.2.0.0+0.0.0.1.2.0+0.0.0.1.2 19-20|0.0.1.0.0 17-18|0.0.0.1.1 16-17|0.0.0.1.4.0.1.0 15-16|0.0.0.1.4.0.1 13-14|0.0.0.1.4.0.1.1.2 9-10|0.0.0.1.4.0.1.1.3.0 8-9|0.0.0.1.4.0.1.1.3 7-8|0.0.0.1.4.0.1.1.3.0.0 5-6|0.0.0.1.2.1.1.1+0.0.0.1.2.1.1.0.0+0.0.0.1.2.1.1.0+0.0.0.1.2.1.1 4-5|0.0.0.1.2.1 3-4|0.0.0.1.4.0.1.1.0 0-1|0.0.0.1.2.1.0.0.0+0.0.0.1.2.1.0.0+0.0.0.1.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:28.165
(z / zinc 
      :mod-of (f / finger 
            :domain-of (o / organization 
                  :name (n / name 
                        :op1 "CLD") 
                  :purpose (r / repeat-01 
                        :ARG1 (k / kinesin) 
                        :ARG2 1 
                        :domain-of (p / person 
                              :name (n3 / name 
                                    :op1 "ZnF") 
                              :op3-of (a / and 
                                    :op1 (o3 / organization 
                                          :name (n5 / name 
                                                :op1 "LD")) 
                                    :op2 (p2 / person 
                                          :name (n4 / name 
                                                :op1 "LZ") 
                                          :wiki -))) 
                        :domain-of (o2 / organization 
                              :domain (c / cyclophilin 
                                    :mod-of (d / domain)) 
                              :name (n2 / name 
                                    :op1 "KBD")) 
                        :mod-of (d2 / domain 
                              :ARG1-of (i / internal-02 
                                    :ARG2 (d3 / domain) 
                                    :op2-of (r2 / ran-bind 
                                          :mod-of (d6 / domain) 
                                          :op1 (b / binding-07 
                                                :ARG0 (d8 / domain) 
                                                :ARG1 (d4 / domain) 
                                                :ARG2 4 
                                                :op1-of (z2 / zipp 
                                                      :mod-of (d7 / domain 
                                                            :mod (l / leucine))))))))) 
            :mod-of (c2 / cluster 
                  :mod-of (d5 / domain 
                        :time 4))))

# ::snt Cox 11 Inhibits HKI Activity and the LD of RanBP2 Reverses the Inhibition of Cox11 over HKI .
# ::tok Cox 11 Inhibits HKI Activity and the LD of RanBP2 Reverses the Inhibition of Cox11 over HKI .
# ::alignments 9-15|0.1.5+0.1.4+0.1.3+0.1.2+0.1.1+0.1.0+0.1+0 7-8|0.0.2.0.0+0.0.2.0+0.0.2 5-6|0.0 3-5|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 2-3|0.0.1.0 1-2|0.0.1.2 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:28.247
(t / thing 
      :location (a / and 
            :op1 (p / person 
                  :name (n4 / name 
                        :op1 "Cox")) 
            :op2 (t2 / thing 
                  :ARG1-of (i / inhibit-01) 
                  :name (n3 / name 
                        :op1 (h / HKI) 
                        :op2 (a2 / Activity)) 
                  :quant 11) 
            :op3 (o / organization 
                  :name (n2 / name 
                        :op1 "LD"))) 
      :name (n / name 
            :op1 "RanBP2" 
            :op2 "Reverses" 
            :op3 "the" 
            :op4 "Inhibition" 
            :op5 "of" 
            :op6 "Cox11"))

# ::snt To probe whether the interaction of Cox11 and HKI with the LD of RanBP2 modulates the enzymatic activity of HKI , we first examined the effect of increasing concentrations of Cox11 on the initial rates of HKI enzymatic activity ( Figure 2A ) .
# ::tok To probe whether the interaction of Cox11 and HKI with the LD of RanBP2 modulates the enzymatic activity of HKI , we first examined the effect of increasing concentrations of Cox11 on the initial rates of HKI enzymatic activity ( Figure 2A ) .
# ::alignments 40-41|0.0.0.0.1.1.1 38-39|0.0.0.0.1.1.0.0.0.0 37-38|0.0.0.0.1.1.0.0.0.0.0 34-35|0.0.0.0.1.1.0.0.0 33-34|0.0.0.0.1.1.0.0.0.1 28-29|0.0.0.0.1.1.0 27-28|0.0.0.0.1.1.0.0 25-26|0.0.0.0.1.1 23-24|0.0.0.0.1 21-22|0.0.0.0.1.0 17-18|0.0.0 16-17|0.0.0.1 14-15|0.0.0.0 13-14|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 11-12|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 8-9|0.1.0.0+0.1.0+0.1 7-8|0 4-5|0.0 1-2|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:28.937
(a3 / and 
      :ARG1-of (i3 / interact-01 
            :ARG0-of (a2 / activity-06 
                  :ARG1-of (m / modulate-01 
                        :ARG0 (t / thing 
                              :name (n / name 
                                    :op1 "RanBP2") 
                              :part (o / organization 
                                    :name (n2 / name 
                                          :op1 "LD"))) 
                        :condition-of (e3 / examine-01 
                              :ARG0 (w / we 
                                    :ARG0-of (p / probe-01)) 
                              :ARG1 (e2 / effect-03 
                                    :ARG0 (c / concentration 
                                          :ARG1-of (i2 / increase-01 
                                                :ARG0 (r / rate 
                                                      :source (a / activity-06 
                                                            :mod (e / enzymatic)) 
                                                      :time (i / initial)))) 
                                    :ARG1 (f / figure)))) 
                  :mod (e4 / enzymatic))) 
      :op1 (o2 / organization 
            :name (n3 / name 
                  :op1 "HKI")))

# ::snt Cox11 strongly inhibits HKI activity in a concentration-dependent fashion , and at ~ 15 nM of Cox11 , HKI activity could not be recorded ( Figure 2A ) .
# ::tok Cox11 strongly inhibits HKI activity in a concentration-dependent fashion , and at ~ 15 nM of Cox11 , HKI activity could not be recorded ( Figure 2A ) .
# ::alignments 25-26|0.2 23-24|0.1.0 21-22|0.1.1 20-21|0.1 19-20|0.1.0.0 14-15|0.0.1.0 13-14|0.0.1 10-11|0 8-9|0.0.2.2 4-5|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0.2 1-2|0.0.2.1 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:29.102
(a2 / and 
      :op1 (a3 / activity-06 
            :ARG0 (o / organization 
                  :name (n2 / name 
                        :op1 "HKI")) 
            :ARG1 (1 / 15 
                  :quant-of (n / nm)) 
            :ARG1-of (i / inhibit-01 
                  :ARG0 (c / Cox11) 
                  :ARG1-of (s / strong-02) 
                  :manner (f2 / fashion))) 
      :op2 (p / possible-01 
            :ARG1 (r / record-01 
                  :ARG1 (a / activity-06)) 
            :polarity -) 
      :op3 (f / figure))

# ::snt Cox11 behaves as a partial noncompetitive inhibitor of HKI by affecting the Vmax of HKI for glucose ( Figure 2B ) .
# ::tok Cox11 behaves as a partial noncompetitive inhibitor of HKI by affecting the Vmax of HKI for glucose ( Figure 2B ) .
# ::alignments 18-19|0.1.0 16-17|0.0 10-11|0 8-9|0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 6-7|0.1.1 5-6|0.1.1.0 4-5|0.1.1.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:29.157
(a / affect-01 
      :ARG1 (g / glucose) 
      :manner-of (b / behave-01 
            :ARG1 (f / figure) 
            :ARG2 (i / inhibitor 
                  :mod (n2 / noncompetitive) 
                  :mod (p / partial) 
                  :poss (o / organization 
                        :name (n / name 
                              :op1 "HKI")))))

# ::snt Then , we evaluated the effect of the LD of RanBP2 on the HK activity in the presence of a fixed inhibitory concentration of Cox11 , saturating concentration of glucose substrate , and increasing concentrations of LD .
# ::tok Then , we evaluated the effect of the LD of RanBP2 on the HK activity in the presence of a fixed inhibitory concentration of Cox11 , saturating concentration of glucose substrate , and increasing concentrations of LD .
# ::alignments 34-35|0.0.0.0.1.0.0 33-34|0.0.0.0.1.0 32-33|0.0.0.0.1 30-31|0.0 29-30|0 27-28|0.0.0 26-27|0.0.0.0 24-25|0.0.0.0.0.0.0.1.1.0.1 22-23|0.0.0.0.0.0.0.1.1.0 21-22|0.0.0.0.0.0.0.1.1.0.0 20-21|0.0.0.0.0.0.0.1.1.0.0.0 17-18|0.0.0.0.0.0.0.1.1 14-15|0.0.0.0.0.0.0.1 13-14|0.0.0.0.0.0.0.1.0.0.0+0.0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.0.1.0 10-11|0.0.0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.0.0.1.0+0.0.0.0.0.0.0.0.1 8-9|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:30.037
(g / glucose 
      :mod-of (s / substrate 
            :ARG1-of (c2 / concentrate-02 
                  :ARG1-of (s2 / saturate-01 
                        :ARG0 (w / we 
                              :ARG0-of (e2 / evaluate-01 
                                    :ARG1 (e / effect-03 
                                          :ARG0 (o / organization 
                                                :name (n3 / name 
                                                      :op1 "LD") 
                                                :part-of (p2 / person 
                                                      :name (n2 / name 
                                                            :op1 "RanBP2"))) 
                                          :ARG1 (a2 / activity-06 
                                                :ARG0 (c5 / country 
                                                      :name (n / name 
                                                            :op1 "HK")) 
                                                :location (p / presence 
                                                      :op1 (c4 / concentrate-02 
                                                            :ARG0 (i2 / inhibitory 
                                                                  :ARG1-of (f / fix-03)) 
                                                            :ARG1 (c3 / Cox11))))) 
                                    :time (t / then))) 
                        :op1-of (a / and 
                              :op2 (i / increase-01 
                                    :ARG1 (c / concentration)))))))

# ::snt As shown in Figure 2C , the LD domain sharply reversed the inhibitory effect of Cox11 on HKI activity in a concentration-dependent manner , but under saturating ( and stochiometric ) amounts of LD , the velocity of the reaction did not reach that observed for HKI activity in the absence of Cox11 ( Figure 2A ) , suggesting the LD by itself may also have an effect on HKI activity .
# ::tok As shown in Figure 2C , the LD domain sharply reversed the inhibitory effect of Cox11 on HKI activity in a concentration-dependent manner , but under saturating ( and stochiometric ) amounts of LD , the velocity of the reaction did not reach that observed for HKI activity in the absence of Cox11 ( Figure 2A ) , suggesting the LD by itself may also have an effect on HKI activity .
# ::alignments 70-71|0.0.1.1.1.0.0 64-65|0.0.1.1.2.0 63-64|0.0.1.1.2 58-59|0.0.1.1.3.0.0 54-55|0.0.1.1.1.0.0.0 50-51|0.0.1.1.1.0.1 47-48|0.0.1.1.1.0 44-45|0.0.1.1.1 42-43|0.0.1.1 41-42|0.0.1.1.1.0.0.1 39-40|0.0.1.2.1 36-37|0.0.1.1.0 31-32|0.0.1.2.1.0 28-29|0.0.1.1.3.0 26-27|0.0.1.1.3 24-25|0 22-23|0.0.1.2.2 18-19|0.0.1.2 17-18|0.0.1.2.0.0.0+0.0.1.2.0.0+0.0.1.2.0 15-16|0.0.1.0 13-14|0.0.1 12-13|0.0.1.3 10-11|0.0 9-10|0.0.2 8-9|0.0.0 7-8|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 3-4|0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:31.037
(c / contrast-01 
      :ARG1 (r3 / reverse-01 
            :ARG0 (d / domain 
                  :ARG0-of (s4 / show-01 
                        :ARG1 (f2 / figure)) 
                  :mod (o3 / organization 
                        :name (n2 / name 
                              :op1 "LD"))) 
            :ARG1 (e / effect-03 
                  :ARG0 (c2 / Cox11) 
                  :ARG1-of (r / reach-01 
                        :ARG0 (v / velocity) 
                        :ARG1-of (o / observe-01 
                              :ARG2 (a4 / activity-06 
                                    :ARG1 (a / activity-06 
                                          :ARG0 (f / figure) 
                                          :op1-of -) 
                                    :ARG2 (a3 / absent-01))) 
                        :ARG1-of (p / possible-01 
                              :mod (a2 / also)) 
                        :manner (s2 / saturate-01 
                              :op1-of (a6 / and 
                                    :ARG1-of (s / suggest-01)))) 
                  :ARG3 (a7 / activity-06 
                        :ARG0 (o2 / organization 
                              :name (n / name 
                                    :op1 "HKI")) 
                        :ARG1 (r2 / react-01 
                              :ARG1 (a5 / amount)) 
                        :location (m / manner)) 
                  :mod (i / inhibitory)) 
            :manner (s3 / sharp)))

# ::snt Indeed , a saturating concentration of LD reduced the Vmax but not the Km of HKI ( Figure 2D ) by ~ 20 % under similar conditions .
# ::tok Indeed , a saturating concentration of LD reduced the Vmax but not the Km of HKI ( Figure 2D ) by ~ 20 % under similar conditions .
# ::alignments 26-27|0.0.0 25-26|0.0 23-24|0.1.0.3 22-23|0.1.0.3.0 18-19|0.1.0.0 17-18|0.1.0.2.0 15-16|0.2.0.0+0.2.0+0.2 13-14|0.2.1 11-12|0.2.1.0 10-11|0 7-8|0.1 6-7|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 4-5|0.1.0 3-4|0.1.0.2 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:31.315
(c2 / contrast-01 
      :ARG1 (r / resemble-01 
            :ARG1 (c / condition)) 
      :ARG1-of (r2 / reduce-01 
            :ARG0 (c3 / concentrate-02 
                  :ARG0 2d 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "LD")) 
                  :ARG1-of (s / saturate-01 
                        :ARG0 (f / figure)) 
                  :op1-of (p / percentage-entity 
                        :value 20)) 
            :mod (i / indeed)) 
      :ARG2 (o / organization 
            :name (n / name 
                  :op1 "HKI") 
            :poss-of (k / km 
                  :mod -)))

# ::snt Effect of Cox11 and RanBP2 on HKI Activity .
# ::tok Effect of Cox11 and RanBP2 on HKI Activity .
# ::alignments 6-8|0.1.0.1+0.1.0.0+0.1.0+0.1 4-5|0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:31.435
(e / effect-01 
      :ARG0 (a / and 
            :op1 (c / Cox11) 
            :op2 (t / thing 
                  :name (n2 / name 
                        :op1 "RanBP2"))) 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "HKI" 
                  :op2 "Activity")))

# ::snt ( A ) Saturation kinetics , rate versus glucose of HKI ( 0.24 g ) in the absence ( solid circles ) and presence of Cox11 ( open circles , 0.25 nM ; solid triangles , 7.5 nM ) .
# ::tok ( A ) Saturation kinetics , rate versus glucose of HKI ( 0.24 g ) in the absence ( solid circles ) and presence of Cox11 ( open circles , 0.25 nM ; solid triangles , 7.5 nM ) .
# ::alignments 34-35|0.2 33-34|0.2.0 32-33|0 31-32|0.2.0.0 28-29|0.1.1 27-28|0.1 25-26|0.0.1.1.0 23-24|0.0.1.1 22-23|0.0.1 20-21|0.2.0.1.0 19-20|0.2.0.1 17-18|0.0 13-14|0.1.0 10-11|0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0 8-9|0.0.1.0.0.0 7-8|0.0.1.0.0 6-7|0.0.1.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:31.796
(a / and 
      :ARG1-of (a3 / absent-01 
            :ARG0 (s3 / saturation) 
            :op1-of (a2 / and 
                  :location-of (r / rate 
                        :location (v / versu 
                              :op1 (g2 / glucose 
                                    :poss (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "HKI"))))) 
                  :op2 (p / presence 
                        :mod (c2 / Cox11)))) 
      :op1 (o / open-04 
            :ARG0 (g / g) 
            :ARG1 (c / circle)) 
      :op2 (t / triangl 
            :ARG1-of (s / solid-02 
                  :ARG0 (n / nm) 
                  :ARG1-of (s2 / solid-02 
                        :ARG0 (c3 / circle)))))

# ::snt The activity of HKI decreases with increasing concentrations of Cox11 .
# ::tok The activity of HKI decreases with increasing concentrations of Cox11 .
# ::alignments 7-8|0.1 6-7|0.1.0 4-5|0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:31.823
(d / decrease-01 
      :ARG1 (a / activity-06 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "HKI"))) 
      :ARG2 (c / concentration 
            :ARG1-of (i / increase-01)))

# ::snt No measurable HKI activity was recorded in the presence of 15 nM of Cox11 ( unpublished data ) .
# ::tok No measurable HKI activity was recorded in the presence of 15 nM of Cox11 ( unpublished data ) .
# ::alignments 16-17|0.1 15-16|0 13-14|0.0.0.1 11-12|0.0.0.1.0 10-11|0.0.0.1.0.0 8-9|0.0.0.2.0 5-6|0.0.0.2 3-4|0.0.0 2-3|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0 0-1|0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:32.035
(u / unpublish 
      :ARG0-of (m / measure-01 
            :ARG1 (a / activity-06 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "HKI")) 
                  :ARG1 (c / Cox11 
                        :mod-of (n / nm 
                              :quant 15)) 
                  :ARG1-of (r / record-01 
                        :location (p / presence) 
                        :polarity -))) 
      :mod-of (d / data))

# ::snt ( B ) Hanes-Wolf plot of ( A ) ( 1/rate versus glucose ) in the absence and presence of fixed concentrations of Cox11 .
# ::tok ( B ) Hanes-Wolf plot of ( A ) ( 1/rate versus glucose ) in the absence and presence of fixed concentrations of Cox11 .
# ::alignments 23-24|0.0.0.0.0.0.1 21-22|0.0.0.0.0.0 20-21|0.0.0.0.0.0.0 18-19|0.0.0.0.1 17-18|0.0.0.0 16-17|0.0.0.0.0 12-13|0.0 11-12|0 4-5|0.0.0 1-2|0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:32.176
(v / versu 
      :op1 (g / glucose 
            :ARG1-of (p2 / plot-01 
                  :location (a / and 
                        :op1 (a2 / absent-01 
                              :ARG1 (c2 / concentration 
                                    :ARG1-of (f / fix-03 
                                          :ARG0 (l / location 
                                                :name (n / name 
                                                      :op1 "B") 
                                                :wiki -)) 
                                    :mod (c / Cox11))) 
                        :op2 (p / presence)))))

# ::snt Linearity of reciprocal plots also supported the hyperbolic behavior of the reactions ( unpublished data ) .
# ::tok Linearity of reciprocal plots also supported the hyperbolic behavior of the reactions ( unpublished data ) .
# ::alignments 14-15|0.1 13-14|0 11-12|0.0.1.0 8-9|0.0.1 7-8|0.0.1.1 5-6|0.0 4-5|0.0.2 3-4|0.0.1.2.0 2-3|0.0.1.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:32.410
(u / unpublish 
      :ARG2-of (s / support-01 
            :ARG0 (l / linearity) 
            :ARG1 (b / behave-01 
                  :ARG0 (r / react-01) 
                  :ARG1 (h / hyperbolic) 
                  :mod (r2 / reciprocal 
                        :mod-of (p / plot))) 
            :mod (a / also)) 
      :mod-of (d / data))

# ::snt Cox11 behaves as a noncompetitive inhibitor of HKI by reducing the Vmax of HKI but not its Km toward glucose .
# ::tok Cox11 behaves as a noncompetitive inhibitor of HKI by reducing the Vmax of HKI but not its Km toward glucose .
# ::alignments 19-20|0.1.1.0.1.0 17-18|0.0 15-16|0.1.1.0.0 14-15|0 9-10|0.1.1.0.1 7-8|0.1.0.0+0.1.0+0.1 5-6|0.1.1 4-5|0.1.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:32.473
(c / contrast-01 
      :ARG2 (k / km) 
      :instrument (o / organization 
            :name (n / name 
                  :op1 "HKI") 
            :poss-of (i / inhibitor 
                  :ARG1-of (b / behave-01 
                        :ARG0 - 
                        :manner (r / reduce-01 
                              :ARG1 (g / glucose))) 
                  :mod (n2 / noncompetitive))))

# ::snt ( C ) HKI rate is plotted as a function of LD concentration at saturating glucose and fixed Cox11 ( 7.5 nM ) concentrations .
# ::tok ( C ) HKI rate is plotted as a function of LD concentration at saturating glucose and fixed Cox11 ( 7.5 nM ) concentrations .
# ::alignments 23-24|0.1 18-19|0.0.0.0 17-18|0.0.0.0.0 16-17|0 15-16|0.0 14-15|0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 9-10|0.0.0.1.1 6-7|0.0.0.1.1.0 4-5|0.0.0.1.1.0.1 1-2|0.0.0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:32.689
(a / and 
      :op1 (g / glucose 
            :ARG1-of (s / saturate-01 
                  :ARG0 (c2 / Cox11 
                        :ARG1-of (f / fix-03)) 
                  :ARG1-of (c3 / concentrate-02 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "LD")) 
                        :ARG1-of (f2 / function-01 
                              :ARG2-of (p / plot-01 
                                    :ARG0 (c4 / C) 
                                    :ARG1 (r / rate)))))) 
      :op2 (c / concentration))

# ::snt Note that increasing concentrations of the LD of RanBP2 reverse the inhibition of HKI activity by Cox11 .
# ::tok Note that increasing concentrations of the LD of RanBP2 reverse the inhibition of HKI activity by Cox11 .
# ::alignments 16-17|0.0.1.0.1 14-15|0.0.1.0 13-14|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 11-12|0.0.1 9-10|0.0 8-9|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 6-7|0.0.0.1.1.0+0.0.0.1.1+0.0.0.1 3-4|0.0.0 2-3|0.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:32.962
(n4 / note-01 
      :ARG1 (r / reverse-01 
            :ARG0 (c3 / concentration 
                  :ARG1-of (i2 / increase-01) 
                  :poss (o2 / organization 
                        :location (c2 / country 
                              :name (n2 / name 
                                    :op1 "RanBP2")) 
                        :name (n3 / name 
                              :op1 "LD"))) 
            :ARG1 (i / inhibition 
                  :mod (a / activity-06 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "HKI")) 
                        :ARG1 (c / Cox11)))))

# ::snt A half-maximal effect of the LD of RanBP2 on HKI activity in the presence of 7.5 nM of Cox11 was observed at a concentration of ~ 0.05 nM of LD .
# ::tok A half-maximal effect of the LD of RanBP2 on HKI activity in the presence of 7.5 nM of Cox11 was observed at a concentration of ~ 0.05 nM of LD .
# ::alignments 23-24|0.2 20-21|0 18-19|0.0 16-17|0.0.0 13-14|0.1.2.1 10-11|0.1.2 9-10|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 7-8|0.1.1.0.0+0.1.1.0+0.1.1 5-6|0.1.0.0.0+0.1.0.0+0.1.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:33.173
(o / observe-01 
      :ARG0 (c2 / Cox11 
            :mod-of (n / nm)) 
      :ARG1 (e / effect-03 
            :ARG0 (o3 / organization 
                  :name (n4 / name 
                        :op1 "LD")) 
            :ARG1 (c3 / country 
                  :name (n3 / name 
                        :op1 "RanBP2")) 
            :ARG2 (a / activity-06 
                  :ARG0 (o2 / organization 
                        :name (n2 / name 
                              :op1 "HKI")) 
                  :ARG1 (p / presence))) 
      :ARG2 (c / concentrate-02))

# ::snt ( D ) Rate versus glucose plot in the absence and presence of the LD of RanBP2 .
# ::tok ( D ) Rate versus glucose plot in the absence and presence of the LD of RanBP2 .
# ::alignments 16-17|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 14-15|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 11-12|0.0.1 10-11|0.0 9-10|0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.1 4-5|0.0.0.1.2 3-4|0 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:33.291
(r / rate 
      :location (a / and 
            :op1 (a2 / absent-01 
                  :ARG1 (o / organization 
                        :location (c / country 
                              :name (n / name 
                                    :op1 "RanBP2")) 
                        :name (n2 / name 
                              :op1 "LD")) 
                  :ARG1-of (p2 / plot-01 
                        :ARG0 (d / D) 
                        :mod (g / glucose) 
                        :op1-of (v / versu))) 
            :op2 (p / presence)))

# ::snt At a saturating concentration of the LD of RanBP2 ( 3.75 nM ) , the HKI activity was reduced by about 20 % .
# ::tok At a saturating concentration of the LD of RanBP2 ( 3.75 nM ) , the HKI activity was reduced by about 20 % .
# ::alignments 22-23|0.0.2.1.0 21-22|0.0.2.1.0.0 20-21|0.0.2.1 18-19|0.0.2 16-17|0.0.2.0 15-16|0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 11-12|0 8-9|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 6-7|0.0.0.1.0+0.0.0.1+0.0.0 3-4|0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:33.507
(n2 / nm 
      :ARG0-of (c2 / concentrate-02 
            :ARG1 (o2 / organization 
                  :location (c / country 
                        :name (n3 / name 
                              :op1 "RanBP2")) 
                  :name (n4 / name 
                        :op1 "LD")) 
            :ARG1-of (s / saturate-01) 
            :ARG2-of (r / reduce-01 
                  :ARG1 (a2 / activity-06 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "HKI"))) 
                  :duration (a / about 
                        :op1 (p / percentage-entity 
                              :value 20)))))

# ::snt v , rate ; S , glucose .
# ::tok v , rate ; S , glucose .
# ::alignments 6-7|0.1.1 4-5|0.1.0.0+0.1.0 3-4|0 2-3|0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:33.522
(a / and 
      :op1 (r / rate) 
      :op1-of (v / v 
            :location-of (n / name 
                  :op1 "S-400") 
            :mod-of (g / glucose)))

# ::snt RanBP2 Colocalizes with HK1 , Cox11 , and mHsp70 in the Retina and Cultured Neurons .
# ::tok RanBP2 Colocalizes with HK1 , Cox11 , and mHsp70 in the Retina and Cultured Neurons .
# ::alignments 13-15|0.2.0.1+0.2.0.0+0.2.0+0.2 12-13|0 11-12|0.1.0.0+0.1.0+0.1 8-9|0.0 7-8|0.2.1 5-6|0.2.1.1 0-2|0.2.1.0.0.1+0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:33.588
(a / and 
      :op1 (m / mHsp70) 
      :op2 (c / country 
            :name (n2 / name 
                  :op1 "Retina")) 
      :op3 (p / person 
            :name (n / name 
                  :op1 "Cultured" 
                  :op2 "Neurons") 
            :op3-of (a2 / and 
                  :op1 (p2 / person 
                        :name (n3 / name 
                              :op1 "RanBP2" 
                              :op2 "Colocalizes")) 
                  :op2 (c2 / Cox11))))

# ::snt In addition to its presence at the vicinity of NPCs , we have shown previously that RanBP2 is localized to and abundant in the mitochondria-rich ellipsoid subcellular compartment of photosensory ( photoreceptor ) neurons of the retina [ 19 ] .
# ::tok In addition to its presence at the vicinity of NPCs , we have shown previously that RanBP2 is localized to and abundant in the mitochondria-rich ellipsoid subcellular compartment of photosensory ( photoreceptor ) neurons of the retina [ 19 ] .
# ::alignments 38-39|0.3 36-37|0.4 33-34|0.1.0.2 31-32|0.2 27-28|0.1.0 26-27|0.1.0.0 25-26|0.1.0.1 21-22|0.1.1.0 20-21|0.1.2 18-19|0.1 16-17|0.1.1.1.0+0.1.1.1+0.1.1 14-15|0.5 13-14|0 11-12|0.0 9-10|0.5.0 7-8|0.5.0.0 4-5|0.5.0.0.0 1-2|0.6 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:33.966
(s2 / show-01 
      :ARG0 (w / we) 
      :ARG1 (l / localize-01 
            :ARG0 (c / compartment 
                  :mod (s / subcellular) 
                  :mod (e / ellipsoid) 
                  :poss (n / neuron)) 
            :ARG1 (c2 / country 
                  :domain-of (a / abundance) 
                  :name (n2 / name 
                        :op1 "RanBP2")) 
            :op1-of (a2 / and)) 
      :ARG2 (p / photoreceptor) 
      :op1-of 19 
      :op1-of (r / retina) 
      :time (p2 / previous 
            :quant-of (n3 / npc 
                  :mod-of (v / vicinity 
                        :location-of (p3 / presence)))) 
      :time (a3 / addition))

# ::snt We extended the subcellular colocalization studies on RanBP2 and its novel partners by immunocytochemistry to determine if RanBP2 , Cox11 , HKI , and mHsp70 colocalize in hippocampal neurons ( Figure 3A -- 3C ) , cerebral cortex neurons ( Figure 3D -- 3F ) , ellipsoid ( mitochondria-rich ) subcellular compartments of photosensory neurons of the retina ( Figure 3G -- 3O ) , and dissociated primary glia and neuron cultures from the brain ( Figure 3P -- 3Z ) .
# ::tok We extended the subcellular colocalization studies on RanBP2 and its novel partners by immunocytochemistry to determine if RanBP2 , Cox11 , HKI , and mHsp70 colocalize in hippocampal neurons ( Figure 3A -- 3C ) , cerebral cortex neurons ( Figure 3D -- 3F ) , ellipsoid ( mitochondria-rich ) subcellular compartments of photosensory neurons of the retina ( Figure 3G -- 3O ) , and dissociated primary glia and neuron cultures from the brain ( Figure 3P -- 3Z ) .
# ::alignments 76-77|0.5 74-75|0.4.1.3 71-72|0.4.1.2 70-71|0.4.1.2.0 69-70|0.4.1 68-69|0.4.1.1 67-68|0.4.1.1.0 66-67|0.4 65-66|0 59-60|0.4.3.1 57-58|0.4.0.0.0 54-55|0.4.0.0 51-52|0.4.0 41-42|0.4.2 40-41|0.4.1.0 38-39|0.0.0.0.0.0.1.0.0 37-38|0.0.0.0.0.0.1.0.0.0 36-37|0.0.0.0.0.0.1.0 30-31|0.4.3.0 28-29|0.0.0.0.0.1 25-26|0.3 23-24|0.4.3 21-22|0.2.0.0+0.2.0+0.2 19-20|0.1 15-16|0.0 13-14|0.0.0.0.0.0.1.1 11-12|0.0.0.0.0.0.1 10-11|0.0.0.0.0.0.1.2 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 5-6|0.0.0.0.0 4-5|0.0.0.0.0.2 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:37.666
(a2 / and 
      :ARG1-of (d2 / determine-01 
            :ARG0 (w / we 
                  :ARG0-of (e / extend-01 
                        :ARG1 (s / study-01 
                              :ARG1 (a4 / and 
                                    :op1 (t / thing 
                                          :name (n7 / name 
                                                :op1 "RanBP2")) 
                                    :op2 (p2 / partner-01 
                                          :ARG1 (c4 / cerebral 
                                                :mod-of (n3 / neuron 
                                                      :mod (c3 / cortex))) 
                                          :location (i / immunocytochemistry) 
                                          :mod (n6 / novel))) 
                              :ARG2 (n4 / neuron) 
                              :mod (c7 / colocalization))))) 
      :op1 (c6 / Cox11) 
      :op2 (o / organization 
            :name (n5 / name 
                  :op1 "HKI")) 
      :op3 (c5 / colocalize) 
      :op4 (d / dissociate-01 
            :ARG0 (c2 / compartment 
                  :mod (n2 / neuron 
                        :poss (r / retina))) 
            :ARG1 (a / and 
                  :op1 (f3 / figure) 
                  :op2 (g / glia 
                        :mod (p / primary)) 
                  :op3 (c / culture 
                        :mod (n / neuron)) 
                  :source (b / brain)) 
            :ARG2 3D 
            :op3-of (a3 / and 
                  :op1 (f4 / figure) 
                  :op2 (f2 / figure))) 
      :op5 (f / figure))

# ::snt Double immunostaining with antibodies against these proteins showed that they colocalize to the mitochondria ( Figure 3A -- 3Z ) .
# ::tok Double immunostaining with antibodies against these proteins showed that they colocalize to the mitochondria ( Figure 3A -- 3Z ) .
# ::alignments 15-16|0.0.0.0 13-14|0.0.0.1 9-10|0.2 7-8|0 6-7|0.1 5-6|0.1.0 3-4|0.1.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:37.825
(s / show-01 
      :ARG0 (i / immunostain 
            :ARG1-of (d / double-01 
                  :op1-of (f / figure) 
                  :op1-of (m / mitochondrion))) 
      :ARG1 (p / protein 
            :mod (t2 / this) 
            :prep-against-of (a / antibodi)) 
      :ARG2 (t / they))

# ::snt Localization of RanBP2 and Its LD Molecular Partners .
# ::tok Localization of RanBP2 and Its LD Molecular Partners .
# ::alignments 5-8|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 4-5|0.1.2 3-4|0 2-3|0.1.1.0.0+0.1.1.0+0.1.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:37.854
(a / and 
      :op1 (l / localization) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "LD" 
                  :op2 "Molecular" 
                  :op3 "Partners") 
            :poss (c / country 
                  :name (n2 / name 
                        :op1 "RanBP2")) 
            :poss (i / it)))

# ::snt ( A -- F ) are thin cryosections of an area of the hipocampus ( CA1 neurons ) and cerebral cortex , respectively , immunostained against HKI ( A and D ) , RanBP2 ( B and E ) , and merged images thereof ( C and F ) .
# ::tok ( A -- F ) are thin cryosections of an area of the hipocampus ( CA1 neurons ) and cerebral cortex , respectively , immunostained against HKI ( A and D ) , RanBP2 ( B and E ) , and merged images thereof ( C and F ) .
# ::alignments 47-48|0.2.2+0.2.0.0+0.2.0+0.2 46-47|0 45-46|0.1 43-44|0.2.1.0.1.1.0.0.0 42-43|0.2.1.2 41-42|0.2.1.2.0 40-41|0.2.1 37-38|0.2.1.0.2.1.1 36-37|0.2.1.0.2.1 35-36|0.2.1.0.2.1.0.1+0.2.1.0.2.1.0.0.0+0.2.1.0.2.1.0.0+0.2.1.0.2.1.0 33-34|0.2.1.0.2.0.0+0.2.1.0.2.0+0.2.1.0.2 30-31|0.2.1.1 29-30|0.2.1.0 26-27|0.2.1.0.1.0.0+0.2.1.0.1.0+0.2.1.0.1 22-23|0.0 20-21|0.2.1.2.0.0 19-20|0.2.1.2.0.0.0 18-19|0.2.1.0.1.1 16-17|0.2.1.0.1.1.1 13-14|0.2.1.0.1.1.0.1.0 10-11|0.2.1.0.1.1.0.1 7-8|0.2.1.0.1.1.0 6-7|0.2.1.0.1.1.0.0 3-4|0.2.1.0.0.1+0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:38.389
(a2 / and 
      :mod (r / respective) 
      :op1 (c / C) 
      :op2 (a / aircraft-type 
            :name (n / name 
                  :op1 "F22") 
            :op4-of (a3 / and 
                  :op1 (a5 / and 
                        :op1 (a8 / aircraft-type 
                              :name (n6 / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor") 
                        :op2 (o / organization 
                              :name (n4 / name 
                                    :op1 "HKI") 
                              :op3-of (a6 / and 
                                    :op1 (c4 / cryosection 
                                          :ARG1-of (t2 / thin-03 
                                                :ARG0 (t / thereof)) 
                                          :poss (a7 / area 
                                                :mod (h / hipocampu))) 
                                    :op2 (n5 / neuron))) 
                        :op3 (p / person 
                              :name (n3 / name 
                                    :op1 "RanBP2") 
                              :op1-of (a4 / and 
                                    :op2 (l / location 
                                          :name (n2 / name 
                                                :op1 "B") 
                                          :wiki -) 
                                    :op3 (e / E)))) 
                  :op2 (d / D) 
                  :op3 (i / image 
                        :ARG1-of (m / merge-01 
                              :ARG0 (c2 / cortex 
                                    :mod (c3 / cerebral))))) 
            :wiki "Lockheed_Martin_F-22_Raptor"))

# ::snt Note that while RanBP2 and HKI are widely expressed among and colocalize to hippocampal neurons ( C ) , HKI expression and localization with RanBP2 is restricted to a subset of cortical neurons ( likely interneurons ) ( F ) .
# ::tok Note that while RanBP2 and HKI are widely expressed among and colocalize to hippocampal neurons ( C ) , HKI expression and localization with RanBP2 is restricted to a subset of cortical neurons ( likely interneurons ) ( F ) .
# ::alignments 38-39|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 35-36|0.1.2.1.1 34-35|0.1.2.1 32-33|0.1.1.0 31-32|0.1.1.0.0 29-30|0.1.1 26-27|0.1 22-23|0.1.0.1 21-22|0.1.0 20-21|0.1.0.0 16-17|0.1.2.1.0 14-15|0.0 10-11|0.1.2 8-9|0.1.2.0 7-8|0.1.2.0.1 5-6|0.1.2.0.0.1.0.0+0.1.2.0.0.1.0+0.1.2.0.0.1 4-5|0.1.2.0.0 3-4|0.1.2.0.0.0.0.0+0.1.2.0.0.0.0+0.1.2.0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:39.072
(n6 / note-01 
      :ARG0 (n3 / neuron) 
      :ARG1 (r / restrict-01 
            :ARG1 (a2 / and 
                  :op1 (e / express-01 
                        :ARG1 (a / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor")) 
                  :op2 (l2 / localization)) 
            :ARG2 (s / subset 
                  :mod (n2 / neuron 
                        :mod (c / cortical))) 
            :purpose (a3 / and 
                  :op1 (e2 / express-01 
                        :ARG1 (a4 / and 
                              :op1 (t / thing 
                                    :name (n5 / name 
                                          :op1 "RanBP2")) 
                              :op2 (o / organization 
                                    :name (n4 / name 
                                          :op1 "HKI"))) 
                        :degree (w / wide)) 
                  :op2 (l / likely-01 
                        :ARG0 (c2 / C) 
                        :ARG1 (i / interneuron)))))

# ::snt Images of the distal region of bovine retinal cryosections comprising part of the nuclear layer of photoreceptor neurons and their inner ( myoid and ellipsoid ) segment compartment ( G -- O ) are immunostained against mHsp70 ( G ) and RanBP2 ( H ) , mHsp70 ( J ) and Cox11 ( K ) , HKI ( M ) and Cox11 ( N ) , and merged images thereof ( I -- O ) .
# ::tok Images of the distal region of bovine retinal cryosections comprising part of the nuclear layer of photoreceptor neurons and their inner ( myoid and ellipsoid ) segment compartment ( G -- O ) are immunostained against mHsp70 ( G ) and RanBP2 ( H ) , mHsp70 ( J ) and Cox11 ( K ) , HKI ( M ) and Cox11 ( N ) , and merged images thereof ( I -- O ) .
# ::alignments 73-74|0.2.4.2.2.4.1+0.2.4.2.2.4.0.0+0.2.4.2.2.4.0+0.2.4.2.2.4 71-72|0.2.4.2.4.0.0 69-70|0.3 68-69|0.2.4.2.4 67-68|0.2.4.2.4.0 66-67|0.2.4.2 63-64|0.2.4.1.3 60-61|0.2.4.1.2 58-59|0.2.4.1.1.1+0.2.4.1.1.0.0+0.2.4.1.1.0+0.2.4.1.1 56-57|0.2.4.2.3.0.0+0.2.4.2.3.0+0.2.4.2.3 53-54|0.2.4.1.0 51-52|0.2.4.2.2.3 50-51|0.2.4.2.2 48-49|0.2.4.2.1.1+0.2.4.2.1.0.0+0.2.4.2.1.0+0.2.4.2.1 43-44|0.2.4.2.0 41-42|0.2.4.0.0+0.2.4.0+0.2.4 40-41|0.2.4.1 38-39|0.2.3.1+0.2.3.0.0+0.2.3.0+0.2.3 36-37|0.2.4.2.2.2 31-32|0.2.4.1.2.0.1+0.2.4.1.2.0.0.0+0.2.4.1.2.0.0+0.2.4.1.2.0 29-30|0.2.4.2.2.1.1+0.2.4.2.2.1.0.0+0.2.4.2.2.1.0+0.2.4.2.2.1 27-28|0.2.2 26-27|0.2.2.0 23-24|0.2.4.2.2.0 20-21|0.0 18-19|0.2 17-18|0.2.1 16-17|0.1.0 14-15|0.2.0 13-14|0.2.0.0 9-10|0 8-9|0.1 7-8|0.1.1 6-7|0.1.2 4-5|0.1.3 3-4|0.1.3.0 0-1|0.1.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:40.896
(c3 / comprise-01 
      :ARG0 (i3 / inner) 
      :ARG1 (c4 / cryosection 
            :mod (p4 / photoreceptor) 
            :mod (r / retinal) 
            :mod (b / bovine) 
            :poss-of (r2 / region 
                  :mod (d / distal) 
                  :topic-of (i4 / image))) 
      :ARG2 (a7 / and 
            :op1 (l / layer 
                  :mod (n11 / nucleus)) 
            :op2 (n10 / neuron) 
            :op3 (c2 / compartment 
                  :mod (s / segment)) 
            :op4 (o2 / organization 
                  :name (n7 / name 
                        :op1 "G-8") 
                  :wiki "G8") 
            :op5 (p2 / person 
                  :name (n6 / name 
                        :op1 "RanBP2") 
                  :op1-of (a5 / and 
                        :op2 (k / k) 
                        :op3 (v / vehicle 
                              :name (n3 / name 
                                    :op1 "M1") 
                              :wiki "M1_Abrams") 
                        :op4 (a2 / and 
                              :op1 (p3 / person 
                                    :name (n8 / name 
                                          :op1 "O'Reilly") 
                                    :wiki "Bill_O'Reilly_(political_commentator)")) 
                        :op5 (n2 / N)) 
                  :op1-of (a / and 
                        :op2 (h / h) 
                        :op3 (a4 / aircraft-type 
                              :name (n5 / name 
                                    :op1 "J-10") 
                              :wiki "Chengdu_J-10") 
                        :op4 (a3 / and 
                              :op1 (a6 / and) 
                              :op2 (o3 / organization 
                                    :name (n9 / name 
                                          :op1 "G-8") 
                                    :wiki "G8") 
                              :op3 (m2 / mHsp70) 
                              :op4 (c / Cox11) 
                              :op5 (p / person 
                                    :name (n / name 
                                          :op1 "O'Reilly") 
                                    :wiki "Bill_O'Reilly_(political_commentator)")) 
                        :op5 (o / organization 
                              :name (n4 / name 
                                    :op1 "HKI")) 
                        :op6 (i2 / image 
                              :ARG1-of (m / merge-01 
                                    :ARG0 (i / i)))))) 
      :op1-of (t / thereof))

# ::snt Note the prominent localization of RanBP2 , mHsp70 , and Cox11 at the mitochondria-rich ellipsoid compartment of photoreceptors and the colocalization of RanBP2 and Cox11 with mHsp70 ( I and L ) , while HKI colocalization with Cox11 was limited to restricted foci ( R , arrowheads ) .
# ::tok Note the prominent localization of RanBP2 , mHsp70 , and Cox11 at the mitochondria-rich ellipsoid compartment of photoreceptors and the colocalization of RanBP2 and Cox11 with mHsp70 ( I and L ) , while HKI colocalization with Cox11 was limited to restricted foci ( R , arrowheads ) .
# ::alignments 46-47|0.2.0 44-45|0.3 42-43|0.2.2 41-42|0.2.2.0 39-40|0.2 34-36|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 30-31|0.0.4.1 29-30|0.0.4 28-29|0.0.4.0 23-24|0.0.3 20-21|0.0.3.0.2 18-19|0.0.3.0 17-18|0.0.3.0.1 15-16|0.0.3.0.0 14-15|0.0.3.0.0.0 10-11|0.0.2 9-10|0.0 7-8|0.0.1 5-6|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0.1 2-3|0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:41.899
(n3 / note-01 
      :ARG0 (a5 / and 
            :op1 (c5 / country 
                  :name (n2 / name 
                        :op1 "RanBP2")) 
            :op2 (m / mHsp70) 
            :op3 (c4 / Cox11) 
            :op4 (a3 / and 
                  :op4-of (a4 / and 
                        :op1 (c3 / compartment 
                              :mod (e / ellipsoid)) 
                        :op2 (p / photoreceptor) 
                        :op3 (c2 / colocalization))) 
            :op5 (a2 / and 
                  :op1 (i / i) 
                  :op2 (l2 / L))) 
      :ARG1 (l3 / localization 
            :mod (p2 / prominent)) 
      :ARG2 (l / limit-01 
            :ARG0 (a / arrowhead) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (h / HKI) 
                        :op2 (c / colocalization))) 
            :ARG2 (f / focus-01 
                  :ARG1-of (r2 / restrict-01))) 
      :op1-of (r / r))

# ::snt High-resolution images of dissociated primary cerebral neurons and glial cells confirmed that the colocalization of HKI and Cox11 was highly restricted ( P -- R ) , while RanBP2 extensively colocalized with HKI ( S -- U ) and mHsp70 ( V -- Z ) .
# ::tok High-resolution images of dissociated primary cerebral neurons and glial cells confirmed that the colocalization of HKI and Cox11 was highly restricted ( P -- R ) , while RanBP2 extensively colocalized with HKI ( S -- U ) and mHsp70 ( V -- Z ) .
# ::alignments 43-44|0.0.4 41-42|0.0.5 39-40|0.0.1.0.1.0.0 38-39|0.0.1.0.1.0 36-37|0.0.2.1 34-35|0.0.1.0.1.0.0.0.0+0.0.1.0.1.0.0.0 29-30|0.0.2.0.1.0.1 28-29|0.0.0.0.0+0.0.0.0+0.0.0 24-25|0.0.2.0.1.0.0 22-23|0 20-21|0.0 19-20|0.0.3 16-17|0.0.1.0.1 15-16|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 13-14|0.0.1 10-11|0.0.2 9-10|0.0.2.0.1.3.0 8-9|0.0.2.0.1.3.0.0 7-8|0.0.2.0.1.3 6-7|0.0.2.0.1 5-6|0.0.2.0.1.1 4-5|0.0.2.0.1.2 3-4|0.0.2.0.1.0 1-2|0.0.2.0 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:43.738
(p2 / P60 
      :ARG2-of (r2 / restrict-01 
            :ARG0 (p / person 
                  :name (n2 / name 
                        :op1 "RanBP2")) 
            :ARG1 (c / colocalization 
                  :poss (o / organization 
                        :name (n3 / name 
                              :op1 "HKI") 
                        :op1-of (a2 / and 
                              :op2 (a / and 
                                    :op1 (m / mHsp70 
                                          :name (n / name 
                                                :op1 "S-400")))))) 
            :ARG1-of (c2 / confirm-01 
                  :ARG0 (i / image 
                        :mod (h2 / high-resolution) 
                        :topic (n4 / neuron 
                              :ARG1-of (d / dissociate-01 
                                    :ARG2 (r / r) 
                                    :op1-of (e / extensive)) 
                              :mod (c4 / cerebral) 
                              :mod (p3 / primary) 
                              :op1-of (a3 / and 
                                    :op2 (c3 / cell 
                                          :mod (g / glial))))) 
                  :op1-of (u / u)) 
            :degree (h / high) 
            :op1-of (z / z) 
            :op1-of (v / v)))

# ::snt Scale bars in A -- O and P -- Z are 40 and 10 m , respectively .
# ::tok Scale bars in A -- O and P -- Z are 40 and 10 m , respectively .
# ::alignments 16-17|0.0 14-15|0.1.0.0 13-14|0.2.3 12-13|0.2.1 11-12|0.2.2 9-10|0.2.1.0 7-8|0.3 6-7|0 5-6|0.2.4+0.2.0.0+0.2.0+0.2 1-2|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:43.804
(a2 / and 
      :mod (r / respective) 
      :op1 (s / scale 
            :mod-of (b / bar 
                  :domain-of (m / m))) 
      :op2 (p2 / person 
            :name (n / name 
                  :op1 "O'Reilly") 
            :op1-of (a / and 
                  :op2 (z / z)) 
            :op1-of 40 
            :quant 10 
            :wiki "Bill_O'Reilly_(political_commentator)") 
      :op3 (p / P60))

# ::snt ONL , outer nuclear layer .
# ::tok ONL , outer nuclear layer .
# ::alignments 4-5|0.0.0 3-4|0.0 2-3|0.0.0.0 0-1|0.1.0+0.1+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:43.823
(c / country 
      :domain-of (n / nucleus 
            :mod-of (l / layer 
                  :mod (o / outer))) 
      :name (n2 / name 
            :op1 "ONL"))

# ::snt Haploinsufficiency of RanBP2 Causes Decreased Levels of HKI and Partial Mislocalization of HKI .
# ::tok Haploinsufficiency of RanBP2 Causes Decreased Levels of HKI and Partial Mislocalization of HKI .
# ::alignments 9-11|0.1.0.1+0.1.0.0+0.1.0+0.1 8-9|0 2-8|0.0.0.5+0.0.0.4+0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:43.864
(a / and 
      :op1 (t2 / thing 
            :name (n2 / name 
                  :op1 "RanBP2" 
                  :op2 "Causes" 
                  :op3 "Decreased" 
                  :op4 "Levels" 
                  :op5 "of" 
                  :op6 "HKI")) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (p / Partial) 
                  :op2 (m / Mislocalization))))

# ::snt To determine the physiological implications of the interaction between RanBP2 and HKI ( and other partners ) , we employed a murine embryonic stem 129Ola cell line with a targeted RanBP2 locus produced by gene-trapping to produce stable inbred ( coisogenic ) and mixed background lines , respectively ( Figure 4A and 4B ) .
# ::tok To determine the physiological implications of the interaction between RanBP2 and HKI ( and other partners ) , we employed a murine embryonic stem 129Ola cell line with a targeted RanBP2 locus produced by gene-trapping to produce stable inbred ( coisogenic ) and mixed background lines , respectively ( Figure 4A and 4B ) .
# ::alignments 51-52|0.0.0.0.3 49-50|0.0.1.0.0.0.0.0.0.0.0.1.0.0.0 47-48|0.0.0.0.1 45-46|0.0.1.0.0.0.0.0.0.0.0 44-45|0.0.1.0.0.0.0.0.0.0.0.0 43-44|0.0.1.0.0.0.0.0.0.0.0.1.1 42-43|0.0.1.0.0.0.0.0.0.0.0.1 38-39|0.0.1.0.0.0.0.0.0.0.0.1.0 37-38|0.0.1.0.0.0.0.0.0.0.0.1.0.0 36-37|0.0.1.0.0.0.0.0.0.0 32-33|0.0.1.0.0.0.0.0 31-32|0.0.1.0.0.0.0.0.0 29-30|0.0.1.0.0.0.0.0.0.1 26-27|0.0.1.0.0.0.0.1.0 25-26|0.0.1.0.0.0.0.1.0.0 23-24|0.0.1.0.0.0.0.1.0.1 22-23|0.0.1.0.0.0.0.0.0.0.0.1.1.0 21-22|0.0.1.0.0.0.0.1.0.2 19-20|0.0.1.0.0.0.0.1 18-19|0.0.1.0.0.0.0 15-16|0.0.0 14-15|0.0.0.0.0 13-14|0.0.0.0 11-12|0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 10-11|0 9-10|0.0.2.0+0.0.2+0.0 7-8|0.0.1 4-5|0.0.1.0+0.0.1.0.0 3-4|0.0.1.0.0.0.0.0.0.1.0 1-2|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:46.245
(a4 / and 
      :op1 (c2 / country 
            :ARG0-of (p3 / partner-01 
                  :op2-of (a3 / and 
                        :mod (o / other) 
                        :mod (r / respective) 
                        :op1 (o2 / organization 
                              :name (n / name 
                                    :op1 "HKI")) 
                        :op1-of (a / and))) 
            :ARG0-of (i2 / interact-01 
                  :ARG0-of (i3 / imply-01 
                        :ARG1 (t2 / thing 
                              :ARG1-of (d / determine-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (p2 / produce-01 
                                                :ARG1 (l2 / locu 
                                                      :ARG0-of (p / produce-01 
                                                            :ARG1 (l / line 
                                                                  :mod (b / background) 
                                                                  :op3-of (a2 / and 
                                                                        :op1 (i / inbred 
                                                                              :ARG1-of (s / stable-03 
                                                                                    :ARG0 (f / figure))) 
                                                                        :op2 (m / mix-01 
                                                                              :ARG0 (e / embryonic))))) 
                                                      :ARG1-of (t / target-01 
                                                            :ARG0 (p4 / physiological)))) 
                                          :ARG0-of (e2 / employ-01 
                                                :ARG1 (l3 / line 
                                                      :mod (c / cell) 
                                                      :mod (s2 / stem) 
                                                      :mod (m2 / murine)))))))) 
            :name (n2 / name 
                  :op1 "RanBP2")))

# ::snt Genotyping of 299 F2 offspring revealed a RanBP2 + / + : RanBP2 + /  : RanBP2  /  distribution ( 89:210:0 ) that deviated from the expected Mendelian ratio and supports that the RanBP2  /  mice were embryonically lethal .
# ::tok Genotyping of 299 F2 offspring revealed a RanBP2 + / + : RanBP2 + /  : RanBP2  /  distribution ( 89:210:0 ) that deviated from the expected Mendelian ratio and supports that the RanBP2  /  mice were embryonically lethal .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:46.247
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt E12 .5 embryos show strong expression of RanBP2 in the optic vesicle and throughout much of the embryo , which had no apparent developmental abnormalities ( Figure 4C ) .
# ::tok E12 .5 embryos show strong expression of RanBP2 in the optic vesicle and throughout much of the embryo , which had no apparent developmental abnormalities ( Figure 4C ) .
# ::alignments 26-27|0.1.0 24-25|0.2 23-24|0.2.1 22-23|0.2.0 21-22|0.2.0.0 17-18|0.4.0.0.0 14-15|0.4.0.0 13-14|0.4.0 12-13|0.4 11-12|0.3 10-11|0.3.0 7-8|0.1.1.0.0+0.1.1.0+0.1.1 5-6|0.1 4-5|0.1.2 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:46.808
(s2 / show-01 
      :ARG0 (e3 / embryo) 
      :ARG1 (e2 / express-01 
            :ARG0 (f / figure) 
            :ARG1 (c / country 
                  :name (n / name 
                        :op1 "RanBP2")) 
            :ARG1-of (s / strong-02)) 
      :ARG2 (a / abnormaliti 
            :mod (a2 / apparent 
                  :polarity -) 
            :mod (d / developmental)) 
      :ARG3 (v / vesicle 
            :mod (o / optic)) 
      :manner (a3 / and 
            :op1 (t / throughout 
                  :op1 (m / much 
                        :mod-of (e / embryo)))))

# ::snt In agreement with previous immunocytochemistry analysis [ 19 ] , the RanBP2 gene is expressed across mature retinal neurons , but expression in ganglion cells of the adult retina was extremely strong ( Figure 4D and 4E ) .
# ::tok In agreement with previous immunocytochemistry analysis [ 19 ] , the RanBP2 gene is expressed across mature retinal neurons , but expression in ganglion cells of the adult retina was extremely strong ( Figure 4D and 4E ) .
# ::alignments 35-36|0.0.3.0 33-34|0.0.3.1.0 31-32|0.1 30-31|0.1.2 28-29|0.1.1.0.1 27-28|0.1.1.1 24-25|0.1.1.0 23-24|0.1.1.0.0 21-22|0.1.1 20-21|0 18-19|0.0.2.0 17-18|0.0.2.0.1 16-17|0.0.2.0.0 15-16|0.0.2 14-15|0.0 12-13|0.0.1 7-8|0.1.0 5-6|0.0.3.1 3-4|0.0.0 1-2|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:47.256
(c2 / contrast-01 
      :ARG1 (e3 / express-01 
            :ARG0 (p / previous) 
            :ARG1 (g2 / gene) 
            :location (a3 / across 
                  :op1 (n / neuron 
                        :ARG1-of (m / mature-02) 
                        :mod (r2 / retinal))) 
            :manner (a5 / agree-01 
                  :ARG1 (a / and) 
                  :ARG2 (a4 / analyze-01 
                        :ARG1 (f / figure)))) 
      :ARG2 (s / strong-02 
            :ARG0 19 
            :ARG1 (e2 / express-01 
                  :ARG1 (c / cell 
                        :mod (g / ganglion) 
                        :part-of (r / retina)) 
                  :beneficiary (a2 / adult)) 
            :degree (e / extreme)))

# ::snt Insertion Mutagenesis of the Murine RanBP2 Gene .
# ::tok Insertion Mutagenesis of the Murine RanBP2 Gene .
# ::alignments 5-7|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 4-5|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:47.275
(m / murine 
      :mod-of (p2 / person 
            :name (n2 / name 
                  :op1 "Insertion" 
                  :op2 "Mutagenesis") 
            :topic-of (p / person 
                  :name (n / name 
                        :op1 "RanBP2" 
                        :op2 "Gene"))))

# ::snt ( A ) Diagram of the genomic region of RanBP2 disrupted by insertion trap mutagenesis with a bicistronic reporter vector between exon 1 and 2 .
# ::tok ( A ) Diagram of the genomic region of RanBP2 disrupted by insertion trap mutagenesis with a bicistronic reporter vector between exon 1 and 2 .
# ::alignments 24-25|0.0 23-24|0.1.1.0.0.0.2 22-23|0.1.1.0.0.0.0 21-22|0.1.1.0.0.0.1 19-20|0.1.0 18-19|0.1.2 13-14|0.1 12-13|0 10-11|0.1.1 9-10|0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 7-8|0.1.1.0.0 3-4|0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:47.703
(i / insert-01 
      :ARG1 2 
      :ARG1-of (t / trap-01 
            :ARG0 (v / vector) 
            :ARG0-of (d / disrupt-01 
                  :ARG1 (c / country 
                        :mod-of (r2 / region 
                              :ARG1-of (d2 / diagram-01 
                                    :ARG0 1 
                                    :location (e / exon) 
                                    :op1-of (a / and))) 
                        :name (n / name 
                              :op1 "RanBP2"))) 
            :ARG1-of (r / report-01)))

# ::snt The bicistronic transcript produces two proteins under regulation of RanBP2 .
# ::tok The bicistronic transcript produces two proteins under regulation of RanBP2 .
# ::alignments 9-10|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 7-8|0.0.1 5-6|0 4-5|0.1 3-4|0.0 2-3|0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:47.799
(p / protein 
      :ARG1-of (p2 / produce-01 
            :ARG0 (t / thing 
                  :ARG1-of (t2 / transcribe-01)) 
            :manner (r / regulate-01 
                  :ARG1 (c / country 
                        :name (n / name 
                              :op1 "RanBP2")))) 
      :quant 2)

# ::snt Upon splicing of RanBP2 , a fusion between exon 1 and -geo ( a fusion between the -gal and neo genes ) is generated , while human placental alkaline phophatase ( PLAP ) is independently translated using the internal ribosome entry site .
# ::tok Upon splicing of RanBP2 , a fusion between exon 1 and -geo ( a fusion between the -gal and neo genes ) is generated , while human placental alkaline phophatase ( PLAP ) is independently translated using the internal ribosome entry site .
# ::alignments 41-42|0.1.1 40-41|0.1.1.1 39-40|0.1.1.2 38-39|0.1.1.0 36-37|0.1 35-36|0.1.2 34-35|0.1.2.1 29-30|0.1.3 28-29|0.1.3.0 27-28|0.1.3.0.0.0 26-27|0.1.3.0.0 23-24|0.1.2.2 20-21|0.0 19-20|0.0.0 18-19|0 14-15|0.1.2.0 10-11|0.1.4 9-10|0.1.2.2.0 8-9|0.1.1.0.0 6-7|0.1.0.0.0 3-4|0.1.0.1.0+0.1.0.1+0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:48.348
(a2 / and 
      :op1 (g2 / gene 
            :mod (n / neo)) 
      :op2 (u / use-01 
            :ARG0 (c / country 
                  :ARG1-of (s2 / splice-01 
                        :ARG0 (f2 / fusion)) 
                  :name (n2 / name 
                        :op1 "RanBP2")) 
            :ARG1 (s / site 
                  :ARG1-of (i / internal-02 
                        :ARG0 (e2 / exon)) 
                  :mod (e / entry) 
                  :mod (r / ribosome)) 
            :ARG1-of (t / translate-01 
                  :ARG0 (f / fusion) 
                  :manner (i2 / independent) 
                  :purpose-of (g / generate-01 
                        :ARG1 1)) 
            :ARG2 (p / phophatase 
                  :mod (a / alkaline 
                        :mod (h / human 
                              :mod-of (p2 / placental)))) 
            :op1-of (a3 / and)))

# ::snt Consistent with previous studies , the expression of the former is directed to cell bodies , while expression of the latter is targeted to the axonal processes [ 67,68 ] .
# ::tok Consistent with previous studies , the expression of the former is directed to cell bodies , while expression of the latter is targeted to the axonal processes [ 67,68 ] .
# ::alignments 26-27|0.3.1 25-26|0.3.1.0 22-23|0.3 20-21|0.3.0.0 17-18|0.3.0 14-15|0.2 13-14|0.2.0 11-12|0 9-10|0.0 6-7|0.1 3-4|0.1.0 2-3|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:48.551
(d / direct-01 
      :ARG0 (f / former) 
      :ARG1 (e2 / express-01 
            :ARG1 (s / study-01 
                  :time (p2 / previous))) 
      :ARG2 (b / body 
            :mod (c / cell)) 
      :condition (t / target-01 
            :ARG1 (e / express-01 
                  :ARG1 (l / latter)) 
            :ARG2 (p / process-02 
                  :mod (a / axonal))))

# ::snt Transcriptional 5  RACE analysis detects a fusion between exon 1 and -geo .
# ::tok Transcriptional 5  RACE analysis detects a fusion between exon 1 and -geo .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:48.552
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( B ) Southern analysis of the RanBP2 locus of wild-type and heterozygous genomic DNA of tails of F1 mice digested with PpuMI ( left panel ) and HindIII ( right panel ) with probes at the 3  ( left panel ) and 5  ( right panel ) flanking regions of the insertion breakpoint .
# ::tok ( B ) Southern analysis of the RanBP2 locus of wild-type and heterozygous genomic DNA of tails of F1 mice digested with PpuMI ( left panel ) and HindIII ( right panel ) with probes at the 3  ( left panel ) and 5  ( right panel ) flanking regions of the insertion breakpoint .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:48.558
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Q1 is a cosmid containing the RanBP2 gene up to exon 20 [ 4 ] .
# ::tok Q1 is a cosmid containing the RanBP2 gene up to exon 20 [ 4 ] .
# ::alignments 13-14|0.0.0.0.0 11-12|0.0.1 7-8|0.0.0 6-7|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 4-5|0.0 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:48.622
(c3 / cosmid 
      :ARG0-of (c2 / contain-01 
            :ARG1 (g / gene 
                  :mod (c / country 
                        :mod-of 4 
                        :name (n / name 
                              :op1 "RanBP2"))) 
            :ARG2 20))

# ::snt ( C ) Lateroventral view of a whole-mount stain of a ~ 12.5 dpc heterozygous embryo for PLAP and -gal ( inset picture ) activities .
# ::tok ( C ) Lateroventral view of a whole-mount stain of a ~ 12.5 dpc heterozygous embryo for PLAP and -gal ( inset picture ) activities .
# ::alignments 24-25|0.0.0.1 22-23|0.0 21-22|0 18-19|0.0.0.1.1 15-16|0.0.0.1.1.0 13-14|0.0.0.0 8-9|0.0.0 4-5|0.0.0.2 1-2|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:48.715
(i / inset 
      :mod-of (p / picture 
            :ARG0-of (s / stain-01 
                  :ARG1 (d / dpc) 
                  :ARG1-of (a / activity-06 
                        :ARG0 (c / C) 
                        :op2-of (a2 / and 
                              :op1 (e / embryo))) 
                  :ARG1-of (v / view-02))))

# ::snt Although PLAP was broadly expressed ( e.g. , somites , limbs , and CNS ) , the PLAP and -Gal ( inset picture ) expression was particularly high in the optic vesicle ( arrow ) .
# ::tok Although PLAP was broadly expressed ( e.g. , somites , limbs , and CNS ) , the PLAP and -Gal ( inset picture ) expression was particularly high in the optic vesicle ( arrow ) .
# ::alignments 33-34|0.0.0.1.0 31-32|0.0.0.1.1 30-31|0.0.0.1.1.0 27-28|0.0.0.1 26-27|0.0.0.1.1.1 24-25|0.0.0 22-23|0.0.0.0.0 21-22|0.0.0.0.0.0 18-19|0.0.0.0 13-14|0.4.0.0+0.4.0+0.4 12-13|0 10-11|0.3 8-9|0.2 6-7|0.1 4-5|0.0 3-4|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:49.194
(a3 / and 
      :ARG1-of (e3 / express-01 
            :ARG0 (e / express-01 
                  :ARG1 (a2 / and 
                        :op1 (p2 / picture 
                              :mod (i / inset))) 
                  :ARG1-of (h / high-02 
                        :ARG0 (a / arrow) 
                        :ARG2 (v / vesicle 
                              :mod (o / optic) 
                              :mod (p / particular)))) 
            :manner (b / broad)) 
      :op1 (e2 / e.g.) 
      :op2 (s / somit) 
      :op3 (l / limb) 
      :op4 (o2 / organization 
            :name (n / name 
                  :op1 "CNS")))

# ::snt X-gal single ( D ) and combined staining with PLAP ( E ) of a retinal section of a 3-mo-old RanBP2 + /  mouse .
# ::tok X-gal single ( D ) and combined staining with PLAP ( E ) of a retinal section of a 3-mo-old RanBP2 + /  mouse .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:49.196
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Consistent with previous immunocytochemistry studies , -Gal activity is detected in the neuroretinal bodies and inner segment compartment of photoreceptors with conspicuously strong expression in ganglion cells .
# ::tok Consistent with previous immunocytochemistry studies , -Gal activity is detected in the neuroretinal bodies and inner segment compartment of photoreceptors with conspicuously strong expression in ganglion cells .
# ::alignments 26-27|0.0.0.1 25-26|0.0.0.1.0 23-24|0.0.0 22-23|0.0 21-22|0.0.0.2 19-20|0 17-18|0.0.0.0 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0 14-15|0.0.0.0.1 13-14|0.0.0.0.1.0 9-10|0.0.0.0.1.0.0 7-8|0.0.0.0.1.0.0.0 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:49.719
(p / photoreceptor 
      :ARG0-of (s / strong-02 
            :ARG1 (e / express-01 
                  :ARG0 (c3 / compartment 
                        :mod (i / inner 
                              :mod-of (s2 / segment)) 
                        :op2-of (a / and 
                              :op1 (b / body 
                                    :ARG2-of (d / detect-01 
                                          :ARG1 (a2 / activity-06))))) 
                  :ARG1 (c / cell 
                        :mod (g / ganglion)) 
                  :mod (c2 / conspicuously)) 
            :purpose (s3 / study-01 
                  :ARG1 (i2 / immunocytochemistry) 
                  :time (p2 / previous))))

# ::snt PLAP expression is found throughout the plexiform/synaptic layers and outer segment of photoreceptors ( E ) .
# ::tok PLAP expression is found throughout the plexiform/synaptic layers and outer segment of photoreceptors ( E ) .
# ::alignments 14-15|0.1.0 12-13|0.1.1 10-11|0.0.2 9-10|0.0.2.0 8-9|0.0 7-8|0.0.0 4-5|0.0.1 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:49.796
(f / find-01 
      :ARG0 (a / and 
            :op1 (l / layer) 
            :op1-of (t / throughout) 
            :op2 (s / segment 
                  :domain-of (o / outer))) 
      :ARG1 (e2 / express-01 
            :ARG1 (e / E) 
            :ARG2 (p / photoreceptor)))

# ::snt GC , ganglion cell ; PLAP , human placental alkaline phophatase ; ROS , rod outer segment ; RIS , rod inner segment ; ONL , outer nuclear layer ; OPL , outer plexiform ( synaptic ) layer ; INL , inner nuclear layer ; IPL , inner plexiform ( synaptic ) layer ; GC , ganglion cell layer .
# ::tok GC , ganglion cell ; PLAP , human placental alkaline phophatase ; ROS , rod outer segment ; RIS , rod inner segment ; ONL , outer nuclear layer ; OPL , outer plexiform ( synaptic ) layer ; INL , inner nuclear layer ; IPL , inner plexiform ( synaptic ) layer ; GC , ganglion cell layer .
# ::alignments 58-59|0.1.0.0.3.3.0.0.0.0.0.0 57-58|0.1.0.0.3.3.0.0.0.0.0 56-57|0.1.0.0.3.3.0.0.0.0 52-53|0.0 50-51|0 47-48|0.0.0 45-46|0.1.0.0.3.0.0+0.1.0.0.3.0+0.1.0.0.3 43-44|0.1.0.0.3.1.0 42-43|0.1.0.0.3.1 41-42|0.1.0.0.3.1.0.0 37-38|0.1.0.0.1.0.0.0 35-36|0.1.0.0.1.0.0.0.0 33-34|0.1.0.0.1.0 32-33|0.1.0.0.1.0.0 28-29|0.1 27-28|0.1.1 26-27|0.1.0 24-25|0.1.0.0.2.0.0+0.1.0.0.2.0+0.1.0.0.2 22-23|0.1.0.0.3.2.0 21-22|0.1.0.0.3.2.0.0 20-21|0.1.0.0.3.2 18-19|0.1.0.0.3.3.0.0.0 16-17|0.1.0.0.3.3.0 15-16|0.1.0.0.3.3.0.0 14-15|0.1.0.0.3.3 12-13|0.1.0.0.1 10-11|0.1.0.0.3.4.1 9-10|0.1.0.0.3.4 8-9|0.1.0.0.3.4.0.0 7-8|0.1.0.0.3.4.0 4-5|0.1.0.0 3-4|0.1.0.0.2.1.0 2-3|0.1.0.0.2.1 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:50.431
(s / synaptic 
      :mod-of (l2 / layer 
            :mod (i / inner)) 
      :poss (l5 / layer 
            :mod (o3 / outer 
                  :poss (a2 / and 
                        :op1 (g3 / gc) 
                        :op2 (r4 / ro 
                              :poss (p / plexiform 
                                    :mod (o2 / outer 
                                          :mod-of (l4 / layer 
                                                :mod (s2 / synaptic))))) 
                        :op3 (c2 / country 
                              :name (n4 / name 
                                    :op1 "ONL") 
                              :poss (g2 / ganglion 
                                    :location-of (c3 / cell))) 
                        :op4 (o / organization 
                              :name (n / name 
                                    :op1 "IPL") 
                              :op1-of (n2 / nucleus 
                                    :mod-of (l3 / layer 
                                          :mod (i2 / inner))) 
                              :poss (r / rod 
                                    :mod-of (s3 / segment 
                                          :domain-of (i3 / inner))) 
                              :poss (r3 / rod 
                                    :mod-of (s4 / segment 
                                          :domain-of (o4 / outer 
                                                :op1 (r2 / ri 
                                                      :poss (g / ganglion 
                                                            :mod-of (c / cell 
                                                                  :mod-of (l / layer))))))) 
                              :poss (a / alkaline 
                                    :mod (h / human 
                                          :mod-of (p3 / placental)) 
                                    :mod-of (p2 / phophatase))))) 
            :mod (n3 / nucleus)))

# ::snt In light of the association in vivo of RanBP2 with Cox11 and HKI ( Figures 1 and 3 ) , profound in vitro modulation of HKI enzymatic activity by RanBP2 and Cox11 ( Figure 2 ) , and the critical role of HKI in catalyzing a rate-limiting step of glycolysis , we probed whether RanBP2 + /  mice presented disturbances in HKI , Cox11 , and energy homeostasis .
# ::tok In light of the association in vivo of RanBP2 with Cox11 and HKI ( Figures 1 and 3 ) , profound in vitro modulation of HKI enzymatic activity by RanBP2 and Cox11 ( Figure 2 ) , and the critical role of HKI in catalyzing a rate-limiting step of glycolysis , we probed whether RanBP2 + /  mice presented disturbances in HKI , Cox11 , and energy homeostasis .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:50.438
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Monoallelic expression of RanBP2 does not affect the number of NPCs and their distribution in hippocampal neurons ( Figure 5A , unpublished data ) , but it led to consistent lower expression of RanBP2 by more than 50 % in the CNS ( brain and retina ) in 129Ola ( Figure 5B -- 5D ) , but not in C57BL/6J/129Ola backgrounds ( unpublished data ) .
# ::tok Monoallelic expression of RanBP2 does not affect the number of NPCs and their distribution in hippocampal neurons ( Figure 5A , unpublished data ) , but it led to consistent lower expression of RanBP2 by more than 50 % in the CNS ( brain and retina ) in 129Ola ( Figure 5B -- 5D ) , but not in C57BL/6J/129Ola backgrounds ( unpublished data ) .
# ::alignments 63-64|0.1.2.2 60-61|0.1.0.2.0.0 59-60|0.1.0.2.0.1.0+0.1.0.2.0.1+0.1.0.2.0 57-58|0.1.0.0.0 56-57|0 50-51|0.0 48-49|0.1.0.2.2.0 45-46|0.1.4 44-45|0.1 43-44|0.1.3 41-42|0.1.2.1.0+0.1.2.1+0.1.2 38-39|0.1.2.0 37-38|0.1.2.0.0 35-36|0.1.0.2.2.1.0.0.0 31-32|0.1.0 30-31|0.1.0.0 29-30|0.1.0.1 27-28|0.1.0.2 25-26|0.1.0.2.2 22-23|0.1.0.2.1.0 21-22|0.1.0.2.1.0.0 18-19|0.1.1 16-17|0.1.0.2.2.1.2 13-14|0.1.0.2.2.1.0.0 11-12|0.1.0.2.2.1.0 10-11|0.1.0.2.2.1.0.0.1 8-9|0.1.0.2.2.1.1 6-7|0.1.0.2.2.1 5-6|0.1.0.2.2.1.3 3-4|0.1.0.2.1.1 1-2|0.1.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:52.791
(c2 / contrast-01 
      :ARG1 (f / figure) 
      :ARG2 (a / and 
            :ARG1-of (e / express-01 
                  :ARG1-of (l / low-04 
                        :ARG0 -) 
                  :ARG1-of (c3 / consistent-01) 
                  :ARG2-of (l2 / lead-02 
                        :ARG0 (c / country 
                              :mod-of (b / background) 
                              :name (n / name 
                                    :op1 "C57BL/6J/129Ola")) 
                        :ARG1 (e2 / express-01 
                              :ARG0 (d2 / data 
                                    :mod (u / unpublish)) 
                              :ARG1 (r2 / RanBP2)) 
                        :ARG2-of (c4 / contrast-01 
                              :ARG0 129Ola 
                              :ARG1 (a3 / affect-01 
                                    :ARG0 (a2 / and 
                                          :op1 (d3 / distribute-01 
                                                :ARG0 (m / more) 
                                                :ARG1 (n4 / npc))) 
                                    :ARG1 (n5 / number) 
                                    :manner (n3 / neuron) 
                                    :polarity -)))) 
            :op1 (f2 / figure) 
            :op2 (o / organization 
                  :location-of (p / percentage-entity 
                        :value 50) 
                  :name (n2 / name 
                        :op1 "CNS") 
                  :poss-of (d / data)) 
            :op3 (b2 / brain) 
            :op4 (r / retina)))

# ::snt Hence , we focused our analysis on the inbred RanBP2 + /  129Ola mouse line .
# ::tok Hence , we focused our analysis on the inbred RanBP2 + /  129Ola mouse line .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:52.793
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Although the levels of RanBP2 were decreased in the retina , brain , and hippocampus of RanBP2 + /  mice by ~ 50 % -- 60 % ( Figure 5B and 5C ) , the levels of others nucleoporins , Nup153 and Nup62 , and mHsp70 and Cox11 , remained unchanged ( Figure 5B , unpublished data ) .
# ::tok Although the levels of RanBP2 were decreased in the retina , brain , and hippocampus of RanBP2 + /  mice by ~ 50 % -- 60 % ( Figure 5B and 5C ) , the levels of others nucleoporins , Nup153 and Nup62 , and mHsp70 and Cox11 , remained unchanged ( Figure 5B , unpublished data ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:52.797
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In addition , we observed a strong decrease of the levels of HKI ( 3 - to 4-fold ) ( Figure 5B and 5C ) .
# ::tok In addition , we observed a strong decrease of the levels of HKI ( 3 - to 4-fold ) ( Figure 5B and 5C ) .
# ::alignments 22-23|0 20-21|0.1 14-15|0.0.0.0 12-14|0.0.0.1.0.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 10-11|0.0.0.1 7-8|0.0.0 6-7|0.0 4-5|0.0.0.2 3-4|0.0.0.2.0 1-2|0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:52.933
(a / and 
      :op1 (s / strong-02 
            :ARG1 (d / decrease-01 
                  :ARG0 3 
                  :ARG1 (l / level 
                        :poss (o / organization 
                              :name (n / name 
                                    :op1 "HKI" 
                                    :op2 "("))) 
                  :ARG1-of (o2 / observe-01 
                        :ARG0 (w / we) 
                        :prep-in (a2 / addition)))) 
      :op2 (f / figure))

# ::snt This decrease was selective to the CNS , since HKI levels remained largely unaffected in the skeletal muscle , spleen , and liver ( Figure 5D ) .
# ::tok This decrease was selective to the CNS , since HKI levels remained largely unaffected in the skeletal muscle , spleen , and liver ( Figure 5D ) .
# ::alignments 24-25|0.1.0.0 22-23|0.0.2 21-22|0.0 19-20|0.0.1 17-18|0.0.0 16-17|0.0.0.0 13-14|0.3+0 12-13|0.2 11-12|0.1 10-11|0.1.1 9-10|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 8-9|0.1.2 6-7|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 3-4|0.1.0.1 1-2|0.1.0 0-1|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:53.318
(a2 / affect-01 
      :ARG1 (a / and 
            :op1 (m / muscle-01 
                  :ARG1 (s2 / skeletal)) 
            :op2 (s / spleen) 
            :op3 (l / liver)) 
      :ARG3-of (r / remain-01 
            :ARG0 (d / decrease-01 
                  :ARG1 (f / figure) 
                  :domain-of (s4 / selective 
                        :op1 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "CNS"))) 
                  :mod (t / this)) 
            :ARG1 (l3 / level 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "HKI"))) 
            :op1-of (s3 / since)) 
      :degree (l2 / large) 
      :polarity -)

# ::snt Because HKI plays a key role in the production of energy intermediate substrates and HKI is virtually the sole HK isoform expressed in the CNS [ 33,34 ] , we probed the impact of HKI and RanBP2 reduction in the levels of ATP .
# ::tok Because HKI plays a key role in the production of energy intermediate substrates and HKI is virtually the sole HK isoform expressed in the CNS [ 33,34 ] , we probed the impact of HKI and RanBP2 reduction in the levels of ATP .
# ::alignments 42-43|0.0.2.1.0.0.1.0 40-41|0.0.2.1.0.0.1 37-38|0.0.2.1.0.0.0.0 35-36|0.0.2.1.0.0.0 32-33|0.0.2.1.0.0 30-31|0.0.2.1 29-30|0.0.2.1.0 24-25|0.0.2.3.0.0+0.0.2.3.0+0.0.2.3 21-22|0 20-21|0.0 19-20|0.0.0.0.0+0.0.0.0+0.0.0 18-19|0.0.1 16-17|0.0.2.1.0.0.0.0.0 13-14|0.0.2 12-13|0.0.2.2.0.0.0 11-12|0.0.2.2.0.0.0.1 10-11|0.0.2.2.0.0.0.0 8-9|0.0.2.2.0.0 5-6|0.0.2.2.1 4-5|0.0.2.2.1.0 2-3|0.0.2.2 1-2|0.0.2.2.0.1.0+0.0.2.2.0.1+0.0.2.2.0 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:55.086
(e / express-01 
      :ARG1 (i2 / isoform 
            :mod (c / country 
                  :name (n2 / name 
                        :op1 "HK")) 
            :mod (s / sole) 
            :op2-of (a3 / and 
                  :ARG0-of (c2 / cause-01) 
                  :ARG1-of (p / probe-01 
                        :ARG0 (w / we 
                              :ARG0-of (i / impact-01 
                                    :ARG1 (a2 / and 
                                          :op1 (r / reduce-01 
                                                :ARG0 (v / virtual))) 
                                    :time (l / level 
                                          :mod (a / atp))))) 
                  :op1 (p3 / play-02 
                        :ARG0 (o2 / organization 
                              :ARG0-of (p2 / produce-01 
                                    :ARG1 (s2 / substrat 
                                          :mod (e2 / energy) 
                                          :mod (i3 / intermediate))) 
                              :name (n3 / name 
                                    :op1 "HKI")) 
                        :ARG1 (r2 / role 
                              :ARG1-of (k / key-02))) 
                  :op3 (o / organization 
                        :name (n / name 
                              :op1 "CNS")))))

# ::snt As shown in Figure 5E , there was significant and concordant reduction in levels of ATP in the CNS ( brain and retina ) , but not in non-neuronal tissues .
# ::tok As shown in Figure 5E , there was significant and concordant reduction in levels of ATP in the CNS ( brain and retina ) , but not in non-neuronal tissues .
# ::alignments 29-30|0.0.0 26-27|0.0.1.1.1 25-26|0 22-23|0.0.1.2.1.1.1 21-22|0.0.1.2.1.1 20-21|0.0.1.2.1.1.0 18-19|0.0.1.2.1.0.0+0.0.1.2.1.0+0.0.1.2.1 15-16|0.0.1.0 13-14|0.0.1.2.0 11-12|0.0.1 10-11|0.0.1.2.2 9-10|0.0.1.2 8-9|0.0 3-4|0.0.1.1.0 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:55.378
(c / contrast-01 
      :ARG1 (s / significant-02 
            :ARG0 (t / tissue) 
            :ARG1 (r2 / reduce-01 
                  :ARG1 (a2 / atp) 
                  :ARG1-of (s2 / show-01 
                        :ARG0 (f / figure) 
                        :ARG2 -) 
                  :op2-of (a3 / and 
                        :mod (l / level) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "CNS") 
                              :op1-of (a / and 
                                    :op2 (b / brain) 
                                    :op3 (r / retina))) 
                        :op1 (c2 / concordant)))))

# ::snt Finally , we also observed partial and selective delocalization of HKI , but not of Cox11 , from the ellipsoid ( mitochondria-rich ) to the adjacent myoid subcellular compartment of rod photosensory neurons ( Figure S2A -- S2E ) .
# ::tok Finally , we also observed partial and selective delocalization of HKI , but not of Cox11 , from the ellipsoid ( mitochondria-rich ) to the adjacent myoid subcellular compartment of rod photosensory neurons ( Figure S2A -- S2E ) .
# ::alignments 34-36|0.1.1.1+0.1.1.0+0.1.1+0.1 32-33|0.2.0.2.0 31-32|0.2.0.2.0.0 30-31|0.2.0.2.0.0.0 28-29|0.2.0.2 27-28|0.2.0.2.1 26-27|0.2.0.2.3 25-26|0.2.0.2.2 19-20|0.2.0.0.0 15-16|0.2.0.1 13-14|0.2.1.0 12-13|0 10-11|0.2.0.0.1.0.0+0.2.0.0.1.0+0.2.0.0.1 8-9|0.2.2 7-8|0.2.1 6-7|0.2 5-6|0.0 4-5|0.2.0 3-4|0.2.0.3 2-3|0.2.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.144
(c3 / contrast-01 
      :ARG1 (p2 / partial) 
      :domain-of (t / thing 
            :mod (f2 / final) 
            :name (n / name 
                  :op1 (f / Figure) 
                  :op2 (s / S2A))) 
      :op3-of (a2 / and 
            :ARG1-of (o2 / observe-01 
                  :ARG0 (w / we 
                        :poss-of (e / ellipsoid) 
                        :poss-of (o / organization 
                              :name (n3 / name 
                                    :op1 "HKI"))) 
                  :ARG2 (c2 / Cox11) 
                  :ARG3 (c / compartment 
                        :beneficiary (n2 / neuron 
                              :mod (p / photosensory 
                                    :mod (r / rod))) 
                        :mod (s2 / subcellular) 
                        :mod (a / adjacent) 
                        :mod (m / myoid)) 
                  :mod (a3 / also)) 
            :op1 (s3 / selective 
                  :location-of -) 
            :op2 (d / delocalization)))

# ::snt This was also accompanied by reduced HKI levels in the inner retina , in particular in the inner plexiform ( synaptic ) layer ( Figure S2A -- S2E ) .
# ::tok This was also accompanied by reduced HKI levels in the inner retina , in particular in the inner plexiform ( synaptic ) layer ( Figure S2A -- S2E ) .
# ::alignments 24-26|0.0.1+0+0.0+0.0.0 22-23|0.0.0.0.0.0.0 20-21|0.0.0.0.3 18-19|0.0.0.0.0.0.0.0.0 17-18|0.0.0.0.0.0.0.0 14-15|0.0.0.0.4 11-12|0.0.0.0.0.0.1 10-11|0.0.0.0.0.0.1.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 5-6|0.0.0.0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.2 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.502
(f / Figure 
      :op1-of (n / name 
            :name-of (t / thing 
                  :op1 (a / accompany-01 
                        :ARG0 (l2 / level 
                              :ARG1-of (r2 / reduce-01 
                                    :ARG0 (l / layer 
                                          :mod (i / inner 
                                                :mod-of (p / plexiform))) 
                                    :manner (r / retina 
                                          :mod (i2 / inner))) 
                              :mod (o / organization 
                                    :name (n2 / name 
                                          :op1 "HKI"))) 
                        :ARG1 (t2 / this) 
                        :mod (a2 / also) 
                        :op1-of (s2 / synaptic) 
                        :time (p2 / particular))) 
            :op2 (s / S2A)))

# ::snt Haploinsufficiency of RanBP2 Causes a Decrease in HKI Protein and ATP Levels .
# ::tok Haploinsufficiency of RanBP2 Causes a Decrease in HKI Protein and ATP Levels .
# ::alignments 11-12|0.1.0 10-11|0.1.0.0 9-10|0.3 7-9|0.2.0.1+0.2.0.0+0.2.0+0.2 5-6|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.650
(c2 / cause-01 
      :ARG0 (r / RanBP2) 
      :ARG1 (d / decrease-01 
            :ARG1 (l / level-01 
                  :ARG1 (a / atp))) 
      :location (c / country 
            :name (n / name 
                  :op1 "HKI" 
                  :op2 "Protein")) 
      :op1-of (a2 / and))

# ::snt ( A ) Quantitative analysis of NPCs in dissociated hippocampal neurons of wild-type ( + / + ) and heterozygote ( + /  ) mice upon immunostaining with mAb414 .
# ::tok ( A ) Quantitative analysis of NPCs in dissociated hippocampal neurons of wild-type ( + / + ) and heterozygote ( + /  ) mice upon immunostaining with mAb414 .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.652
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt No difference in the density of NPCs ( 3 -- 4 NPC/m2 ) at the nuclear envelope was found between RanBP2 + / + and RanBP2 + /  mice .
# ::tok No difference in the density of NPCs ( 3 -- 4 NPC/m2 ) at the nuclear envelope was found between RanBP2 + / + and RanBP2 + /  mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.657
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( B ) Immunoblots with anti-RanBP2 / Nup153/Nup62 ( mAb414 ) ,  HKI ,  mHsp70 , and  Cox11 antibodies of retinal ( top panel ) and hippocampal homogenates of + / + and + /  mice .
# ::tok ( B ) Immunoblots with anti-RanBP2 / Nup153/Nup62 ( mAb414 ) ,  HKI ,  mHsp70 , and  Cox11 antibodies of retinal ( top panel ) and hippocampal homogenates of + / + and + /  mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.660
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In comparison to RanBP2 + / + , RanBP2 + /  mice exhibit a reduction in the expression levels of RanBP2 and HKI but not of other proteins .
# ::tok In comparison to RanBP2 + / + , RanBP2 + /  mice exhibit a reduction in the expression levels of RanBP2 and HKI but not of other proteins .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.668
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( C ) Quantitative analysis of relative protein expression levels of RanBP2 , Cox11 , HKI , and mHsp70 in the hippocampus of RanBP2 + / + and RanBP2 + /  mice .
# ::tok ( C ) Quantitative analysis of relative protein expression levels of RanBP2 , Cox11 , HKI , and mHsp70 in the hippocampus of RanBP2 + / + and RanBP2 + /  mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.673
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt There is ~ 2 - and 4-fold reduction of RanBP2 and HKI in heterozygote mice .
# ::tok There is ~ 2 - and 4-fold reduction of RanBP2 and HKI in heterozygote mice .
# ::alignments 14-15|0.0.1.0 13-14|0.0.1.0.0 11-12|0.1.0.0+0.1.0+0.1 10-11|0 7-8|0.0 5-6|0.0.1 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:56.724
(a / and 
      :ARG1-of (r / reduce-01 
            :ARG0 2 
            :op1-of (a2 / and 
                  :op2 (m / mouse 
                        :mod (h / heterozygote)))) 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "HKI")))

# ::snt ( D ) The level of HKI is reduced in the brain but not in other non-neuronal tissues tested ( muscle , spleen , and liver ) .
# ::tok ( D ) The level of HKI is reduced in the brain but not in other non-neuronal tissues tested ( muscle , spleen , and liver ) .
# ::alignments 25-26|0.1.3.3 24-25|0.1.3 22-23|0.1.3.2 20-21|0.1.3.1 18-19|0.1.3.0 17-18|0.1.3.1.0.0 15-16|0.1.3.1.0 13-14|0.1.2 12-13|0 11-12|0.1.1 8-9|0.1 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:57.282
(c / contrast-01 
      :ARG1 (l2 / level 
            :mod (o2 / organization 
                  :name (n / name 
                        :op1 "HKI"))) 
      :ARG2 (r / reduce-01 
            :ARG1 (d / D) 
            :location (b / brain) 
            :mod - 
            :op1-of (a / and 
                  :ARG1-of (t / test-01) 
                  :op2 (m / muscle-01 
                        :ARG1 (o / other 
                              :mod-of (t2 / tissue))) 
                  :op3 (s / spleen) 
                  :op4 (l / liver))))

# ::snt ( E ) The total ATP level is reduced in the CNS tissues ( brain and retina ) but not in non-neuronal tissues tested ( e.g. , spleen ) .
# ::tok ( E ) The total ATP level is reduced in the CNS tissues ( brain and retina ) but not in non-neuronal tissues tested ( e.g. , spleen ) .
# ::alignments 27-28|0.0 25-26|0.1.2.1.0 23-24|0.1.2 22-23|0.1.2.0 19-20|0.2.0 18-19|0 16-17|0.1.1 15-16|0.1 14-15|0.1.0 12-13|0.2.3 11-12|0.2.3.0.0.0+0.2.3.0.0+0.2.3.0 8-9|0.2 6-7|0.2.1 5-6|0.2.1.0 4-5|0.1.2.1 1-2|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:57.992
(c / contrast-01 
      :ARG0 (s / spleen) 
      :ARG1 (a / and 
            :op1 (b / brain) 
            :op2 (r / retina) 
            :op3 (t / test-01 
                  :ARG1 (t2 / tissue) 
                  :ARG2 (t4 / total-01 
                        :ARG2 (e / e.g.)))) 
      :ARG2 (r2 / reduce-01 
            :ARG0 - 
            :ARG1 (l / level 
                  :mod (a2 / atp)) 
            :ARG2 (e2 / E) 
            :location (t3 / tissue 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "CNS")))))

# ::snt Metabolic Disturbances Caused by Haploinsufficiency of RanBP2 .
# ::tok Metabolic Disturbances Caused by Haploinsufficiency of RanBP2 .
# ::alignments 0-3|0.0.2+0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.004
(o / organization 
      :name (n / name 
            :op1 "Metabolic" 
            :op2 "Disturbances" 
            :op3 "Caused"))

# ::snt The growth rates of inbred RanBP2 + /  mice on high-fat ( ~ 10 % fat ) diet were significantly slower than RanBP2 + / + mice ( Figure 6A ) .
# ::tok The growth rates of inbred RanBP2 + /  mice on high-fat ( ~ 10 % fat ) diet were significantly slower than RanBP2 + / + mice ( Figure 6A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.006
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Beginning at around 4 mo of age , RanBP2 + /  mice exhibit a significant slower gain in body mass than wild-type mice ( Figure 6A ) .
# ::tok Beginning at around 4 mo of age , RanBP2 + /  mice exhibit a significant slower gain in body mass than wild-type mice ( Figure 6A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.013
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In addition , RanBP2 + /  inbred mice presented deficits in body mass that were erased by changing the genetic background to a mixed C57BL/6J/129Ola ( Figure 6B ) .
# ::tok In addition , RanBP2 + /  inbred mice presented deficits in body mass that were erased by changing the genetic background to a mixed C57BL/6J/129Ola ( Figure 6B ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.016
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Food consumption did not account for the body weight differences observed ( Figure 6C ) .
# ::tok Food consumption did not account for the body weight differences observed ( Figure 6C ) .
# ::alignments 12-13|0.1.0 10-11|0.1.2 9-10|0.1 8-9|0.1.3 7-8|0.1.1 4-5|0 3-4|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.199
(a / account-01 
      :ARG0 (c / consume-01 
            :ARG1 (f2 / food)) 
      :ARG1 (d / differ-01 
            :ARG0 (f / figure) 
            :ARG1 (b / body) 
            :ARG1-of (o / observe-01) 
            :ARG2 (w / weight)) 
      :polarity -)

# ::snt RanBP2 + /  Mice on High-Fat Diet Exhibit Deficits in Growth .
# ::tok RanBP2 + /  Mice on High-Fat Diet Exhibit Deficits in Growth .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.200
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( A ) In comparison to wild-type mice , RanBP2 + /  mice show slower growth rates beginning at 4 mo of age ( arrow ) , and the difference in body weight between these is maintained afterward .
# ::tok ( A ) In comparison to wild-type mice , RanBP2 + /  mice show slower growth rates beginning at 4 mo of age ( arrow ) , and the difference in body weight between these is maintained afterward .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.203
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Note that RanBP2 + /  mice lack the growth spur observed in wild-type mice between 3 and 4 mo of age .
# ::tok Note that RanBP2 + /  mice lack the growth spur observed in wild-type mice between 3 and 4 mo of age .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.207
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( B ) In comparison to inbred RanBP2 + /  mice ( 129Ola genetic background ) , the difference in body weight between RanBP2 + / + and RanBP2 + /  mice is masked upon placing these on a mixed 129Ola/C57Bl6 genetic background .
# ::tok ( B ) In comparison to inbred RanBP2 + /  mice ( 129Ola genetic background ) , the difference in body weight between RanBP2 + / + and RanBP2 + /  mice is masked upon placing these on a mixed 129Ola/C57Bl6 genetic background .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.210
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( C ) RanBP2 + / + and RanBP2 + /  inbred mice exhibit similar rates of food consumption .
# ::tok ( C ) RanBP2 + / + and RanBP2 + /  inbred mice exhibit similar rates of food consumption .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.213
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Mice in ( A ) , ( B ) , and ( C ) were placed on a high-fat diet since birth ( n = 5 ) .
# ::tok Mice in ( A ) , ( B ) , and ( C ) were placed on a high-fat diet since birth ( n = 5 ) .
# ::alignments 25-26|0.0 21-22|0.3.0 20-21|0.3 19-20|0.2 15-16|0 12-13|0.3.0.0.1 10-11|0.3.0.0 7-8|0.3.0.0.0.1+0.3.0.0.0.0.0+0.3.0.0.0.0+0.3.0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.403
(p / place-01 
      :ARG0 5 
      :ARG1 (m / mouse) 
      :ARG2 (d / diet) 
      :time (s / since 
            :op1 (b / birth-01 
                  :ARG1 (a / and 
                        :op1 (l / location 
                              :name (n / name 
                                    :op1 "B") 
                              :wiki -) 
                        :op2 (c / C)))))

# ::snt HKI in the CNS ( brain and retina ) accounts virtually for all expression of HK isozymes and glucose utilization in the CNS [ 33,34 ] .
# ::tok HKI in the CNS ( brain and retina ) accounts virtually for all expression of HK isozymes and glucose utilization in the CNS [ 33,34 ] .
# ::alignments 19-20|0.0.0.0.0.1.1 18-19|0.0.0.0.0.1.1.0 17-18|0.0.0.0.0.1 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0.1.1.1.0.0+0.0.0.0.0.1.1.1.0+0.0.0.0.0.1.1.1 13-14|0.0.0.0.0 12-13|0.0.0.0.0.2 10-11|0.0.0.0.0.1.0 9-10|0.0.0.0 7-8|0.2 6-7|0 5-6|0.1 3-4|0.0.1.0+0.0.1+0.0 0-1|0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:16:58.930
(a4 / and 
      :op1 (o / organization 
            :location-of (o2 / organization 
                  :ARG0-of (a3 / account-01 
                        :ARG1 (e / express-01 
                              :ARG1 (i / isozym) 
                              :op1-of (a / and 
                                    :mod (v / virtual) 
                                    :op2 (u / utilize-01 
                                          :ARG0 (g / glucose) 
                                          :ARG1 (c / country 
                                                :name (n / name 
                                                      :op1 "HK")))) 
                              :quant (a2 / all))) 
                  :name (n3 / name 
                        :op1 "HKI")) 
            :name (n2 / name 
                  :op1 "CNS")) 
      :op2 (b / brain) 
      :op3 (r / retina))

# ::snt Moreover , glucose is the sole reliance source of energy in the CNS under normal conditions , the CNS lacks glucose storage sources , and despite the disproportionate mass of the CNS to the rest of the body , the CNS consumes daily about 60 % of the body 's glucose and 25 % of the total oxygen [ 35,36 ] .
# ::tok Moreover , glucose is the sole reliance source of energy in the CNS under normal conditions , the CNS lacks glucose storage sources , and despite the disproportionate mass of the CNS to the rest of the body , the CNS consumes daily about 60 % of the body 's glucose and 25 % of the total oxygen [ 35,36 ] .
# ::alignments 57-58|0.3.1.1.2 56-57|0.3.1.1 53-54|0.3.1.0.0 52-53|0.3.1.0.0.0 51-52|0.3 50-51|0.3.1.0 48-49|0.3.1.0.1 45-46|0.2 44-45|0.2.1 43-44|0.2.0 41-42|0.3.1 37-38|0.1.0.0.0 34-35|0.1.0.0 28-29|0.0.0.1 27-28|0.0.0.1.0 24-25|0 22-23|0.0.0 21-22|0.0.0.0 20-21|0.0.0.0.0 19-20|0.0 15-16|0.3.0.0 14-15|0.3.0 12-13|0.3.1.1.1.1.0+0.3.1.1.1.1+0.3.1.1.1 9-10|0.3.1.1.1.0 7-8|0.1 6-7|0.1.2 5-6|0.1.1 2-3|0.1.0 0-1|0.3.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:00.917
(a3 / and 
      :ARG0-of (l / lack-01 
            :ARG1 (s / source 
                  :mod (s2 / storage 
                        :mod (g2 / glucose)) 
                  :mod-of (m / mass 
                        :mod (d / disproportionate)))) 
      :op1 (s3 / source 
            :domain (g3 / glucose 
                  :mod-of (r / rest 
                        :part-of (b2 / body))) 
            :frequency (s4 / sole) 
            :mod (r2 / reliance)) 
      :op2 (p2 / percentage-entity 
            :op1-of (a2 / about) 
            :value 60) 
      :op3 (a / and 
            :op1 (n / normal-02 
                  :ARG1 (c2 / condition)) 
            :op2 (c / consume-01 
                  :ARG1 (g / glucose 
                        :location-of (p / percentage-entity 
                              :value 25) 
                        :poss (b / body)) 
                  :purpose-of (t / total-01 
                        :ARG0 (m2 / moreover) 
                        :ARG1 (o2 / organization 
                              :location-of (e / energy) 
                              :name (n2 / name 
                                    :op1 "CNS")) 
                        :ARG2 (o / oxygen)))))

# ::snt To determine the impact of RanBP2 haploinsufficiency on the utilization , formation , and uptake of glucose , we carried out several physiological assays .
# ::tok To determine the impact of RanBP2 haploinsufficiency on the utilization , formation , and uptake of glucose , we carried out several physiological assays .
# ::alignments 23-24|0.0.0.0.1.0.0.0 22-23|0.0.0.0.1.0.0.0.0 21-22|0.0.0.0.1.0.0.0.1 19-20|0.0.0.0.1.0.0 18-19|0.0.0.0.1.0 16-17|0.0 14-15|0.0.0.1.0 13-14|0.0.0.1 11-12|0 9-10|0.0.0 6-7|0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.004
(f / form-01 
      :ARG1 (g / glucose 
            :ARG1-of (u2 / utilize-01 
                  :ARG1-of (i / impact-01 
                        :ARG0 (h / haploinsufficiency) 
                        :ARG1-of (d / determine-01 
                              :ARG0 (w / we 
                                    :ARG0-of (c / carry-01 
                                          :ARG1 (a / assay 
                                                :mod (p / physiological) 
                                                :quant (s / several)))))) 
                  :op1-of (a2 / and 
                        :op2 (u / uptake)))))

# ::snt In contrast to mice placed on a normal chow diet ( ~ 5 % fat ; unpublished data ) , RanBP2 + /  mice on a higher fat diet ( ~ 10 % fat ) performed significantly worse in the glucose tolerance test beginning at 6 mo of age ( Figure 7A and 7B ) , thus supporting that the RanBP2 + /  mice exhibited a deficit in glucose clearance .
# ::tok In contrast to mice placed on a normal chow diet ( ~ 5 % fat ; unpublished data ) , RanBP2 + /  mice on a higher fat diet ( ~ 10 % fat ) performed significantly worse in the glucose tolerance test beginning at 6 mo of age ( Figure 7A and 7B ) , thus supporting that the RanBP2 + /  mice exhibited a deficit in glucose clearance .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.007
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt This deficit was rescued in RanBP2 + /  mice of mixed C57BL/6J/129Ola background ( Figure S3 ) .
# ::tok This deficit was rescued in RanBP2 + /  mice of mixed C57BL/6J/129Ola background ( Figure S3 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.009
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Glucose clearance was not affected due to a disturbance in insulin-mediated glucose uptake ( Figure 7C ) .
# ::tok Glucose clearance was not affected due to a disturbance in insulin-mediated glucose uptake ( Figure 7C ) .
# ::alignments 14-15|0.0 12-13|0.1.0 11-12|0.1.0.0 10-11|0.1.0.1 8-9|0.1.0.2 4-5|0 3-4|0.2 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.083
(a / affect-01 
      :ARG0 (f / figure) 
      :ARG1 (c / clear-02 
            :ARG0 (u / uptake 
                  :mod (g / glucose) 
                  :mod (i / insulin-mediat) 
                  :mod-of (d / disturbance)) 
            :ARG1 (g2 / glucose)) 
      :polarity -)

# ::snt Then , we probed whether RanBP2 induces impairment of gluconeogenesis , which could contribute to the pathophysiological production and clearance of glucose .
# ::tok Then , we probed whether RanBP2 induces impairment of gluconeogenesis , which could contribute to the pathophysiological production and clearance of glucose .
# ::alignments 21-22|0.2.0 19-20|0.2 18-19|0 17-18|0.1 13-14|0.0 12-13|0.0.0 9-10|0.0.0.0.1.0 7-8|0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0.0.2 2-3|0.0.0.0.2.0 0-1|0.0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.334
(a / and 
      :ARG2-of (c2 / contribute-01 
            :ARG1-of (p2 / possible-01 
                  :time (i2 / induce-01 
                        :ARG0 (r / RanBP2) 
                        :ARG1 (i / impairment 
                              :mod (g2 / gluconeogenesi)) 
                        :ARG1-of (p3 / probe-01 
                              :ARG0 (w / we) 
                              :time (t / then))))) 
      :op1 (p / produce-01) 
      :op2 (c / clear-02 
            :ARG1 (g / glucose)))

# ::snt To this end , the administration of the gluconeogenic substrate precursor , pyruvate ( pyruvate tolerance test ) , showed that there was no difference in glucose production in RanBP2 + /  mice ( Figure 7D ) .
# ::tok To this end , the administration of the gluconeogenic substrate precursor , pyruvate ( pyruvate tolerance test ) , showed that there was no difference in glucose production in RanBP2 + /  mice ( Figure 7D ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.337
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Hence , partial loss-of-function of RanBP2 had no impact on the gluconeogenesis pathway .
# ::tok Hence , partial loss-of-function of RanBP2 had no impact on the gluconeogenesis pathway .
# ::alignments 12-13|0.0.0 11-12|0.0 8-9|0.0.0.0 7-8|0.0.0.0.0 2-3|0.0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.372
(h / hence 
      :poss (g / gluconeogenesi 
            :mod-of (p / pathway 
                  :ARG1-of (i / impact-01 
                        :polarity -) 
                  :op1 (p2 / partial))))

# ::snt However , upon glucose production ( 15 min ) , the clearance rates of glucose were again significantly slower in RanBP2 + /  than in RanBP2 + / + mice ( Figure 7D ) , confirming an impairment in glucose breakdown .
# ::tok However , upon glucose production ( 15 min ) , the clearance rates of glucose were again significantly slower in RanBP2 + /  than in RanBP2 + / + mice ( Figure 7D ) , confirming an impairment in glucose breakdown .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.376
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Metabolic Phenotypes of RanBP2 + /  Inbred Mice on High-Fat Diet .
# ::tok Metabolic Phenotypes of RanBP2 + /  Inbred Mice on High-Fat Diet .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.379
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( A ) 3-mo-old inbred RanBP2 + /  mice ( n = 5 ) have normal glucose clearance rates upon glucose challenge and overnight fasting .
# ::tok ( A ) 3-mo-old inbred RanBP2 + /  mice ( n = 5 ) have normal glucose clearance rates upon glucose challenge and overnight fasting .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.382
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( B ) In contrast , 6-mo-old inbred RanBP2 + /  mice ( n = 5 ) have significantly decreased glucose clearance rates upon glucose challenge and overnight fasting .
# ::tok ( B ) In contrast , 6-mo-old inbred RanBP2 + /  mice ( n = 5 ) have significantly decreased glucose clearance rates upon glucose challenge and overnight fasting .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.389
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( C ) Fasted 6 - to 8-mo-old RanBP2 + / + and RanBP2 + /  mice have no difference in insulin-mediated glucose uptake as assayed by insulin tolerance test ( n = 5 ) .
# ::tok ( C ) Fasted 6 - to 8-mo-old RanBP2 + / + and RanBP2 + /  mice have no difference in insulin-mediated glucose uptake as assayed by insulin tolerance test ( n = 5 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.393
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( D ) Pyruvate tolerance test shows normal rise in glucose but decreased glucose clearance between inbred RanBP2 + / + and RanBP2 + /  mice ( n = 5 ) .
# ::tok ( D ) Pyruvate tolerance test shows normal rise in glucose but decreased glucose clearance between inbred RanBP2 + / + and RanBP2 + /  mice ( n = 5 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.397
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Haploinsufficiency of RanBP2 Causes Deficits in the Electrophysiological Output of Receptoral and Postreceptoral Retinal Neurons .
# ::tok Haploinsufficiency of RanBP2 Causes Deficits in the Electrophysiological Output of Receptoral and Postreceptoral Retinal Neurons .
# ::alignments 13-15|0.1.0.1+0.1.0.0+0.1.0+0.1 11-12|0 7-11|0.0.1.3+0.0.1.2+0.0.1.1+0.0.1.0+0.0.1+0.0 3-5|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.464
(a / and 
      :op1 (t2 / thing 
            :medium-of (o / organization 
                  :name (n4 / name 
                        :op1 "Causes" 
                        :op2 "Deficits")) 
            :name (n3 / name 
                  :op1 "Electrophysiological" 
                  :op2 "Output" 
                  :op3 "of" 
                  :op4 "Receptoral")) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (r / Retinal) 
                  :op2 (n2 / Neurons))))

# ::snt In light of the prominent expression of RanBP2 and HKI in retinal neurons [ 1,19 ] , the vital dependence of the neuronal retina ( and brain ) on glucose as the main substrate source for energy production , and the determinant impact of metabolic disorders , such as diabetes , in retinal function ( e.g. , diabetic retinopathy ) [ 37 ] , we probed the impact of deficits in RanBP2 , HKI , and ATP , on the electrophysiological responses of subclasses ( rod and cone ) photoreceptor and postreceptor retinal neurons of RanBP2 + /  and in RanBP2 + / + mice .
# ::tok In light of the prominent expression of RanBP2 and HKI in retinal neurons [ 1,19 ] , the vital dependence of the neuronal retina ( and brain ) on glucose as the main substrate source for energy production , and the determinant impact of metabolic disorders , such as diabetes , in retinal function ( e.g. , diabetic retinopathy ) [ 37 ] , we probed the impact of deficits in RanBP2 , HKI , and ATP , on the electrophysiological responses of subclasses ( rod and cone ) photoreceptor and postreceptor retinal neurons of RanBP2 + /  and in RanBP2 + / + mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.480
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The scotopic ( dark-adapted ) responses mediated by the rod photoreceptor pathway at low-stimulus intensities and mixed rod and cone pathways at high-stimulus intensities were substantially reduced in RanBP2 + /  mice ( Figure 8A ) .
# ::tok The scotopic ( dark-adapted ) responses mediated by the rod photoreceptor pathway at low-stimulus intensities and mixed rod and cone pathways at high-stimulus intensities were substantially reduced in RanBP2 + /  mice ( Figure 8A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:01.490
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The differences in the photopic ( light-adapted ) responses , initiated by cone photoreceptors , which make up 3 % of the photosensory neurons in the mouse retina [ 38 ] , were less obvious but still exhibited a trend toward reduced amplitudes across a range of increasing light stimulus intensities ( Figure 8B ) .
# ::tok The differences in the photopic ( light-adapted ) responses , initiated by cone photoreceptors , which make up 3 % of the photosensory neurons in the mouse retina [ 38 ] , were less obvious but still exhibited a trend toward reduced amplitudes across a range of increasing light stimulus intensities ( Figure 8B ) .
# ::alignments 52-53|0.2.2.0.0 50-51|0.2.2.0.1 49-50|0.2.2.0.1.2 48-49|0.2.2.0.1.0 47-48|0.2.2.0.1.1 45-46|0.2.2.0 43-44|0.2.2 42-43|0.2.1.1 41-42|0.2.1.1.0 39-40|0.2.1 37-38|0.2 36-37|0.2.3 35-36|0 34-35|0.1 33-34|0.1.1 29-30|0.1.0 27-28|0.2.0.0.1.0 26-27|0.2.0.0.1.0.0 23-24|0.2.0.0.1 19-20|0.2.2.0.1.1.0 18-19|0.2.1.0 13-14|0.2.0.0.0 12-13|0.2.0.0.0.0 10-11|0.2.0.0 8-9|0.2.0.1.0+0.2.0.1 6-7|0.0 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:02.115
(c / contrast-01 
      :ARG0 (l3 / light-adapt) 
      :ARG1 (o / obvious-01 
            :ARG1 38 
            :degree (l2 / less)) 
      :ARG2 (e / exhibit-01 
            :ARG0 (d / differ-01 
                  :ARG1 (i3 / initiate-01 
                        :ARG0 (p2 / photoreceptor 
                              :mod (c2 / cone)) 
                        :ARG1 (n / neuron 
                              :location (r3 / retina 
                                    :mod (m / mouse)))) 
                  :ARG2 (t2 / thing 
                        :ARG2-of (r4 / respond-01))) 
            :ARG1 (t / trend-01 
                  :ARG1 3 
                  :ARG2 (a2 / amplitud 
                        :ARG1-of (r2 / reduce-01))) 
            :location (a / across 
                  :op1 (r / range-01 
                        :ARG0 (f / figure) 
                        :ARG1 (i / intensiti 
                              :ARG1-of (l / light-06) 
                              :ARG1-of (i2 / increase-01 
                                    :ARG2 (p / percentage-entity)) 
                              :mod (s / stimulus)))) 
            :mod (s2 / still)))

# ::snt The reduction in the scotopic responses included decreases in both b-wave ( Figure 8C ) and a-wave ( Figure 8D ) amplitudes mediated by postreceptoral and receptoral neurons , respectively .
# ::tok The reduction in the scotopic responses included decreases in both b-wave ( Figure 8C ) and a-wave ( Figure 8D ) amplitudes mediated by postreceptoral and receptoral neurons , respectively .
# ::alignments 29-30|0.2.3.0.0.0 27-28|0.1 25-26|0 22-23|0.2 21-22|0.2.1 18-19|0.2.2 15-16|0.2.3 12-13|0.2.0 9-10|0.0 7-8|0.2.3.0.0 6-7|0.2.3.0 5-6|0.2.3.0.1.0.0+0.2.3.0.1.0 1-2|0.2.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:02.683
(a / and 
      :mod (b / both) 
      :op1 (n / neuron) 
      :path-of (m / mediate-01 
            :ARG0 (f2 / figure) 
            :ARG1 (a2 / amplitud) 
            :ARG2 (f / figure) 
            :op2-of (a3 / and 
                  :op1 (i / include-01 
                        :ARG1 (d / decrease-01 
                              :ARG1 (r / respective)) 
                        :ARG2 (r3 / reduce-01 
                              :ARG1 (t / thing 
                                    :ARG2-of (r2 / respond-01)))))))

# ::snt Postreceptoral second-order neuron responses , represented by the b-wave , tended to be more consistently and substantially reduced than the a-waves , which directly reflect photoreceptor activity .
# ::tok Postreceptoral second-order neuron responses , represented by the b-wave , tended to be more consistently and substantially reduced than the a-waves , which directly reflect photoreceptor activity .
# ::alignments 26-27|0.1.1.0.0 25-26|0.1.1.0.0.0 24-25|0.1.1.0 23-24|0.1.1.0.1 20-21|0.1.1 17-18|0.1 16-17|0.1.2.2 15-16|0.1.2 14-15|0.1.2.1 13-14|0.1.2.0 10-11|0 5-6|0.0.0.1.0 3-4|0.0.0+0.0 2-3|0.0.0.1 1-2|0.1.0 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:02.931
(t / tend-01 
      :ARG0 (t2 / thing 
            :ARG2-of (r4 / respond-01 
                  :ARG0 (o / organization 
                        :name (n2 / name 
                              :op1 "Postreceptoral")) 
                  :ARG1 (n / neuron 
                        :ARG1-of (r3 / represent-01)))) 
      :ARG1 (r2 / reduce-01 
            :ARG0 (s2 / second-ord) 
            :ARG1 (a2 / a-wav 
                  :ARG0-of (r / reflect-01 
                        :ARG1 (a / activity-06 
                              :ARG1 (p / photoreceptor)) 
                        :ARG1-of (d / direct-02))) 
            :manner (a3 / and 
                  :op1 (m / more) 
                  :op2 (c / consistent) 
                  :op3 (s / substantial))))

# ::snt Since second-order neuron responses depend on input from photoreceptors , this suggests that reduced b-wave amplitudes are the result of the accumulation of decreases in the light response of both photoreceptors and postreceptoral neurons .
# ::tok Since second-order neuron responses depend on input from photoreceptors , this suggests that reduced b-wave amplitudes are the result of the accumulation of decreases in the light response of both photoreceptors and postreceptoral neurons .
# ::alignments 33-34|0.0 31-32|0.1 29-30|0.2.1.0.0.0 27-28|0 26-27|0.3 23-24|0.4 21-22|0.2.1.0.0.1 18-19|0.2.1.0.0 15-16|0.2.1.0 13-14|0.2.1 11-12|0.2 10-11|0.2.0 8-9|0.2.2.0.0.0.0 6-7|0.2.2.0.0.0 4-5|0.2.2.0.0 3-4|0.2.2.0.1+0.2.2.0 2-3|0.2.2.0.1.0 1-2|0.4.0 0-1|0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:03.625
(r / respond-01 
      :ARG0 (n / neuron) 
      :ARG1 (a / and) 
      :ARG1-of (s / suggest-01 
            :ARG0 (t / this) 
            :ARG2 (r3 / reduce-01 
                  :ARG1 (a3 / amplitud 
                        :ARG2-of (r2 / result-01 
                              :ARG0 (b / both) 
                              :ARG1 (a2 / accumulation)))) 
            :time (s3 / since 
                  :op1 (t2 / thing 
                        :ARG0-of (d2 / depend-01 
                              :ARG1 (i / input 
                                    :source (p / photoreceptor))) 
                        :ARG2-of (r4 / respond-01 
                              :ARG1 (n2 / neuron))))) 
      :ARG1-of (l / light-06) 
      :ARG1-of (d / decrease-01 
            :ARG0 (s2 / second-ord)))

# ::snt Anesthetics , particularly ketamine , can cause sustained elevation of glucose in mice , which in turn affects electroretinogram responses [ 39 ] .
# ::tok Anesthetics , particularly ketamine , can cause sustained elevation of glucose in mice , which in turn affects electroretinogram responses [ 39 ] .
# ::alignments 21-22|0.1.0.0 19-20|0.3.0.1.0.0+0.3.0.1.0 18-19|0.3.0.1.0.0.0 17-18|0.3.0.1 16-17|0.3.0 12-13|0.3 10-11|0.1.1 8-9|0.1 7-8|0.1.0 6-7|0 5-6|0.2 3-4|0.3.0.0.0 2-3|0.3.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:03.989
(c / cause-01 
      :ARG0 (a2 / anesthetic) 
      :ARG1 (e2 / elevation 
            :ARG1-of (s / sustain-01 
                  :ARG0 39) 
            :mod (g / glucose)) 
      :ARG1-of (p / possible-01) 
      :location (m / mouse 
            :ARG1-of (t2 / turn-01 
                  :ARG0 (p2 / particular 
                        :mod-of (k / ketamine)) 
                  :ARG0-of (a / affect-01 
                        :ARG1 (t / thing 
                              :ARG2-of (r / respond-01 
                                    :ARG1 (e / electroretinogram)))))))

# ::snt Thus , we were concerned that differences in electroretinogram amplitudes between RanBP2 + /  and RanBP2 + / + may reflect differences in glucose level changes in response to anesthesia .
# ::tok Thus , we were concerned that differences in electroretinogram amplitudes between RanBP2 + /  and RanBP2 + / + may reflect differences in glucose level changes in response to anesthesia .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:03.991
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt However , we found no significant differences in glucose levels measured before and every 15 min during 75 min of anesthesia ( n = 4 -- 5 ) .
# ::tok However , we found no significant differences in glucose levels measured before and every 15 min during 75 min of anesthesia ( n = 4 -- 5 ) .
# ::alignments 26-27|0.0.2.0 24-25|0.0.0 22-23|0 20-21|0.0.1.2.0 18-19|0.0.1.2 17-18|0.0.1.2.1 15-16|0.0.3.0 14-15|0.0.3.0.1 13-14|0.0.3.0.0 12-13|0.0.3 11-12|0.0.1.0.0.1 10-11|0.0.1.0.0 9-10|0.0.1.0.0.0 8-9|0.0.1.0.0.0.0 6-7|0.0 5-6|0.0.2 4-5|0.0.1.1 3-4|0.0.1 2-3|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:04.984
(n / n 
      :ARG0-of (d / differ-01 
            :ARG1 4 
            :ARG1-of (f / find-01 
                  :ARG0 (w / we 
                        :ARG0-of (m3 / measure-01 
                              :ARG1 (l / level 
                                    :mod (g / glucose)) 
                              :time (b / before))) 
                  :polarity - 
                  :time (m / min 
                        :mod (a / anesthesia) 
                        :quant 75)) 
            :ARG1-of (s / significant-02 
                  :ARG0 5) 
            :op1-of (a2 / and 
                  :op2 (m2 / min 
                        :mod (e / every) 
                        :quant 15))))

# ::snt Glucose rose at the same rate and reached a maximum of approximately 3.3 times the pre-anesthesia level in both genotypes ( unpublished data ) .
# ::tok Glucose rose at the same rate and reached a maximum of approximately 3.3 times the pre-anesthesia level in both genotypes ( unpublished data ) .
# ::alignments 22-23|0.1.0.0.0 21-22|0.1.0.0.0.0 19-20|0.0.0 18-19|0.0 16-17|0.1.0.0.1.0.0 11-12|0.1.0.0.1.0.1 9-10|0.1.1 7-8|0.1 6-7|0 5-6|0.1.0.0.1 4-5|0.1.0.0.1.0 1-2|0.1.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.204
(a2 / and 
      :mod (b / both 
            :mod-of (g / genotyp)) 
      :op1 (r / reach-01 
            :ARG0 (g2 / glucose 
                  :ARG1-of (r3 / rise-01 
                        :ARG0 (d / data 
                              :mod (u / unpublish)) 
                        :ARG2 (r2 / rate 
                              :ARG1-of (s / same-01 
                                    :ARG0 (l / level) 
                                    :ARG2 (a / approximately))))) 
            :ARG1 (m / maximum)))

# ::snt Electroretinograms from 6-Mo-Old RanBP2 + /  and RanBP2 + / + Inbred Mice Showing Photoreceptor and Postreceptor Neuron Electrophysiological Response Phenotypes .
# ::tok Electroretinograms from 6-Mo-Old RanBP2 + /  and RanBP2 + / + Inbred Mice Showing Photoreceptor and Postreceptor Neuron Electrophysiological Response Phenotypes .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.205
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( A ) Scotopic ( dark-adapted ) responses from RanBP2 + /  mice to light stimuli of increasing intensity , beginning at threshold , have reduced amplitudes compared to those observed in RanBP2 + / + mice .
# ::tok ( A ) Scotopic ( dark-adapted ) responses from RanBP2 + /  mice to light stimuli of increasing intensity , beginning at threshold , have reduced amplitudes compared to those observed in RanBP2 + / + mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.209
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The three lower intensities represent responses generated in the rod photoreceptor neuronal pathway .
# ::tok The three lower intensities represent responses generated in the rod photoreceptor neuronal pathway .
# ::alignments 12-13|0.1.1.0.1 11-12|0.1.1.0 10-11|0.1.1.0.0 9-10|0.1.1.0.0.0 6-7|0.1.0 5-6|0.1.1+0.1 4-5|0 3-4|0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.307
(r3 / represent-01 
      :ARG0 (i / intensiti 
            :ARG1-of (l / low-04 
                  :ARG0 3)) 
      :ARG1 (t / thing 
            :ARG1-of (g / generate-01) 
            :ARG2-of (r2 / respond-01 
                  :ARG1 (n / neuronal 
                        :mod (p2 / photoreceptor 
                              :mod (r / rod)) 
                        :mod-of (p / pathway)))))

# ::snt The upper intensities are comprised of responses generated in both the rod and cone pathways .
# ::tok The upper intensities are comprised of responses generated in both the rod and cone pathways .
# ::alignments 14-15|0.1.0.0.2 13-14|0.1.0.0.2.0 12-13|0.1.0.0 11-12|0.1.0.0.1 9-10|0.1.0.0.0 7-8|0.1.0 6-7|0.1.1+0.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.544
(c2 / comprise-01 
      :ARG1 (i / intensiti 
            :mod (u / upper)) 
      :topic (t / thing 
            :ARG1-of (g / generate-01 
                  :op1-of (a / and 
                        :mod (b / both) 
                        :op2 (r / rod) 
                        :op3 (p / pathway 
                              :mod (c / cone)))) 
            :ARG2-of (r2 / respond-01)))

# ::snt ( B ) Photopic ( light-adapted , cone photoreceptor pathway ) responses of RanBP2 + /  mice to increasing light stimulus intensities also exhibited reduced amplitudes compared to those observed in RanBP2 + / + mice .
# ::tok ( B ) Photopic ( light-adapted , cone photoreceptor pathway ) responses of RanBP2 + /  mice to increasing light stimulus intensities also exhibited reduced amplitudes compared to those observed in RanBP2 + / + mice .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.547
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( C ) Average  SE ( n = 9 ) scotopic b-wave amplitudes from RanBP2 + /  ( open circles ) and RanBP2 + / + ( filled squares ) mice representing postreceptoral neuron function .
# ::tok ( C ) Average  SE ( n = 9 ) scotopic b-wave amplitudes from RanBP2 + /  ( open circles ) and RanBP2 + / + ( filled squares ) mice representing postreceptoral neuron function .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.550
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( Note : log amplitude scale . )
# ::tok ( Note : log amplitude scale . )
# ::alignments 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.589
(n / note-01 
      :ARG0-of (l / log-01 
            :ARG1 (s / scale 
                  :mod (a / amplitude))))

# ::snt ( D ) Average  SE ( n = 5 ) scotopic a-wave amplitudes , representing photoreceptor function , for RanBP2 + /  and RanBP2 + / + mice in response to bright flashes .
# ::tok ( D ) Average  SE ( n = 5 ) scotopic a-wave amplitudes , representing photoreceptor function , for RanBP2 + /  and RanBP2 + / + mice in response to bright flashes .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.591
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Amplitudes of responses from RanBP2 + /  mice were lower over the entire range of stimulus intensities for both b - and a-waves .
# ::tok Amplitudes of responses from RanBP2 + /  mice were lower over the entire range of stimulus intensities for both b - and a-waves .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.594
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Asterisks represent significant differences between the groups ( Student 's t test , p < 0.05 ) .
# ::tok Asterisks represent significant differences between the groups ( Student 's t test , p < 0.05 ) .
# ::alignments 13-14|0 11-12|0.0.0.0 10-11|0.0.0.0.0 8-9|0.0+0.0.0 6-7|0.0.0.0.1.0 3-4|0.0.0.0.1 2-3|0.0.0.0.1.1 1-2|0.0.0.0.1.2 0-1|0.0.0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.829
(p / p 
      :ARG1-of (s / study-01 
            :ARG0 (p2 / person 
                  :ARG0-of (t / test-01 
                        :ARG1 (t2 / t) 
                        :ARG1-of (d / differ-01 
                              :ARG0 (g / group) 
                              :ARG1-of (s2 / significant-02) 
                              :ARG1-of (r / represent-01 
                                    :ARG0 (a / asterisk)))))))

# ::snt Statistical significance was found across all intensities for b-wave amplitudes ( 2-way ANOVA , p < 0.0001 ) , but not for the a-wave .
# ::tok Statistical significance was found across all intensities for b-wave amplitudes ( 2-way ANOVA , p < 0.0001 ) , but not for the a-wave .
# ::alignments 20-21|0.1.0.0.0 19-20|0 14-15|0.1.0.0.1.0 12-13|0.0 9-10|0.1.0.0.2 6-7|0.1 5-6|0.1.1 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1.0.0.1 0-1|0.1.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:05.961
(c / contrast-01 
      :ARG1 (a / anova) 
      :purpose (i / intensiti 
            :op1-of (a4 / across 
                  :location-of (f / find-01 
                        :ARG0 - 
                        :ARG1 (s / significant-02 
                              :ARG1 (p / p) 
                              :mod (s2 / statistical)) 
                        :purpose (a2 / amplitud))) 
            :quant (a3 / all)))

# ::snt Our findings support that RanBP2 plays a determinant role in modulating glucose and energy homeostasis .
# ::tok Our findings support that RanBP2 plays a determinant role in modulating glucose and energy homeostasis .
# ::alignments 14-15|0.1.1.1.1 13-14|0.1.1.1.1.0 12-13|0.1.1.1 11-12|0.1.1.1.0 10-11|0.1.1.1.0.0 8-9|0.1.1 7-8|0.1.1.0 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:06.081
(s / support-01 
      :ARG0 (t / thing 
            :ARG1-of (f / find-01 
                  :ARG0 (w / we))) 
      :ARG1 (p / play-02 
            :ARG0 (r2 / RanBP2) 
            :ARG1 (r / role 
                  :mod (d / determinant) 
                  :op1-of (a / and 
                        :op2 (g / glucose 
                              :ARG1-of (m / modulate-01)) 
                        :op3 (h / homeostasi 
                              :mod (e / energy))))))

# ::snt The data support that Cox1 and HKI are novel partners in vivo for the large LD of RanBP2 ( Figures 1 and 2 ) .
# ::tok The data support that Cox1 and HKI are novel partners in vivo for the large LD of RanBP2 ( Figures 1 and 2 ) .
# ::alignments 22-23|0.1.2 21-22|0.2 20-21|0.1.1 19-20|0.2.0 17-18|0.4.2 15-16|0.4.1.0+0.4.1+0.4 14-15|0.4.0 11-12|0.0.0 9-10|0.0 8-9|0.0.1 6-7|0.3.0.0+0.3.0+0.3 5-6|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:06.370
(a2 / and 
      :ARG1-of (p / partner-01 
            :location (v / vivo) 
            :mod (n2 / novel)) 
      :op1 (s / support-01 
            :ARG1 (d / data) 
            :ARG2 1 
            :op1-of 2) 
      :op1-of (a / and 
            :op2 (f / figure)) 
      :op2 (o2 / organization 
            :name (n3 / name 
                  :op1 "HKI")) 
      :op3 (o / organization 
            :mod (l / large) 
            :name (n / name 
                  :op1 "LD") 
            :part-of (r / RanBP2)))

# ::snt The LD of RanBP2 exhibits chaperone activity toward folding intermediates of Cox11 , and possibly , the mature HKI ( Figure 1 ) .
# ::tok The LD of RanBP2 exhibits chaperone activity toward folding intermediates of Cox11 , and possibly , the mature HKI ( Figure 1 ) .
# ::alignments 21-22|0.1.1 20-21|0.0.1.2 18-19|0.1.0.1.0+0.1.0.1+0.1.0 17-18|0.1.0.0 14-15|0.0.1.1 13-14|0.0.1 11-12|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 9-10|0.2 8-9|0.2.0 6-7|0.1 5-6|0.1.2 4-5|0 3-4|0.0.2 1-2|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:07.042
(e / exhibit-01 
      :ARG0 (o2 / organization 
            :name (n3 / name 
                  :op1 "LD") 
            :op1-of (a / and 
                  :op2 (t / thing 
                        :name (n2 / name 
                              :op1 "Cox11")) 
                  :op3 (p / possible-01) 
                  :op4 (f / figure)) 
            :part-of (r / RanBP2)) 
      :ARG1 (a2 / activity-06 
            :ARG0 (o / organization 
                  :ARG1-of (m / mature-02) 
                  :name (n / name 
                        :op1 "HKI")) 
            :ARG1 1 
            :ARG1-of (c / chaperone-01)) 
      :location (i / intermediate 
            :ARG1-of (f2 / fold-01)))

# ::snt Cox11 inhibits noncompetitively the activity of HKI with ~ 2 -- 3 molecules of Cox11 ( assuming formation of Cox11 dimer ) required to inhibit completely the activity of a molecule of HKI ( Figure 2A and 2B ) .
# ::tok Cox11 inhibits noncompetitively the activity of HKI with ~ 2 -- 3 molecules of Cox11 ( assuming formation of Cox11 dimer ) required to inhibit completely the activity of a molecule of HKI ( Figure 2A and 2B ) .
# ::alignments 36-37|0 34-35|0.0.0.0.1.0.0 30-31|0.0.0.0.1.0.1.0.1.1 27-28|0.0.0.0.1.0.1.0.1 25-26|0.0.0.0.1.0.1.0.2 24-25|0.0.0.0.1.0.1.0 22-23|0.0.0.0.1.0.1 20-21|0.0.0.0.1.0.2 17-18|0.0.0.0.1.0 16-17|0.0.0.0.1 12-13|0.0.0.0.1.0.1.0.1.0 11-12|0.0.0.0.1.0.1.0.1.0.0 9-10|0.0.0.0.1.0.1.0.0 6-7|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 4-5|0.0.0.0 2-3|0.0.0.1 1-2|0.0.0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:07.548
(a / and 
      :op1 (p / person 
            :ARG0-of (i2 / inhibit-01 
                  :ARG1 (a4 / activity-06 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "HKI")) 
                        :ARG1 (a3 / assume-02 
                              :ARG1 (f2 / form-01 
                                    :ARG0 (f / figure) 
                                    :ARG0-of (r / require-01 
                                          :ARG1 (i / inhibit-01 
                                                :ARG0 2 
                                                :ARG1 (a2 / activity-06 
                                                      :ARG0 (m2 / molecule 
                                                            :quant 3) 
                                                      :ARG1 (m / molecule)) 
                                                :ARG1-of (c / complete-02))) 
                                    :ARG1 (d / dimer)))) 
                  :manner (n2 / noncompetitively)) 
            :name (n3 / name 
                  :op1 "Cox11")))

# ::snt Cox11 sequesters HKI by binding to HKI at a site that is distinct from the active site and effectively reduces the availability of [ HKI ] tot for catalysis .
# ::tok Cox11 sequesters HKI by binding to HKI at a site that is distinct from the active site and effectively reduces the availability of [ HKI ] tot for catalysis .
# ::alignments 28-29|0.0.1.0 26-27|0.0.1.1 21-22|0.0.1 19-20|0.0 18-19|0.0.2 17-18|0 16-17|0.0.0.0.0.0 15-16|0.0.0.0.0 12-13|0.0.0.1.0 9-10|0.0.0.1 4-5|0.0.1.1.0 1-2|0.0.0 0-1|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:07.760
(a2 / and 
      :op1 (r / reduce-01 
            :ARG0 (s3 / sequester-01 
                  :ARG0 (p / person 
                        :ARG0-of (a3 / activity-06 
                              :ARG1 (s / site)) 
                        :name (n / name 
                              :op1 "Cox11")) 
                  :location (s2 / site 
                        :domain-of (d / distinct))) 
            :ARG1 (a / available-02 
                  :ARG1 (c / catalysi) 
                  :ARG2 (t / tot-01 
                        :ARG1 (b / binding-07))) 
            :ARG1-of (e / effective-04)))

# ::snt This is reflected by a reduction of the Vmax of HKI without significantly affecting the Km of the active site of HKI toward glucose ( Figure 2A and 2B ) .
# ::tok This is reflected by a reduction of the Vmax of HKI without significantly affecting the Km of the active site of HKI toward glucose ( Figure 2A and 2B ) .
# ::alignments 27-28|0 25-26|0.0.1.1.0.1.0.0 23-24|0.0.0 19-20|0.0.1.1.0.1 18-19|0.0.1.1.0.1.0 15-18|0.0.1.1.0.0.2+0.0.1.1.0.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 13-14|0.0.1.1 12-13|0.0.1.1.1 8-11|0.0.2.0.2+0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 5-6|0.0 2-3|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:08.026
(a / and 
      :op1 (r / reduce-01 
            :ARG0 (g / glucose) 
            :ARG0-of (r2 / reflect-01 
                  :ARG1 (t / this) 
                  :manner (a3 / affect-01 
                        :ARG1 (o / organization 
                              :name (n / name 
                                    :op1 "Km" 
                                    :op2 "of" 
                                    :op3 "the") 
                              :poss-of (s / site 
                                    :ARG1-of (a2 / activity-06 
                                          :ARG2 (f / figure)))) 
                        :ARG2 (s2 / significant-02))) 
            :ARG1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "Vmax" 
                        :op2 "of" 
                        :op3 "HKI"))))

# ::snt The inhibitory property of Cox11 over HKI is suppressed by RanBP2 ( Figure 2C ) , which by itself has a weak but significant inhibitory activity over HKI ( Figure 2D ) .
# ::tok The inhibitory property of Cox11 over HKI is suppressed by RanBP2 ( Figure 2C ) , which by itself has a weak but significant inhibitory activity over HKI ( Figure 2D ) .
# ::alignments 30-31|0.0 29-30|0.1.0.2.1 25-26|0.1.0 24-25|0.1.0.1 23-24|0.1.0.2 22-23|0 21-22|0.1 12-13|0.1.0.2.0 10-11|0.1.0.0.0.0 8-9|0.1.0.0.0 6-7|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 4-5|0.1.0.0.0.1.1 2-3|0.1.0.0.0.1 1-2|0.1.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:08.602
(c / contrast-01 
      :ARG0 2d 
      :ARG1 (w / weak-02 
            :ARG1 (a / activity-06 
                  :ARG0 (o / organization 
                        :ARG2-of (s2 / suppress-01 
                              :ARG0 (r / RanBP2) 
                              :ARG1 (p / property 
                                    :mod (i2 / inhibitory) 
                                    :mod (c2 / Cox11))) 
                        :name (n / name 
                              :op1 "HKI")) 
                  :ARG1 (i / inhibitory) 
                  :ARG1-of (s / significant-02 
                        :ARG0 (f2 / figure) 
                        :ARG2 (f / figure)))))

# ::snt The sub-stochiometry effect of the LD of RanBP2 over the inhibition of HKI by Cox11 supports that a LD-dependent chaperonin-like mechanism underlies the suppression of Cox11-dependent inhibition of HKI by RanBP2 , and that RanBP2 acts as a molecular `` buffer '' over HK1 and Cox11 activities .
# ::tok The sub-stochiometry effect of the LD of RanBP2 over the inhibition of HKI by Cox11 supports that a LD-dependent chaperonin-like mechanism underlies the suppression of Cox11-dependent inhibition of HKI by RanBP2 , and that RanBP2 acts as a molecular `` buffer '' over HK1 and Cox11 activities .
# ::alignments 46-47|0.1 44-45|0 43-44|0.0 40-41|0.1.0 38-39|0.1.0.0.0.2.1.0 35-36|0.1.0.0 32-33|0.1.0.0.0 26-27|0.1.0.0.0.2.1.1 23-24|0.1.0.0.0.2.1 21-22|0.1.0.0.0.2 20-21|0.1.0.0.0.2.0 15-16|0.1.0.0.0.0 14-15|0.1.0.0.0.1 10-11|0.1.0.0.0.0.1 7-8|0.1.0.0.0.0.0.0 2-3|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:09.129
(a2 / and 
      :op1 (h / HK1) 
      :op2 (a / activity-06 
            :ARG1-of (b / buffer-01 
                  :ARG1-of (a3 / act-02 
                        :op3-of (a4 / and 
                              :ARG1-of (s2 / support-01 
                                    :ARG0 (e / effect-03 
                                          :ARG1 (r / RanBP2)) 
                                    :location (i2 / inhibition)) 
                              :op1 (c / Cox11) 
                              :op2 (u / underlie-01 
                                    :ARG0 (m2 / mechanism) 
                                    :ARG1 (s / suppress-01 
                                          :ARG0 (m / molecule) 
                                          :ARG1 (i / inhibition))))))))

# ::snt The partial loss of the RanBP2 chaperone activity in RanBP2 + /  mice also leads to deficits in the sequestration of HKI in the ellipsoid compartment of photosensory neurons .
# ::tok The partial loss of the RanBP2 chaperone activity in RanBP2 + /  mice also leads to deficits in the sequestration of HKI in the ellipsoid compartment of photosensory neurons .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:09.130
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt This possibly underlies the mistargeting of HKI to the myoid compartment of these neurons ( Figure S2 ) .
# ::tok This possibly underlies the mistargeting of HKI to the myoid compartment of these neurons ( Figure S2 ) .
# ::alignments 16-17|0.2.0.0 15-16|0.2.0 13-14|0.3.1 12-13|0.3.1.0 10-11|0.3 9-10|0.3.0 6-7|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:09.232
(u / underlie-01 
      :ARG0 (t2 / this) 
      :ARG1 (m2 / mistarget 
            :poss (o / organization 
                  :name (n2 / name 
                        :op1 "HKI"))) 
      :ARG1-of (p / possible-01 
            :ARG0 (f / figure 
                  :mod (s / S2))) 
      :ARG3 (c / compartment 
            :mod (m / myoid) 
            :poss (n / neuron 
                  :mod (t / this))))

# ::snt The data support that the ultimate pathophysiological outcome in HKI , caused by a reduction in RanBP2 levels and its chaperone activity , is the selective degradation of HKI as reflected by the reduced levels of HKI ( and ATP ) but not of other mitochondrial and NPC components ( Figure 5 ) .
# ::tok The data support that the ultimate pathophysiological outcome in HKI , caused by a reduction in RanBP2 levels and its chaperone activity , is the selective degradation of HKI as reflected by the reduced levels of HKI ( and ATP ) but not of other mitochondrial and NPC components ( Figure 5 ) .
# ::alignments 51-52|0.0 50-51|0.1.1.0 48-49|0.1.2.2 47-48|0.1.1.2.0.0.0.0.0.0.1+0.1.1.2.0.0.0.0.0.0.0.0+0.1.1.2.0.0.0.0.0.0.0+0.1.1.2.0.0.0.0.0.0 46-47|0.1.2 45-46|0.1.2.1 44-45|0.1.2.0 42-43|0.1.1.2.0.0.0.2 41-42|0 38-39|0.1.1.2.0.0.0.1 34-35|0.1.1.2.0.0.0.0 33-34|0.1.1.2.0.0.0.0.0 30-31|0.1.1.2.0.0.0 26-27|0.1.1.2.0.0 25-26|0.1.1.2.0 21-22|0.1.1 20-21|0.1.1.2 18-19|0.1 17-18|0.1.1.1 14-15|0.1.0 11-12|0.1.0.1 9-10|0.1.0.1.0.0.0.0+0.1.0.1.0.0.0+0.1.0.1.0.0 7-8|0.1.0.1.0 5-6|0.1.0.1.0.1 2-3|0.1.0.0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:10.234
(c2 / contrast-01 
      :ARG1 5 
      :ARG2 (a4 / and 
            :ARG1-of (r3 / reduce-01 
                  :ARG0 (d2 / data 
                        :ARG1-of (s2 / support-01)) 
                  :ARG0-of (c4 / cause-01 
                        :ARG1 (o3 / outcome 
                              :location (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "HKI")) 
                              :mod (u / ultimate)))) 
            :op1 (a3 / activity-06 
                  :ARG0 (f / figure) 
                  :ARG1 (l2 / level) 
                  :ARG1-of (c3 / chaperone-01 
                        :ARG0 (s / selective 
                              :mod-of (d / degradation 
                                    :ARG1-of (r2 / reflect-01 
                                          :ARG0 (l / level 
                                                :ARG1-of (r / reduce-01 
                                                      :ARG0 (g / government-organization 
                                                            :name (n / name 
                                                                  :op1 "NPC") 
                                                            :wiki "National_People's_Congress"))) 
                                          :ARG2 (a2 / and) 
                                          :polarity -))))) 
            :op1-of (a / and 
                  :mod (o / other) 
                  :op2 (m / mitochondrial) 
                  :op3 (c / component))))

# ::snt Through this process , it is also possible that deficits in RanBP2 cause a disturbance in the equilibrium between Cox11 , HK1 , and RanBP2 by leading to an increase of the inhibitory activity of Cox11 over HKI that promotes the uncoupling of the interaction of HKI from RanBP2 , ultimately causing HKI degradation .
# ::tok Through this process , it is also possible that deficits in RanBP2 cause a disturbance in the equilibrium between Cox11 , HK1 , and RanBP2 by leading to an increase of the inhibitory activity of Cox11 over HKI that promotes the uncoupling of the interaction of HKI from RanBP2 , ultimately causing HKI degradation .
# ::alignments 53-54|0.1 51-52|0 50-51|0.2 44-45|0.0.2.0.0 41-42|0.0.1 39-40|0.0 37-38|0.0.0.0.0+0.0.0.0+0.0.0 33-34|0.0.2 32-33|0.0.2.1 29-30|0.0.2.0 26-27|0.0.2.0.1 23-24|0.0.2.0.1.1 21-22|0.0.2.0.1.1.1.0.0+0.0.2.0.1.1.1.0+0.0.2.0.1.1.1 19-20|0.0.2.0.1.1.0.0.0+0.0.2.0.1.1.0.0+0.0.2.0.1.1.0 17-18|0.0.2.0.1.2.1.0 14-15|0.0.2.0.1.2.1 12-13|0.0.2.0.1.2 11-12|0.0.2.0.1.2.0 9-10|0.0.2.0.1.0 7-8|0.0.2.0.1.2.2 6-7|0.0.2.0.1.2.2.0 2-3|0.0.2.0.1.2.2.1.0 1-2|0.0.2.0.1.2.2.1.0.0 0-1|0.0.2.0.1.2.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:11.070
(c / cause-01 
      :ARG0 (p / promote-02 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "HKI")) 
            :ARG1 (u2 / uncouple) 
            :ARG2 (a / activity-06 
                  :ARG1-of (i3 / increase-01 
                        :ARG1-of (i / interact-01) 
                        :ARG2-of (l / lead-01 
                              :ARG0 (d3 / deficit) 
                              :ARG1 (a2 / and 
                                    :op1 (p2 / person 
                                          :name (n3 / name 
                                                :op1 "Cox11")) 
                                    :op2 (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "HK1"))) 
                              :manner-of (c2 / cause-01 
                                    :ARG0 (r / RanBP2) 
                                    :ARG1 (d2 / disturbance 
                                          :location (e / equilibrium)) 
                                    :ARG1-of (p3 / possible-01 
                                          :mod (a3 / also) 
                                          :time (t2 / through 
                                                :op1 (p4 / process-02 
                                                      :mod (t / this))))))) 
                  :mod (i2 / inhibitory))) 
      :ARG1 (d / degradation) 
      :time (u / ultimate))

# ::snt Regardless , lower levels of HKI likely contribute to the decreased levels in ATP , slower growth rates , and diminished ability to metabolize glucose of RanBP2 + /  mice ( Figures 5 -- 7 ) .
# ::tok Regardless , lower levels of HKI likely contribute to the decreased levels in ATP , slower growth rates , and diminished ability to metabolize glucose of RanBP2 + /  mice ( Figures 5 -- 7 ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:11.073
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt As discussed subsequently , the ATP deficits in the retina likely account for the reduced electrophysiological responses of retinal neurons ( Figure 8 ) .
# ::tok As discussed subsequently , the ATP deficits in the retina likely account for the reduced electrophysiological responses of retinal neurons ( Figure 8 ) .
# ::alignments 22-23|0.3.1 21-22|0.2.0 19-20|0.1.1.0 18-19|0.1.1.0.0 16-17|0.1.1+0.1 14-15|0.1.0 11-12|0 10-11|0.2 9-10|0.0 6-7|0.3.0 5-6|0.3.0.0.0.0+0.3.0.0.0+0.3.0.0 2-3|0.3.2 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:11.269
(a / account-01 
      :ARG0 (r4 / retina) 
      :ARG1 (t / thing 
            :ARG1-of (r3 / reduce-01) 
            :ARG2-of (r2 / respond-01 
                  :ARG1 (n / neuron 
                        :mod (r / retinal)))) 
      :ARG1-of (l / likely-01 
            :ARG0 (f / figure)) 
      :purpose (d2 / discuss-01 
            :ARG0 (d / deficit 
                  :poss (o / organization 
                        :name (n2 / name 
                              :op1 "ATP"))) 
            :ARG1 8 
            :time (s / subsequent)))

# ::snt Various domains of RanBP2 have been previously implicated with a chaperone role in the cell .
# ::tok Various domains of RanBP2 have been previously implicated with a chaperone role in the cell .
# ::alignments 14-15|0.1.1 11-12|0.1 10-11|0.1.0 7-8|0 6-7|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:11.401
(i / implicate-01 
      :ARG1 (d / domain 
            :mod (v / variou)) 
      :ARG2 (r / role 
            :ARG1-of (c2 / chaperone-01) 
            :mod (c / cell)) 
      :time (p / previous))

# ::snt These include the enhancement of the biogenesis of red/green opsin by the combination of the RBD4-CY domains [ 6,7 ] and the stabilization by the Ran-binding domains of RanBP2 of the guanosine triphosphate-bound conformational state of RanGTPase and interaction of Ran with importin- [ 11,40,41 ] .
# ::tok These include the enhancement of the biogenesis of red/green opsin by the combination of the RBD4-CY domains [ 6,7 ] and the stabilization by the Ran-binding domains of RanBP2 of the guanosine triphosphate-bound conformational state of RanGTPase and interaction of Ran with importin- [ 11,40,41 ] .
# ::alignments 40-41|0.1.0.1 38-39|0.1 37-38|0 36-37|0.0.0.0.0+0.0.0.0+0.0.0 34-35|0.0 33-34|0.0.2 31-32|0.0.1 28-29|0.0.3 26-27|0.1.0.0 25-26|0.1.0.3.0.0.0+0.1.0.3.0.0+0.1.0.3.0 22-23|0.1.0 20-21|0.1.0.3 16-17|0.1.0.2.0.0.0 15-16|0.1.0.2.0.0.0.0.0.0+0.1.0.2.0.0.0.0.0+0.1.0.2.0.0.0.0 12-13|0.1.0.2.0.0 9-10|0.1.0.2.0.1.0 6-7|0.1.0.2.0.1 3-4|0.1.0.2.0 1-2|0.1.0.2 0-1|0.1.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:12.360
(a / and 
      :op1 (s / state 
            :location (c / country 
                  :name (n / name 
                        :op1 "RanGTPase")) 
            :mod (g / guanosine) 
            :mod (c2 / conformational) 
            :poss-of (r2 / RanBP2)) 
      :op2 (i / interact-01 
            :ARG1 (s2 / stabilize-01 
                  :ARG1 (d / domain) 
                  :ARG1-of (r / run-01) 
                  :ARG2 (i2 / include-01 
                        :ARG1 (e / enhance-01 
                              :ARG0 (c3 / combine-01 
                                    :ARG1 (d2 / domain 
                                          :mod (t2 / thing 
                                                :name (n3 / name 
                                                      :op1 "RBD4-CY")))) 
                              :ARG1 (b / biogenesi 
                                    :mod (o / opsin))) 
                        :ARG2 (t3 / this)) 
                  :op1-of (a2 / and 
                        :op2 (t / thing 
                              :name (n2 / name 
                                    :op1 "Ran-binding"))))))

# ::snt The data herein show that the multi-chaperone role of RanBP2 extends also to its LD in light of its ability to associate to distinct folding species of Cox11 and to prevent HKI from being degraded .
# ::tok The data herein show that the multi-chaperone role of RanBP2 extends also to its LD in light of its ability to associate to distinct folding species of Cox11 and to prevent HKI from being degraded .
# ::alignments 34-35|0.1.1.0.0.0 31-32|0.1.1.0.0.1.0+0.1.1.0.0.1+0.1.1.0.0 30-31|0.1.1.0 28-29|0.1.1 27-28|0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 25-26|0.1.1.1.0 24-25|0.1.1.1.0.0 23-24|0.1.1.1.0.1 21-22|0.1.1.1 19-20|0.1.1.1.1 16-17|0.1.1.1.1.0 14-15|0.1.2.0.0+0.1.2.0+0.1.2 11-12|0.1.3 10-11|0.1 9-10|0.1.0.0 7-8|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:12.970
(s2 / show-01 
      :ARG0 (h / herein 
            :mod (d3 / data)) 
      :ARG1 (e / extend-01 
            :ARG0 (r2 / role 
                  :poss (r / RanBP2)) 
            :ARG1 (a / and 
                  :ARG0-of (p / prevent-01 
                        :ARG1 (o / organization 
                              :ARG1-of (d / degrade-01) 
                              :name (n / name 
                                    :op1 "HKI"))) 
                  :op1 (a2 / associate-01 
                        :ARG2 (s / species 
                              :ARG1-of (f / fold-01) 
                              :mod (d2 / distinct)) 
                        :purpose-of (a3 / ability 
                              :poss-of (l / light))) 
                  :op2 (p2 / person 
                        :name (n2 / name 
                              :op1 "Cox11"))) 
            :ARG2 (o2 / organization 
                  :name (n3 / name 
                        :op1 "LD")) 
            :mod (a4 / also)))

# ::snt This chaperone function is likely to be complemented by other partners of RanBP2 with similar and pleiotropic functions .
# ::tok This chaperone function is likely to be complemented by other partners of RanBP2 with similar and pleiotropic functions .
# ::alignments 17-18|0.2 15-16|0 14-15|0.1 12-13|0.0.0 10-11|0.0 9-10|0.0.3 7-8|0.0.2 4-5|0.0.2.0 2-3|0.0.1.0 1-2|0.0.1 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:13.204
(a / and 
      :ARG2-of (p / partner-01 
            :ARG1 (r2 / RanBP2) 
            :ARG1-of (c2 / chaperone-01 
                  :ARG1-of (f2 / function-01 
                        :mod (t / this))) 
            :ARG1-of (c / complement-01 
                  :ARG1-of (l / likely-01)) 
            :mod (o / other)) 
      :op1 (r / resemble-01) 
      :op2 (f / function-01))

# ::snt For example , the combination of the CLD of RanBP2 with several subunits of the 19S cap of the proteasome [ 14 ] , and of its neighboring internal repeat , W1W2/IR with the E3-ubiquitin ligase , parkin [ 20 ] , and the E2 SUMO-1-conjugating protein , Ubc9 [ 15 ] may contribute to the down-regulation of HKI by 26S proteasome-mediated proteolysis and modulation of the molecular and subcellular partitioning of these partners .
# ::tok For example , the combination of the CLD of RanBP2 with several subunits of the 19S cap of the proteasome [ 14 ] , and of its neighboring internal repeat , W1W2/IR with the E3-ubiquitin ligase , parkin [ 20 ] , and the E2 SUMO-1-conjugating protein , Ubc9 [ 15 ] may contribute to the down-regulation of HKI by 26S proteasome-mediated proteolysis and modulation of the molecular and subcellular partitioning of these partners .
# ::alignments 73-74|0.1.1.0.0.0.1 72-73|0.1.1.0.0.0.1.1 70-71|0.1.1.0.0.0 68-69|0.1.1.0.0.0.2 67-68|0.1.1.0.0.0.2.0 64-65|0.1.1.0.3 63-64|0.1.1.0 62-63|0.1.1.0.2 61-62|0.1.1.0.2.0 60-61|0.1.1.0.2.1 58-59|0.1.1.0.1.0.0+0.1.1.0.1.0+0.1.1.0.1 53-54|0.1.1.0.0 52-53|0.1.1.0.0.1 50-51|0.1.1.0.0.1.0.1.1 46-47|0 45-46|0.0 44-45|0.1.0.0+0.1.0+0.1 42-43|0.1.1 39-40|0.1.1.0.0.0.0 35-36|0.1.1.0.0.0.1.0.0 34-35|0.1.1.0.0.0.1.0.1.0+0.1.1.0.0.0.1.0.1+0.1.1.0.0.0.1.0 29-30|0.1.1.0.0.1.0 28-29|0.1.1.0.0.1.0.1 27-28|0.1.1.0.0.1.0.2 24-25|0.1.1.0.0.2 21-22|0.1.1.0.0.2.0.0 16-17|0.1.1.0.0.1.0.0 15-16|0.1.1.0.0.1.0.0.0 12-13|0.1.1.0.0.1.0.1.0.0 11-12|0.1.1.0.0.1.0.1.0 7-10|0.1.1.0.0.2.0.1.0.2+0.1.1.0.0.2.0.1.0.1+0.1.1.0.0.2.0.1.0.0+0.1.1.0.0.2.0.1.0+0.1.1.0.0.2.0.1 4-5|0.1.1.0.0.2.0 1-2|0.1.1.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:15.500
(p6 / protein 
      :mod (s / sumo-1-conjugat) 
      :mod (t2 / thing 
            :name (n2 / name 
                  :op1 "E2") 
            :op1-of (a3 / and 
                  :op2 (a2 / and 
                        :ARG0-of (c / contribute-01 
                              :ARG1 (p2 / partition-01 
                                    :ARG0 20 
                                    :ARG1 (p / partner-01 
                                          :ARG1 (c2 / country 
                                                :mod-of (l / ligase) 
                                                :name (n3 / name 
                                                      :op1 "E3-ubiquitin")) 
                                          :mod (t / this)) 
                                    :op2-of (a / and 
                                          :op1 (m / molecule))) 
                              :ARG1-of (p5 / possible-01 
                                    :ARG2 (r / repeat-01 
                                          :ARG1 (c3 / cap 
                                                :quant 19) 
                                          :ARG1-of (i / internal-02 
                                                :ARG0 (s3 / several 
                                                      :quant-of (s2 / subunit)) 
                                                :ARG2 15) 
                                          :ARG1-of (n4 / neighbor-01))) 
                              :ARG2 (a4 / and 
                                    :ARG2-of (c4 / combine-01 
                                          :ARG0 14 
                                          :ARG1 (o2 / organization 
                                                :name (n5 / name 
                                                      :op1 "CLD" 
                                                      :op2 "of" 
                                                      :op3 "RanBP2"))) 
                                    :op1 (e / example))) 
                        :op1 (o / organization 
                              :name (n / name 
                                    :op1 "HKI")) 
                        :op2 (p3 / proteolysi 
                              :mod (p4 / proteasome-mediat) 
                              :quant 26) 
                        :op3 (m2 / modulation)))))

# ::snt In this regard , it will be interesting to probe whether parkin also causes deficits in HKI in dopaminergic neurons , since parkin was reported to modulate RanBP2 turnover [ 20 ] , and parkin loss-of-function also causes energy and growth deficits [ 26 -- 29,42 ] .
# ::tok In this regard , it will be interesting to probe whether parkin also causes deficits in HKI in dopaminergic neurons , since parkin was reported to modulate RanBP2 turnover [ 20 ] , and parkin loss-of-function also causes energy and growth deficits [ 26 -- 29,42 ] .
# ::alignments 43-44|0.0.2.2.1.0 41-42|0.0.0 40-41|0.1 39-40|0 38-39|0.0.2.1 37-38|0.0 36-37|0.0.1 33-34|0.0.2 30-31|0.0.2.0.0.0 28-29|0.0.2.2.1.1 26-27|0.0.2.2.1 24-25|0.0.2.2 21-22|0.0.2.2.2 19-20|0.0.2.0.0.1.1 16-17|0.0.2.2.0.1.0+0.0.2.2.0.1+0.0.2.2.0 14-15|0.0.2.2.0.0 13-14|0.0.2.0.0.1 12-13|0.0.2.0.0.1.2 11-12|0.0.2.0.0.1.0 9-10|0.0.2.0.0 7-8|0.0.2.0 2-3|0.0.2.0.1 1-2|0.0.2.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:16.435
(a / and 
      :ARG0-of (c / cause-01 
            :ARG1 (d / deficit) 
            :mod (a2 / also) 
            :op2-of (a3 / and 
                  :op1 (i / interest-01 
                        :ARG2 (p2 / probe-01 
                              :ARG0 20 
                              :ARG1 (c2 / cause-01 
                                    :ARG0 (p / parkin) 
                                    :ARG1 (n / neuron) 
                                    :mod (a4 / also))) 
                        :time (r2 / regard-01 
                              :mod (t2 / this))) 
                  :op1-of (e / energy) 
                  :time (r / report-01 
                        :ARG0 (o / organization 
                              :location-of (d2 / deficit) 
                              :name (n2 / name 
                                    :op1 "HKI")) 
                        :ARG1 (m / modulate-01 
                              :ARG0 26 
                              :ARG1 (t / turnover)) 
                        :op1-of (s / since)))) 
      :op1 (g / grow-01))

# ::snt These data add a new dimension to the complexity of the regulation of the glycolytic pathway , in particular in the CNS , where glycolysis plays a major role in supplying energy and where the proteasome machinery may play a critical role in modulating components of the energy supply machinery [ 43 ] .
# ::tok These data add a new dimension to the complexity of the regulation of the glycolytic pathway , in particular in the CNS , where glycolysis plays a major role in supplying energy and where the proteasome machinery may play a critical role in modulating components of the energy supply machinery [ 43 ] .
# ::alignments 51-52|0.1.2.0 49-50|0.2.3.1 48-49|0.2.3.1.0 47-48|0.2.3.1.0.0 44-45|0.2.3.0 43-44|0.2.3 41-42|0.2.1 40-41|0.2.1.0 38-39|0.2 37-38|0.2.2 36-37|0.2.0 32-33|0 31-32|0.1.2.1 30-31|0.1.2 28-29|0.1.1 27-28|0.1.1.0 25-26|0.1 24-25|0.1.0 21-22|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 18-19|0.0.0.0.0.0.0 15-16|0.0.1 11-12|0.0 8-9|0.0.2 5-6|0.0.0.0.0.0 4-5|0.0.0.0.0.0.1 2-3|0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:18.456
(a / and 
      :op1 (r3 / regulate-01 
            :ARG0 (t / this 
                  :mod-of (d2 / data 
                        :ARG1-of (a2 / add-02 
                              :ARG2 (d / dimension 
                                    :mod (p4 / particular 
                                          :location (o / organization 
                                                :name (n / name 
                                                      :op1 "CNS"))) 
                                    :mod (n2 / new))))) 
            :ARG1 (p5 / pathway) 
            :topic-of (c3 / complexity)) 
      :op2 (p3 / play-02 
            :ARG0 (g / glycolysi) 
            :ARG1 (r2 / role 
                  :ARG1-of (m4 / major-02)) 
            :ARG2 (s2 / supply-01 
                  :ARG0 43 
                  :ARG1 (e2 / energy))) 
      :op3 (p / play-01 
            :ARG0 (m3 / machinery) 
            :ARG1 (r / role 
                  :ARG1-of (c2 / critical-02)) 
            :ARG1-of (p2 / possible-01) 
            :ARG2 (m2 / modulate-01 
                  :ARG1 (c / component) 
                  :ARG2 (m / machinery 
                        :ARG0-of (s / supply-01 
                              :ARG1 (e / energy))))))

# ::snt This is further evidenced by the presence of genetic modifiers in RanBP2 + /  mice on a mixed genetic background that compensates for deficits in RanBP2 and deregulation of its partners in glucose/energy homeostasis as observed in the coisogenic line .
# ::tok This is further evidenced by the presence of genetic modifiers in RanBP2 + /  mice on a mixed genetic background that compensates for deficits in RanBP2 and deregulation of its partners in glucose/energy homeostasis as observed in the coisogenic line .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:18.458
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The presence of such compensatory mechanisms is also supported by the identification of a quantitative trait locus , which encompasses RanBP2 , and modifies the expression of diabetes-related phenotypes [ 44 ] .
# ::tok The presence of such compensatory mechanisms is also supported by the identification of a quantitative trait locus , which encompasses RanBP2 , and modifies the expression of diabetes-related phenotypes [ 44 ] .
# ::alignments 30-31|0.1.1.0.0 28-29|0.0 27-28|0.1.0.0.0 25-26|0 23-24|0.1 22-23|0.1.1 20-21|0.1.1.0.1 19-20|0.1.1.0 16-17|0.1.0 15-16|0.1.0.1 14-15|0.1.0.2 11-12|0.1.0.0 8-9|0.1.0.0.1 7-8|0.1.0.0.1.1 5-6|0.1.0.0.1.0.0 3-4|0.1.0.0.1.0.0.0 1-2|0.1.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:18.775
(e / express-01 
      :ARG1 (p / phenotyp) 
      :ARG1-of (m / modify-01 
            :ARG0 (l / locu 
                  :ARG1-of (i / identify-02 
                        :ARG0 (d / diabetes-relat) 
                        :ARG0-of (s / support-01 
                              :ARG1 (p2 / presence 
                                    :poss (m2 / mechanism 
                                          :mod (s2 / such))) 
                              :mod (a2 / also))) 
                  :mod (t / trait) 
                  :mod (q / quantitative)) 
            :op2-of (a / and 
                  :op1 (e2 / encompass-01 
                        :ARG0 44 
                        :ARG1 (r / RanBP2)))))

# ::snt The data herein show tissues with a decrease of RanBP2 and HKI levels mirror a reduction in the ATP levels .
# ::tok The data herein show tissues with a decrease of RanBP2 and HKI levels mirror a reduction in the ATP levels .
# ::alignments 19-20|0.1.0.0 18-19|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 15-16|0.1.0.0.0 13-14|0.1.0.0.0.1 12-13|0.1 11-12|0.0.0.0+0.0.0+0.0 10-11|0 7-8|0.1.0 4-5|0.1.0.0.0.0 3-4|0.1.0.0.0.0.0 2-3|0.1.0.0.0.0.0.0 1-2|0.1.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:18.921
(a / and 
      :op1 (o2 / organization 
            :name (n2 / name 
                  :op1 "HKI")) 
      :op2 (l2 / level 
            :ARG1-of (d / decrease-01 
                  :ARG0 (l / level 
                        :ARG1-of (r / reduce-01 
                              :ARG0 (t / tissue 
                                    :ARG0-of (s / show-01 
                                          :ARG1 (h / herein 
                                                :mod (d2 / data)))) 
                              :op1-of (m / mirror)) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "ATP"))))))

# ::snt Since the constitutive Na + / K + ATPase pump and the ATP-dependent conversion of glutamine to glutamate ( both fundamental to maintain the electrical activity in the CNS ) consumes the vast majority of the energy produced by the CNS [ 45 -- 47 ] , this likely underlies the suppression of the electrophysiological output responses of retinal neurons ( Figure 8 ) .
# ::tok Since the constitutive Na + / K + ATPase pump and the ATP-dependent conversion of glutamine to glutamate ( both fundamental to maintain the electrical activity in the CNS ) consumes the vast majority of the energy produced by the CNS [ 45 -- 47 ] , this likely underlies the suppression of the electrophysiological output responses of retinal neurons ( Figure 8 ) .
# ::alignments 62-63|0.0.1.0.1.0.2.0 61-62|0.0.1.0.0.0 59-60|0.0.1.0.1.0.1.0.0.0 58-59|0.0.1.0.1.0.1.0.0.0.0 56-57|0.0.1.0.1.0.1.0.0+0.0.1.0.1.0.1.0 55-56|0.0.1.0.1.0.1.0.0.1 51-52|0.0.1.0.1.0.1 49-50|0.0.1.0.1.0 48-49|0.0.1.0.1.0.2 47-48|0.0.1.0.1.0.0 44-45|0.0.1.2.0 42-43|0.0.0 37-38|0.0.1.0.0 36-37|0.0.1.0.0.1 33-34|0.0.1.0.0.2 32-33|0.0.1.0.0.2.0 30-31|0.0.1.0 28-29|0.0.1.2.1.0.0.0+0.0.1.2.1.0.0+0.0.1.2.1.0 25-26|0.0.1.2.1 24-25|0.0.1.2.1.2 22-23|0.0.1.2 20-21|0.0.1.2.2 19-20|0.0.1.2.2.0 15-16|0 13-14|0.0 10-11|0.0.1 9-10|0.0.1.1 6-7|0.0.1.1.0.0 5-6|0.0.1.1.0 3-4|0.0.1.1.0.1.0.0+0.0.1.1.0.1.0+0.0.1.1.0.1 2-3|0.0.1.2.1.1 0-1|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:21.909
(g / glutamine 
      :ARG1-of (c2 / convert-01 
            :ARG0 45 
            :op2-of (a2 / and 
                  :ARG0-of (c / consume-01 
                        :ARG1 (p / produce-01 
                              :ARG0 (f / figure) 
                              :ARG1 (e / energy) 
                              :manner (m / majority 
                                    :degree (v / vast))) 
                        :op1-of (s3 / since 
                              :time-of (u / underlie-01 
                                    :ARG0 (t2 / this) 
                                    :ARG1 (s / suppress-01 
                                          :ARG1 (t / thing 
                                                :ARG2-of (r2 / respond-01 
                                                      :ARG0 (n / neuron 
                                                            :mod (r / retinal)) 
                                                      :ARG1 (o / output)))) 
                                    :ARG1-of (l / likely-01 
                                          :ARG0 8)))) 
                  :op1 (p2 / pump-01 
                        :op2-of (s2 / slash 
                              :mod-of (k / k) 
                              :op1 (t3 / thing 
                                    :name (n3 / name 
                                          :op1 "Na")))) 
                  :op3 (m2 / maintain-01 
                        :ARG0 47 
                        :ARG1 (a / activity-06 
                              :ARG0 (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "CNS")) 
                              :ARG1 (c3 / constitutive) 
                              :mod (e2 / electricity)) 
                        :domain-of (f2 / fundamental 
                              :degree (b / both))))))

# ::snt Moreover , deficits in HKI may lead to intracellular hyperglycemia in the CNS , promote sorbitol-induced osmotic stress , and compromise further the ATPase-dependent Na + / K + pump activity [ 48 -- 50 ] .
# ::tok Moreover , deficits in HKI may lead to intracellular hyperglycemia in the CNS , promote sorbitol-induced osmotic stress , and compromise further the ATPase-dependent Na + / K + pump activity [ 48 -- 50 ] .
# ::alignments 34-35|0.1.0.0.0.0.1.0.0 32-33|0.1.0.0.0.0.0.0 30-31|0.1 29-30|0 27-28|0.0 26-27|0.0.0 23-25|0.1.0.0.0.0.1.0.1.0.1+0.1.0.0.0.0.1.0.1.0.0+0.1.0.0.0.0.1.0.1.0+0.1.0.0.0.0.1.0.1 21-22|0.1.0.0.0.0.2.1 20-21|0.1.0.0.0.0.2 19-20|0.1.0.0.0.0 17-18|0.1.0.0.0.0.1.0 16-17|0.1.0.0.0.0.1.0.2 15-16|0.1.0.0.0.0.1.0.3 14-15|0.1.0.0.0.0.1 12-13|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 9-10|0.1.0.0.0.0.2.0 6-7|0.1.0.0.0 5-6|0.1.0.0.0.0.0 4-5|0.1.0.1.0+0.1.0.1+0.1.0 2-3|0.1.0.0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:22.718
(p / pump-01 
      :ARG0 (k / k 
            :op1-of (s / slash)) 
      :ARG1 (a / activity-06 
            :ARG0 (o4 / organization 
                  :location-of (d / deficit 
                        :ARG0-of (l / lead-03 
                              :ARG1 (a2 / and 
                                    :ARG1-of (p3 / possible-01 
                                          :ARG0 48) 
                                    :op1 (p2 / promote-02 
                                          :ARG1 (s2 / stress-02 
                                                :ARG0 50 
                                                :ARG1 (o / organization 
                                                      :name (n / name 
                                                            :op1 "ATPase-dependent" 
                                                            :op2 "Na")) 
                                                :mod (o2 / osmotic) 
                                                :mod (s3 / sorbitol-induc))) 
                                    :op2 (c / compromise-01 
                                          :ARG1 (h / hyperglycemia) 
                                          :degree (f / further))) 
                              :ARG4 (o3 / organization 
                                    :name (n2 / name 
                                          :op1 "CNS")))) 
                  :name (n3 / name 
                        :op1 "HKI")) 
            :ARG1 (m / moreover)))

# ::snt This may be exacerbated by a decrease of ATP , since the activity of HKI is also stimulated by ATP [ 51 ] .
# ::tok This may be exacerbated by a decrease of ATP , since the activity of HKI is also stimulated by ATP [ 51 ] .
# ::alignments 21-22|0.0 17-18|0.1.2.0 16-17|0.1.2.0.1 14-15|0.1.2.0.0.0.0.0+0.1.2.0.0.0.0+0.1.2.0.0.0 12-13|0.1.2.0.0 10-11|0.1.2 8-9|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 6-7|0.1.0 3-4|0.1 1-2|0 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:22.870
(p / possible-01 
      :ARG0 51 
      :ARG1 (e / exacerbate-01 
            :ARG0 (d / decrease-01 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "ATP"))) 
            :ARG1 (t / this) 
            :time (s2 / since 
                  :op1 (s / stimulate-01 
                        :ARG1 (a2 / activity-06 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "HKI"))) 
                        :mod (a / also)))))

# ::snt The cumulative effects of a reduction in ATP and intracellular hyperglycemia are known to act synergistically and modulate the electrophysiological properties of neuronal activity .
# ::tok The cumulative effects of a reduction in ATP and intracellular hyperglycemia are known to act synergistically and modulate the electrophysiological properties of neuronal activity .
# ::alignments 23-24|0.0 22-23|0 20-21|0.0.0 17-18|0.0.0.0 16-17|0.0.0.0.0 15-16|0.0.0.0.0.1.2 14-15|0.0.0.0.0.1 12-13|0.0.0.0.0.0 10-11|0.0.0.0.0.1.1 9-10|0.0.0.0.0.1.1.0 8-9|0.0.0.0.0.1.0 7-8|0.0.0.0.0.1.0.0.1.0+0.0.0.0.0.1.0.0.1+0.0.0.0.0.1.0.0 5-6|0.0.0.0.0.1.0.0.0 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:23.214
(n / neuronal 
      :mod-of (a / activity-06 
            :mod-of (p / property 
                  :ARG1-of (m / modulate-01 
                        :op2-of (a2 / and 
                              :ARG2-of (k / know-02 
                                    :ARG1 (e / effect 
                                          :mod (c / cumulative))) 
                              :op1 (a3 / act-02 
                                    :ARG0 (a4 / and 
                                          :op1 (o / organization 
                                                :ARG1-of (r / reduce-01) 
                                                :name (n2 / name 
                                                      :op1 "ATP"))) 
                                    :ARG1 (h / hyperglycemia 
                                          :mod (i / intracellular)) 
                                    :manner (s / synergistically)))))))

# ::snt Figure 9 integrates in a model these variables and implications of the data presented herein .
# ::tok Figure 9 integrates in a model these variables and implications of the data presented herein .
# ::alignments 14-15|0.1.0.0 13-14|0.1.0 12-13|0.1.0.1.2.0.0 9-10|0.1.0.1.2.0+0.1.0.1.2 8-9|0.1.0.1 7-8|0.1.0.1.1 6-7|0.1.0.1.0 5-6|0.1 2-3|0 1-2|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:23.641
(i2 / integrate-01 
      :ARG0 9 
      :ARG1 (m / model 
            :ARG0-of (p / present-01 
                  :ARG1 (h / herein) 
                  :op3-of (a / and 
                        :mod (t2 / this) 
                        :op1 (v / variabl) 
                        :op2 (t / thing 
                              :ARG1-of (i / imply-01 
                                    :ARG2 (d / data)))))) 
      :time (f / figure))

# ::snt Still , other bona fide RanBP2 partners previously identified and described in the Introduction also become strong candidates to play a role in energy homeostasis .
# ::tok Still , other bona fide RanBP2 partners previously identified and described in the Introduction also become strong candidates to play a role in energy homeostasis .
# ::alignments 24-25|0.0.0.1.0.0 23-24|0.0.0.1.0.0.0 21-22|0.0.0.1.0 19-20|0.0.0.1 17-18|0.0.0 16-17|0.0.0.0 15-16|0.0 14-15|0.0.1 13-14|0.2.1 10-11|0.2 9-10|0 8-9|0.1 7-8|0.1.1 6-7|0.2.0 2-3|0.2.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:24.068
(a2 / and 
      :ARG1-of (b / become-01 
            :ARG2 (c / candidate 
                  :ARG1-of (s / strong-02) 
                  :purpose (p / play-01 
                        :ARG1 (r / role 
                              :mod (h / homeostasi 
                                    :mod (e / energy))))) 
            :mod (a / also)) 
      :op1 (i2 / identify-01 
            :ARG1 (s2 / still) 
            :time (p2 / previous)) 
      :op2 (d / describe-01 
            :ARG0 (p3 / partner-01 
                  :mod (o / other)) 
            :ARG1 (i / introduction)))

# ::snt For example , the unfolding and chaperone activity of components of the 19S cap of the proteasome may be modulated by the CLD of RanBP2 [ 14 ] and contribute to the selective HKI ( and other substrates ) degradation [ 43 ] , while association of nuclear import receptor , importin- with the Ran-binding domains of RanBP2 [ 10,11 ] , may mediate the nuclear translocation of multifunctional substrates , such as glyceraldehyde-3-phosphate dehydrogenase .
# ::tok For example , the unfolding and chaperone activity of components of the 19S cap of the proteasome may be modulated by the CLD of RanBP2 [ 14 ] and contribute to the selective HKI ( and other substrates ) degradation [ 43 ] , while association of nuclear import receptor , importin- with the Ran-binding domains of RanBP2 [ 10,11 ] , may mediate the nuclear translocation of multifunctional substrates , such as glyceraldehyde-3-phosphate dehydrogenase .
# ::alignments 74-75|0.1.1.1.1.0.2.2.0.0.0.1 71-72|0.1.1.1.1.0.2.2.0.0.0.0 69-70|0.1.1.1.1.0.1.0.0 66-67|0.1.1.1.1.0.1.0 65-66|0.1.1.1.1.0.1.0.1 63-64|0.1.1.1.1.0.1 62-63|0.1.1.1.1.0 55-56|0.1.1.1.0 54-55|0.1.1.1.1.2.0.0+0.1.1.1.1.2.0+0.1.1.1.1.2 49-50|0.1.1.1.1.0.2.2.0.0 48-49|0.1.1.1.1.0.2.2.0.0.0 47-48|0.1.1.1.1.0.2.2.0.0.0.2 45-46|0.1.1.1.1.0.2.2.0 41-42|0.1.1.1.1.0.0 39-40|0.1.1.1.1.0.2.2 37-38|0.1.1.1.1.0.2.1 36-37|0.1.1.1.1.0.2.1.0 35-36|0.1.1.1.1.0.2 33-34|0.1.1.1.1.0.2.2.0.1.0.0+0.1.1.1.1.0.2.2.0.1.0+0.1.1.1.1.0.2.2.0.1 32-33|0.1.1.1.1.0.2.0 29-30|0.1.1.1 28-29|0.1.1.1.1 26-27|0.0.0 22-25|0.1.1.1.1.1.0.0.2+0.1.1.1.1.1.0.0.1+0.1.1.1.1.1.0.0.0+0.1.1.1.1.1.0.0+0.1.1.1.1.1.0 19-20|0.1.1.1.1.1 17-18|0.1.1.1.1.1.2 16-17|0.1.1.1.1.1.1 13-14|0.1.1.1.1.1.1.0 12-13|0.1.1.1.1.1.1.0.0 9-10|0.1.1.0 7-8|0.1.1 6-7|0.1 5-6|0 4-5|0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:26.013
(a5 / and 
      :op1 (u / unfold-01 
            :ARG1 14) 
      :op2 (c4 / chaperone-01 
            :ARG0 (e / example) 
            :ARG1 (a4 / activity-06 
                  :ARG0 (c3 / component) 
                  :ARG1-of (c / contribute-01 
                        :ARG0 (d2 / domain) 
                        :op2-of (a3 / and 
                              :condition (p / possible-01 
                                    :ARG0 43 
                                    :ARG1 (m / mediate-01 
                                          :ARG1 (t / translocation 
                                                :mod (s2 / substrat) 
                                                :mod (n / nucleus))) 
                                    :op4-of (a2 / and 
                                          :op1 (s4 / selective) 
                                          :op2 (s3 / substrat 
                                                :mod (o / other)) 
                                          :op3 (d3 / degradation 
                                                :ARG0-of (a / associate-01 
                                                      :ARG1 (r / receptor 
                                                            :mod (i / import-01 
                                                                  :ARG1 (s / such) 
                                                                  :ARG2 (d / dehydrogenase) 
                                                                  :mod (n3 / nucleus))) 
                                                      :ARG2 (o2 / organization 
                                                            :name (n4 / name 
                                                                  :op1 "HKI")))))) 
                              :op1 (m2 / modulate-01 
                                    :ARG0 (o3 / organization 
                                          :name (n5 / name 
                                                :op1 "CLD" 
                                                :op2 "of" 
                                                :op3 "RanBP2")) 
                                    :ARG1 (p3 / proteasome 
                                          :poss-of (c2 / cap 
                                                :quant 19)) 
                                    :ARG1-of (p2 / possible-01)) 
                              :op3 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "Ran-binding")))))))

# ::snt This trafficking process is selectively inhibited by the neuroprotective drug , R - ( - ) - deprenyl and derivates thereof , and are often employed to treat Parkinson disease [ 52 -- 57 ] .
# ::tok This trafficking process is selectively inhibited by the neuroprotective drug , R - ( - ) - deprenyl and derivates thereof , and are often employed to treat Parkinson disease [ 52 -- 57 ] .
# ::alignments 33-34|0.0.3.0.1.0 31-32|0.0.1.1 29-30|0.0.1.1.0 28-29|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 27-28|0.0.1 25-26|0.0 24-25|0.0.2 22-23|0.0.3 20-21|0.0.3.0.1.1.0 18-19|0 11-12|0.0.0 9-10|0.0.3.0.0 5-6|0.0.3.0 4-5|0.0.3.0.2 2-3|0.0.3.0.1 1-2|0.0.3.0.1.1 0-1|0.0.3.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:26.963
(a2 / and 
      :op1 (e / employ-01 
            :ARG0 (r / r) 
            :ARG1 (t / treat-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Parkinson")) 
                  :ARG2 (52 / 52 
                        :mod (d / disease))) 
            :frequency (o / often) 
            :op2-of (a / and 
                  :op1 (i / inhibit-01 
                        :ARG0 (d2 / drug) 
                        :ARG1 (p2 / process-02 
                              :ARG0 57 
                              :ARG1 (t3 / traffic-01 
                                    :ARG1 (t2 / thereof)) 
                              :mod (t4 / this)) 
                        :manner (s / selectively)))))

# ::snt Hence , RanBP2 and its partners emerge as key players and target genes in mediating neuropathophysiological mechanisms implicated in various genetic and environmental lesions to the CNS , as in patients with Parkinson , diabetes with insulin-resistance , and other neuropathies and neurodegenerative diseases , often linked to aging manifestations .
# ::tok Hence , RanBP2 and its partners emerge as key players and target genes in mediating neuropathophysiological mechanisms implicated in various genetic and environmental lesions to the CNS , as in patients with Parkinson , diabetes with insulin-resistance , and other neuropathies and neurodegenerative diseases , often linked to aging manifestations .
# ::alignments 49-50|0.0 48-49|0 46-47|0.0.0 45-46|0.0.0.1 43-44|0.0.0.2.4 42-43|0.0.0.2.4.0 41-42|0.0.0.2 40-41|0.0.0.2.2 39-40|0.0.0.2.0 38-39|0.0.0.2.3 34-35|0.0.0.2.3.0 32-33|0.0.0.2.1.1.0+0.0.0.2.1.1+0.0.0.2.1 30-31|0.0.0.2.1.0.1+0.0.0.2.1.0+0.0.0.2.1.0.0 26-27|0.0.0.0.0.1.0.1.0.0+0.0.0.0.0.1.0.1.0+0.0.0.0.0.1.0.1 23-24|0.0.0.0.2 22-23|0.0.0.0.2.0 21-22|0.0.0.0 20-21|0.0.0.0.1 19-20|0.0.0.0.0.1.0.0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.1 14-15|0.0.0.0.0.1.0 12-13|0.0.0.0.0.1.0.0.0.1.1 11-12|0.0.0.0.0.1.0.0.0.1.1.0 10-11|0.0.0.0.0.1.0.0.0.1 9-10|0.0.0.0.0.1.0.0.0.1.0.0+0.0.0.0.0.1.0.0.0.1.0 8-9|0.0.0.0.0.1.0.0.0.1.0.1 6-7|0.0.0.0.0.1.0.0.0 5-6|0.0.0.0.0.1.0.0.1.0 3-4|0.0.0.0.0.1.0.0 2-3|0.0.0.0.0.1.0.0.1 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:30.686
(a / age-01 
      :ARG1 (m / manifestation 
            :ARG2-of (l / link-01 
                  :ARG1 (a4 / and 
                        :op1 (i / implicate-01 
                              :ARG0 (h2 / hence) 
                              :ARG1 (m2 / mechanism 
                                    :ARG1-of (m3 / mediate-01 
                                          :ARG0 (a6 / and 
                                                :ARG0-of (e2 / emerge-01 
                                                      :ARG1 (v / various) 
                                                      :op1-of (a5 / and 
                                                            :op2 (p4 / person 
                                                                  :ARG0-of (p5 / play-01) 
                                                                  :ARG1-of (k / key-02)) 
                                                            :op3 (g2 / gene 
                                                                  :ARG1-of (t / target-01)))) 
                                                :op1 (r / RanBP2 
                                                      :ARG1-of (p6 / partner-01))) 
                                          :ARG2 (o3 / organization 
                                                :name (n4 / name 
                                                      :op1 "CNS"))))) 
                        :op2 (g / gene) 
                        :op3 (l2 / lesion 
                              :mod (e / environment))) 
                  :frequency (o / often) 
                  :op4-of (a2 / and 
                        :mod (o2 / other) 
                        :op1 (p / person 
                              :ARG1-of (h / have-rel-role-91 
                                    :ARG0 (p2 / person) 
                                    :ARG2 (p3 / patient)) 
                              :name (n3 / name 
                                    :op1 "Parkinson")) 
                        :op2 (n2 / neuropathi) 
                        :op2-of (a3 / and 
                              :op1 (d2 / diabetes)) 
                        :op3 (d / disease 
                              :mod (n / neurodegenerative))))))

# ::snt To this effect , the RanBP2 mouse model will serve as a unique genetic tool to probe selective , multiple and novel pathways , which may have not been anticipated to be linked to metabolic processes and allied pathophysiological states .
# ::tok To this effect , the RanBP2 mouse model will serve as a unique genetic tool to probe selective , multiple and novel pathways , which may have not been anticipated to be linked to metabolic processes and allied pathophysiological states .
# ::alignments 39-40|0.0.1.1.0 38-39|0.0.1.0.0.0.1 37-38|0.0.1.1 36-37|0.0.1 35-36|0.0.1.0.0.0 34-35|0.0.1.0.0.0.2 32-33|0.0.1.0.0 29-30|0.0.1.0 27-28|0.0.1.0.2 25-26|0.0.1.0.1 22-23|0.3 21-22|0.2 20-21|0 19-20|0.0.0.0.1.0 17-18|0.1 16-17|0.0 14-15|0.0.0 13-14|0.0.1.0.0.0.0 12-13|0.0.0.1 9-10|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 2-3|0.0.0.0.1 1-2|0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:31.343
(a4 / and 
      :ARG1-of (p5 / probe-01 
            :ARG0 (t / tool 
                  :ARG1-of (s3 / serve-01 
                        :ARG0 (m3 / model 
                              :mod (m4 / mouse)) 
                        :ARG2 (e / effect-03 
                              :ARG1 (m2 / multiple) 
                              :mod (t2 / this))) 
                  :mod (u / unique)) 
            :op1-of (a2 / and 
                  :op2 (a3 / anticipate-01 
                        :ARG1 (l / link-01 
                              :ARG2 (p2 / process-02 
                                    :ARG1 (g / gene) 
                                    :ARG2 (p / pathophysiological) 
                                    :mod (m / metabolic))) 
                        :ARG1-of (p3 / possible-01) 
                        :polarity -) 
                  :op3 (a / ally-01 
                        :ARG1 (s / state)))) 
      :op1 (s2 / selective) 
      :op2 (n / novel) 
      :op3 (p4 / pathway))

# ::snt Model Depicting a Role of RanBP2 and Some of Its Partners in Metabolic and Neuronal Function .
# ::tok Model Depicting a Role of RanBP2 and Some of Its Partners in Metabolic and Neuronal Function .
# ::alignments 15-16|0.1.2 14-15|0.1.2.0 13-14|0.1 12-13|0.1.1 10-11|0 9-10|0.0 7-8|0.2 6-7|0.1.0.1.0 5-6|0.1.0.1.0.0 3-4|0.1.0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:31.511
(p / partner-01 
      :ARG0 (i / it) 
      :ARG1 (a / and 
            :ARG2-of (d / depict-01 
                  :ARG0 (m2 / model-01) 
                  :ARG1 (r2 / role 
                        :op1-of (a2 / and 
                              :op2 (r / RanBP2)))) 
            :op1 (m / metabolic) 
            :op2 (f / function-01 
                  :ARG1 (n / neuronal))) 
      :quant (s / some))

# ::snt RanBP2 interacts with Cox11 and HKI and the triad is in equilibrium under normal physiological conditions .
# ::tok RanBP2 interacts with Cox11 and HKI and the triad is in equilibrium under normal physiological conditions .
# ::alignments 15-16|0.4.0.0 14-15|0.4.0 13-14|0.4.0.0.0 11-12|0.4 8-9|0.3 6-7|0 5-6|0.2.0.0+0.2.0+0.2 4-5|0.1.1 3-4|0.1.0.0+0.1.0+0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:31.661
(a / and 
      :ARG2-of (i / interact-01 
            :ARG0 (r / RanBP2)) 
      :op1 (p2 / person 
            :name (n3 / name 
                  :op1 "Cox11") 
            :op1-of (a2 / and)) 
      :op2 (o / organization 
            :name (n2 / name 
                  :op1 "HKI")) 
      :op3 (t / triad) 
      :time (e / equilibrium 
            :source (p / physiological 
                  :mod-of (c / condition 
                        :ARG1-of (n / normal-02)))))

# ::snt RanBP2 prevents the inhibition of HKI by Cox11 and its degradation .
# ::tok RanBP2 prevents the inhibition of HKI by Cox11 and its degradation .
# ::alignments 10-11|0.0.1 8-9|0.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.1.0.0.0+0.1.0.0+0.1.0 3-4|0.1 1-2|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:32.131
(p2 / prevent-01 
      :ARG0 (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "Cox11")) 
            :op2 (d / degradation)) 
      :ARG1 (i / inhibition 
            :poss (o / organization 
                  :name (n2 / name 
                        :op1 "HKI"))) 
      :ARG2 (r / RanBP2))

# ::snt The ultimate effect of RanBP2 on its partners is the stimulation of the glycolytic pathway and production of ATP .
# ::tok The ultimate effect of RanBP2 on its partners is the stimulation of the glycolytic pathway and production of ATP .
# ::alignments 18-19|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 16-17|0.1.1 15-16|0.1 14-15|0.1.0 13-14|0.1.0.0 10-11|0 7-8|0.0.0.0 4-5|0.0.0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:32.205
(s / stimulation 
      :ARG1-of (e / effect-03 
            :ARG0 (r / RanBP2 
                  :ARG1-of (p3 / partner-01)) 
            :mod (u / ultimate)) 
      :op1-of (a / and 
            :op2 (p2 / pathway 
                  :mod (g / glycolytic)) 
            :op3 (p / produce-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "ATP")))))

# ::snt The glycolytic pathway is critical to fuel the constitutive Na + / K + - ATPase pump to maintain the dark current between the inner and outer segment compartments of photosensory neurons .
# ::tok The glycolytic pathway is critical to fuel the constitutive Na + / K + - ATPase pump to maintain the dark current between the inner and outer segment compartments of photosensory neurons .
# ::alignments 31-32|0.3.0.0.0.0.2 28-29|0.3 27-28|0.3.1 26-27|0.3.0 25-26|0 24-25|0.2 21-22|0.3.0.0.1.0 20-21|0.3.0.0.1.0.0 18-19|0.3.0.0.1 16-17|0.3.0.0 12-13|0.3.0.0.1.0.0.0 11-12|0.1 9-10|0.0.0.0+0.0.0+0.0 8-9|0.3.0.0.0.0.0 6-7|0.3.0.0.0.0.1 4-5|0.3.0.0.0.0 2-3|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:32.697
(a / and 
      :op1 (t / thing 
            :name (n2 / name 
                  :op1 "Na")) 
      :op2 (s2 / slash) 
      :op3 (i / inner) 
      :op4 (c / compartment 
            :mod (o / outer 
                  :mod-of (p / pump-01 
                        :ARG0 (p2 / pathway 
                              :ARG1-of (c4 / critical-02 
                                    :ARG0 (c3 / constitutive) 
                                    :ARG2 (f / fuel) 
                                    :op1-of (n / neuron))) 
                        :ARG1 (m / maintain-01 
                              :ARG1 (c2 / current 
                                    :ARG1-of (d / dark-02 
                                          :ARG0 (k / k)))))) 
            :mod (s / segment)))

# ::snt A deficit ( haploinsufficiency ) in RanBP2 disturbs the equilibrium between RanBP2 , HKI , and Cox11 .
# ::tok A deficit ( haploinsufficiency ) in RanBP2 disturbs the equilibrium between RanBP2 , HKI , and Cox11 .
# ::alignments 16-17|0.4.1.0.0+0.4.1.0+0.4.1 15-16|0.4 13-14|0.4.0.0.0+0.4.0.0+0.4.0 9-10|0.1 7-8|0 6-7|0.3 3-4|0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:32.889
(d / disturb-01 
      :ARG0 (h / haploinsufficiency) 
      :ARG1 (e / equilibrium) 
      :ARG2 (d2 / deficit) 
      :manner (r / RanBP2) 
      :op1-of (a / and 
            :op2 (o / organization 
                  :name (n2 / name 
                        :op1 "HKI")) 
            :op3 (p / person 
                  :name (n / name 
                        :op1 "Cox11"))))

# ::snt This pathophysiological event promotes the destabilization and degradation of HKI and a decrease in ATP production required to maintain the depolarization state neurons , and , hence , a reduction in the response of receptoral and postreceptoral neurons .
# ::tok This pathophysiological event promotes the destabilization and degradation of HKI and a decrease in ATP production required to maintain the depolarization state neurons , and , hence , a reduction in the response of receptoral and postreceptoral neurons .
# ::alignments 37-38|0.1.0.0 35-36|0.1.0 32-33|0 29-30|0.1 26-27|0.1.1.0.2.1.0 24-25|0.1.1 22-23|0.1.1.0.0 21-22|0.1.1.0.0.0 20-21|0.0 18-19|0.1.1.0 16-17|0.1.1.0.1 15-16|0.1.1.0.2 14-15|0.1.1.0.2.0.0.0+0.1.1.0.2.0.0+0.1.1.0.2.0 12-13|0.1.1.0.2.1 10-11|0.1.1.0.2.1.1 9-10|0.1.1.0.2.1.1.1.0.0+0.1.1.0.2.1.1.1.0+0.1.1.0.2.1.1.1 7-8|0.1.1.0.2.1.1.0 6-7|0.1.1.0.2.1.1.0.0 5-6|0.1.1.0.2.1.1.0.0.0.1 3-4|0.1.1.0.2.1.1.0.0.0 2-3|0.1.1.0.2.1.1.0.0.0.0 0-1|0.1.1.0.2.1.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:34.645
(r / respond-01 
      :ARG1 (d / depolarization) 
      :ARG1-of (r2 / reduce-01 
            :op1-of (a / and 
                  :op2 (n / neuron)) 
            :op1-of (a2 / and 
                  :ARG0-of (m / maintain-01 
                        :ARG1 (n2 / neuron 
                              :mod (s / state)) 
                        :ARG1-of (r3 / require-01) 
                        :ARG3 (p / produce-01 
                              :ARG1 (o / organization 
                                    :name (n3 / name 
                                          :op1 "ATP")) 
                              :ARG1-of (d2 / decrease-01 
                                    :ARG0 (h / hence) 
                                    :op3-of (a3 / and 
                                          :op1 (d3 / degradation 
                                                :op2-of (a4 / and 
                                                      :op1 (p2 / promote-02 
                                                            :ARG0 (e / event 
                                                                  :mod (t / this)) 
                                                            :ARG1 (d4 / destabilization)))) 
                                          :op2 (o2 / organization 
                                                :name (n4 / name 
                                                      :op1 "HKI")))))))))

# ::snt A reduction in ATP levels also negatively modulates HKI activity/level .
# ::tok A reduction in ATP levels also negatively modulates HKI activity/level .
# ::alignments 8-9|0.1.0.0+0.1.0+0.1 7-8|0 6-7|0.2 5-6|0.3 4-5|0.0.0 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:34.688
(m / modulate-01 
      :ARG0 (r / reduce-01 
            :ARG1 (l / level 
                  :mod (o2 / organization 
                        :name (n3 / name 
                              :op1 "ATP")))) 
      :ARG1 (o / organization 
            :name (n / name 
                  :op1 "HKI")) 
      :manner (n2 / negatively) 
      :mod (a / also))

# ::snt Decreased levels of HKI promote intracellular hyperglycemia and activate stress kinases , which modulate negatively the Na + / K + - ATPase pump by phosphorylation .
# ::tok Decreased levels of HKI promote intracellular hyperglycemia and activate stress kinases , which modulate negatively the Na + / K + - ATPase pump by phosphorylation .
# ::alignments 25-26|0.0 23-24|0 19-20|0.1.0 18-19|0.0.0 16-17|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 14-15|0.1.1.0.1 13-14|0.1.1.0 10-11|0.1.1 9-10|0.1.1.1 8-9|0.1 7-8|0.1.2 6-7|0.1.2.0.1 5-6|0.1.2.0.1.0 4-5|0.1.2.0 3-4|0.1.2.0.0.1.0.0+0.1.2.0.0.1.0+0.1.2.0.0.1 1-2|0.1.2.0.0 0-1|0.1.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:35.023
(p2 / pump-01 
      :ARG0 (p / phosphorylate-01 
            :ARG1 (s / slash)) 
      :time-of (a / activate-01 
            :ARG0 (k / k) 
            :ARG1 (k2 / kinas 
                  :ARG0-of (m / modulate-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Na")) 
                        :manner (n2 / negatively)) 
                  :ARG1-of (s2 / stress-02)) 
            :op2-of (a2 / and 
                  :op1 (p3 / promote-02 
                        :ARG0 (l / level 
                              :ARG1-of (d / decrease-01) 
                              :mod (o / organization 
                                    :name (n3 / name 
                                          :op1 "HKI"))) 
                        :ARG1 (h / hyperglycemia 
                              :mod (i / intracellular))))))

# ::snt Pathophysiological pathways promoted by RanBP2 haploinsufficiency are represented by dash lines .
# ::tok Pathophysiological pathways promoted by RanBP2 haploinsufficiency are represented by dash lines .
# ::alignments 10-11|0.0.0.0.0.0 9-10|0.0.0.0.0.0.0 7-8|0.0.0.0.0 5-6|0.0 4-5|0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:35.057
(r2 / RanBP2 
      :mod-of (h / haploinsufficiency 
            :ARG0-of (p / promote-01 
                  :ARG1 (p2 / pathway 
                        :ARG1-of (r / represent-01 
                              :ARG0 (l / line 
                                    :ARG1-of (d / dash-01))) 
                        :mod (p3 / Pathophysiological)))))

# ::snt RIS , rod inner segment ; ROS , rod outer segment .
# ::tok RIS , rod inner segment ; ROS , rod outer segment .
# ::alignments 10-11|0.1.0.0.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0.0.0.0 6-7|0.1 5-6|0 4-5|0.1.0.1 3-4|0.1.0 2-3|0.1.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:35.094
(a / and 
      :op1 (r4 / ri) 
      :op2 (r2 / ro 
            :location-of (i / inner 
                  :mod (r3 / rod 
                        :mod-of (o / outer 
                              :domain (s / segment 
                                    :mod (r / rod)))) 
                  :mod-of (s2 / segment))))

# ::snt Finally , RanBP2 appears to join other nucleoporins , such as Nup96 [ 58 ] , in novel physiological functions that are vital for complex organisms and that were not anticipated from cell-based studies .
# ::tok Finally , RanBP2 appears to join other nucleoporins , such as Nup96 [ 58 ] , in novel physiological functions that are vital for complex organisms and that were not anticipated from cell-based studies .
# ::alignments 33-34|0.1.0.2 32-33|0.1.0.2.2 30-31|0.1.0 29-30|0.1.0.3 26-27|0.1 25-26|0.1.0.0 24-25|0.1.0.0.1 22-23|0.1.0.0.0 19-20|0.1.0.0.0.0 18-19|0.1.0.0.0.0.0 17-18|0.1.0.0.0.0.1 13-14|0.1.0.2.1 11-12|0.1.0.2.0.0.0+0.1.0.2.0.0+0.1.0.2.0 9-10|0.1.0.1 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 3-4|0 2-3|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:35.626
(a3 / appear-02 
      :ARG1 (j / join-01 
            :ARG0 (r / RanBP2) 
            :ARG1 (n3 / nucleoporin 
                  :mod (o3 / other))) 
      :op1-of (a2 / and 
            :op2 (a / anticipate-01 
                  :ARG0 (o / organism 
                        :beneficiary-of (v / vital 
                              :ARG0-of (f / function-01 
                                    :mod (p / physiological) 
                                    :mod (n / novel))) 
                        :mod (c2 / complex)) 
                  :ARG1 (s2 / such) 
                  :ARG2 (s / study-01 
                        :ARG0 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "Nup96")) 
                        :ARG1 58 
                        :mod (c / cell-bas)) 
                  :polarity -)) 
      :time (f2 / final))

# ::snt The reduced expression of these proteins in whole-animal models generates phenotypes that are tissue-restricted and more importantly , do not seem to recapitulate phenotypes observed with knockdown experiments in cell-based culture assays .
# ::tok The reduced expression of these proteins in whole-animal models generates phenotypes that are tissue-restricted and more importantly , do not seem to recapitulate phenotypes observed with knockdown experiments in cell-based culture assays .
# ::alignments 31-32|0.0.0.0.0.0.0.1 30-31|0.0.0.0.0.0.0.1.0 29-30|0.0.0.0.0.0.0.1.1 27-28|0.0.0.0.0.0.0 26-27|0.0.0.0.0.0.0.0 24-25|0.0.0.0.0.0 23-24|0.0.0.0.0 22-23|0.0.0.0 20-21|0.0.0.0.1 19-20|0.0.0.0.1.1 16-17|0.0.0.0.1.0.0.0 15-16|0.0.0.0.1.0.0.0.0 14-15|0 13-14|0.0 10-11|0.0.0 9-10|0.0.0.0.1.0 8-9|0.0.0.0.1.0.1 5-6|0.0.0.0.1.0.0.1 4-5|0.0.0.0.1.0.0.1.0 2-3|0.0.0.0.1.0.0 1-2|0.0.0.0.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:36.494
(a2 / and 
      :op1 (t / tissue-restrict 
            :domain (p2 / phenotyp 
                  :ARG0-of (r / recapitulate-01 
                        :ARG1 (p / phenotyp 
                              :ARG1-of (o / observe-01 
                                    :ARG2 (e / experiment-01 
                                          :ARG1 (k / knockdown) 
                                          :ARG2 (a / assay 
                                                :mod (c / culture) 
                                                :mod (c2 / cell-bas))))) 
                        :ARG1-of (s / seem-01 
                              :ARG1-of (g / generate-01 
                                    :ARG0 (e2 / express-01 
                                          :ARG0 (i / important 
                                                :degree (m / more)) 
                                          :ARG1 (p3 / protein 
                                                :mod (t2 / this)) 
                                          :ARG1-of (r2 / reduce-01)) 
                                    :manner (m2 / model)) 
                              :polarity -)))))

# ::snt For example , short interfering RNA-mediated knockdown of RanBP2 [ 9 ] and members of the Nup107-Nup160 complex [ 59 -- 61 ] have shown , respectively , to cause mitotic arrest and disruption of nuclear pore assembly and deficits in mRNA export in cell culture .
# ::tok For example , short interfering RNA-mediated knockdown of RanBP2 [ 9 ] and members of the Nup107-Nup160 complex [ 59 -- 61 ] have shown , respectively , to cause mitotic arrest and disruption of nuclear pore assembly and deficits in mRNA export in cell culture .
# ::alignments 45-46|0.1.0.0.3.1.2.3 44-45|0.1.0.0.3.1.2.3.0 42-43|0.1.0.0.3.1.2 41-42|0.1.0.0.3.1.2.0 39-40|0.1.0.0.3.2 38-39|0.1.0.0.3 37-38|0.1.0.0.3.1 36-37|0.1.0.0.3.1.0 35-36|0.1.0.0.3.1.1 33-34|0.1.0.0.3.0 32-33|0.1.0 31-32|0.1.0.0 30-31|0.1.0.0.2 29-30|0.1 26-27|0.0.0 24-25|0 21-22|0.1.0.0.3.1.2.1 19-20|0.1.0.0.3.1.0.0 17-18|0.1.0.0.3.1.2.2 16-17|0.2.0.0+0.2.0+0.2 13-14|0.0.1.0.0+0.0.1.0+0.0.1 12-13|0.0 10-11|0.1.0.0.1 6-7|0.1.0.0.0 5-6|0.2.1.0.0+0.2.1.0+0.2.1 4-5|0.1.0.0.0.0 3-4|0.1.0.0.0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:38.495
(s / show-01 
      :ARG0 (a5 / and 
            :mod (r / respective) 
            :op1 (p2 / person 
                  :ARG0-of (h / have-org-role-91 
                        :ARG2 (m3 / member)))) 
      :ARG0-of (c3 / cause-01 
            :ARG1 (a3 / and 
                  :op1 (a4 / arrest-01 
                        :ARG0 (k / knockdown 
                              :ARG1-of (i / interfere-01) 
                              :mod (s2 / short)) 
                        :ARG2 9 
                        :mod (m2 / mitotic) 
                        :op1-of (a / and 
                              :op2 (d2 / disruption) 
                              :op3 (a2 / assembly 
                                    :ARG1-of (p / pore-01 
                                          :ARG0 59) 
                                    :mod (n / nucleus) 
                                    :op1 (e / export-01 
                                          :ARG1 (m / mrna) 
                                          :op1-of 61 
                                          :op1-of (c4 / complex) 
                                          :topic (c / culture 
                                                :mod (c2 / cell)))) 
                              :op4 (d / deficit)))) 
            :ARG2 (e2 / example)) 
      :ARG1 (t / thing 
            :name (n2 / name 
                  :op1 "Nup107-Nup160") 
            :part (t2 / thing 
                  :name (n3 / name 
                        :op1 "RNA-mediated"))))

# ::snt Yet , haploinsufficiency of RanBP2 ( this work ) and Nup96 [ 58 ] predominantly produce , instead , CNS-restricted deficits in energy metabolism and alterations in the immune system linked to the down-regulation of interferon--regulated proteins and increased susceptibility of viral infection , respectively .
# ::tok Yet , haploinsufficiency of RanBP2 ( this work ) and Nup96 [ 58 ] predominantly produce , instead , CNS-restricted deficits in energy metabolism and alterations in the immune system linked to the down-regulation of interferon--regulated proteins and increased susceptibility of viral infection , respectively .
# ::alignments 44-45|0.0.1.2.1 42-43|0.0.1 41-42|0.0.1.1 39-40|0.0.1.2 38-39|0.0.1.2.0 37-38|0.0 36-37|0 35-36|0.0.0.1.0 30-31|0.0.0.3.0.0.1 29-30|0.0.0.3.0.0 28-29|0.0.0.3.0.0.0 25-26|0.0.0.3.0 24-25|0.0.0.3 23-24|0.0.0.0.0 22-23|0.0.0.0.0.0 20-21|0.0.0.0 19-20|0.0.0.0.1 17-18|0.0.0.1 15-16|0.0.0 14-15|0.0.0.2 12-13|0.0.1.0 10-11|0.0.0.3.0.0.1.0.1.0.0+0.0.0.3.0.0.1.0.1.0+0.0.0.3.0.0.1.0.1 9-10|0.0.0.3.0.0.1.0 7-8|0.0.0.3.0.0.0.1 6-7|0.0.0.3.0.0.0.1.0 4-5|0.0.0.3.0.0.1.0.0 2-3|0.0.0.3.0.0.1.0.0.0 0-1|0.0.0.3.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:40.255
(p / protein 
      :op2-of (a / and 
            :op1 (p2 / produce-01 
                  :ARG1 (d / deficit 
                        :location (m / metabolism 
                              :mod (e / energy)) 
                        :mod (c / cns-restrict)) 
                  :ARG1-of (i5 / instead-of-91 
                        :ARG0 (i3 / interferon--regulat)) 
                  :mod (p3 / predominant) 
                  :op1-of (a3 / and 
                        :op2 (a2 / alteration 
                              :location (s2 / system 
                                    :ARG1-of (i4 / immune-02 
                                          :ARG0 (y / yet) 
                                          :ARG1-of (w / work-01 
                                                :mod (t / this))) 
                                    :ARG1-of (l / link-01 
                                          :ARG2 (a4 / and 
                                                :op1 (r2 / RanBP2 
                                                      :mod-of (h / haploinsufficiency)) 
                                                :op2 (o / organization 
                                                      :name (n / name 
                                                            :op1 "Nup96")))))))) 
            :op3 (i / infect-01 
                  :ARG1 58 
                  :ARG2 (v / viral) 
                  :mod-of (s / susceptibility 
                        :ARG1-of (i2 / increase-01) 
                        :mod (r / respective)))))

# ::snt While these apparent outcome disparities among experimental systems remain unclear , they could potentially result from variations in redundancies and compensatory mechanisms inherent to each experimental system .
# ::tok While these apparent outcome disparities among experimental systems remain unclear , they could potentially result from variations in redundancies and compensatory mechanisms inherent to each experimental system .
# ::alignments 26-27|0.5.1.0.0 25-26|0.5.1.0.0.0 24-25|0.5.1.0.0.1 22-23|0.5.1.0 21-22|0.5.1 19-20|0.5 18-19|0.5.0 16-17|0.3 14-15|0 13-14|0.4 12-13|0.1 11-12|0.0 9-10|0.1.0.1.1+0.1.0.1 8-9|0.1.0 7-8|0.1.0.1.0 6-7|0.1.0.1.0.0 4-5|0.1.0.0 3-4|0.1.0.0.1 2-3|0.1.0.0.0 1-2|0.1.0.0.2 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:40.879
(r2 / result-01 
      :ARG1 (t / they) 
      :ARG1-of (p2 / possible-01 
            :condition (r3 / remain-01 
                  :ARG1 (d / dispariti 
                        :mod (a2 / apparent) 
                        :mod (o / outcome) 
                        :mod (t2 / this)) 
                  :ARG3 (c / clear-06 
                        :ARG1 (s2 / system 
                              :mod (e3 / experiment-01)) 
                        :polarity -))) 
      :ARG1-of (w / while-01) 
      :ARG2 (v / variation) 
      :domain-of (p / potential) 
      :op1-of (a / and 
            :op2 (r / redundanci) 
            :op3 (m / mechanism 
                  :mod (i / inherent 
                        :beneficiary (s / system 
                              :mod (e / experiment-01) 
                              :mod (e2 / each))))))

# ::snt Regardless , these genetic and whole-animal models set the stage to probe novel molecular pathways in various physiological and genetic contexts , and provide also a link to pathophysiological processes underlying several human diseases .
# ::tok Regardless , these genetic and whole-animal models set the stage to probe novel molecular pathways in various physiological and genetic contexts , and provide also a link to pathophysiological processes underlying several human diseases .
# ::alignments 33-34|0.1.0.2.2.1.1.0 32-33|0.1.0.2.2.1.1.0.0 31-32|0.1.0.2.2.1.1.0.1 30-31|0.1.0.2.2.1.1 29-30|0.1.0.2.2.1 26-27|0.1.0.2.2 24-25|0.1.0.2.1.1 23-24|0.1.0.2.1 22-23|0.1.0.2 20-21|0.1.0.2.1.0.2 19-20|0.1.0.2.2.1.0 18-19|0.1.0.2.1.0 17-18|0.1.0.2.1.0.1 16-17|0.1.0.2.1.0.0 14-15|0.1.0.0 13-14|0.1.0.0.0 12-13|0.1.1 11-12|0.1.0 9-10|0.1.0.1 6-7|0.1 4-5|0 3-4|0.0 2-3|0.1.0.2.2.0 0-1|0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:42.136
(a4 / and 
      :op1 (g2 / gene) 
      :op2 (m2 / model 
            :ARG0-of (p5 / probe-01 
                  :ARG1 (p4 / pathway 
                        :mod (m / molecule)) 
                  :consist (s2 / stage) 
                  :op1-of (a2 / and 
                        :mod (r / regardles) 
                        :op2 (p2 / provide-01 
                              :ARG1 (a3 / and 
                                    :mod (v / various) 
                                    :op1 (p3 / physiological) 
                                    :op2 (c / context)) 
                              :mod (a / also)) 
                        :op3 (l / link-01 
                              :ARG0 (t / this) 
                              :ARG1 (p / process-02 
                                    :ARG1 (g / gene) 
                                    :ARG1-of (u / underlie-01 
                                          :ARG0 (d / disease 
                                                :mod (h / human) 
                                                :quant (s / several))))))) 
            :mod (n / novel)))

# ::snt Yeast two-hybrid screening and assays .
# ::tok Yeast two-hybrid screening and assays .
# ::alignments 4-5|0.0.0 3-4|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:42.149
(s / screen-01 
      :op1-of (a2 / and 
            :op2 (a / assay)))

# ::snt The LD of human RanBP2 ( residues 62 -- 711 ) was subcloned in-frame into the GAL4 DNA-binding domain of bait vector , pBUTE ( a kanamycin-resistant version of GAL4 bait vector pGBDUC1 ) [ 62 ] and HybriZAP pBD-GAL4 vector ( Stratagene , La Jolla , California , United States ) .
# ::tok The LD of human RanBP2 ( residues 62 -- 711 ) was subcloned in-frame into the GAL4 DNA-binding domain of bait vector , pBUTE ( a kanamycin-resistant version of GAL4 bait vector pGBDUC1 ) [ 62 ] and HybriZAP pBD-GAL4 vector ( Stratagene , La Jolla , California , United States ) .
# ::alignments 49-51|0.1.0.0.3.1+0.1.0.0.3.0.1+0.1.0.0.3.0.0+0.1.0.0.3.0+0.1.0.0.3 47-48|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 44-46|0.4.0.1+0.4.0.0+0.4.0+0.4 40-41|0.1.0.0.2 38-39|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 37-38|0.1.0.0 35-36|0.0 32-33|0.2.0 31-32|0.2.0.0 30-31|0 27-28|0.2 21-22|0.1.0 20-21|0.1 18-19|0.1.0.1 16-18|0.1.0.1.0.0.1+0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 9-10|0.6 7-8|0.3 6-7|0.5 1-5|0.1.0.0.0.0.3+0.1.0.0.0.0.2+0.1.0.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:42.741
(b / bait-01 
      :ARG1 62 
      :ARG2-of (b2 / bait-01 
            :ARG1 (v4 / vector 
                  :op2-of (a / and 
                        :op1 (o / organization 
                              :name (n6 / name 
                                    :op1 "LD" 
                                    :op2 "of" 
                                    :op3 "human" 
                                    :op4 "RanBP2")) 
                        :op3 (t / thing 
                              :name (n4 / name 
                                    :op1 "HybriZAP")) 
                        :op4 (v / vector) 
                        :op5 (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States") 
                              :wiki "United_States")) 
                  :poss-of (d / domain 
                        :mod (t2 / thing 
                              :name (n5 / name 
                                    :op1 (g / GAL4) 
                                    :op2 (d2 / DNA-binding))))) 
            :op1-of (s / state 
                  :name (n2 / name 
                        :op1 "California") 
                  :wiki "California")) 
      :mod-of (v3 / version 
            :mod (p / pGBDUC1 
                  :mod (v2 / vector))) 
      :op1-of 62 
      :op1-of (c2 / country 
            :name (n3 / name 
                  :op1 "La" 
                  :op2 "Jolla")) 
      :op1-of (r / residu) 
      :op1-of 711)

# ::snt The former was used to screen ~ 18 million clones via mating from murine 9 - to 10-d-old embryo and brain cDNA libraries at the Molecular Interaction Facility ( MIF ) , University of Wisconsin , Madison , Wisconsin .
# ::tok The former was used to screen ~ 18 million clones via mating from murine 9 - to 10-d-old embryo and brain cDNA libraries at the Molecular Interaction Facility ( MIF ) , University of Wisconsin , Madison , Wisconsin .
# ::alignments 38-39|0.1.0.3.1+0.1.0.3.0.0+0.1.0.3.0+0.1.0.3 36-37|0.4.1.0+0.4.1+0.4 34-35|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 29-30|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 25-28|0.1.0.2.0.0.2+0.1.0.2.0.0.1+0.1.0.2.0.0.0+0.1.0.2.0.0+0.1.0.2.0 22-23|0.3.0.0 21-22|0.3.0 20-21|0.3 19-20|0 18-19|0.2 14-15|0.4.0 13-14|0.1 11-12|0.1.0 9-10|0.1.0.2 7-8|0.1.0.0 5-6|0.1.0.2.1 3-4|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:43.332
(a / and 
      :op1 (u / use-01 
            :ARG0 (s2 / state 
                  :name (n3 / name 
                        :op1 "Wisconsin") 
                  :wiki "Wisconsin") 
            :ARG1 (f / former)) 
      :op2 (m / murine 
            :location-of (m2 / mate-01 
                  :ARG0 18 
                  :ARG1 (o / organization 
                        :name (n4 / name 
                              :op1 "MIF")) 
                  :manner-of (c3 / clone-01 
                        :ARG0 (o2 / organization 
                              :name (n5 / name 
                                    :op1 "Molecular" 
                                    :op2 "Interaction" 
                                    :op3 "Facility")) 
                        :ARG1 (s3 / screen)) 
                  :op1-of (s / state 
                        :name (n / name 
                              :op1 "Wisconsin") 
                        :wiki "Wisconsin"))) 
      :op3 (e / embryo) 
      :op4 (b / brain 
            :mod-of (c2 / cdna 
                  :mod-of (l / library))) 
      :op5 (c / country 
            :mod 9 
            :name (n2 / name 
                  :op1 "Madison")))

# ::snt The latter was used to screen via transformation of ~ 5 million clones from bovine retinal cDNA libraries [ 32 ] .
# ::tok The latter was used to screen via transformation of ~ 5 million clones from bovine retinal cDNA libraries [ 32 ] .
# ::alignments 19-20|0.0.1.2.0.0 17-18|0.0.0 16-17|0 15-16|0.0.0.1 14-15|0.0.0.0 12-13|0.0 10-11|0.0.1.0 7-8|0.0.1.2.0 5-6|0.0.1.2 3-4|0.0.1 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:43.437
(c / cdna 
      :ARG2-of (c2 / clone-01 
            :ARG1 (l / library 
                  :mod (b / bovine) 
                  :mod (r / retinal)) 
            :purpose (u / use-01 
                  :ARG0 5 
                  :ARG1 (l2 / latter) 
                  :ARG2 (s / screen 
                        :topic (t / transform-01 
                              :ARG1 32)))))

# ::snt The screens generated six clones .
# ::tok The screens generated six clones .
# ::alignments 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:43.451
(s / screen-01 
      :ARG0-of (g / generate-01 
            :ARG1 (c / clone-01 
                  :quant 6)))

# ::snt One and two in-frame clones were independently isolated from the embryonic and adult brain libraries , respectively , and the interactions were validated .
# ::tok One and two in-frame clones were independently isolated from the embryonic and adult brain libraries , respectively , and the interactions were validated .
# ::alignments 22-23|0.0.2.0 20-21|0.0.2.0.1 18-19|0.0.2 16-17|0.0.0.0 14-15|0.2 13-14|0.0.0.2 12-13|0.0.2.0.0 11-12|0 10-11|0.1 7-8|0.0 6-7|0.0.1 4-5|0.0.0 2-3|0.0.0.3 1-2|0.0.0.1 0-1|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:43.647
(a3 / and 
      :op1 (i2 / isolate-01 
            :ARG1 (c / clone-01 
                  :ARG0 (r / respective) 
                  :ARG1 (a4 / and) 
                  :domain-of (b / brain 
                        :poss 1) 
                  :quant 2) 
            :manner (i3 / independent) 
            :op1-of (a / and 
                  :op2 (v / validate-01 
                        :ARG0 (a2 / adult) 
                        :ARG1 (i / interaction)))) 
      :op2 (e / embryonic) 
      :op3 (l / library))

# ::snt The three clones encoded Cox11 .
# ::tok The three clones encoded Cox11 .
# ::alignments 4-5|0.1.0.0+0.1.0+0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:43.671
(e / encode-01 
      :ARG0 (c / clone-01 
            :quant 3) 
      :ARG1 (p / person 
            :name (n / name 
                  :op1 "Cox11")))

# ::snt Interactions between Cox11 , LD , and subdomains thereof were quantified by liquid -galactosidase ( Applied Biosystems , Foster City , California , United States ) and growth assays [ 63 ] .
# ::tok Interactions between Cox11 , LD , and subdomains thereof were quantified by liquid -galactosidase ( Applied Biosystems , Foster City , California , United States ) and growth assays [ 63 ] .
# ::alignments 30-31|0.1.0.1 28-29|0.1 27-28|0.1.0 26-27|0 23-25|0.0.0.1+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 21-22|0.0.3.0.0.1+0.0.3.0.0.0.0+0.0.3.0.0.0+0.0.3.0.0 18-20|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 15-17|0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 12-13|0.1.0.0 10-11|0.0.3.0 8-9|0.0.3.0.2 7-8|0.0.3.2 6-7|0.0.3 4-5|0.0.3.1.0.0+0.0.3.1.0+0.0.3.1 2-3|0.0.2.0+0.0.2+0.0 0-1|0.0.3.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.012
(a2 / and 
      :op1 (p / person 
            :mod (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :mod (c2 / country 
                  :location-of (o / organization 
                        :name (n4 / name 
                              :op1 "Applied" 
                              :op2 "Biosystems")) 
                  :name (n3 / name 
                        :op1 "Foster" 
                        :op2 "City")) 
            :name (n6 / name 
                  :op1 "Cox11") 
            :op1-of (a3 / and 
                  :manner-of (q / quantify-01 
                        :ARG0 (s / state 
                              :name (n2 / name 
                                    :op1 "California") 
                              :wiki "California") 
                        :ARG1 (i / interaction) 
                        :time (t / thereof)) 
                  :op2 (o2 / organization 
                        :name (n5 / name 
                              :op1 "LD")) 
                  :op3 (s2 / subdomain))) 
      :op2 (a / assay 
            :mod (g / grow-01 
                  :ARG0 (l / liquid) 
                  :ARG1 63)))

# ::snt The maximum specific growth speed ( max ) was determined by calculating max = ( ln ( xt )  ln ( x0 ) ) / t , where xt is the OD600 of the culture at t = t , x0 is the OD600 at t = 0 and t is the time between x0 and xt .
# ::tok The maximum specific growth speed ( max ) was determined by calculating max = ( ln ( xt )  ln ( x0 ) ) / t , where xt is the OD600 of the culture at t = t , x0 is the OD600 at t = 0 and t is the time between x0 and xt .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.015
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Assays were performed with three independent clones and three samples of each clone , the results were averaged , and the standard deviations calculated .
# ::tok Assays were performed with three independent clones and three samples of each clone , the results were averaged , and the standard deviations calculated .
# ::alignments 23-24|0.3 22-23|0.3.0 21-22|0.3.0.0 19-20|0 17-18|0.2 15-16|0.2.0.0+0.2.0 12-13|0.3.1.0.0.0.0 11-12|0.3.1.0.0.0 9-10|0.1.0+0.1 8-9|0.1.1 7-8|0.3.1 6-7|0.3.1.0 5-6|0.3.1.0.0.1+0.3.1.0.0 4-5|0.3.0.0.0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.426
(a / and 
      :op1 (p / perform-02 
            :ARG1 (a4 / assay)) 
      :op2 (t2 / thing 
            :ARG1-of (s2 / sample-01) 
            :quant 3) 
      :op3 (a2 / average-01 
            :ARG1 (t / thing 
                  :ARG2-of (r / result-01))) 
      :op4 (c / calculate-01 
            :ARG0 (d / deviation 
                  :ARG1-of (s / standard-02 
                        :ARG0 3)) 
            :ARG1 (a3 / and 
                  :op1 (c3 / clone-01 
                        :ARG0-of (d2 / depend-01 
                              :ARG1 (e / each 
                                    :mod-of (c2 / clone)) 
                              :polarity -)))))

# ::snt Site-directed and deletion mutagenesis and plasmid construction .
# ::tok Site-directed and deletion mutagenesis and plasmid construction .
# ::alignments 6-7|0.2.1 5-6|0.2.1.0 4-5|0.2 3-4|0.1 2-3|0.2.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.456
(a2 / and 
      :op1 (s / site-direct) 
      :op2 (m / mutagenesi) 
      :op3 (a / and 
            :op1 (d / deletion) 
            :op2 (c / construct-01 
                  :mod (p / plasmid))))

# ::snt Deletion mutagenesis was carried out with pairs of primers against domains of interest described in the figure legends .
# ::tok Deletion mutagenesis was carried out with pairs of primers against domains of interest described in the figure legends .
# ::alignments 17-18|0.2.0.0.0 16-17|0.2.0.0.0.0 13-14|0.2.0.0 12-13|0.2.0 10-11|0.2 8-9|0.0.0 6-7|0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.577
(c / carry-out-03 
      :ARG0 (p2 / pair-01 
            :ARG1 (p / primer)) 
      :ARG1 (m / mutagenesi 
            :mod (d3 / deletion)) 
      :prep-against (d2 / domain 
            :ARG2-of (i / interest-01 
                  :ARG0-of (d / describe-01 
                        :ARG1 (l / legend 
                              :mod (f / figure))))))

# ::snt PCR products were subcloned into pGEX-KG [ 64 ] , HybriZAP pBD-GAL4 vector ( Stratagene ) , and pBUTE [ 62 ] vectors .
# ::tok PCR products were subcloned into pGEX-KG [ 64 ] , HybriZAP pBD-GAL4 vector ( Stratagene ) , and pBUTE [ 62 ] vectors .
# ::alignments 22-23|0.1 20-21|0.1.0 17-18|0 12-13|0.0.1 10-11|0.0.2.0+0.0.2+0.0 7-8|0.1.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.633
(a / and 
      :op1 (t / thing 
            :domain (p / product) 
            :mod-of (v2 / vector) 
            :name (n / name 
                  :op1 "HybriZAP")) 
      :op2 (v / vector 
            :quant (6 / 62 
                  :poss-of 64)))

# ::snt GST-LDZIP alone comprised residues 447 -- 483 of human RanBP2 .
# ::tok GST-LDZIP alone comprised residues 447 -- 483 of human RanBP2 .
# ::alignments 9-10|0.0.0 8-9|0.0 3-4|0.1 2-3|0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.660
(c / comprise-01 
      :ARG0 (h / human 
            :mod-of (r / RanBP2)) 
      :ARG1 (r2 / residu) 
      :manner (a / alone))

# ::snt GST pull-down and immunoprecipitation assays .
# ::tok GST pull-down and immunoprecipitation assays .
# ::alignments 4-5|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.669
(a / assay 
      :op1-of (a2 / and))

# ::snt CHAPS-solubilized retinal extracts , expression , and purification of GST-fused constructs were prepared as previously described [ 65 ] .
# ::tok CHAPS-solubilized retinal extracts , expression , and purification of GST-fused constructs were prepared as previously described [ 65 ] .
# ::alignments 17-18|0.1.0.0 15-16|0.0.0 14-15|0.0.0.1 12-13|0 10-11|0.0.0.0 9-10|0.1.2.0.0+0.1.2.0+0.1.2 7-8|0.1.1 6-7|0.1 4-5|0.1.0 2-3|0.0.1+0.0 1-2|0.0.2 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:44.882
(p2 / prepare-02 
      :ARG0 (t2 / thing 
            :ARG1-of (d / describe-01 
                  :ARG0 (c / construct) 
                  :time (p / previous)) 
            :ARG1-of (e2 / extract-01) 
            :mod (r / retinal) 
            :mod (c2 / chaps-solubiliz)) 
      :ARG1 (a / and 
            :op1 (e / express-01 
                  :ARG1 65) 
            :op2 (p3 / purification) 
            :op3 (t / thing 
                  :name (n / name 
                        :op1 "GST-fused"))))

# ::snt GST pull-down assays were carried out with 0.5 -- 2.2 M of GST-fused proteins [ 65 ] .
# ::tok GST pull-down assays were carried out with 0.5 -- 2.2 M of GST-fused proteins [ 65 ] .
# ::alignments 15-16|0.3.0 13-14|0.0.1 12-13|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 10-11|0.0.2+0.0.0.0+0.0.0+0.0 9-10|0.2 7-8|0.3 4-5|0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:45.087
(c / carry-out-03 
      :ARG0 (v / vehicle 
            :name (n2 / name 
                  :op1 "M1") 
            :quant-of (p / protein 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "GST-fused"))) 
            :wiki "M1_Abrams") 
      :ARG1 (a / assay) 
      :ARG2 2.2 
      :time (0 / 0.5 
            :mod 65))

# ::snt Co-precipitates were resolved on SDS-PAGE and analyzed by Western blot with antibodies described in the Results section .
# ::tok Co-precipitates were resolved on SDS-PAGE and analyzed by Western blot with antibodies described in the Results section .
# ::alignments 16-17|0.0 15-16|0 12-13|0.0.0 11-12|0.0.0.0 9-10|0.0.0.1.0 8-9|0.0.0.1.0.0.1+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 6-7|0.0.0.1 5-6|0.0.0.1.2 2-3|0.0.0.1.1.0 0-1|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:45.216
(r / result-01 
      :ARG1 (s / section 
            :ARG2-of (d / describe-01 
                  :ARG1 (a / antibodi) 
                  :purpose-of (a2 / analyze-01 
                        :ARG0 (b / blot-01 
                              :mod (w / world-region 
                                    :name (n / name 
                                          :op1 "West") 
                                    :wiki "Western_world")) 
                        :ARG1 (c / co-precipitat 
                              :ARG1-of (r2 / resolve-01)) 
                        :op1-of (a3 / and)))))

# ::snt Unfolded and partially denatured Cox11 were generated by incubating recombinant and native Cox11 overnight with 5.6 and 7 M guanidine hydrochloride and urea , respectively .
# ::tok Unfolded and partially denatured Cox11 were generated by incubating recombinant and native Cox11 overnight with 5.6 and 7 M guanidine hydrochloride and urea , respectively .
# ::alignments 24-25|0.0.0.2.0 22-23|0.0.1.1 21-22|0.0.1 20-21|0.0.1.0 19-20|0.0.1.0.0 18-19|0.0.1.0.1.2+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 17-18|0.0.0.0.0 16-17|0.0.1.0.1.1 15-16|0.0.0.2.1.0 13-14|0.0.2 11-12|0.2 10-11|0 9-10|0.1 8-9|0.0 6-7|0.0.0.0 4-5|0.0.0.1.0+0.0.0.1+0.0.0 3-4|0.0.0.2.2 2-3|0.0.0.2.2.0 1-2|0.0.0.2 0-1|0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:46.524
(a3 / and 
      :ARG1-of (i / incubate-01 
            :ARG0 (p / person 
                  :ARG1-of (g2 / generate-01 
                        :ARG0 7) 
                  :name (n3 / name 
                        :op1 "Cox11") 
                  :op3-of (a4 / and 
                        :mod (r / respective) 
                        :op1 (u2 / unfold-01 
                              :ARG0 5.6) 
                        :op2 (d / denature 
                              :mod (p2 / partial)))) 
            :ARG2 (a / and 
                  :op1 (h / hydrochloride 
                        :mod (g / guanidine) 
                        :mod (v / vehicle 
                              :name (n / name 
                                    :op1 "M1") 
                              :op1-of (a2 / and) 
                              :wiki "M1_Abrams")) 
                  :op2 (u / urea)) 
            :time (o / overnight)) 
      :op1 (r2 / recombinant) 
      :op2 (n2 / native))

# ::snt The Cox11 conformers were then diluted ~ 20-fold in CHAPS-binding buffer containing GST-LD .
# ::tok The Cox11 conformers were then diluted ~ 20-fold in CHAPS-binding buffer containing GST-LD .
# ::alignments 12-13|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 11-12|0.1.0 10-11|0.1 9-10|0.1.1 5-6|0 4-5|0.2 2-3|0.0 1-2|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:46.591
(d / dilute-01 
      :ARG1 (c3 / conformer 
            :mod (p / person 
                  :name (n2 / name 
                        :op1 "Cox11"))) 
      :location (b / buffer-01 
            :ARG0-of (c / contain-01 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "GST-LD"))) 
            :mod (c2 / chaps-bind)) 
      :time (t / then))

# ::snt Immunoprecipitation assays with 5 g of antibody and Western blots ( ~ 200 -- 400 ng/ml of antibody ) were performed exactly as described previously [ 13 ] .
# ::tok Immunoprecipitation assays with 5 g of antibody and Western blots ( ~ 200 -- 400 ng/ml of antibody ) were performed exactly as described previously [ 13 ] .
# ::alignments 26-27|0.1.2.1.0 24-25|0.1.2.2 23-24|0.1.2 21-22|0.1.3 20-21|0.1 17-18|0.1.2.1.1 14-15|0.1.1 12-13|0.1.0 9-10|0.1.2.1 8-9|0.1.2.1.3.1+0.1.2.1.3.0.0+0.1.2.1.3.0+0.1.2.1.3 7-8|0 6-7|0.1.2.1.2 4-5|0.0 3-4|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:46.847
(a2 / and 
      :op1 (g / g) 
      :op2 (p2 / perform-02 
            :ARG0 200 
            :ARG1 400 
            :condition (d / describe-01 
                  :ARG0 5 
                  :ARG1 (b / blot-01 
                        :ARG0 13 
                        :ARG1 (a / antibody) 
                        :ARG2 (a3 / antibody) 
                        :mod (w / world-region 
                              :name (n / name 
                                    :op1 "West") 
                              :wiki "Western_world")) 
                  :time (p / previous)) 
            :manner (e / exact)))

# ::snt Hexokinase I assay .
# ::tok Hexokinase I assay .
# ::alignments 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:46.853
(a / assay 
      :mod (i / i))

# ::snt Hexokinase I activity was determined spectrophotometrically at 25 C by the method of coupling the glucose-6-phosphate production via glucose-6-phosphate dehydrogenase with the change in the absorbance of NADPH at 340 nm and as described by [ 66 ] .
# ::tok Hexokinase I activity was determined spectrophotometrically at 25 C by the method of coupling the glucose-6-phosphate production via glucose-6-phosphate dehydrogenase with the change in the absorbance of NADPH at 340 nm and as described by [ 66 ] .
# ::alignments 36-37|0.0.1.1.0 33-34|0.0.1.0.0 31-32|0.0.1.1.1.2 30-31|0.0.1.1.1.2.0 25-26|0.0.1.0 22-23|0.0.1 19-20|0.0.1.1.1.0 16-17|0.0.1.1.1 13-14|0.0.1.1 11-12|0.0.1.1.2 8-9|0.0.2 7-8|0.0.1.1.1.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:47.138
(d3 / determined-02 
      :ARG1 (a3 / activity-06 
            :ARG0 (i / i) 
            :ARG1 (c / change-01 
                  :ARG1 (a2 / absorbance 
                        :ARG1-of (d / describe-01)) 
                  :ARG2-of (c2 / couple-01 
                        :ARG0 66 
                        :ARG1 (p / produce-01 
                              :ARG0 (d2 / dehydrogenase) 
                              :ARG1 25 
                              :op1-of (a / and 
                                    :op2 (n / nm))) 
                        :instrument (m / method))) 
            :duration (c3 / C)))

# ::snt The reaction was started by the addition of purified brain hexokinase I ( 0.24 g ) ( gift from J. Wilson ) to 1.0 ml of reaction mixture containing 0.05 M Tris-HCl ( pH 8.5 ) , 7.4 mM MgCl2 , 6.6 mM ATP , 0.65 mM NADP , 11.1 mM monothioglycerol , and 1 unit of glucose 6-phosphate dehydrogenase .
# ::tok The reaction was started by the addition of purified brain hexokinase I ( 0.24 g ) ( gift from J. Wilson ) to 1.0 ml of reaction mixture containing 0.05 M Tris-HCl ( pH 8.5 ) , 7.4 mM MgCl2 , 6.6 mM ATP , 0.65 mM NADP , 11.1 mM monothioglycerol , and 1 unit of glucose 6-phosphate dehydrogenase .
# ::alignments 59-60|0.1.6.0 57-58|0.1.6.0.0 55-56|0.1.6 54-55|0.2 53-54|0.1 51-52|0.1.5 46-48|0.1.4.0.1+0.1.4.0.0+0.1.4.0+0.1.4 43-44|0.1.3.0.0+0.1.3.0+0.1.3 39-40|0.1.2 38-39|0.1.2.0 37-38|0.0.0.1 34-35|0.0.0.2.3.0.0.0 33-34|0.0.0.2.2 30-32|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 28-29|0 27-28|0.0 26-27|0.0.0 24-25|0.0.1 19-21|0.1.0.1.1+0.1.0.1.0+0.1.0.1+0.1.0 17-18|0.1.0.0+0.1.0.0.0 14-15|0.0.0.0 11-12|0.0.0.2.0 9-10|0.0.0.2.3.0 8-9|0.0.0.2.3.0.0 6-7|0.0.0.2.3 3-4|0.0.0.2 1-2|0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:50.622
(c / contain-01 
      :ARG0 (m6 / mixture 
            :mod (r / react-01 
                  :ARG0 (g3 / g) 
                  :ARG1 7.4 
                  :ARG2 (s / start-01 
                        :ARG0 (i / i) 
                        :ARG1 (r2 / react-01) 
                        :ARG2 (p / ph) 
                        :ARG3 (a2 / addition 
                              :mod (b / brain 
                                    :ARG1-of (p3 / purify-01 
                                          :ARG2 8.5))))) 
            :mod-of (m7 / ml)) 
      :ARG1 (a / and 
            :op1 (p2 / person 
                  :ARG0-of (g2 / gift-01 
                        :ARG1 (t4 / thing)) 
                  :name (n5 / name 
                        :op1 "J." 
                        :op2 "Wilson")) 
            :op2 (t2 / thing 
                  :name (n4 / name 
                        :op1 (m5 / M) 
                        :op2 (t3 / Tris-HCl))) 
            :op3 (m3 / MgCl2 
                  :mod (m4 / mm)) 
            :op4 (o / organization 
                  :name (n3 / name 
                        :op1 "ATP")) 
            :op5 (t / thing 
                  :name (n / name 
                        :op1 (m2 / mM) 
                        :op2 (n2 / NADP))) 
            :op6 (m / monothioglycerol) 
            :op7 (u / unit 
                  :poss (d / dehydrogenase 
                        :mod (g / glucose)))) 
      :ARG2 1)

# ::snt In the case of hexokinase activity measured in the presence of Cox11 and LD , the purified HKI was incubated with the recombinant proteins for 15 min at 4 C before measurement of the activity .
# ::tok In the case of hexokinase activity measured in the presence of Cox11 and LD , the purified HKI was incubated with the recombinant proteins for 15 min at 4 C before measurement of the activity .
# ::alignments 34-35|0.0.0 31-32|0.0.0.0 30-31|0.0.0.0.0 29-30|0.0.0.0.0.0 28-29|0.3.0.0.0 26-27|0.2.0.1 25-26|0.2.0.1.0 23-24|0.2.0.0 22-23|0.2.0.0.0 19-20|0.2.0 16-18|0.2.1.1+0.2.1.0+0.2.1+0.2 13-14|0.1.0.0+0.1.0+0.1 12-13|0 11-12|0.0.1.0+0.0.1+0.0 9-10|0.3 6-7|0.3.0 5-6|0.3.0.0 2-3|0.3.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:51.738
(a2 / and 
      :op1 (p3 / person 
            :ARG0-of (a / activity-06 
                  :ARG1-of (m / measure-01 
                        :op1-of (b / before 
                              :time-of (c / C)))) 
            :name (n3 / name 
                  :op1 "Cox11")) 
      :op2 (o / organization 
            :name (n2 / name 
                  :op1 "LD")) 
      :op3 (t / thing 
            :ARG1-of (i / incubate-01 
                  :ARG2 (p / protein 
                        :mod (r / recombinant)) 
                  :purpose (m2 / min 
                        :quant 15)) 
            :name (n / name 
                  :op1 (p2 / purified) 
                  :op2 (h / HKI))) 
      :poss-of (p4 / presence 
            :location-of (m3 / measure-01 
                  :ARG1 (a3 / activity-06 
                        :ARG1 4 
                        :ARG1-of (c2 / case-03)))))

# ::snt The data were fitted directly into the Michaelis-Menten equation using SIGMAPLOT ( SPSS Science ) .
# ::tok The data were fitted directly into the Michaelis-Menten equation using SIGMAPLOT ( SPSS Science ) .
# ::alignments 12-14|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 10-11|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 9-10|0.2.0 8-9|0.2 4-5|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:51.871
(f / fit-01 
      :ARG1 (d2 / data) 
      :ARG1-of (d / direct-02 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "SPSS" 
                        :op2 "Science"))) 
      :ARG2 (e / equation 
            :ARG0-of (u / use-01 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "SIGMAPLOT")))))

# ::snt Antibodies .
# ::tok Antibodies .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:51.874
(a / antibodi)

# ::snt Rabbit antisera were raised against the recombinant murine Cox11 ( residues 40 -- 275 ) and affinity-purified under non-denaturing conditions ( Stereogene ) as previously described [ 13 ] .
# ::tok Rabbit antisera were raised against the recombinant murine Cox11 ( residues 40 -- 275 ) and affinity-purified under non-denaturing conditions ( Stereogene ) as previously described [ 13 ] .
# ::alignments 27-28|0.0.0 25-26|0.0.1.0 24-25|0.0.1.0.3 19-20|0.0.1.0.0 18-19|0.0.1.0.0.0 15-16|0 11-12|0.0.1.0.1 10-11|0.0.1.0.2 8-9|0.0.2.2.0+0.0.2.2+0.0.2 7-8|0.0.2.0 6-7|0.0.2.1 3-4|0.0 0-2|0.0.1.1.1+0.0.1.1.0+0.0.1.1+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:52.165
(a / and 
      :op1 (r3 / raise-01 
            :ARG0 13 
            :ARG1 (t / thing 
                  :ARG2-of (d / describe-01 
                        :ARG1 (c / condition 
                              :mod (n / non-denatur)) 
                        :op1-of 40 
                        :op1-of (r / residu) 
                        :time (p / previous)) 
                  :name (n3 / name 
                        :op1 (r4 / Rabbit) 
                        :op2 (a2 / antisera))) 
            :ARG2 (p2 / person 
                  :mod (m / murine) 
                  :mod (r2 / recombinant) 
                  :name (n2 / name 
                        :op1 "Cox11"))))

# ::snt Cox11 antibodies were used at 200 ng/ml for Western analysis .
# ::tok Cox11 antibodies were used at 200 ng/ml for Western analysis .
# ::alignments 9-10|0.1 8-9|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 5-6|0.1.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:52.190
(u / use-01 
      :ARG1 (a2 / antibodi) 
      :ARG2 (a / analyze-01 
            :ARG1 200 
            :mod (w / world-region 
                  :name (n / name 
                        :op1 "West") 
                  :wiki "Western_world")))

# ::snt The monoclonal antibody Hsp70 was from Affinity Bioreagents ( Golden , Colorado , United States ) and antibodies against the KBD ( JX2 ) and ZnF domains of RanBP2 have been described [ 13,16 ] .
# ::tok The monoclonal antibody Hsp70 was from Affinity Bioreagents ( Golden , Colorado , United States ) and antibodies against the KBD ( JX2 ) and ZnF domains of RanBP2 have been described [ 13,16 ] .
# ::alignments 31-32|0.0 28-29|0.5.0 26-27|0.5 24-25|0 22-23|0.0.0.0.0+0.0.0.0+0.0.0 20-21|0.4.0.0+0.4.0+0.4 17-18|0.0.1 16-17|0.0.2 13-15|0.3.1+0.3.0.1+0.3.0.0+0.3.0+0.3 11-12|0.2.0.0+0.2.0+0.2 6-8|0.1.0.1+0.1.0.0+0.1.0+0.1 3-4|0.0.2.0.2.0+0.0.2.0.2+0.0.2.0 2-3|0.0.2.0.0 1-2|0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:52.561
(a / and 
      :ARG1-of (d / describe-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "JX2")) 
            :ARG2 (a2 / antibodi) 
            :op2-of (a3 / and 
                  :op1 (t / thing 
                        :mod (a4 / antibody) 
                        :mod (m / monoclonal) 
                        :name (n6 / name 
                              :op1 "Hsp70")))) 
      :op1 (p / person 
            :name (n5 / name 
                  :op1 "Affinity" 
                  :op2 "Bioreagents")) 
      :op2 (c2 / country 
            :name (n4 / name 
                  :op1 "Colorado")) 
      :op3 (c / country 
            :name (n3 / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States") 
      :op4 (o2 / organization 
            :name (n2 / name 
                  :op1 "KBD")) 
      :op5 (d2 / domain 
            :poss (r / RanBP2)))

# ::snt Polyclonal and monoclonal antibodies against Hexokinase I were provided by J. Wilson .
# ::tok Polyclonal and monoclonal antibodies against Hexokinase I were provided by J. Wilson .
# ::alignments 10-12|0.0.0.1+0.0.0.0+0.0.0+0.0 8-9|0 6-7|0.2 3-4|0.1.0 2-3|0.1.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:52.814
(p2 / provide-01 
      :ARG0 (p / person 
            :name (n / name 
                  :op1 "J." 
                  :op2 "Wilson")) 
      :ARG1 (a2 / and 
            :op1 (a / antibodi 
                  :mod (m / monoclonal))) 
      :ARG2 (i / i))

# ::snt The mAb414 was purchased from Abcam ( Cambridge , Massachusetts , United States ) .
# ::tok The mAb414 was purchased from Abcam ( Cambridge , Massachusetts , United States ) .
# ::alignments 11-13|0.1.0.1+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 9-10|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 7-8|0.0.0.0+0.0.0+0.0 5-6|0.2.0.0+0.2.0+0.2 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:53.010
(p / purchase-01 
      :ARG0 (c2 / country 
            :name (n3 / name 
                  :op1 "Cambridge")) 
      :ARG1 (m / mAb414 
            :mod-of (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :mod-of (s / state 
                  :name (n2 / name 
                        :op1 "Massachusetts") 
                  :wiki "Massachusetts")) 
      :ARG2 (c3 / country 
            :name (n4 / name 
                  :op1 "Abcam")))

# ::snt Immunocytochemistry and microscopy .
# ::tok Immunocytochemistry and microscopy .
# ::alignments 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:53.017
(a / and 
      :op1 (m / microscopy))

# ::snt Retina dissections , radial cryosections ( ~ 6 m ) , and immunohistochemistry procedures were carried out as described elsewhere [ 19 ] .
# ::tok Retina dissections , radial cryosections ( ~ 6 m ) , and immunohistochemistry procedures were carried out as described elsewhere [ 19 ] .
# ::alignments 21-22|0.0.2.0 19-20|0.0.1 18-19|0.0 15-16|0.0.2 13-14|0.0.2.2.1 12-13|0.0.2.2.1.0 11-12|0.0.2.2 8-9|0 7-8|0.0.0 4-5|0.0.2.2.0 3-4|0.0.2.2.0.0 1-2|0.0.2.1 0-1|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:53.456
(m / m 
      :ARG2-of (d / describe-01 
            :ARG0 6 
            :ARG1 (e / elsewhere) 
            :ARG2-of (c / carry-out-03 
                  :ARG0 19 
                  :ARG1 (d2 / dissection 
                        :mod (r2 / retina)) 
                  :purpose (a / and 
                        :op1 (c2 / cryosection 
                              :mod (r / radial)) 
                        :op2 (p / procedure 
                              :mod (i / immunohistochemistry))))))

# ::snt Brains from 3 - to 5-mo-old C57Bl/6 mice were fixed overnight in 2 % paraformaldehyde , infused with 30 % sucrose , and processed for cryosectioning .
# ::tok Brains from 3 - to 5-mo-old C57Bl/6 mice were fixed overnight in 2 % paraformaldehyde , infused with 30 % sucrose , and processed for cryosectioning .
# ::alignments 25-26|0.1.1 23-24|0.1 22-23|0 20-21|0.0.1 19-20|0.0.0.0.0 18-19|0.0.0.0 16-17|0.0 14-15|0.0.0.1.0 13-14|0.0.0.2.0 12-13|0.0.0.2.0.0 10-11|0.0.0.1.1 9-10|0.0.0.1 7-8|0.0.0.2 2-3|0.1.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:53.627
(a / and 
      :op1 (i / infuse-01 
            :ARG1 (b / brain-01 
                  :ARG1 (3 / 30 
                        :quant-of (p2 / percentage-entity)) 
                  :ARG1-of (f / fix-03 
                        :location (p3 / paraformaldehyde) 
                        :time (o / overnight)) 
                  :ARG2 (m / mouse 
                        :duration (p4 / percentage-entity 
                              :value 2))) 
            :ARG2 (s / sucrose)) 
      :op2 (p / process-01 
            :ARG0 3 
            :ARG1 (c / cryosection)))

# ::snt Primary brain neurons and glial cells were prepared from the cerebral cortex .
# ::tok Primary brain neurons and glial cells were prepared from the cerebral cortex .
# ::alignments 11-12|0.1 10-11|0.1.0 7-8|0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0 2-3|0.0.0 1-2|0.0.1.1 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:53.698
(p / prepare-02 
      :ARG1 (a / and 
            :op1 (n / neuron 
                  :mod (p2 / primary)) 
            :op2 (c3 / cell 
                  :mod (g / glial) 
                  :mod (b / brain))) 
      :ARG2 (c / cortex 
            :mod (c2 / cerebral)))

# ::snt This was macerated in the Hank 's Balanced Salt solution and triturated .
# ::tok This was macerated in the Hank 's Balanced Salt solution and triturated .
# ::alignments 11-12|0.0.1.0 10-11|0.0.1 9-10|0.0 7-9|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.0.2.0.0+0.0.2.0+0.0.2 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:53.782
(m / macerate-01 
      :ARG0 (s / solution 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Balanced" 
                        :op2 "Salt")) 
            :op1-of (a / and 
                  :op2 (t / triturat)) 
            :poss (p / person 
                  :name (n2 / name 
                        :op1 "Hank"))) 
      :ARG1 (t2 / this))

# ::snt Primary cells were cultured in DMEM ( GIBCO , San Diego , California , United States ) and collagen-coated 35-mm glass bottom culture dishes ( MatTek Corporation , Ashland , Maine ) at 5 % CO2/37 C for ~ 2 d and processed for immunocytochemistry .
# ::tok Primary cells were cultured in DMEM ( GIBCO , San Diego , California , United States ) and collagen-coated 35-mm glass bottom culture dishes ( MatTek Corporation , Ashland , Maine ) at 5 % CO2/37 C for ~ 2 d and processed for immunocytochemistry .
# ::alignments 44-45|0.3.3.1 42-43|0.3.3 41-42|0 40-41|0.3.3.0 39-40|0.3.2.3 36-37|0.3.2.0 34-35|0.0.1.0 33-34|0.0.1 30-31|0.3.1.0.1+0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 28-29|0.3.0.1.0.0+0.3.0.1.0+0.3.0.1 25-27|0.2.0.1+0.2.0.0+0.2.0+0.2 23-24|0.3.2 22-23|0.3.2.1 21-22|0.3.2.1.0 20-21|0.3.2.1.0.0 18-19|0.3.2.2 17-18|0.3 14-16|0.1.1+0.1.0.1+0.1.0.0+0.1.0+0.1 12-13|0.0.2+0.0.0.0+0.0.0+0.0 9-11|0.3.1.2+0.3.1.1.1+0.3.1.1.0+0.3.1.1+0.3.1 3-4|0.3.0 1-2|0.3.0.0 0-1|0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:55.109
(a / and 
      :op1 (s2 / state 
            :name (n5 / name 
                  :op1 "California") 
            :quant (5 / 5 
                  :quant-of (p2 / percentage-entity)) 
            :wiki "California") 
      :op2 (c4 / country 
            :name (n4 / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States") 
      :op3 (o2 / organization 
            :name (n3 / name 
                  :op1 "MatTek" 
                  :op2 "Corporation")) 
      :op3-of (a2 / and 
            :location-of (c6 / culture-01 
                  :ARG1 (c7 / cell 
                        :mod (p3 / primary)) 
                  :ARG2 (o / organization 
                        :name (n2 / name 
                              :op1 "Ashland"))) 
            :op1 (c5 / city 
                  :location (s / state 
                        :name (n / name 
                              :op1 "Maine") 
                        :wiki "Maine") 
                  :name (n6 / name 
                        :op1 "San" 
                        :op2 "Diego") 
                  :wiki "San_Diego") 
            :op2 (d2 / dish-01 
                  :ARG0 (c / C) 
                  :ARG1 (c2 / culture 
                        :mod (b / bottom 
                              :mod (g / glass))) 
                  :mod (c3 / collagen-coat) 
                  :op1-of 2) 
            :op4 (p / process-01 
                  :ARG1 (d / d) 
                  :ARG2 (i / immunocytochemistry))))

# ::snt Primary antibodies were used at concentrations ~ 2.5 -- 10 g/ml .
# ::tok Primary antibodies were used at concentrations ~ 2.5 -- 10 g/ml .
# ::alignments 9-10|0.0 7-8|0.1.0.0 5-6|0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:55.140
(u / use-01 
      :ARG0 10 
      :ARG1 (a / antibodi 
            :mod (p / primary 
                  :op1-of 2.5)) 
      :ARG2 (c / concentration))

# ::snt Alexa 488 - and Alexa 594-conjugated secondary antibodies ( 2.5 g/ml ) ( Molecular Probes ) were used for visualization of proteins .
# ::tok Alexa 488 - and Alexa 594-conjugated secondary antibodies ( 2.5 g/ml ) ( Molecular Probes ) were used for visualization of proteins .
# ::alignments 21-22|0.2.0 19-20|0.2 17-18|0 13-15|0.1.1.2.0.1+0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 9-10|0.0 7-8|0.1.1.1 6-7|0.2.1 5-6|0.1.1.0 3-4|0.1.1 0-2|0.1.0.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:55.708
(u / use-01 
      :ARG0 2.5 
      :ARG1 (t / thing 
            :name (n2 / name 
                  :op1 (a3 / Alexa) 
                  :op2 488) 
            :op1-of (a2 / and 
                  :mod 594-conjugat 
                  :op2 (a / antibodi) 
                  :op3 (o / organization 
                        :name (n / name 
                              :op1 "Molecular" 
                              :op2 "Probes")))) 
      :ARG2 (v / visualization 
            :mod (p / protein) 
            :poss (s / secondary)))

# ::snt Crossover of fluorescent probes , background , and autofluorescence were found to be negligible .
# ::tok Crossover of fluorescent probes , background , and autofluorescence were found to be negligible .
# ::alignments 13-14|0.1 10-11|0 8-9|0.0.4 7-8|0.0 5-6|0.0.3 3-4|0.0.2 2-3|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:55.798
(f / find-01 
      :ARG0 (a2 / and 
            :mod (f2 / fluorescent) 
            :op1 (c / crossov) 
            :op2 (p / probe) 
            :op3 (b / background) 
            :op4 (a / autofluorescence)) 
      :ARG1 (n / negligible))

# ::snt Visualization of specimens and localization of proteins were carried out by wide-field epifluorescence microscopy on Nikon ( Tokyo , Japan ) E600 upright and TE2000U inverted research microscopes equipped with similar Apochromat objectives .
# ::tok Visualization of specimens and localization of proteins were carried out by wide-field epifluorescence microscopy on Nikon ( Tokyo , Japan ) E600 upright and TE2000U inverted research microscopes equipped with similar Apochromat objectives .
# ::alignments 32-33|0.4.0.0.1 30-31|0.4.0.0.1.0 28-29|0.4.0.0 27-28|0.4.0 26-27|0.4.0.1 25-26|0.4 24-25|0.3.0.0+0.3.0+0.3 23-24|0 22-23|0.2 21-22|0.4.0.0.0.0.0+0.4.0.0.0.0+0.4.0.0.0 19-20|0.0.1.0.3.1+0.0.1.0.3.0.0+0.0.1.0.3.0+0.0.1.0.3 17-18|0.1.1+0.1.0.0+0.1.0+0.1 15-16|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 13-14|0.0.0 8-9|0.0 6-7|0.0.1.0.2 4-5|0.0.1.0.1 3-4|0.0.1.0 2-3|0.0.1.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:56.589
(a / and 
      :op1 (c3 / carry-out-03 
            :ARG0 (m2 / microscopy 
                  :location (o2 / organization 
                        :name (n5 / name 
                              :op1 "Nikon"))) 
            :ARG1 (v / visualization 
                  :op1-of (a2 / and 
                        :op2 (s / specimen) 
                        :op3 (l / localization) 
                        :op4 (p / protein) 
                        :op5 (c / country 
                              :name (n3 / name 
                                    :op1 "Japan") 
                              :wiki "Japan")))) 
      :op2 (c2 / city 
            :name (n4 / name 
                  :op1 "Tokyo") 
            :wiki "Tokyo") 
      :op3 (u / upright) 
      :op4 (t / thing 
            :name (n / name 
                  :op1 "TE2000U")) 
      :op5 (i / invert-01 
            :ARG1 (m / microscop 
                  :ARG0-of (e / equip-01 
                        :ARG1 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "E600")) 
                        :ARG2 (o / objective 
                              :ARG1-of (r / resemble-01))) 
                  :mod (r2 / research-01))))

# ::snt Images with the Nikon E600 were acquired with a SPOT-RT digital camera coupled to the microscope and driven by SPOT Imaging v4 .0 software ( Diagnostic Instruments , Sterling Heights , Michigan , United States ) .
# ::tok Images with the Nikon E600 were acquired with a SPOT-RT digital camera coupled to the microscope and driven by SPOT Imaging v4 .0 software ( Diagnostic Instruments , Sterling Heights , Michigan , United States ) .
# ::alignments 33-35|0.0.0.1+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 31-32|0.2.0.0+0.2.0+0.2 28-30|0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 25-27|0.0.1.0.1.0.0.1+0.0.1.0.1.0.0.0+0.0.1.0.1.0.0+0.0.1.0.1.0 23-24|0.1.0 19-21|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 17-18|0.1 16-17|0 15-16|0.0.2 12-13|0.0 11-12|0.0.1 10-11|0.0.1.1 6-7|0.0.1.0 3-5|0.0.1.0.1.1.0.1+0.0.1.0.1.1.0.0+0.0.1.0.1.1.0+0.0.1.0.1.1 0-1|0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:57.145
(a / and 
      :op1 (c5 / couple-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :ARG1 (c6 / camera 
                  :ARG2-of (a2 / acquire-01 
                        :ARG0 (c3 / country 
                              :name (n3 / name 
                                    :op1 "Sterling" 
                                    :op2 "Heights")) 
                        :ARG1 (i / image 
                              :poss (c4 / country 
                                    :name (n4 / name 
                                          :op1 "Diagnostic" 
                                          :op2 "Instruments")) 
                              :prep-with (t2 / thing 
                                    :name (n6 / name 
                                          :op1 (n7 / Nikon) 
                                          :op2 (e / E600))))) 
                  :mod (d2 / digital)) 
            :ARG2 (m / microscope)) 
      :op2 (d / drive-02 
            :ARG0 (s / software 
                  :mod (t / thing 
                        :name (n5 / name 
                              :op1 "SPOT" 
                              :op2 "Imaging")))) 
      :op3 (c2 / country 
            :name (n2 / name 
                  :op1 "Michigan")))

# ::snt All images were captured at nonsaturating integration levels , 12-bit mono black/white , and then pseudo-colored .
# ::tok All images were captured at nonsaturating integration levels , 12-bit mono black/white , and then pseudo-colored .
# ::alignments 15-16|0 14-15|0.0.0.1.0.0 13-14|0.0 10-11|0.0.0.0.0.0 7-8|0.0.0.1 6-7|0.0.0.1.0 3-4|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:57.230
(p / pseudo-color 
      :op1-of (a / and 
            :ARG0-of (c / capture-01 
                  :ARG1 (i2 / image 
                        :mod (a2 / all 
                              :mod-of (m / mono))) 
                  :location (l / level 
                        :ARG1-of (i / integrate-01 
                              :ARG0 (t / then))))))

# ::snt Protein colocalization analysis was carried out on the Nikon TE2000U microscope equipped with appropriate excitation and emission filter wheels , cube filters , 100 W mercury light source , Nomarski/DIC , and Plan Apochromat optics ( 100  , 60  , and 40  oil objectives with NA of 1.4 , 40  LWD , and 20  LWD objectives and encoded motorized Z-Stage ( Prior Scientific , Rockland , Maryland , United States ) .
# ::tok Protein colocalization analysis was carried out on the Nikon TE2000U microscope equipped with appropriate excitation and emission filter wheels , cube filters , 100 W mercury light source , Nomarski/DIC , and Plan Apochromat optics ( 100  , 60  , and 40  oil objectives with NA of 1.4 , 40  LWD , and 20  LWD objectives and encoded motorized Z-Stage ( Prior Scientific , Rockland , Maryland , United States ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:57.235
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Images with the inverted Nikon TE2000U microscope were obtained using a CCD camera ( CoolSNAP HQ ; Roper Scientific , Trenton , New Jersey , United States ) .
# ::tok Images with the inverted Nikon TE2000U microscope were obtained using a CCD camera ( CoolSNAP HQ ; Roper Scientific , Trenton , New Jersey , United States ) .
# ::alignments 25-27|0.0.0.0.0.1+0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 22-24|0.0.0.0.1.0.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 20-21|0.3.0.0+0.3.0+0.3 18-19|0.2 17-18|0.2.0 16-17|0 14-16|0.1.0.1+0.1.0.0+0.1.0+0.1 12-13|0.0.0 11-12|0.0.1.0+0.0.1+0.0 9-10|0.0.0.0 8-9|0.0.0.0.1 6-7|0.2.0.0.0 4-6|0.2.0.0.0.0.0.1+0.2.0.0.0.0.0.0+0.2.0.0.0.0.0+0.2.0.0.0.0 3-4|0.2.0.0 0-1|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:57.687
(a / and 
      :op1 (o / organization 
            :mod-of (c5 / camera 
                  :ARG1-of (u / use-01 
                        :ARG0 (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States") 
                              :wiki "United_States") 
                        :ARG1-of (o2 / obtain-01 
                              :ARG0 (c2 / country 
                                    :name (n2 / name 
                                          :op1 "New" 
                                          :op2 "Jersey"))) 
                        :ARG2 (i2 / image))) 
            :name (n5 / name 
                  :op1 "CCD")) 
      :op2 (c4 / country 
            :name (n4 / name 
                  :op1 "CoolSNAP" 
                  :op2 "HQ")) 
      :op3 (s / science 
            :mod (r / rope-01 
                  :ARG1 (i / invert-01 
                        :ARG1 (m / microscope 
                              :mod (t / thing 
                                    :name (n6 / name 
                                          :op1 (n7 / Nikon) 
                                          :op2 (t2 / TE2000U))))))) 
      :op4 (c3 / country 
            :name (n3 / name 
                  :op1 "Trenton")))

# ::snt Images acquired under identical acquisition parameters were analyzed using Metamorph Software v6 .2 ( Universal Imaging , Glendale , Wisconsin , United States ) .
# ::tok Images acquired under identical acquisition parameters were analyzed using Metamorph Software v6 .2 ( Universal Imaging , Glendale , Wisconsin , United States ) .
# ::alignments 21-23|0.1.0.1.1+0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 19-20|0.0.1+0.0.0.0+0.0.0+0.0 17-18|0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 14-16|0.1.0.0.0.1.0.0.1+0.1.0.0.0.1.0.0.0+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0 10-12|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 8-9|0.1 7-8|0 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0 3-4|0.1.0.0.0.1 1-2|0.1.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:58.858
(a / analyze-01 
      :ARG0 (s / state 
            :name (n2 / name 
                  :op1 "Wisconsin") 
            :wiki "Wisconsin") 
      :ARG1 (u / use-01 
            :ARG0 (i2 / image 
                  :ARG1-of (a3 / acquire-01 
                        :time (p / parameter 
                              :ARG1-of (a2 / acquire-01 
                                    :ARG0 (c2 / country 
                                          :name (n3 / name 
                                                :op1 "Glendale"))) 
                              :ARG2-of (i / identical-01 
                                    :ARG1 (o / organization 
                                          :name (n4 / name 
                                                :op1 "Universal" 
                                                :op2 "Imaging"))))) 
                  :poss (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States")) 
            :ARG1 (t / thing 
                  :name (n5 / name 
                        :op1 (s2 / Software) 
                        :op2 (v / v6)))))

# ::snt Whenever applicable , serial optical Z-stacks ( 20 -- 30 focal planes at 100-nm intervals ) were captured and computationally processed by 3-D blind deconvolution methods with the same software .
# ::tok Whenever applicable , serial optical Z-stacks ( 20 -- 30 focal planes at 100-nm intervals ) were captured and computationally processed by 3-D blind deconvolution methods with the same software .
# ::alignments 29-30|0.0.1.0.0 28-29|0.0.1.0.0.0 25-26|0.0.1 24-25|0.0.1.2 23-24|0.0.1.0 22-23|0.0.1.1 20-21|0.1 19-20|0.1.1 18-19|0 17-18|0.0 14-15|0.0.1.0.0.0.0 11-12|0.0.1.0.0.0.0.0 10-11|0.0.1.0.0.0.0.0.0 9-10|0.0.1.0.0.0.0.0.1 7-8|0.0.0 5-6|0.1.0.3.0+0.1.0.3+0.1.0 4-5|0.1.0.2 3-4|0.1.0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:59.180
(a / and 
      :op1 (c2 / capture-01 
            :ARG1 20 
            :manner (m / method 
                  :ARG1-of (b / blind-02 
                        :ARG2 (s / software 
                              :ARG1-of (s2 / same-01 
                                    :ARG0 (i / interval 
                                          :location-of (p2 / plane 
                                                :mod (f / focal) 
                                                :quant 30))))) 
                  :mod 3-d 
                  :mod (d / deconvolution))) 
      :op2 (p / process-01 
            :ARG1 (p3 / person 
                  :ARG1-of (a2 / apply-02) 
                  :mod (s3 / serial) 
                  :mod (o / optics) 
                  :name (n / name 
                        :op1 "Z-stacks")) 
            :manner (c / computationally)))

# ::snt Generation of a mouse line with a disrupted RanBP2 locus and histological analysis of trapped RanBP2 mice .
# ::tok Generation of a mouse line with a disrupted RanBP2 locus and histological analysis of trapped RanBP2 mice .
# ::alignments 16-17|0.0 14-15|0 12-13|0.0.0 11-12|0.0.0.0 10-11|0.0.0.1 9-10|0.0.0.1.0 7-8|0.0.0.1.0.0 4-5|0.0.0.1.1 3-4|0.0.0.1.1.1 0-1|0.0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:59.236
(t / trap-01 
      :ARG1 (m / mouse 
            :ARG2-of (a / analyze-01 
                  :ARG1 (h / histological) 
                  :op2-of (a2 / and 
                        :op1 (l / locu 
                              :ARG1-of (d / disrupt-01)) 
                        :topic-of (l2 / line 
                              :consist (g / generation) 
                              :mod (m2 / mouse))))))

# ::snt A feeder-independent mouse ES cell line derived from the 129P2/OlaHsd strain and harboring a disrupted RanBP2 locus by insertion mutagenesis with the gene trap vector , pGT0pfs [ 67,68 ] ( generated by W. Skarnes ) , was obtained from the Mutant Mouse Regional Resource Center ( University of California Davis , Davis , California , United States ) .
# ::tok A feeder-independent mouse ES cell line derived from the 129P2/OlaHsd strain and harboring a disrupted RanBP2 locus by insertion mutagenesis with the gene trap vector , pGT0pfs [ 67,68 ] ( generated by W. Skarnes ) , was obtained from the Mutant Mouse Regional Resource Center ( University of California Davis , Davis , California , United States ) .
# ::alignments 56-58|0.0.1.0.1+0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 54-55|0.2.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 47-51|0.0.3.0.0.3+0.0.3.0.0.2+0.0.3.0.0.1+0.0.3.0.0.0+0.0.3.0.0+0.0.3.0 41-46|0.0.1.1.0.4+0.0.1.1.0.3+0.0.1.1.0.2+0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 38-39|0.0.1 33-35|0.2.1.1+0.2.1.0+0.2.1+0.2 31-32|0.2.0 26-27|0.1.1.0.0 24-25|0.0.3.1.0 23-24|0.0.3 22-23|0.0.3.1 19-20|0.1.0 18-19|0.1.0.0 16-17|0.1.1 14-15|0.1.1.0 12-13|0.1 11-12|0 10-11|0.0.2.1+0.0.2 6-7|0.0 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.1 2-3|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:59.900
(a / and 
      :op1 (d2 / derive-01 
            :ARG1 (l2 / line 
                  :mod (c2 / cell) 
                  :mod (e / e)) 
            :ARG1-of (o3 / obtain-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :ARG2 (o2 / organization 
                        :name (n4 / name 
                              :op1 "Mutant" 
                              :op2 "Mouse" 
                              :op3 "Regional" 
                              :op4 "Resource" 
                              :op5 "Center"))) 
            :ARG2 (s2 / strain 
                  :part (m2 / mouse) 
                  :wiki "Influenza_A_virus_subtype_H5N1") 
            :time (t / trap-01 
                  :ARG0 (o / organization 
                        :name (n3 / name 
                              :op1 "University" 
                              :op2 "of" 
                              :op3 "California" 
                              :op4 "Davis")) 
                  :ARG1 (g2 / gene 
                        :mod-of (v / vector)))) 
      :op2 (h / harbor-01 
            :ARG0 (m / mutagenesi 
                  :ARG1-of (i / insert-01)) 
            :ARG1 (l / locu 
                  :ARG1-of (d / disrupt-01 
                        :ARG0 (p2 / pgt0pf)))) 
      :op3 (p / person 
            :ARG0-of (g / generate-01 
                  :ARG1 (s / state 
                        :name (n2 / name 
                              :op1 "California") 
                        :wiki "California")) 
            :name (n5 / name 
                  :op1 "W." 
                  :op2 "Skarnes")))

# ::snt The gene trap vector contains a promoterless neo-lacZ fusion gene with a splice acceptor site at the 5  end followed by an internal ribosome entry site ( IRES ) and the human placental alkaline phosphatase ( PLAP ) reporter cassette .
# ::tok The gene trap vector contains a promoterless neo-lacZ fusion gene with a splice acceptor site at the 5  end followed by an internal ribosome entry site ( IRES ) and the human placental alkaline phosphatase ( PLAP ) reporter cassette .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:17:59.902
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The RanBP2 129Ola ES line was injected into C57BL/6J blastocysts and four male chimeras were generated .
# ::tok The RanBP2 129Ola ES line was injected into C57BL/6J blastocysts and four male chimeras were generated .
# ::alignments 15-16|0.1 13-14|0.1.0 12-13|0.1.0.0 11-12|0.0.1.1 10-11|0 9-10|0.0.1 8-9|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 6-7|0.0 4-5|0.0.0 2-4|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:00.059
(a / and 
      :op1 (i / inject-01 
            :ARG1 (l / line 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 129Ola 
                              :op2 (e / ES)))) 
            :ARG2 (b / blastocyst 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "C57BL/6J")) 
                  :quant 4)) 
      :op2 (g / generate-01 
            :ARG1 (c / chimera 
                  :mod (m / male))))

# ::snt These were bred into 129P2/OlaHsd ( Harlan , Indianapolis , Indiana , United States ) and C57BL/6J ( Jackson Laboratory , Bar Harbor , Maine , United States ) females .
# ::tok These were bred into 129P2/OlaHsd ( Harlan , Indianapolis , Indiana , United States ) and C57BL/6J ( Jackson Laboratory , Bar Harbor , Maine , United States ) females .
# ::alignments 29-30|0.2.5 26-28|0.2.4.1+0.2.4.0.1+0.2.4.0.0+0.2.4.0+0.2.4 24-25|0.2.3.3+0.2.3.2.0+0.2.3.2+0.2.3 21-23|0.2.2.0.1+0.2.2.0.0+0.2.2.0+0.2.2 18-20|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 16-17|0.2.0.0.0+0.2.0.0+0.2.0 15-16|0.2 12-14|0.2.3.0.1+0.2.3.0.0.1+0.2.3.0.0.0+0.2.3.0.0+0.2.3.0 10-11|0.2.3.1.0.0.0+0.2.3.1.0.0+0.2.3.1.0 8-9|0.2.3.1.2+0.2.3.1.1.0+0.2.3.1.1+0.2.3.1 6-7|0.0.0.0+0.0.0+0.0 2-3|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:00.546
(b / breed-01 
      :ARG0 (p3 / person 
            :name (n9 / name 
                  :op1 "Harlan")) 
      :ARG1 (t / this) 
      :destination (a / and 
            :op1 (p2 / person 
                  :name (n5 / name 
                        :op1 "C57BL/6J")) 
            :op2 (p / person 
                  :name (n4 / name 
                        :op1 "Jackson" 
                        :op2 "Laboratory")) 
            :op3 (o / organization 
                  :name (n3 / name 
                        :op1 "Bar" 
                        :op2 "Harbor")) 
            :op4 (s / state 
                  :domain (c2 / country 
                        :name (n6 / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :location-of (c4 / city 
                        :location (c3 / country 
                              :name (n7 / name 
                                    :op1 "Indiana")) 
                        :name (n8 / name 
                              :op1 "Indianapolis") 
                        :wiki "Indianapolis") 
                  :name (n2 / name 
                        :op1 "Maine") 
                  :wiki "Maine") 
            :op5 (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :op6 (f / female)))

# ::snt The two resulting and independent F1s lines , with 129P2/OlaHsd inbred and 129P2/OlaHsd/C57BL / 6J mixed genetic backgrounds , were tested for germline transmission by PCR and Southern blot analysis of tail genomic DNA .
# ::tok The two resulting and independent F1s lines , with 129P2/OlaHsd inbred and 129P2/OlaHsd/C57BL / 6J mixed genetic backgrounds , were tested for germline transmission by PCR and Southern blot analysis of tail genomic DNA .
# ::alignments 33-34|0.1.1.0.0.3.0 31-32|0.1.1.0.0.3.0.0 29-30|0.1.1.0.0.3 28-29|0.1.1.0.0.3.1 27-28|0.1.1.0.0.2.0.0+0.1.1.0.0.2.0+0.1.1.0.0.2 26-27|0.1.1.0.0 25-26|0.1.1.0.0.1 23-24|0.1.1.0.1 20-21|0.1.1.0 17-18|0.1.1.2 16-17|0.1.1.2.1 15-16|0.0 13-14|0.1.1.2.0 11-12|0 10-11|0.2 6-7|0.1.1.1 5-6|0.1.1.1.0 4-5|0.1.1.0.0.0.0+0.1.1.0.0.0 3-4|0.1.1 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:01.678
(a3 / and 
      :ARG1-of (m / mix-01) 
      :ARG2-of (r / result-01 
            :ARG1 2 
            :op1-of (a4 / and 
                  :condition-of (t4 / test-01 
                        :ARG0 (a2 / and 
                              :ARG0-of (d2 / depend-01 
                                    :polarity -) 
                              :op1 (p / PCR) 
                              :op2 (t2 / thing 
                                    :name (n / name 
                                          :op1 "Southern")) 
                              :op3 (a / analyze-01 
                                    :ARG1 (d / DNA 
                                          :ARG1-of (t / tail-01)) 
                                    :ARG2 (b / blot-01))) 
                        :ARG2 (t3 / transmission)) 
                  :op2 (l / line 
                        :mod (f / f1)) 
                  :op3 (b2 / background 
                        :mod (s / slash) 
                        :mod (g / gene)))) 
      :op1 (i / inbred))

# ::snt -gal and PLAP activities in whole mount embryos and retinal sections were detected , respectively , by incubation with 5-bromo-4-chloro-3-indolyl -D-galactopyranoside and AP staining buffer ( 0.1 mg/ml 5-bromo-4-chloro-3-indolyl phosphate , 1 mg/ml nitroblue tetrazolium in 100 mM Tris-HCl ( pH 9.5 ) , 100 mM NaCl , 5 mM MgCl2 ) as described elsewhere [ 67,68 ] .
# ::tok -gal and PLAP activities in whole mount embryos and retinal sections were detected , respectively , by incubation with 5-bromo-4-chloro-3-indolyl -D-galactopyranoside and AP staining buffer ( 0.1 mg/ml 5-bromo-4-chloro-3-indolyl phosphate , 1 mg/ml nitroblue tetrazolium in 100 mM Tris-HCl ( pH 9.5 ) , 100 mM NaCl , 5 mM MgCl2 ) as described elsewhere [ 67,68 ] .
# ::alignments 54-55|0.0.0 53-54|0.0 50-51|0.2.2.6 48-49|0.1.2 44-45|0.2.2.4 40-41|0.1.0 37-38|0.1.1.0 36-37|0.2.2.5 34-35|0.2.2.2.0 33-34|0.2.2.2 31-32|0.0.1 29-30|0.2.2.1.0.0.0 26-27|0.2.1.0 24-25|0.1.1 23-24|0.1 22-23|0.3.1+0.3.0.0+0.3.0+0.3 21-22|0 17-18|0.2.2.0 14-15|0.2.2.3 12-13|0.2.2 10-11|0.2.2.1.1 9-10|0.2.2.1.1.0 8-9|0.2.2.1 7-8|0.2.2.1.0 6-7|0.2.2.1.0.0 5-6|0.2.2.1.0.1 3-4|0.2.1 2-3|0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:03.346
(a / and 
      :ARG0-of (d / describe-01 
            :ARG1 (e / elsewhere) 
            :ARG2 1) 
      :location-of (s / stain-01 
            :ARG0 (p / ph) 
            :ARG1 (b / buffer-01 
                  :ARG1 (m2 / mm)) 
            :ARG2 5) 
      :op1 (a4 / and 
            :op1 (p4 / PLAP) 
            :op2 (a3 / activity-06 
                  :ARG1 0.1) 
            :op3 (d2 / detect-01 
                  :ARG0 (i / incubation) 
                  :ARG1 (a2 / and 
                        :op1 (e2 / embryo 
                              :ARG1-of (m3 / mount-01 
                                    :ARG2 (p2 / phosphate)) 
                              :mod (w / whole)) 
                        :op2 (s2 / section 
                              :mod (r2 / retinal))) 
                  :ARG2 (n / nitroblue 
                        :mod-of (t / tetrazolium)) 
                  :mod (r / respective) 
                  :op1-of 100 
                  :op1-of 100 
                  :op1-of (m / MgCl2))) 
      :op2 (p3 / publication 
            :name (n2 / name 
                  :op1 "AP") 
            :wiki "Associated_Press"))

# ::snt Western blot and quantitation analysis of protein expression and ATP levels .
# ::tok Western blot and quantitation analysis of protein expression and ATP levels .
# ::alignments 10-11|0.0.1.1 9-10|0.0.1.1.1.0.0+0.0.1.1.1.0+0.0.1.1.1 8-9|0.0.1 7-8|0.0.1.0.0 6-7|0.0.1.1.0 4-5|0.0 3-4|0.0.0 2-3|0 1-2|0.0.1.0 0-1|0.0.1.0.1.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:03.437
(a3 / and 
      :op1 (a2 / analyze-01 
            :ARG1 (q / quantitation) 
            :op2-of (a / and 
                  :op1 (b / blot-01 
                        :ARG1 (e / express-01) 
                        :mod (w / world-region 
                              :name (n2 / name 
                                    :op1 "West") 
                              :wiki "Western_world")) 
                  :op3 (l / level 
                        :mod (p / protein) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "ATP"))))))

# ::snt Homogenates and detergent solubilized extracts of tissues and immunoblots were prepared as described elsewhere [ 69 ] .
# ::tok Homogenates and detergent solubilized extracts of tissues and immunoblots were prepared as described elsewhere [ 69 ] .
# ::alignments 15-16|0.0.0.1.0 13-14|0.0.1 12-13|0.0 10-11|0.0.0.0 8-9|0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 4-5|0.0.0.1+0.0.0 2-3|0.0.0.0.1.1 1-2|0.0.0.0.1 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:03.854
(i / immunoblot 
      :ARG0-of (d / describe-01 
            :ARG1 (t2 / thing 
                  :ARG0-of (p / prepare-02 
                        :ARG1 (a / and 
                              :op1 (t / tissue)) 
                        :op3-of (a2 / and 
                              :op1 (h / homogenat) 
                              :op2 (d2 / detergent))) 
                  :ARG1-of (e2 / extract-01 
                        :ARG0 69)) 
            :location (e / elsewhere)))

# ::snt Quantitation of immunoblot bands calibrated against internal marker bands , such as mHsp70 and Nup153 , was carried out with Gel Pro Analyzer ( MediaCybernetics , San Diego , California , United States ) .
# ::tok Quantitation of immunoblot bands calibrated against internal marker bands , such as mHsp70 and Nup153 , was carried out with Gel Pro Analyzer ( MediaCybernetics , San Diego , California , United States ) .
# ::alignments 31-33|0.0.1.0.3.1+0.0.1.0.3.0.1+0.0.1.0.3.0.0+0.0.1.0.3.0+0.0.1.0.3 29-30|0.1.1+0.1.0.0+0.1.0+0.1 26-28|0.0.1.2.1+0.0.1.2.0.1+0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 24-25|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 20-23|0.0.0.0.0.0.2+0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 17-18|0.0.0.0 14-15|0.0.1.0.2 13-14|0.0.1.0 12-13|0.0.1.0.1 10-11|0.0.1.0.0 8-9|0.0 7-8|0 6-7|0.0.0 4-5|0.0.1 3-4|0.0.1.1 2-3|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:05.081
(m2 / mark-01 
      :ARG1 (b / band 
            :ARG1-of (i / internal-02 
                  :purpose-of (c3 / carry-out-03 
                        :ARG0 (o2 / organization 
                              :name (n5 / name 
                                    :op1 "Gel" 
                                    :op2 "Pro" 
                                    :op3 "Analyzer")) 
                        :ARG1 (o / organization 
                              :name (n4 / name 
                                    :op1 "MediaCybernetics")))) 
            :ARG2-of (c4 / calibrate-01 
                  :ARG0 (a / and 
                        :op1 (s2 / such) 
                        :op2 (m / mHsp70) 
                        :op3 (n6 / Nup153) 
                        :op4 (c / country 
                              :name (n / name 
                                    :op1 "United" 
                                    :op2 "States") 
                              :wiki "United_States")) 
                  :ARG1 (b2 / band 
                        :mod (i2 / immunoblot)) 
                  :op1-of (c2 / city 
                        :name (n3 / name 
                              :op1 "San" 
                              :op2 "Diego") 
                        :wiki "San_Diego"))) 
      :ARG2 (s / state 
            :name (n2 / name 
                  :op1 "California") 
            :wiki "California"))

# ::snt For determination of ATP levels , freshly dissected and flash-frozen tissues were homogenized in 2.5 % trichloroacetic acid ( TCA ) , neutralized , and diluted to a final concentration of 0.1 % with Tris-Acetate ( pH 7.75 ) .
# ::tok For determination of ATP levels , freshly dissected and flash-frozen tissues were homogenized in 2.5 % trichloroacetic acid ( TCA ) , neutralized , and diluted to a final concentration of 0.1 % with Tris-Acetate ( pH 7.75 ) .
# ::alignments 36-37|0.1.1 34-35|0.0.0.2.3.0.0+0.0.0.2.3.0+0.0.0.2.3 32-33|0.1.2.1 31-32|0.1.2.1.0 29-30|0.1.2 28-29|0.1.2.2 25-26|0.1 24-25|0 22-23|0.0 19-20|0.1.0.0.0+0.1.0.0+0.1.0 17-18|0.1.2.0 15-16|0.0.0.2.2 14-15|0.0.0.0 10-11|0.0.0.2.1 9-10|0.0.0.2.1.0 8-9|0.0.0.2 7-8|0.0.0 6-7|0.0.0.1 4-5|0.0.0.2.0.0 3-4|0.0.0.2.0.0.0.0.0+0.0.0.2.0.0.0.0+0.0.0.2.0.0.0 1-2|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:06.089
(a / and 
      :op1 (n2 / neutralize-01 
            :ARG1 (d2 / dissect-01 
                  :ARG1 2.5 
                  :ARG1-of (f3 / fresh-04) 
                  :op1-of (a3 / and 
                        :ARG0-of (d3 / determine-01 
                              :ARG1 (l / level 
                                    :mod (o2 / organization 
                                          :name (n4 / name 
                                                :op1 "ATP")))) 
                        :op2 (t / tissue 
                              :mod (f2 / flash-frozen)) 
                        :op3 (p4 / percentage-entity) 
                        :op4 (p2 / person 
                              :name (n / name 
                                    :op1 "Tris-Acetate"))))) 
      :op2 (d / dilute-01 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "TCA")) 
            :ARG1 (p / ph) 
            :ARG2 (c / concentrate-02 
                  :ARG0 (a2 / acid) 
                  :ARG2 (p3 / percentage-entity 
                        :value 0.1) 
                  :mod (f / final))))

# ::snt ATP measurements were carried out with the ENLITEN ATP Assay System Bioluminescence Detection Kit for ATP ( Promega , Madison , Wisconsin , United States ) as per the manufacturer 's instruction in SpectraMax-M5 ( Molecular Devices , Sunnyvale , California , United States ) .
# ::tok ATP measurements were carried out with the ENLITEN ATP Assay System Bioluminescence Detection Kit for ATP ( Promega , Madison , Wisconsin , United States ) as per the manufacturer 's instruction in SpectraMax-M5 ( Molecular Devices , Sunnyvale , California , United States ) .
# ::alignments 42-44|0.2.0.1+0.2.0.0.1+0.2.0.0.0+0.2.0.0+0.2.0 40-41|0.2.1.1+0.2.1.0.0+0.2.1.0+0.2.1 38-39|0.4.0.0+0.4.0+0.4 35-37|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 33-34|0.2.2.0.0.0+0.2.2.0.0+0.2.2.0 31-32|0.2.2 29-30|0.2 23-25|0.3.1+0.3.0.1+0.3.0.0+0.3.0+0.3 21-22|0.1.3.1+0.1.3.0.0+0.1.3.0+0.1.3 19-20|0.1.2.0.0+0.1.2.0+0.1.2 17-18|0.1.1.0.0+0.1.1.0+0.1.1 7-14|0.0.0.6+0.0.0.5+0.0.0.4+0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 3-4|0 1-2|0.1 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:06.943
(c6 / carry-out-03 
      :ARG0 (o3 / organization 
            :name (n10 / name 
                  :op1 "ENLITEN" 
                  :op2 "ATP" 
                  :op3 "Assay" 
                  :op4 "System" 
                  :op5 "Bioluminescence" 
                  :op6 "Detection" 
                  :op7 "Kit") 
            :part-of (o / organization 
                  :name (n4 / name 
                        :op1 "Molecular" 
                        :op2 "Devices"))) 
      :ARG1 (m2 / measure-01 
            :ARG0 (o4 / organization 
                  :name (n11 / name 
                        :op1 "ATP")) 
            :ARG1 (o2 / organization 
                  :name (n9 / name 
                        :op1 "Promega")) 
            :ARG2 (c5 / country 
                  :name (n8 / name 
                        :op1 "Madison")) 
            :op1-of (s2 / state 
                  :name (n7 / name 
                        :op1 "Wisconsin") 
                  :wiki "Wisconsin")) 
      :ARG2-of (m / manufacture-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :ARG1 (s / state 
                  :name (n2 / name 
                        :op1 "California") 
                  :wiki "California") 
            :poss-of (i / instruction 
                  :location (c3 / country 
                        :name (n5 / name 
                              :op1 "SpectraMax-M5")))) 
      :location (c4 / country 
            :name (n6 / name 
                  :op1 "United" 
                  :op2 "States") 
            :wiki "United_States") 
      :location (c2 / country 
            :name (n3 / name 
                  :op1 "Sunnyvale")))

# ::snt Protein concentration was measured by the BCA method ( BioRad , Hercules , California , United States ) using BSA as a standard .
# ::tok Protein concentration was measured by the BCA method ( BioRad , Hercules , California , United States ) using BSA as a standard .
# ::alignments 22-23|0.2.2 19-20|0.2.1.0.0+0.2.1.0+0.2.1 18-19|0.2 15-17|0.1.3.1+0.1.3.0.1+0.1.3.0.0+0.1.3.0+0.1.3 13-14|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 11-12|0.1.2.0.0+0.1.2.0+0.1.2 9-10|0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:07.936
(m2 / measure-01 
      :ARG0 (m / method 
            :mod (o3 / organization 
                  :name (n6 / name 
                        :op1 "BCA"))) 
      :ARG1 (c3 / concentrate-02 
            :ARG0 (s2 / state 
                  :name (n3 / name 
                        :op1 "California") 
                  :wiki "California") 
            :ARG1 (p / protein) 
            :ARG2 (c2 / country 
                  :name (n4 / name 
                        :op1 "Hercules")) 
            :op1-of (c / country 
                  :name (n2 / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States")) 
      :manner (u / use-01 
            :ARG0 (o2 / organization 
                  :name (n5 / name 
                        :op1 "BioRad")) 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "BSA")) 
            :ARG2 (s / standard)))

# ::snt Metabolic assays .
# ::tok Metabolic assays .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:07.945
(a / assay 
      :mod (m / metabolic))

# ::snt Two groups of male mice were kept under separate diet since gestation or birth .
# ::tok Two groups of male mice were kept under separate diet since gestation or birth .
# ::alignments 13-14|0.0.2 12-13|0.0 11-12|0.0.0 10-11|0.0.1 9-10|0.0.1.0 8-9|0.0.1.0.0 6-7|0 4-5|0.0.1.0.1 3-4|0.0.2.0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:08.223
(k / keep-01 
      :ARG0 (o / or 
            :op1 (g / gestation) 
            :op1-of (s / since 
                  :time-of (d / diet 
                        :ARG1-of (s2 / separate-02) 
                        :location-of (m / mouse))) 
            :op2 (b / birth-01 
                  :ARG0 (m2 / male))) 
      :ARG1 (g2 / group 
            :quant 2))

# ::snt One group was fed with a normal chow diet ( PicoLab Rodent Diet 20  5053 ; LabDiet , Richmond , Indiana , United States ) , while the other was placed on a higher energy and fat diet ( PicoLab Mouse Diet 20  5058 ; LabDiet ) .
# ::tok One group was fed with a normal chow diet ( PicoLab Rodent Diet 20  5053 ; LabDiet , Richmond , Indiana , United States ) , while the other was placed on a higher energy and fat diet ( PicoLab Mouse Diet 20  5058 ; LabDiet ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:08.225
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Glucose tolerance test was performed on overnight-fasted mice injected intraperitoneally with 2 g of glucose per kg of body weight .
# ::tok Glucose tolerance test was performed on overnight-fasted mice injected intraperitoneally with 2 g of glucose per kg of body weight .
# ::alignments 19-20|0.0 18-19|0 16-17|0.0.0.0.0.0.0.0.0 14-15|0.0.0.1 12-13|0.0.0 11-12|0.0.0.2 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.1 4-5|0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:08.350
(b / body 
      :part (w / weight 
            :topic-of (g2 / g 
                  :instrument-of (i / inject-01 
                        :ARG1 (m / mouse 
                              :ARG1-of (p / perform-02 
                                    :ARG2 (t / test-01 
                                          :ARG1 (t2 / tolerate-01 
                                                :ARG1 (k / kg)) 
                                          :mod (g3 / glucose))) 
                              :mod (o / overnight-fast))) 
                  :mod (g / glucose) 
                  :quant 2)))

# ::snt Venous blood glucose values were determined at immediately before ( 0 min ) , and 15 , 30 , 60 , and 120 min after the injection with an automatic glucose monitor instrument ( One Touch Ultra , Lifescan ) .
# ::tok Venous blood glucose values were determined at immediately before ( 0 min ) , and 15 , 30 , 60 , and 120 min after the injection with an automatic glucose monitor instrument ( One Touch Ultra , Lifescan ) .
# ::alignments 38-39|0.2.1.0.0+0.2.1.0+0.2.1 35-37|0.2.2.0.1.0.1+0.2.2.0.1.0.0+0.2.2.0.1.0+0.2.2.0.1 34-35|0.2.2.0.1.1 32-33|0.2.2.0.0 31-32|0.2.2.0.0.1 30-31|0.2.2.0.0.2 29-30|0.2.2.0.0.0 26-27|0.2.2.0 24-25|0.2.2 22-23|0.2.2.0.0.1.1 21-22|0.2.0 19-20|0.2.2.0.2 17-18|0.2.2.0.0.1.0 15-16|0.2.2.1 14-15|0.2 11-12|0.2.2.0.0.1.2.0 10-11|0.2.2.0.0.1.2 8-9|0.1 7-8|0.1.0 5-6|0 3-4|0.0 2-3|0.0.0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:08.872
(d / determined-02 
      :ARG0 (v / value 
            :mod (b2 / blood 
                  :mod-of (g2 / glucose)) 
            :mod (v2 / venou)) 
      :ARG1 (b / before 
            :mod (i3 / immediate)) 
      :op1-of (a4 / and 
            :op2 (a3 / and) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "Lifescan")) 
            :time (a2 / after 
                  :op1 (i2 / inject-01 
                        :ARG0 (i / instrument 
                              :mod (a / automatic) 
                              :mod (m / monitor-01 
                                    :ARG0 30 
                                    :ARG1 120 
                                    :ARG2 (0 / 0 
                                          :quant-of (m2 / min))) 
                              :mod (g / glucose)) 
                        :ARG1 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "Touch" 
                                    :op2 "Ultra") 
                              :quant 1) 
                        :ARG2 60) 
                  :time-of 15)))

# ::snt Insulin tolerance test was performed the same way as that described for the glucose tolerance test with the exception that human insulin ( 0.75 U/kg of body mass ) was injected intraperitoneally in non-fasted mice .
# ::tok Insulin tolerance test was performed the same way as that described for the glucose tolerance test with the exception that human insulin ( 0.75 U/kg of body mass ) was injected intraperitoneally in non-fasted mice .
# ::alignments 34-35|0.1.0 33-34|0.1.0.0 30-31|0.1 27-28|0.0.0.1.0.0.0 26-27|0.0.0.1.0.0 21-22|0 20-21|0.2 18-19|0.0 15-16|0.0.0.2 14-15|0.0.0.2.0 13-14|0.0.0.2.0.0 10-11|0.0.0 9-10|0.0.0.0 7-8|0.0.0.1.1.0 6-7|0.0.0.1.1.0.0 4-5|0.0.0.1.1 2-3|0.0.0.1 1-2|0.0.0.1.0 0-1|0.0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:09.330
(i2 / insulin 
      :ARG1-of (e / except-01 
            :ARG2-of (d / describe-01 
                  :ARG0 (t3 / that) 
                  :ARG1 (t4 / test-01 
                        :ARG1 (t5 / tolerate-01 
                              :ARG1 (b / body 
                                    :mod-of (m2 / mass))) 
                        :ARG2-of (p / perform-02 
                              :ARG1 (w / way 
                                    :ARG1-of (s / same-01))) 
                        :mod (i3 / insulin)) 
                  :purpose (t / test-01 
                        :ARG1 (t2 / tolerate-01 
                              :ARG1 (g / glucose))))) 
      :ARG2-of (i / inject-01 
            :ARG1 (m / mouse 
                  :mod (n / non-fast))) 
      :mod (h / human))

# ::snt Pyruvate challenge test was performed the same way as that described for the glucose tolerance test with the exception that pyruvate dissolved in saline ( 2 g/kg of body mass ) was injected intraperitoneally in overnight-fasted mice .
# ::tok Pyruvate challenge test was performed the same way as that described for the glucose tolerance test with the exception that pyruvate dissolved in saline ( 2 g/kg of body mass ) was injected intraperitoneally in overnight-fasted mice .
# ::alignments 36-37|0.1.0 35-36|0.1.0.0 32-33|0.1 29-30|0.1.1.0.1.2.0.0.0.0 28-29|0.1.1.0.1.2.0.0.0 25-26|0.1.1.0.1.0 23-24|0.0.0 21-22|0.0 20-21|0 18-19|0.1.1 15-16|0.1.1.0.2 14-15|0.1.1.0.2.0 13-14|0.1.1.0.2.0.0 10-11|0.1.1.0 9-10|0.1.1.0.0 7-8|0.1.1.0.1.2.0 6-7|0.1.1.0.1.2.0.0 4-5|0.1.1.0.1.2 2-3|0.1.1.0.1 1-2|0.1.1.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:09.874
(p / pyruvate 
      :ARG1-of (d / dissolve-01 
            :ARG2 (s / saline)) 
      :ARG2-of (i / inject-01 
            :ARG1 (m / mouse 
                  :mod (o / overnight-fast)) 
            :ARG1-of (e / except-01 
                  :ARG2-of (d2 / describe-01 
                        :ARG0 (t3 / that) 
                        :ARG1 (t4 / test-01 
                              :ARG1 2 
                              :ARG1-of (c / challenge-01) 
                              :ARG2-of (p2 / perform-02 
                                    :ARG1 (w / way 
                                          :ARG1-of (s2 / same-01 
                                                :ARG0 (b / body 
                                                      :mod-of (m2 / mass)))))) 
                        :purpose (t / test-01 
                              :ARG1 (t2 / tolerate-01 
                                    :ARG1 (g / glucose)))))))

# ::snt Electroretinography .
# ::tok Electroretinography .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:09.877
(e / Electroretinography)

# ::snt Five ~ 6-mo-old male RanBP2 + / + and RanBP2 + /  mice in 129ola background were kept in dim cyclic light ( 10 lux ) for 2 wk before electroretinographic responses were recorded .
# ::tok Five ~ 6-mo-old male RanBP2 + / + and RanBP2 + /  mice in 129ola background were kept in dim cyclic light ( 10 lux ) for 2 wk before electroretinographic responses were recorded .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:09.878
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The mice were anesthetized intraperitoneally with ketamine ( 80 mg/kg ) and xylazine ( 4 mg/kg ) .
# ::tok The mice were anesthetized intraperitoneally with ketamine ( 80 mg/kg ) and xylazine ( 4 mg/kg ) .
# ::alignments 14-15|0.1.0 12-13|0.2.0.0 11-12|0.2.0 8-9|0.0 6-7|0.2 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:09.965
(a2 / anesthetize-01 
      :ARG0 80 
      :ARG1 (m / mouse 
            :poss-of 4) 
      :manner (k / ketamine 
            :op1-of (a / and 
                  :op2 (x / xylazine))))

# ::snt Body temperature was maintained with a heating pad at 37.5  1 C throughout the recording .
# ::tok Body temperature was maintained with a heating pad at 37.5  1 C throughout the recording .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:09.966
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The pupils were fully dilated with 0.5 % tropicamide and 2.5 % phenylephrine HCl , and both eyes were recorded simultaneously .
# ::tok The pupils were fully dilated with 0.5 % tropicamide and 2.5 % phenylephrine HCl , and both eyes were recorded simultaneously .
# ::alignments 20-21|0.2.2 19-20|0.2 17-18|0.2.1 16-17|0.2.1.0 15-16|0 13-14|0.1 12-13|0.1.0 11-12|0.2.0 10-11|0.0.0 9-10|0.0.2 7-8|0.0.3 6-7|0.0.3.0 4-5|0.0 3-4|0.0.4 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.253
(a / and 
      :op1 (d / dilate-01 
            :ARG0 2.5 
            :ARG1 (p4 / pupil) 
            :ARG2 (a2 / and) 
            :ARG3 (p3 / percentage-entity 
                  :value 0.5) 
            :manner (f / full)) 
      :op2 (h / HCl 
            :mod (p / phenylephrine)) 
      :op3 (r / record-01 
            :ARG0 (p2 / percentage-entity) 
            :ARG1 (e / eye 
                  :mod (b / both)) 
            :manner (s / simultaneous)))

# ::snt Corneal gold-wire loops were used as the active electrodes under 0.5 % proparacaine hydrochloride topical anesthesia .
# ::tok Corneal gold-wire loops were used as the active electrodes under 0.5 % proparacaine hydrochloride topical anesthesia .
# ::alignments 15-16|0.2 14-15|0.2.0 13-14|0.2.1 11-12|0.0.0 10-11|0.0.0.0 8-9|0.1 7-8|0.1.0 4-5|0 2-3|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.368
(u / use-01 
      :ARG1 (l / loop-01 
            :ARG0 (p / percentage-entity 
                  :value 0.5) 
            :ARG1 (c / corneal)) 
      :ARG2 (e / electrod 
            :ARG1-of (a2 / activity-06)) 
      :manner (a / anesthesia 
            :mod (t / topic) 
            :mod (h / hydrochloride)))

# ::snt Gold-wire electrodes placed on the sclera near the limbus served as reference electrodes .
# ::tok Gold-wire electrodes placed on the sclera near the limbus served as reference electrodes .
# ::alignments 12-13|0.1 11-12|0.1.0 9-10|0 8-9|0.0.0.0.0 6-7|0.0.0.0 5-6|0.0.0.1 2-3|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.427
(s / serve-01 
      :ARG0 (e2 / electrod 
            :ARG1-of (p / place-01 
                  :ARG1-of (n / near-02 
                        :ARG2 (l / limbu)) 
                  :ARG2 (s2 / sclera))) 
      :ARG1 (e / electrod 
            :ARG1-of (r / reference-04)))

# ::snt A ground wire was attached to the ear .
# ::tok A ground wire was attached to the ear .
# ::alignments 7-8|0.1 4-5|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.443
(a / attach-01 
      :ARG1 (w / wire-01 
            :ARG1 (g / ground)) 
      :ARG2 (e / ear))

# ::snt Scotopic responses were recorded from threshold to 9 log units of intensity above threshold , amplified , and filtered ( 5,000 gain , 0.1 -- 1,000 Hz ) .
# ::tok Scotopic responses were recorded from threshold to 9 log units of intensity above threshold , amplified , and filtered ( 5,000 gain , 0.1 -- 1,000 Hz ) .
# ::alignments 26-27|0 23-24|0.0.0.1.0.0.1 21-22|0.0 18-19|0.0.0.3 17-18|0.0.0 15-16|0.0.0.2 13-14|0.0.0.1 12-13|0.0.0.1.0 11-12|0.0.0.0 9-10|0.0.0.1.0.0.0 8-9|0.0.0.1.0.0 7-8|0.0.0.3.0 5-6|0.0.0.1.0.0.0.0.1 3-4|0.0.0.1.0.0.0.0 1-2|0.0.0.1.0.0.0.0.0.0+0.0.0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.705
(h / hz 
      :ARG1-of (g / gain-02 
            :ARG2 (a / and 
                  :location-of (i / intensity) 
                  :op1 (t / threshold 
                        :op1-of (a3 / above 
                              :location-of (l / log-01 
                                    :ARG0 (u / unit 
                                          :ARG2-of (r / record-01 
                                                :ARG1 (t3 / thing 
                                                      :ARG2-of (r2 / respond-01)) 
                                                :source (t2 / threshold))) 
                                    :ARG1 0.1))) 
                  :op2 (a2 / amplify-01) 
                  :op3 (f / filter-02 
                        :ARG1 9))))

# ::snt For photopic recordings background light at 34 cd/m2 was used to suppress rod function .
# ::tok For photopic recordings background light at 34 cd/m2 was used to suppress rod function .
# ::alignments 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1 9-10|0 6-7|0.1.2 4-5|0.1.0 3-4|0.1.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.904
(u / use-01 
      :ARG0 (r2 / recording) 
      :ARG2 (s / suppress-01 
            :ARG0 (l / light 
                  :mod (b / background)) 
            :ARG1 (f / function-01 
                  :ARG1 (r / rod)) 
            :op1-of 34))

# ::snt Western Blot Analysis of the Association of LD of RanBP2 with HKI and Cox11 across Tissues .
# ::tok Western Blot Analysis of the Association of LD of RanBP2 with HKI and Cox11 across Tissues .
# ::alignments 13-16|0.1.1.0.2+0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 12-13|0.1 11-12|0.1.0.0.0+0.1.0.0+0.1.0 5-10|0.1.0.1.0.4+0.1.0.1.0.3+0.1.0.1.0.2+0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 0-5|0.0.4+0.0.3+0.0.2+0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:10.957
(t / thing 
      :name (n4 / name 
            :op1 "Western" 
            :op2 "Blot" 
            :op3 "Analysis" 
            :op4 "of" 
            :op5 "the") 
      :op1-of (a / and 
            :op2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "HKI") 
                  :prep-with-of (o3 / organization 
                        :name (n3 / name 
                              :op1 "Association" 
                              :op2 "of" 
                              :op3 "LD" 
                              :op4 "of" 
                              :op5 "RanBP2"))) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "Cox11" 
                        :op2 "across" 
                        :op3 "Tissues"))))

# ::snt GST-JX2 ( 2.2 M ) was incubated with different tissue extracts ( ~ 2.0 mg ) and the GST-JX2 coprecipitates from seven different tissues were analyzed by Western blot with the antibodies against HKI and Cox11 .
# ::tok GST-JX2 ( 2.2 M ) was incubated with different tissue extracts ( ~ 2.0 mg ) and the GST-JX2 coprecipitates from seven different tissues were analyzed by Western blot with the antibodies against HKI and Cox11 .
# ::alignments 35-36|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 34-35|0.1.0.0 33-34|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 31-32|0.1.2 28-29|0.1.0 27-28|0.1.0.2.1+0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 25-26|0.1 23-24|0.1.0.3.1 22-23|0.1.0.3 21-22|0.1.0.3.1.0 19-20|0.1.1 16-17|0 14-15|0.1.0.1 10-11|0.0.1.1+0.0.1 9-10|0.0.1.1.0 8-9|0.0.1.0 6-7|0.0 3-4|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.1.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:11.745
(a4 / and 
      :op1 (i / incubate-01 
            :ARG0 (v / vehicle 
                  :name (n4 / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :ARG1 (t2 / thing 
                  :ARG1-of (d2 / differ-02) 
                  :ARG1-of (e / extract-01 
                        :ARG0 (t3 / tissue)))) 
      :op2 (a3 / analyze-01 
            :ARG0 (b / blot-01 
                  :ARG0 (a / and 
                        :op1 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "HKI")) 
                        :op2 (o / organization 
                              :name (n / name 
                                    :op1 "Cox11"))) 
                  :ARG1 (m / mg) 
                  :mod (w / world-region 
                        :name (n3 / name 
                              :op1 "West") 
                        :wiki "Western_world") 
                  :purpose (d / differ-02 
                        :ARG0 2.2 
                        :ARG1 (t / tissue 
                              :quant 7))) 
            :ARG1 (c / coprecipitat) 
            :ARG2 (a2 / antibodi)))

# ::snt The LD of RanBP2 associated with the HKI and Cox11 in all seven tissues tested .
# ::tok The LD of RanBP2 associated with the HKI and Cox11 in all seven tissues tested .
# ::alignments 14-15|0.2.1.0 13-14|0.2.1.0.0 12-13|0.2.1.0.0.0 11-12|0.2.2 9-10|0.2.1.1.0.0+0.2.1.1.0+0.2.1.1 8-9|0.2.1 7-8|0.2.0.0+0.2.0+0.2 4-5|0 3-4|0.1 1-2|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:11.911
(a3 / associate-01 
      :ARG0 (o3 / organization 
            :name (n3 / name 
                  :op1 "LD")) 
      :ARG1 (r / RanBP2) 
      :ARG2 (o2 / organization 
            :name (n2 / name 
                  :op1 "HKI") 
            :op1-of (a2 / and 
                  :ARG0-of (t / test-01 
                        :ARG1 (t2 / tissue 
                              :quant 7)) 
                  :op2 (o / organization 
                        :name (n / name 
                              :op1 "Cox11"))) 
            :quant (a / all)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:11.927
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Immunostaining of Radial Cryosections of Wild-Type ( + / + ) and Heterozygote ( + /  ) RanBP2 Mice Retinas with Anti-HKI and  Cox11 Antibodies .
# ::tok Immunostaining of Radial Cryosections of Wild-Type ( + / + ) and Heterozygote ( + /  ) RanBP2 Mice Retinas with Anti-HKI and  Cox11 Antibodies .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:11.929
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt A1 and B1 represent magnifications of just the distal section of the retina ( inner segment subcellular compartment of the photosensory neuron layer ) .
# ::tok A1 and B1 represent magnifications of just the distal section of the retina ( inner segment subcellular compartment of the photosensory neuron layer ) .
# ::alignments 22-23|0.1.0 21-22|0.1 20-21|0 17-18|0.1.0.0 16-17|0.1.0.0.0 15-16|0.1.0.0.0.0.0 14-15|0.1.0.0.0.0 12-13|0.0.0.0.2 9-10|0.0.0.0 8-9|0.0.0.0.1 6-7|0.0.0.0.0 4-5|0.0.1 3-4|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:12.149
(p / photosensory 
      :ARG2-of (r2 / represent-01 
            :ARG0 (a / and 
                  :op1 (s3 / section 
                        :mod (j / just) 
                        :mod (d / distal) 
                        :part-of (r / retina))) 
            :ARG1 (m / magnification)) 
      :mod-of (n / neuron 
            :mod-of (l / layer 
                  :poss-of (c / compartment 
                        :mod (s / subcellular 
                              :mod (i / inner 
                                    :mod-of (s2 / segment)))))))

# ::snt Note the partial delocalization of HKI to the myoid subcompartment of the inner segment of photoreceptor neurons in + /  mice ( B1 ) and decreased levels of HKI in the inner plexiform ( synaptic ) layer of the retina ( A and B ) .
# ::tok Note the partial delocalization of HKI to the myoid subcompartment of the inner segment of photoreceptor neurons in + /  mice ( B1 ) and decreased levels of HKI in the inner plexiform ( synaptic ) layer of the retina ( A and B ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:12.151
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt This is reflected by a significant increase and decrease of the mean fluorescence intensity ( in arbitrary units ) of HKI in the myoid and inner plexiform ( synaptic ) layers , respectively ( E ) .
# ::tok This is reflected by a significant increase and decrease of the mean fluorescence intensity ( in arbitrary units ) of HKI in the myoid and inner plexiform ( synaptic ) layers , respectively ( E ) .
# ::alignments 34-35|0.4 32-33|0.0.0.1.2.1 30-31|0.0.0.0.0 28-29|0.0.0.1.0 26-27|0.3 25-26|0.2 24-25|0 23-24|0.1 20-21|0.0.0.3.0.0+0.0.0.3.0+0.0.0.3 17-18|0.0.0.1.1.0.0 16-17|0.0.0.1.1.0 13-14|0.0.0 12-13|0.0.0.2 11-12|0.0 8-9|0.0.0.0 7-8|0.0.0.1.2 6-7|0.0.0.1 5-6|0.0.0.1.1 2-3|0.0.0.1.2.0 0-1|0.0.0.1.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:12.573
(a / and 
      :ARG2-of (m2 / mean-01 
            :ARG1 (i2 / intensity 
                  :ARG1-of (d / decrease-01 
                        :ARG0 (l / layer)) 
                  :ARG1-of (i3 / increase-01 
                        :ARG0 (s / synaptic) 
                        :ARG1-of (s2 / significant-02 
                              :purpose (a2 / arbitrary-02 
                                    :ARG1 (u / unit))) 
                        :op1-of (a3 / and 
                              :ARG0-of (r2 / reflect-01 
                                    :ARG1 (t / this)) 
                              :mod (r / respective))) 
                  :mod (f / fluorescence) 
                  :poss (o / organization 
                        :name (n / name 
                              :op1 "HKI")))) 
      :op1 (m / myoid) 
      :op2 (i / inner) 
      :op3 (p / plexiform) 
      :op4 (e / E))

# ::snt AU , arbitrary unit ; ROS , rod outer segment ; RIS , rod inner segment ; ONL , outer nuclear layer ; OPL , outer plexiform layer , INL , inner nuclear layer ; IPL , inner plexiform layer ; GCL , ganglion cell layer ; E and M are , respectively , the ellipsoid ( mitochondria-rich ) and myoid compartments of photosensory neurons .
# ::tok AU , arbitrary unit ; ROS , rod outer segment ; RIS , rod inner segment ; ONL , outer nuclear layer ; OPL , outer plexiform layer , INL , inner nuclear layer ; IPL , inner plexiform layer ; GCL , ganglion cell layer ; E and M are , respectively , the ellipsoid ( mitochondria-rich ) and myoid compartments of photosensory neurons .
# ::alignments 64-65|0.7.1.2.1 61-62|0.7.1.2 60-61|0.7.1.2.0 59-60|0.7.1 55-56|0.0 52-53|0.7.1.0 49-50|0.7.2+0.7.0.0+0.7.0+0.7 48-49|0 47-48|0.6 45-46|0.1 44-45|0.1.0 43-44|0.1.0.0 41-42|0.7.1.2.1.0.0.0+0.7.1.2.1.0.0+0.7.1.2.1.0 39-40|0.7.1.2.0.0.0 37-38|0.7.1.2.0.0 35-36|0.7.1.3.1.0.1.0.0+0.7.1.3.1.0.1.0+0.7.1.3.1.0.1 33-34|0.7.1.2.0.1.0 32-33|0.7.1.2.0.1 31-32|0.7.1.2.0.1.0.0 29-30|0.7.1.1.0.0+0.7.1.1.0+0.7.1.1 27-28|0.2.0 26-27|0.2 25-26|0.2.0.0 21-22|0.3.0 20-21|0.3 19-20|0.3.0.0 15-16|0.4.0 14-15|0.4 13-14|0.4.0.0 11-12|0.7.1.3.2 9-10|0.5.0 8-9|0.5 7-8|0.5.0.0 5-6|0.7.1.3.1 4-5|0.7.1.3 3-4|0.7.1.3.1.0.0 2-3|0.7.1.3.1.0 0-1|0.7.1.3.0.0.0+0.7.1.3.0.0+0.7.1.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:13.503
(a2 / and 
      :domain-of (e / ellipsoid) 
      :example-of (l / layer 
            :mod (c2 / cell 
                  :mod (g / ganglion))) 
      :mod (p / plexiform 
            :mod-of (l4 / layer 
                  :mod (o4 / outer))) 
      :mod (n7 / nucleus 
            :mod-of (l5 / layer 
                  :mod (o5 / outer))) 
      :mod (i3 / inner 
            :domain (s / segment 
                  :mod (r2 / rod))) 
      :mod-of (o6 / outer 
            :domain (s2 / segment 
                  :mod (r4 / rod))) 
      :op1 (e2 / E) 
      :op2 (v / vehicle 
            :name (n2 / name 
                  :op1 "M1") 
            :op2-of (a / and 
                  :mod (r / respective) 
                  :op1 (o3 / organization 
                        :name (n6 / name 
                              :op1 "INL")) 
                  :op3 (c / compartment 
                        :mod (m / myoid 
                              :mod (i / inner 
                                    :mod-of (l2 / layer)) 
                              :mod (n5 / nucleus 
                                    :mod-of (l3 / layer 
                                          :mod (i2 / inner)))) 
                        :mod (n / neuron 
                              :mod (o / organization 
                                    :name (n3 / name 
                                          :op1 "GCL")))) 
                  :op4-of (a3 / and 
                        :op1 (c3 / country 
                              :name (n8 / name 
                                    :op1 "AU")) 
                        :op2 (r5 / ro 
                              :ARG2-of (a4 / arbitrary-02 
                                    :ARG0 (u / unit) 
                                    :ARG1 (o2 / organization 
                                          :name (n4 / name 
                                                :op1 "IPL")))) 
                        :op3 (r3 / ri))) 
            :wiki "M1_Abrams"))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:13.519
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Metabolic Phenotype of RanBP2 + /  Mice in a Mixed Background and High-Fat Diet .
# ::tok Metabolic Phenotype of RanBP2 + /  Mice in a Mixed Background and High-Fat Diet .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:13.520
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt There was no difference in the glucose tolerance test between RanBP2 + / + and RanBP2 + /  mice on a mixed 129Ola/C57Bl6 genetic background ( C ) .
# ::tok There was no difference in the glucose tolerance test between RanBP2 + / + and RanBP2 + /  mice on a mixed 129Ola/C57Bl6 genetic background ( C ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:13.524
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:13.544
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt We thank John Wilson for purified HKI , antibodies against HKI , HKII , HKIII , and glucokinase , and support ; Arthur Haas for help with kinetic analysis of HKI ; and William Skarnes for helpful suggestions with the analysis of ES insertion trap lines .
# ::tok We thank John Wilson for purified HKI , antibodies against HKI , HKII , HKIII , and glucokinase , and support ; Arthur Haas for help with kinetic analysis of HKI ; and William Skarnes for helpful suggestions with the analysis of ES insertion trap lines .
# ::alignments 45-46|0.0.0.1.1.2.0.0 44-45|0.0.0.1.1.2.0.0.0 43-44|0.0.0.1.1.2.0.0.0.0 42-43|0.0.0.1.1.2.0.0.0.0.0 40-41|0.0.0.1.1.2.0 37-38|0.0.0.1.1.2.0.1+0.0.0.1.1.2.0.1.0 36-37|0.0.0.1.1.2.0.1.0.0 33-35|0.0.0.1.1.2.1.1+0.0.0.1.1.2.1.0+0.0.0.1.1.2.1+0.0.0.1.1.2 32-33|0.0.0.1.1 28-29|0.0.0.1.1.1.0 27-28|0.0.0.1.1.1.0.1 25-26|0.0.0.1.1.1.0.0 22-24|0.0.0.1.1.1.1.1+0.0.0.1.1.1.1.0+0.0.0.1.1.1.1+0.0.0.1.1.1 21-22|0.0.0.1.1.0 20-21|0.0.5 19-20|0.0 16-17|0 14-15|0.0.4.0.0+0.0.4.0+0.0.4 12-13|0.0.3.0.0+0.0.3.0+0.0.3 8-9|0.0.2 5-7|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 2-4|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:14.922
(a6 / and 
      :op1 (a5 / and 
            :ARG3-of (t4 / thank-01 
                  :ARG0 (w / we) 
                  :ARG1 (p4 / person 
                        :name (n6 / name 
                              :op1 "John" 
                              :op2 "Wilson") 
                        :op1-of (a2 / and 
                              :op2 (a4 / and) 
                              :op3 (p2 / person 
                                    :ARG0-of (a3 / analyze-01 
                                          :ARG2-of (h2 / help-01) 
                                          :manner (k / kinetic)) 
                                    :name (n2 / name 
                                          :op1 "Arthur" 
                                          :op2 "Haas")) 
                              :op4 (p / person 
                                    :ARG0-of (a / analyze-01 
                                          :ARG1 (l / line 
                                                :ARG0-of (t / trap-01 
                                                      :ARG1 (i / insert-01 
                                                            :ARG1 (e / e)))) 
                                          :ARG2-of (s / suggest-01 
                                                :ARG1 (t2 / thing 
                                                      :ARG1-of (h / helpful-04)))) 
                                    :name (n / name 
                                          :op1 "William" 
                                          :op2 "Skarnes"))))) 
            :op1 (t3 / thing 
                  :name (n5 / name 
                        :op1 (p3 / purified) 
                        :op2 (h3 / HKI))) 
            :op2 (a7 / antibodi) 
            :op3 (o2 / organization 
                  :name (n4 / name 
                        :op1 "HKII")) 
            :op4 (o / organization 
                  :name (n3 / name 
                        :op1 "HKIII")) 
            :op5 (s2 / support-01)))

# ::snt CLD - cyclophilin-like domain .
# ::tok CLD - cyclophilin-like domain .
# ::alignments 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:14.927
(d / domain)

# ::snt CNS - central nervous system .
# ::tok CNS - central nervous system .
# ::alignments 4-5|0 3-4|0.0 2-3|0.2 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:14.945
(s / system 
      :ARG1-of (n / nervous-01) 
      :consist (o / organization 
            :name (n2 / name 
                  :op1 "CNS")) 
      :mod (c / central))

# ::snt HKI - hexokinase type I. LD - leucine-rich domain .
# ::tok HKI - hexokinase type I. LD - leucine-rich domain .
# ::alignments 8-9|0 4-6|0.0.1.1+0.0.1.0+0.0.1+0.0 3-4|0.0.0 2-3|0.0.0.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:14.974
(d / domain 
      :mod-of (p / person 
            :mod (t / type 
                  :mod (h / hexokinase 
                        :mod (o / organization 
                              :name (n2 / name 
                                    :op1 "HKI")))) 
            :name (n / name 
                  :op1 "I." 
                  :op2 "LD")))

# ::snt NPC - nuclear pore complex .
# ::tok NPC - nuclear pore complex .
# ::alignments 4-5|0 3-4|0.0 2-3|0.1 0-1|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:14.996
(c / complex 
      :ARG1-of (p / pore-01 
            :ARG0 (g / government-organization 
                  :name (n2 / name 
                        :op1 "NPC") 
                  :wiki "National_People's_Congress")) 
      :mod (n / nucleus))

# ::snt RanBP2 - Ran-binding protein 2 .
# ::tok RanBP2 - Ran-binding protein 2 .
# ::alignments 4-5|0.1 3-4|0 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.010
(p / protein 
      :mod (r / ran-bind 
            :degree (r2 / RanBP2)) 
      :mod 2)

# ::snt $ Current address : Fugent LLC , Madison , Wisconsin , United States of America .
# ::tok $ Current address : Fugent LLC , Madison , Wisconsin , United States of America .
# ::alignments 11-15|0.0.0.0.3+0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.0.0.1.1.1+0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 7-8|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 4-6|0.0.1.1+0.0.1.0+0.0.1+0.0 2-3|0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.069
(a / address 
      :mod-of (o / organization 
            :location (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States" 
                        :op3 "of" 
                        :op4 "America") 
                  :op3-of (c3 / current 
                        :op1 (c2 / country 
                              :name (n3 / name 
                                    :op1 "Madison")) 
                        :op2 (s / state 
                              :name (n2 / name 
                                    :op1 "Wisconsin") 
                              :wiki "Wisconsin"))) 
            :name (n4 / name 
                  :op1 "Fugent" 
                  :op2 "LLC")))

# ::snt Competing interests .
# ::tok Competing interests .
# ::alignments 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.077
(c / compete-01 
      :topic-of (i / interest))

# ::snt The authors have declared that no competing interests exist .
# ::tok The authors have declared that no competing interests exist .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.121
(d / declare-01 
      :ARG0 (a / author-01) 
      :ARG1 (e / exist-01 
            :ARG1 (i / interest 
                  :ARG1-of (c / compete-02)) 
            :polarity -))

# ::snt A previous version of this article appeared as an Early Online Release on September 1 , 2006 ( DOI : 10.1371 / journal.pgen .0020177 .
# ::tok A previous version of this article appeared as an Early Online Release on September 1 , 2006 ( DOI : 10.1371 / journal.pgen .0020177 .
# ::alignments 21-22|0.2.0 20-21|0.2.3.2+0.2.3.1+0.2.3.0+0.2.3 18-19|0.0 13-17|0.3.2+0.3.1+0.3.0+0.3 11-12|0.2 10-11|0.2.2 9-10|0.2.1 6-7|0 5-6|0.1 4-5|0.1.0 2-3|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.547
(a / appear-01 
      :ARG0 (d2 / doi) 
      :ARG1 (a2 / article 
            :mod (t / this) 
            :mod (v / version 
                  :time (p / previous))) 
      :prep-as (r / release-01 
            :ARG0 (s / slash) 
            :ARG1 (e / early) 
            :mod (o / online) 
            :time (d / date-entity 
                  :day 71 
                  :month 13 
                  :year 10)) 
      :time (d3 / date-entity 
            :day 1 
            :month 9 
            :year 2006))

# ::snt eor ) .
# ::tok eor ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.550
(a / amr-empty)

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.555
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt AA , RB , MG , DR , RAB , and PAF conceived and designed the experiments .
# ::tok AA , RB , MG , DR , RAB , and PAF conceived and designed the experiments .
# ::alignments 16-17|0.5.0 14-15|0.5 13-14|0 12-13|0.5.1.0 11-12|0.4.0.0+0.4.0+0.4 10-11|0.5.1 8-9|0.3.0.0+0.3.0+0.3 4-5|0.2 2-3|0.1 0-1|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.672
(a / and 
      :op1 (n3 / name 
            :op1 "AA") 
      :op2 (r / rb) 
      :op3 (m / mg) 
      :op4 (o2 / organization 
            :name (n2 / name 
                  :op1 "RAB")) 
      :op5 (o / organization 
            :name (n / name 
                  :op1 "PAF")) 
      :op6 (d / design-01 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt AA , RB , MG , JO , DR , XL , and CBB performed the experiments .
# ::tok AA , RB , MG , JO , DR , XL , and CBB performed the experiments .
# ::alignments 16-17|0.0.0 14-15|0.0 13-14|0.5.0.0+0.5.0+0.5 12-13|0 10-11|0.4 6-7|0.3.0.0+0.3.0+0.3 4-5|0.2 2-3|0.1 0-1|0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.727
(a / and 
      :ARG0-of (p / perform-02 
            :ARG1 (e / experiment-01 
                  :ARG1 (n3 / name 
                        :op1 "AA"))) 
      :op1 (r / rb) 
      :op2 (m / mg) 
      :op3 (p2 / person 
            :name (n2 / name 
                  :op1 "JO")) 
      :op4 (x / xl) 
      :op5 (o / organization 
            :name (n / name 
                  :op1 "CBB")))

# ::snt AA , RB , MG , JO , DR , RAB , PAS , and PAF analyzed the data .
# ::tok AA , RB , MG , JO , DR , RAB , PAS , and PAF analyzed the data .
# ::alignments 18-19|0.1 16-17|0 15-16|0.0.6.0.0+0.0.6.0+0.0.6 14-15|0.0 12-13|0.0.5.0.0+0.0.5.0+0.0.5 10-11|0.0.4.0.0+0.0.4.0+0.0.4 6-7|0.0.3.0.0+0.0.3.0+0.0.3 4-5|0.0.2 2-3|0.0.1 0-1|0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.813
(a / analyze-01 
      :ARG0 (a2 / and 
            :destination-of (n5 / name 
                  :op1 "AA") 
            :op1 (r / rb) 
            :op2 (m / mg) 
            :op3 (p / person 
                  :name (n4 / name 
                        :op1 "JO")) 
            :op4 (o3 / organization 
                  :name (n3 / name 
                        :op1 "RAB")) 
            :op5 (o2 / organization 
                  :name (n2 / name 
                        :op1 "PAS")) 
            :op6 (o / organization 
                  :name (n / name 
                        :op1 "PAF"))) 
      :ARG1 (d / data))

# ::snt PAF contributed reagents/materials/analysis tools .
# ::tok PAF contributed reagents/materials/analysis tools .
# ::alignments 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.827
(c / contribute-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "PAF")) 
      :ARG1 (t / tool 
            :purpose (r / reagents/materials/analysi)))

# ::snt PAF wrote the paper .
# ::tok PAF wrote the paper .
# ::alignments 3-4|0.1 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.842
(w / write-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "PAF")) 
      :ARG1 (p / paper))

# ::snt Funding .
# ::tok Funding .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:15.845
(f / fund-01)

# ::snt Work supported by The National Institutes of Health EY11993/EY012665 to PAF and The National Institutes of Health 2P30-EY005722 -- 21 .
# ::tok Work supported by The National Institutes of Health EY11993/EY012665 to PAF and The National Institutes of Health 2P30-EY005722 -- 21 .
# ::alignments 19-20|0.1.0 12-19|0.2.1.0.6+0.2.1.0.5+0.2.1.0.4+0.2.1.0.3+0.2.1.0.2+0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 11-12|0.2 10-11|0.2.0.0.0+0.2.0.0+0.2.0 4-9|0.0.0.4+0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:16.074
(s / support-01 
      :ARG0 (o3 / organization 
            :name (n3 / name 
                  :op1 "National" 
                  :op2 "Institutes" 
                  :op3 "of" 
                  :op4 "Health" 
                  :op5 "EY11993/EY012665")) 
      :ARG1 (w / work-01 
            :ARG1 21) 
      :op1-of (a / and 
            :op2 (o2 / organization 
                  :name (n2 / name 
                        :op1 "PAF")) 
            :op3 (o / organization 
                  :name (n / name 
                        :op1 "The" 
                        :op2 "National" 
                        :op3 "Institutes" 
                        :op4 "of" 
                        :op5 "Health" 
                        :op6 "2P30-EY005722" 
                        :op7 "--"))))

# ::snt PAF is the Jules and Doris Stein Research to Prevent Blindness Professor .
# ::tok PAF is the Jules and Doris Stein Research to Prevent Blindness Professor .
# ::alignments 11-12|0.0.0.1+0.0.0 9-11|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 5-8|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 4-5|0 3-4|0.0.2.0+0.0.2+0.0 0-1|0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T05:18:16.141
(a / and 
      :op1 (p4 / person 
            :ARG0-of (h / have-org-role-91 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (p2 / Prevent) 
                              :op2 (b / Blindness))) 
                  :ARG2 (p / professor)) 
            :domain (o / organization 
                  :name (n4 / name 
                        :op1 "PAF")) 
            :name (n3 / name 
                  :op1 "Jules")) 
      :op2 (p3 / person 
            :name (n2 / name 
                  :op1 "Doris" 
                  :op2 "Stein" 
                  :op3 "Research")))

